[{"card":{"key":"249e4b5c-674f-456b-a2e7-0f27466cd5e4","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2024","description":"","img":{"alt":"cell and gene therapy dna strand","src":"-/media/assets/amerisourcebergen/manufacturer/cgt---dna-strand.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/thinklive-cgt-recap","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"ThinkLive Cell and Gene Therapy Summit 2024"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638600382600000000,"title":"thinklive cell and gene therapy summit 2024"},{"card":{"key":"b5f7bb71-be10-4966-975c-64565f8ff278","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2020","description":"AmerisourceBergen’s response to the COVID-19 pandemic: manufacturer questions answered.","img":{"alt":"COVID-19_masks-handsanitizer","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/covid-19_masks-handsanitizer.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-the-pharma-supply-chain-is-responding-to-covid-19","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How the Pharma Supply Chain is Responding to COVID-19"},"categories":["covid-19","distribution","secure supply chain"],"segments":["manufacturers"],"timestamp":637214420920000000,"title":"how the pharma supply chain is responding to covid-19"},{"card":{"key":"08aa9a5f-0960-42b6-aa21-f7c6fbda4b2e","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"Navigating the complexities of the changing medical device landscape in Canada can be challenging. ","img":{"alt":"Shot of a young businesswoman using a digital tablet and laptop while working in her home office","src":"-/media/assets/innomarstrategies/insights/med-device-webinar-banner.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/webinar-on-demand---a-panel-discussion-on-navigating-medical-devices-in-canada","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Webinar on-demand - A Panel Discussion on Navigating Medical Devices in Canada"},"categories":["commercialization","market access","product access","regulatory"],"segments":[],"timestamp":638554546200000000,"title":"webinar on-demand - a panel discussion on navigating medical devices in canada"},{"card":{"key":"fd624898-5fd5-4461-9ad2-abe1ce08f60b","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2019","description":"We asked 100 physicians to share their perspectives on biosimilar utilization, cost savings, and adoption barriers. See what they said and what it means for the market and manufacturers.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilar-adoption-in-the-united-states","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Biosimilars Check Up: Part 2"},"categories":["biosimilars"],"segments":["manufacturers"],"timestamp":637131403800000000,"title":"biosimilars check up: part 2"},{"card":{"key":"b34ae610-8989-4c33-932f-70def0f0071f","authorName":"Myra Reinhardt","authorCompany":"Biopharma Services","date":"March 2020","description":"Executive Q&A: Myra Reinhardt, Lash Group's Vice President of Product Innovation and Analytics, discusses why it's critical for even the most high-tech patient support providers to keep patients at the center of everything they do.","img":{"alt":"lightbulb w patient DNA strand","src":"-/media/assets/amerisourcebergen/tecnhology/technology/lighbulb_dna.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/a-patient-centric-approach-to-technology-and-analytics","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"A Patient-Centric Approach to Technology and Analytics"},"categories":["affordability","commercialization","medication adherence","patient support services","product access","technology","data","analytics"],"segments":["manufacturers"],"timestamp":637201472350000000,"title":"a patient-centric approach to technology and analytics"},{"card":{"key":"a214f039-0fe1-4314-a81e-f91b55762643","authorName":"Lash Group","authorCompany":null,"date":"January 2020","description":"Lash Group measured the impact of an adherence program on multiple myeloma patients. See the difference nurse navigators made on therapy adherence.","img":{"alt":"PageDesign_Infusion","src":"-/media/assets/lash/images/pagedesign_infusion.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/case-study-real-world-benefits-of-an-oncology-navigation-program","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case study: real-world benefits of an oncology navigation program"},"categories":["commercialization","engagement","patient support services","medication adherence"],"segments":["manufacturers"],"timestamp":637157439930000000,"title":"case study: real-world benefits of an oncology navigation program"},{"card":{"key":"12687964-8515-46e9-8be3-e8ee824664c0","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2021","description":"Biosimilars have made great strides since the first US launch, but there still appears to be room for growth in their uptake. Download these slides to learn more about how payer decision-making is affecting overall adoption of biosimilars, cost reduction and ultimately impact on patients.
","img":{"alt":"Market access professionals","src":"-/media/assets/xcenda/english/images/solutions/marketaccessleaders.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/webinar-uptake-or-heartbreak-with-biosimilars-progress-and-perspectives","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: uptake or heartbreak with biosimilars? Progress and perspectives"},"categories":["biosimilars","reimbursement","market access"],"segments":["manufacturers"],"timestamp":637497760150000000,"title":"webinar: uptake or heartbreak with biosimilars? progress and perspectives"},{"card":{"key":"77c0e470-59fa-4097-8511-b3f898aa5156","authorName":"Xcenda","authorCompany":null,"date":"March 2022","description":"","img":{"alt":"Debunking PIE misperceptions","src":"-/media/assets/xcenda/english/images/insights/debunking-pie-misperceptions.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/debunking-common-pie-misperceptions-webinar","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Webinar: Debunking common PIE misperceptions to enhance your PIE strategy and tactics"},"categories":["regulatory","market access","policy","product access"],"segments":[],"timestamp":637836457980000000,"title":"webinar: debunking common pie misperceptions to enhance your pie strategy and tactics"},{"card":{"key":"b3a857a3-8006-4988-b7eb-a6ac8c6c41b8","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2022","description":"","img":{"alt":"Cell and gene therapy Alternate payer engagement models","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/alternate-payer-engagement-models.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/alternate-payer-engagement-models-are-changing-the-landscape","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Alternate payer engagement models are changing the landscape"},"categories":["cell and gene therapy","commercialization","innovation","value-based care"],"segments":["manufacturers"],"timestamp":637950527700000000,"title":"alternate payer engagement models are changing the landscape"},{"card":{"key":"84636f6c-7e87-4af5-b56f-a64b64a18b24","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2022","description":"","img":{"alt":"Channel strategy for a rare disease product","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/channel-strategy-for-a-rare-disease-product.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/what-to-consider-when-building-a-channel-strategy-for-a-rare-disease-product","linkText":"Download checklist","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"What to consider when building a channel strategy for a rare disease product"},"categories":["commercial supply chain","commercialization","distribution","orphan drugs"],"segments":["manufacturers"],"timestamp":637958312630000000,"title":"what to consider when building a channel strategy for a rare disease product"},{"card":{"key":"88d3dc3c-43a4-4436-8387-a5a40e89f3c5","authorName":"Amanda OHora","authorCompany":"","date":"July 2022","description":"Cell and gene-based therapies (CGTs) have captured our imagination for their potential to cure disease after a single course of therapy but have also raised eyebrows for their astronomical price tags.","img":{"alt":"Business meeting","src":"-/media/assets/gnp/images/01-home-page-new-images/home-page-service-images/business-meeting.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/navigating-reimbursement-and-access-challenges-for-novel-cell-and-gene-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Navigating reimbursement and access challenges for novel cell and gene therapies"},"categories":["cell and gene therapy","reimbursement"],"segments":["manufacturers"],"timestamp":637934028190000000,"title":"navigating reimbursement and access challenges for novel cell and gene therapies"},{"card":{"key":"ae71ee5f-c479-4298-95ee-10af638ebbbc","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"July 2024","description":"","img":{"alt":"cgt","src":"-/media/assets/worldcourier/english/images/article-images/exploring-the-landscape-modalities-and-logistics-of-cell-and-gene-therapies.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/overcoming-challenges-and-optimizing-logistics-for-cgts","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Navigating the supply chain maze: Overcoming challenges and optimizing logistics for CGTs"},"categories":["cell and gene therapy","secure supply chain"],"segments":["manufacturers"],"timestamp":638554582770000000,"title":"navigating the supply chain maze: overcoming challenges and optimizing logistics for cgts"},{"card":{"key":"21aef89d-23f7-4cff-8797-91359a844b30","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2024","description":"","img":{"alt":"Abstract","src":"-/media/assets/amerisourcebergen/gettyimages-1356933529-rt-rgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/access-usa-2024-digital-investments-session-download","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Prioritizing Digital Investments in Your Patient Assistance Model"},"categories":["patient care","patient support services","technology"],"segments":["manufacturers"],"timestamp":638471679600000000,"title":"prioritizing digital investments in your patient assistance model"},{"card":{"key":"0ebdf337-fe9c-4207-bd27-d2bce915be91","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2023","description":"","img":{"alt":"Cell and gene therapy insights ","src":"-/media/assets/amerisourcebergen/manufacturer/cell-and-gene-therapy-market-services.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/streamlining-patient-access-to-cell-and-gene-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Streamlining Patient Access to Cell and Gene Therapies"},"categories":["cell and gene therapy","market access","patient support services","patient care"],"segments":["manufacturers"],"timestamp":638387042470000000,"title":"streamlining patient access to cell and gene therapies"},{"card":{"key":"d6510267-35cc-45a4-82ce-ca7967547fb5","authorName":"Rich Tremonte","authorCompany":"AmerisourceBergen","date":"August 2017","description":"Rich Tremonte on the current healthcare landscape, the role of the wholesaler and how the new organizational structure at AmerisourceBergen brings out the best in both.
","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/improving-customer-experience-and-driving-long-term-value-for-manufacturers","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Improving Customer Experience and Driving Long-Term Value for Manufacturers"},"categories":["biosimilars","distribution"],"segments":["manufacturers"],"timestamp":636384237600000000,"title":"improving customer experience and driving long-term value for manufacturers"},{"card":{"key":"63f75c3f-5031-4632-98ee-d826251b2f02","authorName":"Xcenda","authorCompany":null,"date":"February 2021","description":"Melissa Muchahey, Vice President of Field Services Business Development and Strategy at Xcenda, discusses how field services teams have been able to innovate and adapt to the challenges of COVID-19.","img":{"alt":"woman with mask at computer","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/woman-with-mask-at-computer.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/launching-field-services-in-the-midst-of-covid-19","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Launching field services in the midst of COVID-19"},"categories":["commercialization","reimbursement","product access","covid-19","patient support services"],"segments":["manufacturers"],"timestamp":637479766110000000,"title":"launching field services in the midst of covid-19"},{"card":{"key":"d5989732-51e5-4f15-8b32-418db1a88036","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2022","description":"","img":{"alt":"policy impacts on pharma","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/policy-impacts-on-pharma.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/policy-and-its-impact-on-the-pharmaceutical-industry","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Roundtable: Policy and its impact on the pharmaceutical industry"},"categories":["advocacy","affordability","legislation","our role in healthcare","policy"],"segments":["manufacturers"],"timestamp":637921067360000000,"title":"roundtable: policy and its impact on the pharmaceutical industry"},{"card":{"key":"212eda66-091f-4a43-a218-1236dcc610a9","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2023","description":"","img":{"alt":"Autologous cell and gene therapies","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/clinical-to-commercial-transition-for-autologous-therapies.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/industry-led-product-development-in-a-rapidly-changing-cgt-landscape","linkText":"Listen now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Podcast: Industry led product development in a rapidly changing CGT landscape"},"categories":["cell and gene therapy","commercialization","innovation"],"segments":["manufacturers"],"timestamp":638264920550000000,"title":"podcast: industry led product development in a rapidly changing cgt landscape"},{"card":{"key":"7e10a44a-fff9-408f-8dbd-a91798072e37","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2022","description":"The right global market access partner will move beyond talk and into action. They will work with you not just to develop a strategy, but also to share ideas on how to activate it.","img":{"alt":"GettyImages-1175219989","src":"-/media/assets/gettyimages-1175219989.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/three-questions-to-ask-about-your-market-access-partner","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Three questions to ask about your market access partner "},"categories":["market access"],"segments":["manufacturers"],"timestamp":638054307600000000,"title":"three questions to ask about your market access partner "},{"card":{"key":"c18c730e-2076-43ad-b58c-5f62e4e87608","authorName":"Xcenda","authorCompany":null,"date":"September 2020","description":"What information do payers want from pharma? How can manufacturers deliver it in today's virtual world?","img":{"alt":"PIE","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pie.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/is-your-pie-incomplete","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Is your PIE incomplete?"},"categories":["commercialization","data","market access"],"segments":["manufacturers"],"timestamp":637358705760000000,"title":"is your pie incomplete?"},{"card":{"key":"af08bf50-d11b-464d-b2cc-743422c074f8","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2019","description":"Executive Q&A: How shifting coverage for some drugs from Medicare Part B to Part D could impact access and affordability for patients.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/moving-medicare-coverage","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Moving Medicare Coverage"},"categories":["affordability","advocacy","legislation","policy","product access"],"segments":["manufacturers","physician practices"],"timestamp":636857686750000000,"title":"moving medicare coverage"},{"card":{"key":"38ea9c10-30f8-4f16-ac4f-f709e2544e19","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2024","description":"In this special themed edition, our colleagues at Vintura, a Cencora company, explore the potential of value-based partnerships (VBPs). First outlining the principles, goals and potential benefits of VBPs, this edition also provides two case studies that demonstrate how successful partnerships work in practice.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/hta-quarterly-fall-2024-summary","linkText":"Read more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"HTA Quarterly Fall 2024"},"categories":["consulting","policy","regulatory"],"segments":["manufacturers"],"timestamp":638603859000000000,"title":"hta quarterly fall 2024"},{"card":{"key":"6d0c1e19-a7e7-435a-b23a-3371f1bfe39a","authorName":"HTA Quarterly","authorCompany":"","date":"May 2022","description":"Whilst Orphan diseases individually are rare, collectively they are not; population prevalence of rare diseases is put at 5% to 10%. Whilst developers look for high prices to cover their costs, can payers afford them? A review of the “lock” system in the Netherlands suggests maybe not.","img":{"alt":"Panama Canal Orphan Drug Lock Article Image","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-lock.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-summer-2022-orphan-drugs-trapped-in-the-lock","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Orphan drugs: trapped in the lock? A review of the lock system in the Netherlands"},"categories":["market access","orphan drugs"],"segments":[],"timestamp":637883097600000000,"title":"orphan drugs: trapped in the lock? a review of the lock system in the netherlands"},{"card":{"key":"44a821c2-4cbc-4b08-8aec-8d78db8d3ccb","authorName":"AmerisourceBergen","authorCompany":"","date":"May 2023","description":"","img":{"alt":"Pharma 2023 - 3","src":"-/media/assets/amerisourcebergen/pharma-2023--stage-picture-2.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-evolution-of-the-cell-and-gene-therapy-field","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Q&A: The evolution of the cell and gene therapy field"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638191748050000000,"title":"q&a: the evolution of the cell and gene therapy field"},{"card":{"key":"cd124e49-72fe-47de-812b-a3a3af2b7dda","authorName":"Joanna Ng","authorCompany":"Cencora","date":"July 2024","description":"","img":{"alt":"","src":"-/media/assets/alvana-maliqi/joanna_professional-headshot.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/4-questions-with-joanna-ng","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"4 questions with Joanna Ng"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638557821600000000,"title":"4 questions with joanna ng"},{"card":{"key":"581c238c-c2dc-4148-bfd9-d46bce5aef7e","authorName":"Ana Stojanovska; Myra Reinhardt","authorCompany":"Biopharma Services","date":"July 2021","description":"In this Q&A with experts from Xcenda and Lash Group, learn the latest on reimbursement and patient support for innovative cell and gene therapies.","img":{"alt":"abstract-brand-colors-texture","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/abstract-brand-colors-texture.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/what-manufacturers-need-to-know-about-reimbursement-and-patient-support-for-cell-and-gene-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"What manufacturers need to know about reimbursement and patient support for cell and gene therapies"},"categories":["cell and gene therapy","commercialization","patient support services","reimbursement"],"segments":["manufacturers"],"timestamp":637617994870000000,"title":"what manufacturers need to know about reimbursement and patient support for cell and gene therapies"},{"card":{"key":"314d7ecd-8cd3-4fb3-b0a1-56edffd6c487","authorName":"Ben Penley","authorCompany":"Cencora","date":"June 2024","description":"","img":{"alt":"headshot","src":"-/media/assets/amerisourcebergen/ben-penley-hr.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/decoding-payer-perspectives","linkText":"Discover now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Decoding payer perspectives: Insights from Ben Penley"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638544945000000000,"title":"decoding payer perspectives: insights from ben penley"},{"card":{"key":"ff1744b5-6e8a-49d6-a8b1-af86b19994b6","authorName":"Xcenda","authorCompany":null,"date":"November 2020","description":"An advocate working on behalf of oral and infusion specialty therapies, Ashley helps cancer patients start and stay on lifesaving medications.","img":{"alt":"Doctor talking to patient","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/doctor-talking-to-patient.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharma-in-the-field-ashley","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pharma in the field: Ashley's story"},"categories":["affordability","commercialization","market access","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637405442760000000,"title":"pharma in the field: ashley's story"},{"card":{"key":"8c9668bc-4882-4980-8047-ba9825212a35","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2019","description":"Executive Q&A: The market trends and technology solutions impacting medication adherence today.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-tech-enabled-solutions-impact-adherence","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"How Tech-Enabled Solutions Impact Adherence"},"categories":["medication adherence","patient support services","commercialization"],"segments":["manufacturers"],"timestamp":636924958740000000,"title":"how tech-enabled solutions impact adherence"},{"card":{"key":"b6a4e356-3d36-4403-ae06-f674c14e2d33","authorName":"Corey Ford, MHA","authorCompany":"","date":"March 2019","description":"Over the past two years, pharmacy benefit managers (PBMs) and commercial health plans have launched copay accumulator adjustment programs, an insurance design with potential adverse impacts on patients’ adherence to prescribed therapy regimens. Copay accumulator adjustment programs exclude the use of manufacturer-sponsored commercial copay assistance from a patient’s accrual of out-of-pocket (OOP) expenses throughout a plan benefit year. In this issue brief, Xcenda and the Lash Group explore recent trends around copay accumulators, the impact on patients, and solutions for consideration.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rolling-back-the-tide-consultative-approach-tackle-expansion-of-copay-accumulators","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"Managing the Growing Expansion of Copay Accumulators"},"categories":["affordability","commercialization","legislation","patient support services","policy","reimbursement"],"segments":["manufacturers"],"timestamp":636874103300000000,"title":"managing the growing expansion of copay accumulators"},{"card":{"key":"0f827788-0bf9-4684-8f49-53246609c3e9","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2023","description":"What makes a good commercialization partner? How do you find the right match? A checklist for manufacturers, starting with pre-launch needs.","img":{"alt":"AB-Lab and Science-Female_RGB_Large_JPG","src":"-/media/assets/amerisourcebergen/insights/ab-lab-and-science-female_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pre-launch-check-list","linkText":"See checklist","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pre-launch checklist: What to look for in a commercialization partner"},"categories":["commercialization","innovation","market access","medication adherence","patient support services","reimbursement"],"segments":["manufacturers"],"timestamp":638224539600000000,"title":"pre-launch checklist: what to look for in a commercialization partner"},{"card":{"key":"9afae7d0-6b3c-4163-8608-53fa5f30fda7","authorName":"Corey Ford, MHA; Dale Hanna","authorCompany":"","date":"December 2020","description":"Over the past four years, commercial health plans and pharmacy benefit managers have devised copay accumulator programs, which exclude the use of manufacturer-sponsored commercial copay assistance from a patient’s accrual of out-of-pocket (OOP) expenses throughout a plan benefit year. As the use of copay accumulators continues against pharmacy benefit drugs, commercial plans may explore new models targeting medical benefit products.","img":{"alt":"lash group copay accumulator program","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/insurance-card-and-tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/webinar-the-growing-utilization-of-copay-accumulator-programs","linkText":"Watch webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: the growing utilization of copay accumulator programs"},"categories":["affordability","commercialization","reimbursement","patient support services","policy"],"segments":["manufacturers"],"timestamp":637431252000000000,"title":"webinar: the growing utilization of copay accumulator programs"},{"card":{"key":"2ad36d44-e574-46bc-9f46-5fe466bfe0f1","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2021","description":"Distributors have become an essential source of market insights and customer connections, helping OTC healthcare products manufacturers reach consumers and raising the bar for what you should expect from a distribution partner.","img":{"alt":"stack of blue shopping baskets","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/consumer_shopping-baskets_stacked.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/ebook-the-evolution-of-the-otc-market","linkText":"Get the ebook","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"eBook: The evolution of the OTC market"},"categories":["consumer products"],"segments":["manufacturers"],"timestamp":637575664650000000,"title":"ebook: the evolution of the otc market"},{"card":{"key":"d98baa17-9a49-432b-b586-f43aa0642f30","authorName":"Glen Martin; Donna Gilbert; Nancy Hoak","authorCompany":"AmerisourceBergen","date":"September 2021","description":"Watch on demand to rethink commercialization strategy and the role of the right partner. From drug development through post-launch, see how commercialization solutions can be reimagined and integrated at every step of a drug’s journey to market. Learn how to rethink logistics and deliver clinical trial meds direct to patients. Reimagine field and patient services to remove access barriers even when patients are getting virtual care. Explore market-moving channel strategies and innovative logistics. And hear about it all from the team that designs and delivers commercialization strategies and solutions for our manufacturer partners every day.","img":{"alt":"Manufacturer commercialization Services","src":"-/media/assets/amerisourcebergen/manufacturer/manufacturer-commercialization-services.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rethink-your-commercialization-strategy","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Rethink your commercialization strategy"},"categories":["commercialization","data","distribution","innovation"],"segments":["manufacturers"],"timestamp":637679129130000000,"title":"webinar: rethink your commercialization strategy"},{"card":{"key":"8e159bae-2450-4fa3-8c41-111c5c9cedcd","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"business man with healthcare worker","src":"-/media/assets/healthforward/images/colour/business-man-and-healthcare-worker.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/understanding-how-to-extend-the-lifespan-of-mature-drugs","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Understanding how to energize, extend and capitalize the lifespan of mature drugs"},"categories":["distribution","our role in healthcare"],"segments":["manufacturers"],"timestamp":638526956960000000,"title":"understanding how to energize, extend and capitalize the lifespan of mature drugs"},{"card":{"key":"2f34d4c6-c8c3-475e-8c46-bd8940dc35c6","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"Video from Belinda Yap, Director, Health Economics & Outcomes Research (HEOR), about ways you can use real world evidence (RWE) to bridge this data gap from pre- to post-launch.","img":{"alt":"patients","src":"-/media/assets/innomarstrategies/who-we-support/patients-and-healthcare-providers/patients-and-hcps_top-banner.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/real-world-evidence-the-importance-for-rare-disease-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Real world evidence: The importance for rare disease therapies"},"categories":["our role in healthcare"],"segments":["manufacturers"],"timestamp":638560533000000000,"title":"real world evidence: the importance for rare disease therapies"},{"card":{"key":"ce11e0ef-c053-4013-9a31-ec26a8533801","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2019","description":"An animated, immersive biosimilar market snapshot with actionable insight for manufacturers.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilars-shaping-a-moving-market","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Biosimilars: Shaping a Moving Market"},"categories":["biosimilars","commercialization"],"segments":["manufacturers"],"timestamp":637043607390000000,"title":"biosimilars: shaping a moving market"},{"card":{"key":"fbe895ac-471e-45d2-be85-e9b4dc468805","authorName":"Lash Group","authorCompany":null,"date":"November 2019","description":"Lash Group's nurse educators offer empathy, experience and expertise to help patients navigate the complexities of today's specialty therapies. Learn how they add critical value to adherence programs.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-patient-support-program-nurse-educators-break-down-adherence-barriers","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"How Patient Support Program Nurses Help Break Down Adherence Barriers"},"categories":["commercialization","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":637088308110000000,"title":"how patient support program nurses help break down adherence barriers"},{"card":{"key":"e3d66f96-082c-491f-bd68-8ae81116bb2e","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"Patients and pharmacists face a lot of choice. They have limited time to focus on product selection and limited resources to solve financial barriers. Learn how targeted marketing programs like AmerisourceBergen's BRx Catalog and CustomConnect can integrate tailored messages seamlessly into pharmacy customers’ workflow where they are engaged and ready to act.","img":{"alt":"Connecting your brand message with the healthcare providers","src":"-/media/assets/amerisourcebergen/manufacturer/targeted-marketing-programs.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/maximize-your-brands-visibility-case-studies","linkText":"Download case studies","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case studies: Maximize your brand's visibility"},"categories":["commercialization","marketing"],"segments":["manufacturers"],"timestamp":638559936000000000,"title":"case studies: maximize your brand's visibility"},{"card":{"key":"75eb36df-8d9d-4edd-ad24-7ccede937599","authorName":"Lash Group","authorCompany":null,"date":"November 2018","description":"How combining the PAM survey with individual care planning can improve patient activation and adherence.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-power-of-patient-activation-part-three","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Insight","headline":"The Power of Patient Activation: Part Three"},"categories":["medication adherence","patient support services"],"segments":[],"timestamp":636770338690000000,"title":"the power of patient activation: part three"},{"card":{"key":"4e85c445-5c93-4f4c-aef0-66de35a167ff","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2020","description":"The success of a manufacturer’s product depends heavily on provider uptake, patient and provider access to the product, and demonstrating product value to payers. And while all these touchpoints may happen at various stages of the product life cycle, they’ve all been impacted by COVID-19. ","img":{"alt":"coronavirus_stock","src":"-/media/assets/amerisourcebergen/homepage/coronavirus_stock.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/virtual-drug-commercialization-ebook","linkText":"Download ebook","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Ebook: Virtual drug commercialization"},"categories":["covid-19","commercialization","distribution","market access","marketing"],"segments":["manufacturers"],"timestamp":637398568800000000,"title":"ebook: virtual drug commercialization"},{"card":{"key":"66ff8a8b-e98c-464b-aaac-8b252e9e8735","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"webinar_RGB_Large_JPG","src":"-/media/assets/intrinsiq/images/webinar_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/value-based-healthcare-webinar","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Value-Based Healthcare (VBHC): A game changer for pharma to accelerate patient access"},"categories":["consulting","patient care"],"segments":["manufacturers"],"timestamp":638526943410000000,"title":"value-based healthcare (vbhc): a game changer for pharma to accelerate patient access"},{"card":{"key":"9cbb4503-21b3-414f-9b86-bccf31c7903d","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2017","description":"What does the future of benefit verification look like for manufacturer patient support programs?","img":{"alt":"headset","src":"-/media/assets/amerisourcebergen/physician-practices/headset.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rethink-the-future-of-benefit-verification","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Manufacturers","headline":"Rethink: The Future of Benefit Verification"},"categories":["commercialization","patient support services","affordability"],"segments":["manufacturers"],"timestamp":636420520460000000,"title":"rethink: the future of benefit verification"},{"card":{"key":"bec3cad1-f252-4b4b-bbe2-6a9079994cba","authorName":"Ana Stojanovska","authorCompany":"Biopharma Services","date":"June 2018","description":"An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-navigate-cell-and-gene-therapy-reimbursement-part-two","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"How to Navigate Cell and Gene Therapy Reimbursement: Part Two"},"categories":["cell and gene therapy","commercialization","financial management","market access","oncology","orphan drugs","policy","reimbursement"],"segments":["manufacturers"],"timestamp":636658819860000000,"title":"how to navigate cell and gene therapy reimbursement: part two"},{"card":{"key":"6f2ca831-fbec-48d5-ab86-6ac688d36fd0","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2023","description":"","img":{"alt":"Biosimilars adoption","src":"-/media/assets/amerisourcebergen/biosimilars-page/biosimilars-adoption.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/education-the-centerpiece-of-biosimilars-adoption","linkText":"Watch on demand","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Education: The centerpiece of biosimilar adoption"},"categories":["biosimilars","affordability","commercialization","market access","regulatory"],"segments":["manufacturers"],"timestamp":638110307470000000,"title":"education: the centerpiece of biosimilar adoption"},{"card":{"key":"6ab57d52-c806-4759-bd37-08c1bc189ed1","authorName":"Innomar Strategies","authorCompany":null,"date":"June 2021","description":"What started as a three-person huddle in 2001 became a modern fixture in Canadian healthcare. Here's how Innomar Strategies went from a small team with big dreams to the largest COVID-19 vaccine distribution vendor in Canada's history.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/innomar-strategies---20-years-of-innovative-market-access-solutions","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"Innomar Strategies: 20 years of innovative market access solutions"},"categories":["covid-19","distribution","market access"],"segments":["manufacturers"],"timestamp":637586208000000000,"title":"innomar strategies: 20 years of innovative market access solutions"},{"card":{"key":"88278f60-ff86-4b35-9ddf-27e9f6deb051","authorName":"Lash Group","authorCompany":null,"date":"May 2020","description":"","img":{"alt":"AdobeStock_313394356","src":"-/media/assets/lashgroup/images/9-2-leadership-associates/adobestock_313394356.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/2020-webinar-patient-assistance-in-the-wake-of-covid19-lash-group-and-xcenda","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Patient Assistance in the Wake of COVID19"},"categories":["commercialization","covid-19","patient support services","affordability","product access"],"segments":["manufacturers"],"timestamp":637245396000000000,"title":"webinar: patient assistance in the wake of covid19"},{"card":{"key":"19c89499-902c-43a1-8894-3b7eda923837","authorName":"Ana Stojanovska","authorCompany":"Biopharma Services","date":"June 2018","description":"An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-navigate-cell-and-gene-therapy-reimbursement-part-one","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"How to Navigate Cell and Gene Therapy Reimbursement: Part One"},"categories":["cell and gene therapy","commercialization","financial management","market access","oncology","orphan drugs","policy","reimbursement"],"segments":["manufacturers"],"timestamp":636658819860000000,"title":"how to navigate cell and gene therapy reimbursement: part one"},{"card":{"key":"032131e7-3ec6-4f26-b18a-d456cde4b655","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2023","description":"","img":{"alt":"patient services","src":"-/media/assets/amerisourcebergen/gettyimages-1190951043-rt2-rgb.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-move-from-overwhelmed-to-optimized","linkText":"Download the case study","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case Study: How to move from overwhelmed to optimized"},"categories":["patient support services","patient care"],"segments":["manufacturers"],"timestamp":638279011840000000,"title":"case study: how to move from overwhelmed to optimized"},{"card":{"key":"5375e011-ef6f-4a8f-b9fa-4fc0ff463242","authorName":"Matt Sample","authorCompany":"AmerisourceBergen","date":"May 2019","description":"Phase II of DSCSA requires interoperable systems for the electronic tracking of product through the supply chain. Is pharma prepared? Learn what stakeholders need to know and do know to prepare for 2023.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/preparing-for-dscsa-interoperability","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Preparing for DSCSA Interoperability"},"categories":["distribution","legislation","secure supply chain","technology"],"segments":["manufacturers","pharmacies","health systems"],"timestamp":636934550300000000,"title":"preparing for dscsa interoperability"},{"card":{"key":"bfbc4894-8e21-4219-b4bb-41a0717f9e49","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2023","description":"","img":{"alt":"globe with stethoscope","src":"-/media/assets/amerisourcebergen/newsroom/global_health_full.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/enhancing-patient-reported-outcomes","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Enhancing Patient-Reported Outcomes (PROs) in German AMNOG Assessments: Insights from the ISPOR Europe 2023 Conference"},"categories":["consulting","market access","patient support services","research"],"segments":["manufacturers"],"timestamp":638385311460000000,"title":"enhancing patient-reported outcomes (pros) in german amnog assessments: insights from the ispor europe 2023 conference"},{"card":{"key":"622d0d5a-2fab-40dc-947b-6f91629fccb7","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2022","description":"","img":{"alt":"barriers to biosimilar adoption","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/barriers-to-biosimilar-adoption.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/why-biopharma-companies-must-understand-barriers-to-biosimilar-adoption","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Why biopharma companies must understand barriers to biosimilar adoption"},"categories":["biosimilars","product access"],"segments":["manufacturers"],"timestamp":637874519320000000,"title":"why biopharma companies must understand barriers to biosimilar adoption"},{"card":{"key":"479b350d-8841-4a5e-9914-d2b5969645b2","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"Medic discussing billing with a patient","src":"-/media/assets/besse/images/general/patient-medic-clipboard.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/patient-support-programs-a-significant-source-of-real-world-data","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Patient support programs: A significant source of real-world data"},"categories":["our role in healthcare","patient support services"],"segments":["manufacturers"],"timestamp":638560548000000000,"title":"patient support programs: a significant source of real-world data"},{"card":{"key":"f8e801e0-5b07-4940-8fc4-5a7b496f9089","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2017","description":"Learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/commercializing-cell-and-gene-therapies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Commercializing Cell and Gene Therapies"},"categories":["cell and gene therapy","third party logistics","commercialization","reimbursement","commercialization","product access","affordability"],"segments":["manufacturers"],"timestamp":636348804000000000,"title":"commercializing cell and gene therapies"},{"card":{"key":"9fe616aa-1340-4f8d-965b-4b23d8d8aea3","authorName":"Jessica Donati","authorCompany":"Strategic Global Sourcing at AmerisourceBergen","date":"October 2020","description":"While it may seem that the role of distributors like AmerisourceBergen in helping over-the-counter (OTC) product manufacturers find commercial success is simply to make sure product gets from our warehouse to the pharmacy shelves, we’re actually instrumental in a lot more than that. In recent years, distributors have become an essential source of market insights and customer connections. ","img":{"alt":"consumer scanning products on smartphone in store","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/consumer-scanning-products-on-smartphone-in-store.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/five-growth-drivers-for-the-consumer-healthcare-products-market","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Five growth drivers for the consumer healthcare products market"},"categories":["commercialization","data","analytics","distribution","consumer products"],"segments":["manufacturers"],"timestamp":637384732090000000,"title":"five growth drivers for the consumer healthcare products market"},{"card":{"key":"74dbcb78-a9c0-4828-ad4b-983364300d9e","authorName":"Lash Group","authorCompany":null,"date":"November 2018","description":"Open enrollment for Health Insurance Marketplace plans is here. Do PAP patients know their coverage options?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/preparing-patients-for-open-enrollment","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Preparing Patients for Open Enrollment"},"categories":["affordability","patient support services","policy","product access","medication adherence"],"segments":["manufacturers"],"timestamp":636772063300000000,"title":"preparing patients for open enrollment"},{"card":{"key":"f26343f5-2b9f-45ce-89d1-9dadf67d8da4","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2024","description":"","img":{"alt":"event","src":"-/media/assets/amerisourcebergen/access-usa-2024-general-session/access-usa-2024---general-session.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/our-thought-leadership-at-access-usa-2024","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Cencora thought leadership at Access USA 2024"},"categories":["patient care","patient support services","technical services","technology"],"segments":["manufacturers"],"timestamp":638471490340000000,"title":"cencora thought leadership at access usa 2024"},{"card":{"key":"ea67400d-8d87-4aa7-9d79-2c47a899d7d6","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2022","description":"","img":{"alt":"Cell and gene therapy commercialization","src":"-/media/assets/amerisourcebergen/manufacturer/advanced-therapies-week-2022.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/getting-the-right-drug-to-the-right-patient-at-the-right-place-at-the-right-time","linkText":"Read article","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Getting the right drug to the right patient at the right place at the right time"},"categories":["cell and gene therapy","commercialization","financial management","innovation"],"segments":["manufacturers"],"timestamp":637916031670000000,"title":"getting the right drug to the right patient at the right place at the right time"},{"card":{"key":"b3fa1316-06e9-44cf-9212-9215d4b1e72b","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2024","description":"","img":{"alt":"Man talking to veterinarian during a business meeting","src":"-/media/assets/mwianimalhealth/images/solutions/solutions-cards/partner_programs_card.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/new-access-and-reimbursement-solutions","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"New from Cencora: Access Navigator and Pharmacy Account Manager"},"categories":["field support"],"segments":["manufacturers"],"timestamp":638495626340000000,"title":"new from cencora: access navigator and pharmacy account manager"},{"card":{"key":"7016e652-ca3b-4224-8f9d-4dbb91548cbd","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"January 2023","description":"","img":{"alt":"blue genes","src":"-/media/assets/worldcourier/english/images/generic-images/blue-genes.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/with-landmark-approval-spotlight-on-cryogenic-logistics-intensifies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"With landmark approval, spotlight on cryogenic logistics intensifies"},"categories":["cell and gene therapy","regulatory"],"segments":[],"timestamp":638085727500000000,"title":"with landmark approval, spotlight on cryogenic logistics intensifies"},{"card":{"key":"488a965d-c3a1-4743-bdd7-86c70f6a43ce","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2024","description":"","img":{"alt":"Webinar","src":"-/media/assets/amerisourcebergen/screenshot-ira-webinar-july-2024.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/panel-discussion-strategically-prepare-for-ira-part-d-redesign","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Panel discussion: Strategically prepare for IRA Part D redesign"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638604582210000000,"title":"panel discussion: strategically prepare for ira part d redesign"},{"card":{"key":"f280c06f-453d-4cef-8e4d-6466da4447be","authorName":"Bob Raffo","authorCompany":"","date":"February 2024","description":"","img":{"alt":"Cost-of-medications-article-image","src":"-/media/assets/firstview/images/cost-of-medications-article-image.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rethinking-financial-services","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Rethinking financial services in biopharma patient affordability programs"},"categories":["affordability","financial technologies and processing","patient care"],"segments":["manufacturers"],"timestamp":638434498140000000,"title":"rethinking financial services in biopharma patient affordability programs"},{"card":{"key":"0a6f9e12-2933-4164-baba-25fdcf594a81","authorName":"Mareike Konstanski, MSc; Susanne Kossow, PhD; Ruairi O'Donnell, PhD; Kim Joline Schmidt, MSc","authorCompany":"Cencora","date":"May 2024","description":"Less than one year before the implementation of the European Union Health Technology Assessment Regulation (EU HTAR), industry and national HTA bodies are still missing clarity on the Joint Scientific Consultation (JSC) and Joint Clinical Assessment (JCA) procedures. The first implementing act of the EU HTAR for JCA of medicinal products has now been published, but does it address the stakeholders’ concerns?","img":{"alt":"HTA JCA implementing acts","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/htaq-jca-jsc-6-implmenting-acts.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-summer-2024-first-six-implementing-acts","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Embarking on the EU HTAR realization journey: Key insights from the first of six implementing acts "},"categories":["consulting","regulatory"],"segments":["manufacturers"],"timestamp":638507945400000000,"title":"embarking on the eu htar realization journey: key insights from the first of six implementing acts "},{"card":{"key":"ac819621-6899-461c-8638-927de0515bf9","authorName":"Jane Ha, PharmD, MS","authorCompany":"Cencora","date":"May 2024","description":"","img":{"alt":"meeting","src":"-/media/assets/amerisourcebergen/meeting---opt-2.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/5-questions-with-jane-ha","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"5 questions with Jane Ha"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638519016520000000,"title":"5 questions with jane ha"},{"card":{"key":"7619c782-e876-43d2-8fce-f705a5519c59","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"Lab tech with DNA","src":"-/media/assets/xcenda/english/images/expertise/cgt-dna.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/adapting-learnings-to-advance-cgt-clinical-manufacturing","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Adapting learnings to advance CGT clinical manufacturing"},"categories":["cell and gene therapy"],"segments":[],"timestamp":638570080200000000,"title":"adapting learnings to advance cgt clinical manufacturing"},{"card":{"key":"8eb49319-6925-4816-bb42-6192064f98ad","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"February 2023","description":"Evolving advanced therapy medicinal product regulations require new logistics complexity","img":{"alt":"Regualatory article 2","src":"-/media/assets/worldcourier/english/images/cell-and-gene/regualatory-article-2.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/evolving-atmp-regulations-require-news-logistics-complexity","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Evolving ATMP regulations require news logistics complexity"},"categories":["cell and gene therapy","regulatory"],"segments":[],"timestamp":638131966990000000,"title":"evolving atmp regulations require news logistics complexity"},{"card":{"key":"ca73481a-2d19-4726-8897-58a2565f32a8","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"July 2022","description":"Record number of cell therapies signals a surge in commercializations, emphasizing the complex supply chain needs for ATMPs.","img":{"alt":"Speakers live round table cgt","src":"-/media/assets/worldcourier/english/images/events/speakers-live-round-table-cgt.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/to-freeze-or-not-to-freeze","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Fresh or frozen: cell and gene therapy supply chain"},"categories":["cell and gene therapy"],"segments":[],"timestamp":637922669100000000,"title":"fresh or frozen: cell and gene therapy supply chain"},{"card":{"key":"bb8d97bd-cbb3-42bf-9f2c-2d1bf2aa9275","authorName":"Xcenda","authorCompany":null,"date":"December 2020","description":"As a field reimbursement and access specialist (FRAS) at Xcenda, Heather spends her days helping healthcare providers get to the bottom of any issue that might prevent patients from being able to access the therapy they need.","img":{"alt":"Doctor talking to patient","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/doctor-talking-to-patient.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharma-in-the-field-heather","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pharma in the field: Heather's story"},"categories":["affordability","commercialization","patient support services","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637432200110000000,"title":"pharma in the field: heather's story"},{"card":{"key":"3ea95811-ad28-4496-beab-33a8aab3a1ab","authorName":"Lung-I Cheng","authorCompany":"Biopharma Services","date":"July 2024","description":"","img":{"alt":"patient","src":"-/media/assets/csl/images/doctor-using-table-with-patient.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-power-of-patient-engagement-fireside","linkText":"Available now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The power of patient engagement: A trailblazing journey to elevate access"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638554665210000000,"title":"the power of patient engagement: a trailblazing journey to elevate access"},{"card":{"key":"570cadf1-8ce3-4a7f-b450-73f9e3b77741","authorName":"Shaila Yoshida","authorCompany":"Cencora","date":"September 2024","description":"","img":{"alt":"Man and woman business meeting","src":"-/media/assets/san/images/conf-room.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/unraveling-payer-trends","linkText":"Get the white paper","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Unraveling payer trends: Critical insights on healthcare decision-making strategies"},"categories":["formulary solutions"],"segments":["manufacturers"],"timestamp":638611528300000000,"title":"unraveling payer trends: critical insights on healthcare decision-making strategies"},{"card":{"key":"e4ef56f5-2c67-4f5a-a497-cd466035f80b","authorName":"AmerisourceBergen","authorCompany":"","date":"October 2023","description":"","img":{"alt":"GettyImages-1139001612_RGB_Large_JPG (1)","src":"-/media/assets/amerisourcebergen/insights/gettyimages-1139001612_rgb_large_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/valuing-potential-cures-icer-approach-sst","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Valuing potential cures: An examination of ICER’s approach to assessing high-impact single and short-term therapies"},"categories":["commercialization","consulting","managed care","market access","cell and gene therapy"],"segments":["manufacturers"],"timestamp":638319888000000000,"title":"valuing potential cures: an examination of icer’s approach to assessing high-impact single and short-term therapies"},{"card":{"key":"46685f42-6c52-46cd-8728-99dde1e48b9c","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2018","description":"How manufacturers can benefit from provider-led care coordination to improve patient outcomes.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rethink-channel-strategy-for-oral-oncolytics","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Rethink: Channel Strategy for Oral Oncolytics"},"categories":["commercialization","distribution","data","medication adherence","oncology","specialty pharmacy","product access"],"segments":["manufacturers"],"timestamp":636632080780000000,"title":"rethink: channel strategy for oral oncolytics"},{"card":{"key":"b6e5e5e5-56ad-4a57-a50b-76a1227e866d","authorName":"Barbara Whitten","authorCompany":"Lash Group","date":"December 2019","description":"Executive Q&A: How to make the annual benefits reverification process as smooth as possible for patients and key stakeholders.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/scaling-up-for-annual-reverification","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Scaling Up for Annual Reverification"},"categories":["affordability","patient support services","product access","technology"],"segments":["manufacturers"],"timestamp":637110875760000000,"title":"scaling up for annual reverification"},{"card":{"key":"992346c4-947d-4019-b9ec-59aabcc40592","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2023","description":"Jennifer Fenwick, Senior Manager, Personalized Supply Chain at World Courier, part of Cencora, joins with Dr Matthew Lakelin, Vice President, Scientific Affairs and Product Development at TrakCel, for a Q&A about decentralized supply chains.

They delve into the reasons why therapy developers should consider investing in an integrated, digital supply chain for CGT, and why finding the right partners will be critical to their digital infrastructure success.
","img":{"alt":"Decentralized clinical trials for CGTs","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/world-courier-qa-thumbnail-trakcel-qa-jf.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-the-tendency-towards-decentralized-supply-chains-has-changed-in-cgt","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Q&A – How the tendency towards decentralized supply chains has changed in CGT"},"categories":["cell and gene therapy","commercialization","distribution"],"segments":["manufacturers"],"timestamp":638339260080000000,"title":"q&a – how the tendency towards decentralized supply chains has changed in cgt"},{"card":{"key":"4e232c6b-7180-4c67-90c6-f553f1b74a96","authorName":"Innomar Strategies","authorCompany":null,"date":"June 2021","description":"Put return-to-work fears at rest with an app that helps your employees prioritize what matters.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/overcoming-reentry-concerns-with-workplace-wellness-technology","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Insight","headline":"Overcoming reentry concerns with workplace wellness technology"},"categories":["advocacy","engagement","patient care","technology"],"segments":[],"timestamp":637593984000000000,"title":"overcoming reentry concerns with workplace wellness technology"},{"card":{"key":"0196c431-f913-44d6-a3d9-178e0ff80323","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2017","description":"How are payers thinking about apps, wearables and other digital health technologies?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/what-do-payers-think-about-digital-health-technologies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"What Do Payers Think About Digital Health Technologies"},"categories":["reimbursement","technology","market access"],"segments":["manufacturers"],"timestamp":636419638800000000,"title":"what do payers think about digital health technologies"},{"card":{"key":"b322e740-070a-4744-96ae-e7d5628bafcb","authorName":"Melissa Lattanzi","authorCompany":"Cencora","date":"May 2024","description":"","img":{"alt":"CGT_Header","src":"-/media/assets/worldcourier/english/images/cell-and-gene/cgt_header.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/unlocking-success-in-cell-and-gene-therapy-distribution","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Unlocking success in cell and gene therapy distribution"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638525262600000000,"title":"unlocking success in cell and gene therapy distribution"},{"card":{"key":"630b78c5-44d2-42b9-8f65-44bc002d8ec8","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"Innomar","src":"-/media/assets/innomarstrategies/3pl-distribution.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/innovative-logistics-solutions-for-specialty-medications","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Innovative logistics solutions for specialty medications"},"categories":[],"segments":["manufacturers"],"timestamp":638573536910000000,"title":"innovative logistics solutions for specialty medications"},{"card":{"key":"d9721eaf-ff66-42ad-8da8-8d456e806d7d","authorName":"AmerisourceBergen","authorCompany":"","date":"August 2022","description":"","img":{"alt":"Abstract image of Red Color Illuminated Fiber Optics Selective Focus on Blue Background.","src":"-/media/assets/xcenda/english/images/insights/gettyimages-1179988450_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/three-reasons-why-early-planning-is-critical-for-hta-countries","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Market access abroad: Three reasons why early planning is critical for HTA countries"},"categories":["market access","regulatory"],"segments":["manufacturers"],"timestamp":637967963050000000,"title":"market access abroad: three reasons why early planning is critical for hta countries"},{"card":{"key":"4a6a6d82-9bb9-4485-aff9-89bf92184d5a","authorName":"Todd Wells","authorCompany":"Biopharma Services","date":"November 2019","description":"Executive Q&A: best practices for a patient support program launch.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-launch-a-patient-support-program","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"How to Launch a Patient Support Program"},"categories":["affordability","commercialization","medication adherence","product access"],"segments":["manufacturers"],"timestamp":637088419270000000,"title":"how to launch a patient support program"},{"card":{"key":"32e3ba6c-24f6-4c62-86b0-799781bd2216","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2022","description":"Download our latest infographic that outlines the latest on copay accumulators, the industry action, and what steps you can take now to prepare for 2023. ","img":{"alt":"Hand giving copay card to pharmacist","src":"-/media/assets/xcenda/english/images/insights/copay_pharmacy.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/preparing-for-2023-piloting-copay-assistance-through-strong-headwinds","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Preparing for 2023: piloting copay assistance through strong headwinds"},"categories":[],"segments":[],"timestamp":637782143230000000,"title":"preparing for 2023: piloting copay assistance through strong headwinds"},{"card":{"key":"302c7dd9-b4a8-47f3-be59-1603ddb7a6f6","authorName":"Michael Hennig, PhD","authorCompany":"PharmaLex, part of Cencora","date":"May 2024","description":"","img":{"alt":"lash group consultation","src":"-/media/assets/lashgroup/images/9-4-contact-us/lash-group-consultation.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-latest-guidelines-for-statistical-analysis-in-eu-health","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Q&A on the latest guidelines for statistical analysis in EU Health Technology Assessment"},"categories":["consulting","policy"],"segments":["manufacturers"],"timestamp":638525126960000000,"title":"q&a on the latest guidelines for statistical analysis in eu health technology assessment"},{"card":{"key":"7fc798cf-0339-46ee-a9f3-ec67e4dbe5aa","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2024","description":"","img":{"alt":"Map of Europe","src":"-/media/assets/xcenda/german/images/solutions/europeanmarket.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/alternative-access-pathways-the-key-to-success","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Are alternative access pathways the key to success for small pharma in European markets?"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638487938030000000,"title":"are alternative access pathways the key to success for small pharma in european markets?"},{"card":{"key":"85b215f9-509c-40ee-838a-9b076e1cc22a","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2018","description":"How can manufacturers approach reimbursement and patient support for cell and gene therapies and other medical innovations?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rethinking-reimbursement-and-patient-support-following-medical-innovation","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Rethinking Reimbursement and Patient Support Following Medical Innovation"},"categories":["commercialization","cell and gene therapy","patient support services","reimbursement","affordability"],"segments":["manufacturers"],"timestamp":636519837600000000,"title":"rethinking reimbursement and patient support following medical innovation"},{"card":{"key":"f5d0ddf4-e73a-4fac-a888-bd81be7b0662","authorName":"HTA Quarterly","authorCompany":"","date":"August 2022","description":"The new 2022 European Union (EU) health technology assessment (HTA) regulation is intended to streamline assessment of clinical data across the EU and minimize duplication of effort, for both health technology developers and HTA bodies.","img":{"alt":"EU Flag HTA Assessments","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-fall-2022/shutterstock_388372504-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-fall-2022-eu-regulation-and-health-technology-assessment","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The new EU regulation on health technology assessment: Major change or minor adjustment?"},"categories":[],"segments":["manufacturers"],"timestamp":637975507800000000,"title":"the new eu regulation on health technology assessment: major change or minor adjustment?"},{"card":{"key":"c15f4059-9a42-4586-bf03-2506d9c91b0f","authorName":"Karen Rice","authorCompany":"Lash Group","date":"May 2020","description":"Executive Q&A: How to help employees navigate change while working for the good of patients during times of crisis. Lash Group's Karen Rice shares her insights.","img":{"alt":"KarenRice","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/karenrice.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/people-first-helping-employees-navigate-work-change-and-patient-support","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"People First: Helping Employees Navigate Work, Change and Patient Support"},"categories":["covid-19","engagement","patient support services"],"segments":["manufacturers"],"timestamp":637254175430000000,"title":"people first: helping employees navigate work, change and patient support"},{"card":{"key":"32653322-7820-46bc-a387-69161b4d80e5","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2021","description":"The journey from clinical to commercial for vein-to-vein autologous therapies can be challenging and complex. Manufacturers need to understand all of the key aspects of the value chain to ensure an effective transition. ","img":{"alt":"Autologous cell and gene therapies","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/clinical-to-commercial-transition-for-autologous-therapies.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/clinical-to-commercial-transition-for-autologous-therapies","linkText":"Watch on demand","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Key insights on the clinical to commercial transition for autologous therapies"},"categories":["cell and gene therapy","clinical trial logistics","commercialization"],"segments":["manufacturers"],"timestamp":637673208120000000,"title":"webinar: key insights on the clinical to commercial transition for autologous therapies"},{"card":{"key":"d0a6c071-7c40-40d3-ac6d-8c4590fd471d","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"Success factors for commercializing rare disease and orphan drugs ","img":{"alt":"Commercializing rare and orphan disease products","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/commercializing-rare-and-orphan-disease-products.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/commercializing-a-new-orphan-or-rare-disease-product","linkText":"Watch webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On-demand webinar: Success factors for commercializing rare disease and orphan drugs"},"categories":["cell and gene therapy","commercialization","distribution","innovation","orphan drugs"],"segments":["manufacturers"],"timestamp":637550298000000000,"title":"on-demand webinar: success factors for commercializing rare disease and orphan drugs"},{"card":{"key":"408e944e-92e0-4150-91e2-88d26c0af950","authorName":"AmerisourceBergen","authorCompany":"","date":"September 2022","description":"A partner who understands the clinical development journey is key to unlocking product potential","img":{"alt":"Black female nurse uses stethoscope on older Black female patient","src":"-/media/assets/intrinsiqanalytics/images/gettyimages-950886826_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/innovative-clinical-trial-design","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Innovative clinical trial design"},"categories":["clinical trial logistics","research","advocacy"],"segments":["manufacturers"],"timestamp":637981623050000000,"title":"innovative clinical trial design"},{"card":{"key":"5c8d9534-e35f-48b1-af79-9297ee365a8e","authorName":"Xcenda","authorCompany":null,"date":"April 2022","description":"","img":{"alt":"Differentiate your product with FormularyDecisions","src":"-/media/assets/amerisourcebergen/manufacturer/differentiate-your-product-with-formularydecisions.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/differentiate-your-product-with-formularydecisions","linkText":"Watch video","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Differentiate your product with FormularyDecisions®"},"categories":["data","reimbursement","market access"],"segments":["manufacturers"],"timestamp":637864968600000000,"title":"differentiate your product with formularydecisions®"},{"card":{"key":"c3c75ba8-2329-4350-a6ac-ab36d2b21b5d","authorName":"Rianne Ernst, MSc; Carlijn de Sonnaville, MSc; Silvia Rohr, PhD; Mark Tolboom, MSc","authorCompany":"Vintura, a Cencora company","date":"August 2024","description":"","img":{"alt":"htaq","src":"-/media/assets/amerisourcebergen/htaq-hpw/shutterstock_1450351628.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-fall-2024-embracing-value-based-partnerships","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Embracing value-based partnerships: A path to enhanced healthcare outcomes"},"categories":["consulting","regulatory"],"segments":[],"timestamp":638603856000000000,"title":"embracing value-based partnerships: a path to enhanced healthcare outcomes"},{"card":{"key":"4d8743fc-01a8-427c-8913-e83f79eb2832","authorName":"AmerisourceBergen","authorCompany":"","date":"March 2023","description":"","img":{"alt":"Two millennial-age men at business meeting ","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/gettyimages-1138451162_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/yes-you-can-commercialize-on-your-own","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Yes, you can commercialize on your own—even if you're an emerging biopharma"},"categories":["product access","commercialization"],"segments":["manufacturers"],"timestamp":638149144880000000,"title":"yes, you can commercialize on your own—even if you're an emerging biopharma"},{"card":{"key":"7177e7f9-10fa-479d-8e13-dd50f7e88577","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2022","description":"","img":{"alt":"GPOconnect","src":"-/media/assets/amerisourcebergen/manufacturer/gpoconnect.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-reach-customers-and-cut-through-the-noise-pdf","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How to reach customers in the new world of work"},"categories":["commercialization","marketing","data"],"segments":["manufacturers"],"timestamp":637910083200000000,"title":"how to reach customers in the new world of work"},{"card":{"key":"ae89d12e-dd9f-4f66-b29b-23a0e7be21f6","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"Learn how Lash Group is leveraging mobile app engagement within patient support programs to improve medication adherence.","img":{"alt":"man wearing pink mask using mobile phone","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/man-wearing-pink-mask-using-mobile-phone.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/what-is-a-digital-companion-and-how-is-it-changing-patient-support-for-the-better","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"What is a digital companion, and how is it changing patient support for the better?"},"categories":["commercialization","medication adherence","innovation","technology"],"segments":["manufacturers"],"timestamp":637548013880000000,"title":"what is a digital companion, and how is it changing patient support for the better?"},{"card":{"key":"7fea2a0c-7722-4d71-a525-16f7276bae02","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2018","description":"Patients face a growing number of barriers that can impede medication access and adherence. How can manufacturers help address these hurdles? ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/understanding-and-addressing-critical-barriers","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Understanding and Addressing Critical Barriers"},"categories":["medication adherence","patient support services","technology","affordability"],"segments":["manufacturers"],"timestamp":636673696430000000,"title":"understanding and addressing critical barriers"},{"card":{"key":"d86c1133-2eb5-4f50-8670-799e6759b099","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"Man and woman business meeting","src":"-/media/assets/san/images/conf-room.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/cell-and-gene-therapy-pre-launch-checklist","linkText":"Get the checklist","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Cell and Gene Therapy (CGT): Pre-launch checklist"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638509688270000000,"title":"cell and gene therapy (cgt): pre-launch checklist"},{"card":{"key":"5d947a6e-743a-4540-bb56-b1d361cd4c15","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2023","description":"","img":{"alt":"Accelerating advanced therapies","src":"-/media/assets/amerisourcebergen/manufacturer/cgt/why-successful-partnerships-can-help-accelerate-advanced-therapies.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/in-conversation-with-trakcel-why-successful-partnerships-can-help-accelerate-advanced-therapies","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"In conversation with TrakCel: Why successful partnerships can help accelerate advanced therapies"},"categories":["cell and gene therapy","commercialization","innovation"],"segments":["manufacturers"],"timestamp":638115512360000000,"title":"in conversation with trakcel: why successful partnerships can help accelerate advanced therapies"},{"card":{"key":"7f442f7c-4537-4791-a5d9-2ca6871801d6","authorName":"Kim Joline Schmidt, MSc; Mareike Konstanski, MSc; Ruairi O'Donnell, PhD; Erika Wissinger, PhD; Herbert Altmann, PhD","authorCompany":"Cencora","date":"November 2023","description":"The interim period between the closure of the European Network for Health Technology Assessment 21 (EUnetHTA 21) and the full application of the Health Technology Assessment Regulation (HTAR) has begun. Is sufficient guidance available for biopharma companies, HTA bodies, patients, and clinicians, or do uncertainties remain? ","img":{"alt":"EU JCA countdown","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/eu-jca.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-winter-2023-navigating-the-way-to-the-new-eu-jca","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Navigating the way to the new EU JCA—Are biopharma companies, HTA bodies, patients, and clinicians sufficiently prepared? "},"categories":["consulting","market access","regulatory"],"segments":["manufacturers"],"timestamp":638344435800000000,"title":"navigating the way to the new eu jca—are biopharma companies, hta bodies, patients, and clinicians sufficiently prepared? "},{"card":{"key":"c00338d5-549c-4bcd-952d-99dccca6585c","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2024","description":"","img":{"alt":"mid banner-launch planning","src":"-/media/assets/innomarstrategies/who-we-support/manufacturers/placeholder-images/mid-banner-launch-planning.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/5-questions-to-ask-a-potential-patient-support-partner-when-launching-one-of-your-first-products","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"5 questions to ask a potential patient support partner when launching one of your first products"},"categories":["affordability","innovation","medication adherence","patient support services","technology"],"segments":["manufacturers"],"timestamp":638590712040000000,"title":"5 questions to ask a potential patient support partner when launching one of your first products"},{"card":{"key":"343fc1a6-b3fa-4862-ae9f-2a0bf5686950","authorName":"Shanna Barnes","authorCompany":"Lash Group","date":"April 2020","description":"Executive Q&A: How do you know you're working with a consultative patient support provider?","img":{"alt":"Six people at a conference table","src":"-/media/assets/amerisourcebergen/business-interactions/meetingconfroomgrouplarge11160082.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/building-partnerships-and-scaling-services-to-patient-needs","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Building Partnerships and Scaling Services to Patient Needs"},"categories":["commercialization","patient support services"],"segments":["manufacturers"],"timestamp":637221336770000000,"title":"building partnerships and scaling services to patient needs"},{"card":{"key":"ed6071ce-b44b-4f4a-a718-4deeff043ded","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2023","description":"","img":{"alt":"getting value assessment right for transformational therapies ","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/getting-value-assessment-right-for-transformational-therapies.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-fall-2023-the-cures-conundrum","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The cures conundrum: The importance of getting value assessment right for transformational therapies "},"categories":["affordability","consulting","legislation"],"segments":["manufacturers"],"timestamp":638271831560000000,"title":"the cures conundrum: the importance of getting value assessment right for transformational therapies "},{"card":{"key":"344efa7e-f47e-4473-8337-71818eb9f062","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2017","description":"How can data-driven service design improve patient support programs and outcomes? ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/improving-patient-services-and-outcomes-with-data-driven-design","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Improving Patient Services and Outcomes With Data-Driven Design"},"categories":["patient support services","data","technology"],"segments":["manufacturers"],"timestamp":636423060000000000,"title":"improving patient services and outcomes with data-driven design"},{"card":{"key":"48c9c784-7ae2-47c6-ac61-7e128ee09ed1","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2023","description":"Learn the unintended consequences of channel strategy decisions and the impact on patients and providers.","img":{"alt":"Fridgeration distribution center","src":"-/media/assets/amerisourcebergen/distribution/louisville_distribution_drug_refridgeration_003.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/changing-channels","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Changing Channels"},"categories":["commercial supply chain","product access","distribution","commercialization"],"segments":["manufacturers"],"timestamp":638243280000000000,"title":"changing channels"},{"card":{"key":"e0a17b38-f179-40f1-857d-71e1781b2312","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"The latest approaches to access support are removing barriers to therapy for patients","img":{"alt":"Accelerating access to therapy","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/accelerating-access-to-therapy.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/accelerating-access-to-therapy-a-view-from-the-front-lines","linkText":"Watch webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On-demand webinar: Accelerating access to therapy (a view from the front lines)"},"categories":["commercialization","market access","patient support services","product access"],"segments":["manufacturers"],"timestamp":637546136900000000,"title":"on-demand webinar: accelerating access to therapy (a view from the front lines)"},{"card":{"key":"68f4072c-bc3c-40f5-95fa-909402517743","authorName":"Rod Bryant, MS; MarSha Lewers","authorCompany":"","date":"March 2021","description":"Whether buy-and-bill or self-administered, most specialty medications come with barriers to access and reimbursement. That's why manufacturers engage field support services to navigate the challenges. Xcenda's experts walk us through the difference in support for each model.","img":{"alt":"pills on green textured background","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pills-on-green-textured-background.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/field-services-for-buy-and-bill-vs-self-administered-products","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Buy-and-bill vs. self-administered: Field services remove barriers across access points"},"categories":["commercialization","patient support services","product access","reimbursement","field support"],"segments":["manufacturers"],"timestamp":637511007890000000,"title":"buy-and-bill vs. self-administered: field services remove barriers across access points"},{"card":{"key":"6874677e-3489-40b3-9128-6c39a3ab9273","authorName":"Lash Group","authorCompany":null,"date":"December 2019","description":"For Angela, a nurse navigator with Lash Group, every phone call is an opportunity to help a cancer patient, and sometimes solve problems they didn't even know they had.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/nurse-stories-angela","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Nurse Stories: Angela"},"categories":["medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":637122945170000000,"title":"nurse stories: angela"},{"card":{"key":"35be6fc0-c457-486e-b8e8-a510b3740399","authorName":"Innomar Strategies","authorCompany":null,"date":"May 2018","description":"","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/insight-series-value-of-patient-support-programs","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"Insight Series: Value of Patient Support Programs for Specialty Medications in Canada"},"categories":["patient support services","reimbursement"],"segments":["manufacturers"],"timestamp":636621818470000000,"title":"insight series: value of patient support programs for specialty medications in canada"},{"card":{"key":"c94cb705-59de-40cc-8450-3dcd9df661ec","authorName":"Ruairi O'Donnell, PhD","authorCompany":"Cencora","date":"March 2024","description":"","img":{"alt":"professionals around computer monitor","src":"-/media/assets/xcenda/english/images/solutions/professionals-around-computer--3.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/navigating-new-access-hurdles-in-europe","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Navigating new access hurdles in Europe: A conversation with Cencora’s EU HTA Lead"},"categories":["consulting","patient care","technology"],"segments":["manufacturers"],"timestamp":638459414210000000,"title":"navigating new access hurdles in europe: a conversation with cencora’s eu hta lead"},{"card":{"key":"b27fed06-c01f-43db-9f4d-1939bc2ec3b7","authorName":"FormularyDecisions","authorCompany":"","date":"June 2023","description":"","img":{"alt":"FD insights ","src":"-/media/assets/amerisourcebergen/insights/gettyimages-1210864965_srgb-final-large.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/formulary-fuel-webinar-series","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Formulary Fuel Webinar Series"},"categories":[],"segments":["manufacturers"],"timestamp":638223498980000000,"title":"formulary fuel webinar series"},{"card":{"key":"f2fd72aa-7d0b-47fd-970b-b932a50b4d13","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"pharmacy","src":"-/media/assets/amerisourcebergen/pharmacy_bcn22_0272_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/best-practices-to-advance-patient-support-with-emerging-technology","linkText":"Get the case study","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Best practices to advance patient support with emerging technology"},"categories":["patient support services"],"segments":["manufacturers"],"timestamp":638572751670000000,"title":"best practices to advance patient support with emerging technology"},{"card":{"key":"62aaf21a-0310-407c-b558-5bc5565c2854","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"A light-skinned person with long brown hair holding a tablet and stylus smiles at a colleague during a meeting in a conference room.","src":"-/media/assets/esg-microsite/supply-chain-and-stewardship/cencora-esg-supplier-diversity.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/a-glimpse-into-the-future-of-cgts","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"A glimpse into the future of CGTs with ARM’s Rita Johnson-Greene"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638568449600000000,"title":"a glimpse into the future of cgts with arm’s rita johnson-greene"},{"card":{"key":"ac5acd5c-e00f-44e5-abec-926ab32f25db","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"EU HTA Statistical Guidelines","src":"-/media/assets/amerisourcebergen/manufacturer/square-eu-flag-300x300.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/mastering-the-new-eu-hta-statistical-guidelines","linkText":"Register now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Get set for 2025: Mastering the new EU HTA statistical guidelines"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638560800000000000,"title":"get set for 2025: mastering the new eu hta statistical guidelines"},{"card":{"key":"06c98dc8-1898-4c37-a1c9-f762ab924988","authorName":"Xcenda","authorCompany":null,"date":"October 2022","description":"In this issue our editors provide insights on the new European Union Health Technology Assessment regulation, the United Kingdom's Innovative Licensing and Access Pathway, and the drug reimbursement environment in Canada.","img":{"alt":"HTA Quarterly Logo","src":"-/media/assets/xcenda/german/images/home---about-us/xcenda_2_3_card-02.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-winter-2022-summary-page","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"HTA Quarterly | Winter 2022"},"categories":["market access","regulatory","reimbursement","commercialization"],"segments":["manufacturers"],"timestamp":638023899600000000,"title":"hta quarterly | winter 2022"},{"card":{"key":"e00b14b4-8050-49be-adfa-d5bbff002388","authorName":"Xcenda","authorCompany":null,"date":"November 2022","description":"How to get earlier market access in the UK: Use the Innovative Medicines Fund ","img":{"alt":"Scales weighing lightbulb and dollar sign","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-winter-2022-imf.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-winter-2022-how-to-get-earlier-market-access-in-the-uk","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"How to get earlier market access in the UK: Use the Innovative Medicines Fund"},"categories":[],"segments":[],"timestamp":638034691200000000,"title":"how to get earlier market access in the uk: use the innovative medicines fund"},{"card":{"key":"b17fbe7e-31df-4767-acde-688b0949e959","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2021","description":"What should cell and gene therapies manufacturers know about bringing these innovative treatments to market?","img":{"alt":"Considerations for the commercialization of cell and gene therapies","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/considerations-for-cell-and-gene-therapies.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/considerations-for-the-commercialization-of-cell-and-gene-therapies","linkText":"Watch webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On demand webinar: Considerations for the commercialization of cell and gene therapies"},"categories":["cell and gene therapy","commercialization","distribution","innovation","technology","temperature control solutions"],"segments":["manufacturers"],"timestamp":637521232770000000,"title":"on demand webinar: considerations for the commercialization of cell and gene therapies"},{"card":{"key":"a2c2be90-b2f6-4f2b-bcf5-6d3b778ababd","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2023","description":"Long before any therapy goes to market, manufacturers must make decisions that will ultimately influence commercial success. In the early days of drug development, manufacturers are navigating the near-term logistics of patient recruitment, clinical trial participation, compliance with regulatory requirements, and data collection.

With the right commercialization partner involved from the start, manufacturers can feel more confident that the drug development process establishes the best possible foundation for market entry—even when that may be months or years away.","img":{"alt":"Clinical Development Checklist","src":"-/media/assets/amerisourcebergen/manufacturer/clinical-development-checklist.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/drug-development-checklist","linkText":"Download checklist","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Drug development checklist: What to look for in a commercialization partner"},"categories":["clinical trial logistics","commercialization","direct-to-patient","innovation","pharmaceutical storage and transport management","secure supply chain","temperature control solutions"],"segments":["manufacturers"],"timestamp":638224542600000000,"title":"drug development checklist: what to look for in a commercialization partner"},{"card":{"key":"7f5717f7-80df-4766-b286-dbafff83da79","authorName":"Kim Joline Schmidt, MSc; Mareike Konstanski, MSc; Erika Wissinger, PhD; Patrick Blank, PhD","authorCompany":"Cencora","date":"March 2024","description":"The implementing acts on Joint Scientific Consultation (JSC) and Joint Clinical Assessment (JCA) by the European Commission (EC) are eagerly awaited by the industry and national health technology assessment (HTA) authorities. What are current developments, and how can stakeholders prepare for the European Union (EU) HTA during the interim period?","img":{"alt":"Awaiting the JCA implementing acts","src":"-/media/assets/amerisourcebergen/htaq-spring-2024-jca.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-spring-2024-awaiting-the-implementing-acts-on-the-jca-and-jsc","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"It’s Just…So…Cool – Don’t miss your opportunity for JSC!"},"categories":["consulting","policy","regulatory"],"segments":["manufacturers"],"timestamp":638453439000000000,"title":"it’s just…so…cool – don’t miss your opportunity for jsc!"},{"card":{"key":"ddfbc96c-d785-421e-a3b1-7ff9df521857","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"MeetingConfRoomGroupLarge11160020","src":"-/media/assets/amerisourcebergen/pharmacy/meetingconfroomgrouplarge11160020.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/collaborative-partnerships","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Collaborative partnerships key to clearing the path for new biopharma products"},"categories":["distribution","our role in healthcare"],"segments":["manufacturers"],"timestamp":638501901860000000,"title":"collaborative partnerships key to clearing the path for new biopharma products"},{"card":{"key":"6df01264-5422-4074-8ad0-63eac3a0f3c0","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"jca","src":"-/media/assets/amerisourcebergen/jca-pannel.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/next-steps-with-the-jca","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Anticipating issues, tackling challenges: Next steps with the JCA"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638503598440000000,"title":"anticipating issues, tackling challenges: next steps with the jca"},{"card":{"key":"211393ae-5179-46ba-80ae-7c22601ca719","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"person's hands working on laptop and taking notes","src":"-/media/assets/mwianimalhealth/images/products/online-product-catalog/products_laptop2.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/build-a-better-commercialization-plan","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Analysis paralysis? Build a better commercialization plan with these launch considerations"},"categories":["commercialization"],"segments":["manufacturers"],"timestamp":638501847580000000,"title":"analysis paralysis? build a better commercialization plan with these launch considerations"},{"card":{"key":"b8d6f7fd-9758-4e64-886a-983e92faeb26","authorName":"Jeff Buck","authorCompany":"Biopharma Services","date":"August 2021","description":"Jeff Buck, Vice President of Strategy & Market Development at Lash Group, shares his thoughts on what makes patient support services worth a manufacturer's investment and how these programs pay off in patient outcomes.","img":{"alt":"callcenter remote female","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/callcenter-remote-female.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/work-worth-doing-patient-support-services","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Work worth doing: Patient support services"},"categories":["affordability","commercialization","innovation","medication adherence","patient support services","product access","technology"],"segments":["manufacturers"],"timestamp":637659317480000000,"title":"work worth doing: patient support services"},{"card":{"key":"1843cdbd-5a30-4956-b28c-f39b97052138","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"","img":{"alt":"medication ","src":"-/media/assets/amerisourcebergen/01-home-page-new-images/ab_2_3_card_01.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/hub-spp-2021-webinar-optimize-program-performance","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Webinar: How to continuously optimize program performance: Using innovation to solve for change"},"categories":["patient support services","innovation","technology"],"segments":[],"timestamp":637544624280000000,"title":"webinar: how to continuously optimize program performance: using innovation to solve for change"},{"card":{"key":"0207c204-23fc-4ff2-90ab-4feaddc55492","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2024","description":"","img":{"alt":"pharmacy_customer_payment","src":"-/media/assets/amerisourcebergen/pharmacy/pharmacy_customer_payment.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/support-patient-access-in-pharmacies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Support patient access in pharmacies by addressing affordability issues and coverage complexity"},"categories":["field support"],"segments":["manufacturers"],"timestamp":638587344350000000,"title":"support patient access in pharmacies by addressing affordability issues and coverage complexity"},{"card":{"key":"b48ccbb4-18da-459d-ac70-b28ac92cb9a9","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2024","description":"","img":{"alt":"DNA double helix","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-fall-2019/cgt.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/exploring-the-evolving-landscape-of-cgt","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Exploring the evolving landscape of cell and gene therapies: Insights from Pharma USA 2024"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638485524400000000,"title":"exploring the evolving landscape of cell and gene therapies: insights from pharma usa 2024"},{"card":{"key":"b72bd148-4178-4ede-bcc4-81a7762f4f91","authorName":"Annika Brosig, PhD; Kristina Dittrich, PhD; Werner Kulp, PhD; Jan-Frederik Löpmeier-Röh, MSc; Edith Wehage, PhD","authorCompany":"Cencora","date":"May 2024","description":"The German health technology assessment of newly approved drugs aims to relate the declared added benefit with the pricing of pharmaceutical products. How does the outcome of the AMNOG benefit assessment affect the reimbursement negotiations?","img":{"alt":"AMNOG strikes a balance ","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/amnog.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-summer-2024-how-amnog-strikes-a-balance","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Benefit-driven pricing: How AMNOG strikes a balance between the financial burden on statutory health insurance and reimbursement of innovative medications in Germany"},"categories":["consulting","regulatory"],"segments":["manufacturers"],"timestamp":638507949000000000,"title":"benefit-driven pricing: how amnog strikes a balance between the financial burden on statutory health insurance and reimbursement of innovative medications in germany"},{"card":{"key":"b25eec66-3d18-4105-a1e0-76c2ea0eae25","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"Cell and gene therapy commercialization","src":"-/media/assets/amerisourcebergen/manufacturer/cgt-commercialization.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/csas-guide","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Market access brochure"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638506229250000000,"title":"market access brochure"},{"card":{"key":"59148e37-0851-4d1b-86b0-3f7d81944582","authorName":"Dale Hanna","authorCompany":"Lash Group","date":"November 2022","description":"What are the elements of innovative, effective medication adherence programs -- and how do they address the underlying causes of non-adherence?","img":{"alt":"PageDesign_Patient_Doc","src":"-/media/assets/lash/images/pagedesign_patient_doc.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/copy-of-uncommon-commonalities-part-two","linkText":"Read more","hasImage":true,"isImageMode":false,"label":"Manufacturers","headline":"Uncommon commonalities: A patient-centric strategy for improving medication adherence"},"categories":["commercialization","data","engagement","medication adherence","patient support services","technology","analytics"],"segments":["manufacturers"],"timestamp":638035842000000000,"title":"uncommon commonalities: a patient-centric strategy for improving medication adherence"},{"card":{"key":"4613f972-8ce9-479f-ab17-fc19b8595486","authorName":"Xcenda","authorCompany":null,"date":"February 2023","description":"In this issue, our editors examine assessment of innovation in Italy; while the rules may be clear, the outcomes are not always black and white. Additionally, in a pair of articles focused on the rapidly growing biosimilars market, we consider the market dynamics and incentives that impact biosimilar adoption, pricing, and reimbursement, in both the US and Europe.","img":{"alt":"HTA Quarterly Logo","src":"-/media/assets/xcenda/german/images/home---about-us/xcenda_2_3_card-02.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-spring-2023-summary-page","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"HTA Quarterly | Spring 2023"},"categories":["market access","regulatory","reimbursement","commercialization"],"segments":["manufacturers"],"timestamp":638131899600000000,"title":"hta quarterly | spring 2023"},{"card":{"key":"047ee707-f228-4652-b57d-03607cb89240","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"June 2023","description":"","img":{"alt":"Abstract","src":"-/media/assets/amerisourcebergen/insights/gettyimages-1004202128-rt-rgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-innovations-in-cryologistics-support-patient-access-to-advanced-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How innovations in cryologistics support patient access to advanced therapies"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638221917320000000,"title":"how innovations in cryologistics support patient access to advanced therapies"},{"card":{"key":"488296e9-f372-4886-8ca5-d2d648928e9a","authorName":"Kashyap Patel, MD","authorCompany":"Carolina Blood and Cancer Care","date":"February 2020","description":"Physician Q&A: How manufacturers can realize the potential of biosimilars by improving education and utilization among oncologists.","img":{"alt":"DNA_blue_vial","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/dna_blue_vial.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-boost-confidence-in-biosimilars","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Physician Q&A: How to Boost Confidence in Biosimilars"},"categories":["biosimilars","commercialization","oncology"],"segments":["manufacturers","physician practices"],"timestamp":637175700550000000,"title":"physician q&a: how to boost confidence in biosimilars"},{"card":{"key":"0553cfef-a45e-4500-8580-fc0b9ec08138","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"Women participating in a webinar","src":"-/media/assets/allydvm/images/allydvm_webinar.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharmacy-networks-webinar","linkText":"Watch webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Innovations in limited pharmacy networks to help pharmacies dispense your products"},"categories":["financial technologies and processing","innovation","pharmacy operations"],"segments":["manufacturers"],"timestamp":638521643080000000,"title":"webinar: innovations in limited pharmacy networks to help pharmacies dispense your products"},{"card":{"key":"f486fc3f-4db2-4015-a552-6b2e4fe7e4ac","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2024","description":"","img":{"alt":"Medic discussing billing with a patient","src":"-/media/assets/besse/images/general/patient-medic-clipboard.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/building-patient-trust-and-empowerment-to-improve-the-treatment-experience","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Building patient trust and empowerment to improve the treatment experience"},"categories":["cell and gene therapy","patient support services"],"segments":["manufacturers"],"timestamp":638602834800000000,"title":"building patient trust and empowerment to improve the treatment experience"},{"card":{"key":"686dcfc9-9352-4eb9-9d09-b503a24ce053","authorName":"Teri Burnell, PharmD; Myra Reinhardt","authorCompany":"Biopharma Services","date":"November 2022","description":"Successful future versions of patient and provider services will rely on in-person, hybrid, or virtual approaches to remove access barriers.","img":{"alt":"Patient and doctor","src":"-/media/assets/xcenda/english/images/solutions/patientreportedoutcomes.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/acceleration-of-innovation-in-healthcare-delivery","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":" Acceleration of innovation in healthcare delivery"},"categories":["innovation","data","market access","field support"],"segments":["manufacturers"],"timestamp":638051714340000000,"title":" acceleration of innovation in healthcare delivery"},{"card":{"key":"3ba0bdcb-87a2-40fd-80cd-75215f4a5ea7","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2024","description":"","img":{"alt":"iStock-491119888","src":"-/media/assets/intrinsiqanalytics/images/istock-491119888.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/our-thought-leadership-at-ispor-europe-2023","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Shaping the future of healthcare: Our thought leadership at ISPOR Europe 2023 "},"categories":["consulting","market access","patient support services","research"],"segments":[],"timestamp":638406002350000000,"title":"shaping the future of healthcare: our thought leadership at ispor europe 2023 "},{"card":{"key":"08ecef10-c8cb-4582-9079-91aef87535b8","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2024","description":"The importance of pre-approval information exchange (PIE) with payers and other strategic considerations to help navigate today’s market access challenges and regulatory requirements in bringing promising cell and gene therapies to the market.","img":{"alt":"Man and woman business meeting","src":"-/media/assets/san/images/conf-room.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/from-potential-to-value---carving-a-slice-of-the-cgt-pie","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"From Potential to Value: Carving a Slice of the CGT ‘PIE'"},"categories":["market access","cell and gene therapy","regulatory"],"segments":["manufacturers"],"timestamp":638603611200000000,"title":"from potential to value: carving a slice of the cgt ‘pie'"},{"card":{"key":"418625b1-0d22-46a7-9810-bdc1f767b486","authorName":"Matt Sarnes, PharmD; Allen Lising","authorCompany":"Biopharma Services","date":"June 2020","description":"Payers and IDNs representing more than 275 million lives routinely use FormularyDecisions to access product information. How can manufacturers connect with payers and other healthcare decision makers where they are to deliver pre-, peri- and post-approval product information in the digital space?","img":{"alt":"tech_blue_laptop","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/tech_blue_laptop.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-future-of-payer-engagement-how-pharma-can-break-through","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The Future of Payer Engagement: How Pharma Can Break Through"},"categories":["market access","analytics","commercialization","data","technology"],"segments":["manufacturers"],"timestamp":637280084440000000,"title":"the future of payer engagement: how pharma can break through"},{"card":{"key":"dea977bb-2c94-41bd-85f6-50c1ec79db7d","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2024","description":"If you are an emerging biopharma company, your next best opportunity may not be in your backyard. Expanding product launches globally can be more effective and efficient, particularly when you optimize potential revenue through partners with a true global footprint and experienced in overcoming common pharmaceutical commercialization challenges.","img":{"alt":"new markets for emerging biopharma","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/new-markets-for-emerging-biopharma.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/new-markets-for-emerging-biopharma","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Accelerating global therapeutic impact"},"categories":["commercialization"],"segments":["manufacturers"],"timestamp":638461218600000000,"title":"accelerating global therapeutic impact"},{"card":{"key":"cf8108fa-c1f6-41f8-bef0-f3fc72cf7dad","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2024","description":"On this episode of Not So Different, Cencora's Brian Biehn and Corey Ford take a look back at major policy and regulatory advancements in 2023 and how these changes will change the space going forward.","img":{"alt":"biosimilar_vials","src":"-/media/assets/amerisourcebergen/biosimilars-page/biosimilar_vials.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/adaptations-biosimilar-regulatory-frameworks","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Cencora's Brian Biehn and Corey Ford recommend adaptations for biosimilar regulatory frameworks"},"categories":["biosimilars"],"segments":["manufacturers"],"timestamp":638415630670000000,"title":"cencora's brian biehn and corey ford recommend adaptations for biosimilar regulatory frameworks"},{"card":{"key":"22dfc1f5-ba3f-4244-b6a3-837931afc1b8","authorName":"Alex Guite","authorCompany":"World Courier","date":"June 2020","description":"","img":{"alt":"shutterstock_1259963869 LR","src":"-/media/assets/worldcourier/english/images/direct-to-patient/shutterstock_1259963869-lr.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/webinar-on-demand---dtp-the-future-of-clinical-trials","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Webinar on-demand: DtP - The Future of Clinical Trials?"},"categories":["direct-to-patient","clinical trial logistics","patient care","patient support services"],"segments":[],"timestamp":637291351200000000,"title":"webinar on-demand: dtp - the future of clinical trials?"},{"card":{"key":"a850da00-1ad6-4b42-a026-3cc500e05a7e","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"Protecting your Supply Chain","src":"-/media/assets/worldcourier/english/images/cell-and-gene/protecting-your-supply-chain.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/tackling-the-complex-nature-of-the-cgt-supply-chain","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Tackling the complex nature of the cell and gene therapy supply chain"},"categories":["cell and gene therapy","secure supply chain"],"segments":["manufacturers"],"timestamp":638554594980000000,"title":"tackling the complex nature of the cell and gene therapy supply chain"},{"card":{"key":"c7fa8cbe-8a44-4319-a9b0-f05f95cd9ca6","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2024","description":"","img":{"alt":"Digital screen with icons of healthcare sectors","src":"-/media/assets/xcenda/english/images/solutions/healthcarelandscape.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/assessing-the-evolving-landscape-of-digital-engagement","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Assessing the evolving landscape of digital engagement between healthcare decision makers and biopharma companies"},"categories":["covid-19","formulary solutions"],"segments":["manufacturers"],"timestamp":638411145900000000,"title":"assessing the evolving landscape of digital engagement between healthcare decision makers and biopharma companies"},{"card":{"key":"3dd5c9d6-97ef-4cd7-aaef-3783621cc31c","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2024","description":"","img":{"alt":"access network","src":"-/media/assets/amerisourcebergen/gettyimages-529400769_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/workflow-integration-market-challenges","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Workflow market fragmentation, cost, and technology usage behaviors: Addressing challenges to increase patient support program utilization"},"categories":["patient care","patient support services"],"segments":["manufacturers"],"timestamp":638435320020000000,"title":"workflow market fragmentation, cost, and technology usage behaviors: addressing challenges to increase patient support program utilization"},{"card":{"key":"0ef97a4c-bc7e-4086-a00b-480011559add","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2021","description":"What does it take to deliver patient support that makes an impact on medication adherence? Lash Group shares tips for transforming your adherence program.","img":{"alt":"medication adherence services ebook","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/abstract-true-blue-waves.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/adherence-ebook","linkText":"Get the ebook","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"eBook: Making an impact on medication adherence"},"categories":["commercialization","engagement","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":637575732450000000,"title":"ebook: making an impact on medication adherence"},{"card":{"key":"bde92534-3ae5-49b9-88e2-6f837a8c37e4","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2023","description":"","img":{"alt":"Virtual event on tablet","src":"-/media/assets/xcenda/english/images/solutions/mcn-forum-fall-2023-overview-brochure-4.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/navigating-the-digital-era-and-beyond---on-demand","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On Demand: Engaging Effectively with Healthcare Decision Makers: Navigating the Digital Era and Beyond"},"categories":["formulary solutions"],"segments":["manufacturers"],"timestamp":638346392280000000,"title":"on demand: engaging effectively with healthcare decision makers: navigating the digital era and beyond"},{"card":{"key":"0e06d61e-f5da-402a-9ec4-7aa5e43872aa","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2022","description":"Experts from AmerisourceBergen and TrakCel recently participated in a webinar on commercial supply chain strategies for cell and gene therapies. In this webinar recap, you'll get highlights from the conversation and fast facts on optimizing the commercial supply chain. Think of it like Cliff's Notes for important ideas in the CGT space.","img":{"alt":"Cell and gene therapy cryogenic storage","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ics_brooks_3pl_cryogenic_088_rgb_rtchd_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/clinical-supply-chain-for-cell-and-gene-therapies","linkText":"Download PDF","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Managing clinical supply chain complexity for cell and gene therapies"},"categories":["cell and gene therapy","clinical trial logistics","direct-to-patient","technology","temperature control solutions"],"segments":["manufacturers"],"timestamp":637786523360000000,"title":"managing clinical supply chain complexity for cell and gene therapies"},{"card":{"key":"c49f2631-8715-434a-a012-822fb150690f","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2023","description":"","img":{"alt":"support","src":"-/media/assets/amerisourcebergen/gettyimages-1143491682_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/3-reasons-for-a-shared-resource-model","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"3 reasons biopharma uses shared resources for its field support team"},"categories":["field support","reimbursement","product access","market access"],"segments":["manufacturers"],"timestamp":638361982300000000,"title":"3 reasons biopharma uses shared resources for its field support team"},{"card":{"key":"4c240c5d-c03b-4a65-b0b1-c150c6fb8cf5","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2021","description":"Collaboration has been at the epicenter of the world's response to COVID-19 and other imperatives across the healthcare ecosystem. But it's not just private-private alliances that get things done. Public-private collaborations are just as important.","img":{"alt":"health policy flag stethoscope","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/health-policy-flag-stethoscope.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/working-with-government-entities-to-advance-access-affordability-and-supply-chain-stability","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Working with government entities to advance access, affordability, and supply chain stability"},"categories":["advocacy","affordability","product access","distribution","policy","reimbursement"],"segments":["manufacturers"],"timestamp":637745870470000000,"title":"working with government entities to advance access, affordability, and supply chain stability"},{"card":{"key":"965fd732-afda-4d91-a826-17004150cbc1","authorName":"FormularyDecisions","authorCompany":"","date":"May 2024","description":"FormularyDecisions® provides US healthcare decision makers with access to evidence-based resources and bi-directional communication with life sciences manufacturers.","img":{"alt":"Chemical chain","src":"-/media/assets/xcenda/english/images/solutions/biosimilars.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/amcp-webinar-bracing-for-the-impact-of-biosimilars","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Bracing for the Impact of Biosimilars: Navigating Terrain in the U.S. Market Landscape"},"categories":["regulatory","market access","biosimilars","formulary solutions"],"segments":["manufacturers"],"timestamp":638512206410000000,"title":"webinar: bracing for the impact of biosimilars: navigating terrain in the u.s. market landscape"},{"card":{"key":"882c27a9-cd33-4c66-b262-7731ac594d36","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"post-launch","src":"-/media/assets/innomarstrategies/who-we-support/manufacturers/placeholder-images/post-launch.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/accelerating-product-access","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Accelerating product access: How channel strategy drives success for new product launches"},"categories":["commercialization","product access"],"segments":["manufacturers"],"timestamp":638563268610000000,"title":"accelerating product access: how channel strategy drives success for new product launches"},{"card":{"key":"67fdcf2f-ffa4-498f-ac9d-830d5a146783","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2021","description":"With the advance of technology and increasing needs of an aging population, telehealth has been playing an important role in transforming the delivery of healthcare. The ongoing coronavirus disease (COVID-19) pandemic and the expansion of value-based care (VBC) models have also contributed to its rapid adoption in the US. Telehealth can facilitate data-driven decision making and has great potential to assist providers, biopharmaceutical companies, and medical device manufacturers in reducing uncertainty in demonstrating the value of their products.","img":{"alt":"Laptop and data","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-winter-2021/htaqwinter2021_telehealth.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-winter-2021-telehealth-value-based-care-us","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Telehealth through the lens of value-based care in the US"},"categories":["value-based care","commercialization","covid-19","managed care","patient care","data"],"segments":[],"timestamp":637725132530000000,"title":"telehealth through the lens of value-based care in the us"},{"card":{"key":"b90dfa44-74f9-4eec-97c5-db00efad4241","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2022","description":"","img":{"alt":"Woman looks at pill bottle and her phone","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/gettyimages-1299286865-200dpi.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/5-steps-to-improved-medication-adherence","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"5 steps to improved medication adherence"},"categories":["commercialization","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":637939221510000000,"title":"5 steps to improved medication adherence"},{"card":{"key":"a7fc1511-e3c7-4264-be76-a271a02aea9c","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2021","description":"How your commercialization partner can deliver data-driven insights to propel product success","img":{"alt":"The power of data across your product journey","src":"-/media/assets/amerisourcebergen/manufacturer/the-power-of-data-across-your-product-journey.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-power-of-data-across-your-product-journey","linkText":"Watch webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On-demand webinar: The power of data across your product journey"},"categories":["analytics","business performance","commercialization","data","financial management","inventory management","research","technology"],"segments":["manufacturers"],"timestamp":637523796600000000,"title":"on-demand webinar: the power of data across your product journey"},{"card":{"key":"696cef00-a2bd-4574-80b8-a2364dbb690f","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2020","description":"Data can be powerful when it's paired with actionable insights. Is your patient support provider telling you what you need to know?","img":{"alt":"data","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/data.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/next-level-analytics-part-1","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Next-level analytics part 1: Eight insights to expect from your patient support provider"},"categories":["analytics","data","affordability","patient support services","medication adherence","product access"],"segments":["manufacturers"],"timestamp":637224946200000000,"title":"next-level analytics part 1: eight insights to expect from your patient support provider"},{"card":{"key":"b4caf2c1-3b20-4fcb-b209-2345ef37bbcd","authorName":"NA-ATTC","authorCompany":"ATTC","date":"March 2021","description":"","img":{"alt":"NAATC post","src":"-/media/assets/worldcourier/english/images/cell-and-gene/naatc-post.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/last-100m-naattc","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Case study: "The last 100m" - Managing the logistics of advanced therapies in an acute NHS hospital setting"},"categories":["cell and gene therapy"],"segments":[],"timestamp":637514054430000000,"title":"case study: "the last 100m" - managing the logistics of advanced therapies in an acute nhs hospital setting"},{"card":{"key":"8d217e11-f80e-4f65-84ed-20f9f36ff5af","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2022","description":"White paper: Setup a robust and scalable supply chain for Cell and Gene Therapies","img":{"alt":"shutterstock_1059994115","src":"-/media/assets/worldcourier/english/images/cell-and-gene/lab-tech/shutterstock_1059994115.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/setup-cgt-supply-chain-white-paper","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Whitepaper: setup supply chain for cell and gene therapies"},"categories":["cell and gene therapy"],"segments":[],"timestamp":637782165410000000,"title":"whitepaper: setup supply chain for cell and gene therapies"},{"card":{"key":"a654aa12-164b-463e-8f62-02c52cd4a696","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"June 2021","description":"","img":{"alt":"Andrea Zobel ISCT","src":"-/media/assets/worldcourier/english/images/events/andrea-zobel-isct.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-build-a-cryogenic-logistics-platform-for-allogeneic-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Video: How to build a cryogenic logistics platform for allogeneic therapies"},"categories":["cell and gene therapy"],"segments":[],"timestamp":637595314260000000,"title":"video: how to build a cryogenic logistics platform for allogeneic therapies"},{"card":{"key":"58af49d9-7bd6-4cef-aefe-41302e566b0a","authorName":"Warren Dunn","authorCompany":"AmerisourceBergen","date":"March 2023","description":"Consider the value in having one point of contact guide you through payer relationships. ","img":{"alt":"Close-up of two business women shaking hands","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/hand-shake-close-up.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-form-stronger-working-relationships-with-payers","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How to forge stronger working relationships with payers"},"categories":["commercialization","market access","reimbursement"],"segments":["manufacturers"],"timestamp":638149216130000000,"title":"how to forge stronger working relationships with payers"},{"card":{"key":"660cd8ae-52b6-4801-95dc-4fc73b17e435","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2024","description":"","img":{"alt":"access network","src":"-/media/assets/amerisourcebergen/gettyimages-1371757399-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/optimizing-your-patient-support-program-with-workflow-integration","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Awareness, fax inefficiency, and portal fatigue: Optimizing your patient support program with workflow integration"},"categories":["patient care","patient support services"],"segments":["manufacturers"],"timestamp":638404999150000000,"title":"awareness, fax inefficiency, and portal fatigue: optimizing your patient support program with workflow integration"},{"card":{"key":"2eeb0866-84af-4016-a459-a6f08a3205fd","authorName":"Lung-I Cheng","authorCompany":"Biopharma Services","date":"July 2024","description":"","img":{"alt":"CGT","src":"-/media/assets/amerisourcebergen/arm---cgt-insight.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/reflections-on-impact-and-future-directions-for-cgt","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Breaking barriers and moving forward: Reflections on impact and future directions for CGT"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638569140960000000,"title":"breaking barriers and moving forward: reflections on impact and future directions for cgt"},{"card":{"key":"87081eb4-f9c4-4957-8b53-38a8e719800f","authorName":"Lash Group","authorCompany":null,"date":"January 2020","description":"Nurse navigators work tirelessly to help patients start and stay on specialty medications. Here's how becoming one has not only changed Polly's life, but the lives of many more people with rare and chronic diseases.","img":{"alt":"RN_Polly","src":"-/media/assets/amerisourcebergen/insights/rn_polly.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/nurse-stories-polly","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Nurse Stories: Polly"},"categories":["affordability","patient support services","patient care","product access"],"segments":["manufacturers"],"timestamp":637148023160000000,"title":"nurse stories: polly"},{"card":{"key":"4629da30-a2c3-4988-b64c-aafd73d4495f","authorName":"Bre Penzner; Nancy Young","authorCompany":"Xcenda","date":"May 2020","description":"How Xcenda's VIP 2.0 platform allowed a gene therapy manufacturer to conduct an all-virtual payer value messaging workshop during the COVID-19 pandemic.","img":{"alt":"megaphone","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/megaphone.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-value-of-virtual","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The Value of Virtual: How Remote Workshops Can Keep Market Access Efforts Moving"},"categories":["commercialization","covid-19","market access","technology"],"segments":["manufacturers"],"timestamp":637263676780000000,"title":"the value of virtual: how remote workshops can keep market access efforts moving"},{"card":{"key":"06fcd486-9b03-4f32-9c3b-b212bbe23811","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2023","description":"Relying on a trusted learning solutions partner to assess team needs, develop and implement a curriculum, and report back on results is an efficient way to upksill your staff for tommorrow's biopharma challenges.","img":{"alt":"Young, Black, female employee looks at a clipboard","src":"-/media/assets/amerisourcebergen/insights/cor_gettyimages-591478761_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/why-you-need-a-learning-solutions-partner-with-market-access-and-reimbursement-expertise","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Checklist: Why you need a learning solutions partner with market access and reimbursement expertise"},"categories":["reimbursement","market access"],"segments":["manufacturers"],"timestamp":638324789460000000,"title":"checklist: why you need a learning solutions partner with market access and reimbursement expertise"},{"card":{"key":"5ba54714-ec90-4368-baf3-bf0c8aceef95","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2023","description":"","img":{"alt":"US capitol color","src":"-/media/assets/amerisourcebergen/addressing-public-policy/us-capitol-color.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/gauge-the-impact-striking-down-federal-copay-accumulator-patients-copay-programs","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Gauge the impact: What does the striking down of a federal copay accumulator regulation mean for patients and copay programs?"},"categories":["managed care","consulting","legislation","policy","reimbursement","regulatory"],"segments":["manufacturers"],"timestamp":638324424000000000,"title":"gauge the impact: what does the striking down of a federal copay accumulator regulation mean for patients and copay programs?"},{"card":{"key":"fa576693-2e6d-44c4-819f-e66cd162b3b3","authorName":"Xcenda","authorCompany":null,"date":"January 2021","description":"Learn how Xcenda designed and launched a best-in-class field reimbursement and access program with a pharmaceutical manufacturer","img":{"alt":"insurance card and tablet","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/insurance-card-and-tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/an-innovative-field-reimbursement-program-expands-patient-access","linkText":"Read the case study","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case study: an innovative field reimbursement program expands patient access"},"categories":["market access","reimbursement","product access","field support"],"segments":["manufacturers"],"timestamp":637456519200000000,"title":"case study: an innovative field reimbursement program expands patient access"},{"card":{"key":"ed516991-9296-47f3-8b9f-b17cd1a21a05","authorName":"Lash Group","authorCompany":null,"date":"November 2018","description":"What are the pitfalls of historic approaches to adherence? Learn how leading solutions combine both measurement and engagement for real results.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-power-of-patient-activation-ebook","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Power of Patient Activation: eBook"},"categories":["affordability","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":636777219620000000,"title":"the power of patient activation: ebook"},{"card":{"key":"e448e70c-4712-4f4e-a3ef-abde645eef5e","authorName":"Lash Group","authorCompany":null,"date":"January 2020","description":"Jessica, a Lash Group nurse educator, shares why building rapport with patients is rewarding for the person on both ends of the phone.","img":{"alt":"telehealth_phone_steth","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/telehealth_phone_steth.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/nurse-stories-jessica","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Nurse Stories: Jessica"},"categories":["commercialization","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":637160652000000000,"title":"nurse stories: jessica"},{"card":{"key":"d4796d2c-63a5-44d8-b33f-b197f8e2ee12","authorName":"Xcenda","authorCompany":null,"date":"May 2020","description":"Virtual learning has become all the more relevant in a socially distanced world. Learn how manufacturers are transitioning training for field reimbursement teams out of the office.","img":{"alt":"lightbulb shatter","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/lightbulb-shatter.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/distant-but-engaged-transitioning-to-virtual-training","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Distant But Engaged: Transitioning to Virtual Training"},"categories":["commercialization","market access","reimbursement","covid-19"],"segments":["manufacturers"],"timestamp":637250701220000000,"title":"distant but engaged: transitioning to virtual training"},{"card":{"key":"946febce-3a10-4206-898b-468a6cbf2aeb","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2023","description":"With just over a year to go before the Joint Clinical Assessment (JCA) is implemented, a key question remains: Will the patient voice truly be heard and given weight in the decision-making process? ","img":{"alt":"EU JCA Patients at the center","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/does-the-jca-truly-embrace-the-patients-voice.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/does-the-jca-truly-embrace-the-patients-voice","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Patients at the center – Does the JCA truly embrace the patients’ voice? "},"categories":["regulatory","consulting"],"segments":["manufacturers"],"timestamp":638376487060000000,"title":"patients at the center – does the jca truly embrace the patients’ voice? "},{"card":{"key":"bb4aa6a5-695c-4960-82a2-c482ca05a2bb","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2020","description":"With the future of face-to-face field sales uncertain for a while, how can pharma ensure product messaging reaches the right healthcare audiences and, ultimately, patients) — now and in the new era of healthcare delivery?","img":{"alt":"Manufacturer’s guide to omnichannel marketing","src":"-/media/assets/lash/images/approach/pagedesign_groupcomputer.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/manufacturers-guide-to-omnichannel-marketing","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Manufacturer's Guide to Omnichannel Marketing"},"categories":["marketing"],"segments":["manufacturers"],"timestamp":637358662800000000,"title":"manufacturer's guide to omnichannel marketing"},{"card":{"key":"8580c622-65f9-4555-b2be-055d8aa78bb1","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2021","description":"The product life cycle solutions you need at every stage.","img":{"alt":"How to maximize your drug commercialization investments","src":"-/media/assets/amerisourcebergen/manufacturer/gettyimages-1179988450_rgb_large_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-maximize-your-drug-commercialization-investments","linkText":"View the guide","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How to maximize your drug commercialization investments"},"categories":["commercialization"],"segments":["manufacturers"],"timestamp":637479994800000000,"title":"how to maximize your drug commercialization investments"},{"card":{"key":"e70732e1-44dd-467d-b5f2-20137808b530","authorName":"Dawn Herren, RN, MSN","authorCompany":"Lash Group","date":"December 2018","description":"Why is accreditation important for patient support program providers?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/why-accreditation-matters-for-patient-support-providers","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Why Accreditation Matters for Patient Support Providers"},"categories":["medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":636796267730000000,"title":"why accreditation matters for patient support providers"},{"card":{"key":"e56bb7e1-5210-469e-b62c-34529af03126","authorName":"Lash Group","authorCompany":null,"date":"December 2021","description":"The eBV right solution isn't about having all the bells and whistles, it's about how it can scale with you. When looking for eBV tools that can quickly flex up from simple to sophisticated, consider these five factors.","img":{"alt":"electronic benefit verification article image","src":"-/media/assets/amerisourcebergen/insights/gettyimages-1139001612_rgb_large_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/finding-flexibility-five-important-features-of-pharmacy-ebv-solutions","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Finding flexibility: Five important features of pharmacy eBV solutions"},"categories":["affordability","commercialization","patient support services"],"segments":["manufacturers"],"timestamp":637745828080000000,"title":"finding flexibility: five important features of pharmacy ebv solutions"},{"card":{"key":"29deffb4-2dd5-43c1-9576-440113cc9732","authorName":"Myra Reinhardt; Shanna Barnes","authorCompany":"Biopharma Services","date":"April 2020","description":"","img":{"alt":"Screen Shot 20200410 at 101907 AM","src":"-/media/assets/lashgroup/images/9-news-events/screen-shot-20200410-at-101907-am.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/2020-webinar--part-1-leveraging-ai-within-ebv-to-speed-access-to-therapy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar Part 1: Leveraging AI within eBV to speed access to therapy"},"categories":["patient support services"],"segments":["manufacturers"],"timestamp":637237917000000000,"title":"webinar part 1: leveraging ai within ebv to speed access to therapy"},{"card":{"key":"0fc10153-ce56-417b-9972-3af482a0f5b2","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2024","description":"","img":{"alt":"meeting","src":"-/media/assets/amerisourcebergen/business_bcn22_1112_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/leverage-enterprise-thinking-for-commercialization-progress","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Leverage enterprise thinking for commercialization progress"},"categories":["commercialization","market access","research"],"segments":["manufacturers"],"timestamp":638479335600000000,"title":"leverage enterprise thinking for commercialization progress"},{"card":{"key":"0e614245-934d-4643-89d5-084b20b90a42","authorName":"Dale Hanna","authorCompany":"Cencora","date":"August 2024","description":"","img":{"alt":"panel speakers","src":"-/media/assets/amerisourcebergen/arm---cgt-insight/panel-discussion.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/unwinding-the-patient-journey---simplifying-experiences-and-overcoming-patient-access-barriers","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Unwinding the patient journey: Simplifying experiences and overcoming patient access barriers"},"categories":["cell and gene therapy","patient support services"],"segments":["manufacturers"],"timestamp":638603616600000000,"title":"unwinding the patient journey: simplifying experiences and overcoming patient access barriers"},{"card":{"key":"722c6f00-a33b-4b8c-a92d-e2bdf9786bdd","authorName":"Lash Group","authorCompany":null,"date":"July 2020","description":"Pharmaceutical manufacturers are assessing how they can adjust their patient assistance programs to meet emerging needs during the COVID-19 pandemic. How can patient support flex to ensure access to needed medications?","img":{"alt":"COVID piggy bank","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/covid-piggy-bank.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/patient-support-in-the-time-of-covid-19","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Patient support in the time of COVID-19: Five ways to adapt"},"categories":["affordability","covid-19","patient support services","medication adherence","product access"],"segments":["manufacturers"],"timestamp":637305286510000000,"title":"patient support in the time of covid-19: five ways to adapt"},{"card":{"key":"95c62a4c-86f9-430e-a2f7-cc51507551c6","authorName":"Ben Penley","authorCompany":"Cencora","date":"May 2024","description":"","img":{"alt":"AB-Business-Meeting-Two-Males_RGB_Large-Square","src":"-/media/assets/worldcourier/english/images/ab-business-meeting-two-males_rgb_large_jpg-cropped/ab-business-meeting-two-males_rgb_large-square.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/4-questions-with-ben-penley","linkText":"Discover now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"4 questions with Ben Penley"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638520094430000000,"title":"4 questions with ben penley"},{"card":{"key":"afb7f639-2cc5-4925-a9ce-f2d92ef7ed20","authorName":"Malia Gill, MS; Kimberly Ruiz, EdM; Fi Stewart, MSc; Erika Wissinger, PhD","authorCompany":"Cencora","date":"March 2024","description":"So much scientific evidence, so little time. We assess the performance and capabilities of our newest team member: artificial intelligence. ","img":{"alt":"Rating AI for Lit reviews","src":"-/media/assets/amerisourcebergen/htaq-spring-2024-ai.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-spring-2024-rating-the-robots-artificial-intelligence-for-literature-reviews","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Rating the robots: Artificial intelligence for literature reviews"},"categories":["consulting","policy","regulatory"],"segments":["manufacturers"],"timestamp":638453443800000000,"title":"rating the robots: artificial intelligence for literature reviews"},{"card":{"key":"69b72cda-fb32-4f15-a2f3-e17575183851","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2024","description":"In this edition, we continue our series on preparing for the introduction of European Union HTA; consider how US drug pricing negotiations under the Inflation Reduction Act (IRA) compare with those in countries with an established price negotiation framework, and assess the strengths and limitations of artificial intelligence (AI) tools for literature reviews.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-spring-2024-summary","linkText":"Read more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"HTA Quarterly Spring 2024"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638453502600000000,"title":"hta quarterly spring 2024"},{"card":{"key":"93431ba5-b987-4ff8-b162-77513af276f9","authorName":"Warren Dunn","authorCompany":"AmerisourceBergen","date":"February 2023","description":"","img":{"alt":"emerging biopharma companies launching their first therapy","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/emerging-biopharma-companies-launching-their-first-therapy.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/six-essential-steps-for-emerging-biopharma-companies-launching-their-first-therapy","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Six essential steps for emerging biopharma companies launching a new therapy"},"categories":["market access","consulting","patient support services"],"segments":["manufacturers"],"timestamp":638119901430000000,"title":"six essential steps for emerging biopharma companies launching a new therapy"},{"card":{"key":"6a3d255e-cfca-4b37-a8f4-79ebd51179c8","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"March 2023","description":"","img":{"alt":"GettyImages-1161024014-RGB_PNG","src":"-/media/assets/worldcourier/english/images/gettyimages-1161024014-rgb_png.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/delivering-advanced-cgt-biologic-breakthroughs-to-the-world","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Delivering advanced CGT biologic breakthroughs to the world"},"categories":["cell and gene therapy"],"segments":[],"timestamp":638149185270000000,"title":"delivering advanced cgt biologic breakthroughs to the world"},{"card":{"key":"1f6b4676-5976-40cc-a0eb-603b3265d07f","authorName":"Charles Dragovich","authorCompany":"","date":"March 2023","description":"Biopharma companies that are not participating in PIE with payers are missing a valuable step in their commercialization process. ","img":{"alt":"Abstract photography showing blue and white lines with a sense of motion","src":"-/media/assets/xcenda/english/images/insights/gettyimages-1399150019-rt-rgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/optimize-your-pre-approval-information-exchange-strategy","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Optimize your pre-approval information exchange strategy"},"categories":["market access","regulatory"],"segments":["manufacturers"],"timestamp":638150201300000000,"title":"optimize your pre-approval information exchange strategy"},{"card":{"key":"bf54b080-77de-419c-afa5-e10a1cd99deb","authorName":"Innomar Strategies","authorCompany":null,"date":"April 2020","description":"Executive Q&A: Quality Assurance expert Stuart du Kamp talks about the need for QA to adapt to new industry trends, the benefits of a long-term quality improvement plan, and what manufacturers can gain from integrated solutions. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/3-questions-with---quality-assurance-and-gmp-services","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"Commercializing in Canada: Quality Assurance and GMP Services"},"categories":["commercialization","regulatory"],"segments":["manufacturers"],"timestamp":637227216000000000,"title":"commercializing in canada: quality assurance and gmp services"},{"card":{"key":"b04c5174-3a9f-4b9d-ad83-c488bdb90034","authorName":"AmerisourceBergen","authorCompany":"","date":"September 2022","description":"Not all eBV solutions perform equally. Look for one that leverages AR expertise to automate cases end-to-end.","img":{"alt":"PageDesign_MaleDoc_FemalePatient","src":"-/media/assets/lash/images/pagedesign_maledoc_femalepatient.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-an-automation-solution-helps-more-patients-stay-on-track-with-scheduled-therapies","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How automation helps more patients stay on track with their therapies"},"categories":["analytics","patient support services","affordability"],"segments":["manufacturers"],"timestamp":638000549340000000,"title":"how automation helps more patients stay on track with their therapies"},{"card":{"key":"c8ecf3da-998d-4c7f-99a4-ae7024654814","authorName":"Xcenda","authorCompany":null,"date":"August 2023","description":"","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-fall-2023-summary-page","linkText":"Read more","hasImage":false,"isImageMode":true,"label":"Insight","headline":"HTA Quarterly | Fall 2023"},"categories":["consulting","market access","policy"],"segments":[],"timestamp":638271985060000000,"title":"hta quarterly | fall 2023"},{"card":{"key":"149fea01-499b-4b8f-ab83-a7dde7736db3","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2023","description":"","img":{"alt":"VPAS What's Next","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-fall-2023-vpas.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-fall-2023-vpas-where-next","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"VPAS—Where next?"},"categories":["affordability","consulting","legislation","policy"],"segments":["manufacturers"],"timestamp":638271172010000000,"title":"vpas—where next?"},{"card":{"key":"29198465-258d-4749-897a-abe5a5ac8817","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2020","description":"Leverage our expertise and network of retail and physician customers to promote your brand through the BRx Catalog and CustomConnect®.

Our highly targeted marketing programs leverage our proximity to the customer, connecting your brand message with the healthcare providers who influence your brand’s performance. Your tailored messages are integrated into our customers’ existing workflow so your communication stands out and gets recognized.","img":{"alt":"GettyImages-1222500485-rev","src":"-/media/assets/amerisourcebergen/manufacturer/gettyimages-1222500485-rev.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/promote-your-brand-through-the-brx-catalog-and-customconnect","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case studies: The power of multichannel marketing"},"categories":["affordability"],"segments":["manufacturers"],"timestamp":637327681800000000,"title":"case studies: the power of multichannel marketing"},{"card":{"key":"befca0f9-41b7-45e8-9a37-1885820c5b3d","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2023","description":"Is field reimbursement and access support worth the investment? We asked an expert.","img":{"alt":"4 people having a discussion","src":"-/media/assets/xcenda/english/images/solutions/fieldservices.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/work-worth-doing-field-solutions","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Work worth doing: Innovative field solutions"},"categories":["commercialization","covid-19","data","innovation","market access","reimbursement","product access","field support"],"segments":["manufacturers"],"timestamp":638382599400000000,"title":"work worth doing: innovative field solutions"},{"card":{"key":"3bff804f-7062-4c48-9213-cda48891de50","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2024","description":"","img":{"alt":"Lady sitting at a desk with a laptop","src":"-/media/assets/xcenda/english/images/formularydecisions/formularydecisions-body2-2100-payers.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/unlocking-amcp-format-version","linkText":"Register now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Unlocking AMCP Format Version 5.0: Navigating updates and best practices for formulary dossiers"},"categories":["formulary solutions"],"segments":["manufacturers"],"timestamp":638548623000000000,"title":"unlocking amcp format version 5.0: navigating updates and best practices for formulary dossiers"},{"card":{"key":"49c74168-067b-4d7a-9fb2-d1dd03ba3802","authorName":"Lash Group","authorCompany":null,"date":"June 2021","description":"Don't let a murky coverage landscape or a patient support program that can't keep pace hold your digital therapy back. Keep these do's and don'ts in mind as you commercialize your digital therapeutic.","img":{"alt":"young man on smartphone pink wall","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/young-man-on-smartphone-pink-wall.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/dtx-dos-and-donts","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Patient support for digital therapeutics: Do's and don'ts for designing your program"},"categories":["affordability","commercialization","data","innovation","market access","patient support services","product access","reimbursement","technology"],"segments":["manufacturers"],"timestamp":637595412680000000,"title":"patient support for digital therapeutics: do's and don'ts for designing your program"},{"card":{"key":"4ef9aac5-ef05-4fd1-9cc2-d37fba7e52fb","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"3PL","src":"-/media/assets/innomarstrategies/insights/innomar-3pl.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/comprehensive-3pl-and-qa-services","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Innomar Strategies: Comprehensive 3PL and QA services"},"categories":["our role in healthcare"],"segments":["manufacturers"],"timestamp":638557956000000000,"title":"innomar strategies: comprehensive 3pl and qa services"},{"card":{"key":"9838c810-44e0-460c-9bf9-84639fbf1e6f","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2023","description":"","img":{"alt":"","src":"-/media/assets/worldcourier/english/images/article-images/green-corridor-infographic.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/going-the-distance---delivery-through-the-cell-and-gene-green-corridor","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Going the distance: Delivery through the cell and gene Green Corridor"},"categories":[],"segments":[],"timestamp":638205786000000000,"title":"going the distance: delivery through the cell and gene green corridor"},{"card":{"key":"e385c07a-7873-4d3a-ab3c-369e44e9673b","authorName":"Lash Group","authorCompany":null,"date":"March 2020","description":"Benefits verification (BV) is built into the framework for physician-administered specialty therapies for good reason: it provides patients with both access to leading-edge care and clarity around out-of-pocket costs.","img":{"alt":"Access_to_therapy","src":"-/media/assets/xcenda/english/images/expertise/patientsmeds.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/data-analytics-enables-program-improvements-for-faster-therapy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Data Analytics Enables Program Improvements for Faster Access to Therapy"},"categories":["analytics","patient care","patient support services","product access","commercialization"],"segments":[],"timestamp":637194385800000000,"title":"data analytics enables program improvements for faster access to therapy"},{"card":{"key":"a88b4797-1faf-4699-9208-f3200111672e","authorName":"FormularyDecisions","authorCompany":"","date":"September 2023","description":"FormularyDecisions® can assist healthcare decision makers (HCDMs) as they strive for greater efficiency in their processes. ","img":{"alt":"Two women having discussion in front of computer monitor","src":"-/media/assets/xcenda/english/images/solutions/195436873_two_women_computer_monitor.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/using-the-right-tools-to-improve-the-formulary-review-process","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Using the right tools to improve the formulary review process"},"categories":["formulary solutions"],"segments":["manufacturers"],"timestamp":638313368770000000,"title":"using the right tools to improve the formulary review process"},{"card":{"key":"439159b8-a3a8-4422-8595-2b84792e8889","authorName":"Tasmina Hydery; Sara Linnerooth","authorCompany":"","date":"March 2022","description":"Discussing the transition of going from platform users to employees of FormularyDecisions with the power to affect change.","img":{"alt":"Coworkers at meeting","src":"-/media/assets/xcenda/english/images/insights/gettyimages-1179568324_srgb_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/6-insights-driving-formularydecisions-evolution","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Six insights driving the evolution of FormularyDecisions®"},"categories":["market access","product access","technology"],"segments":["manufacturers"],"timestamp":637843252400000000,"title":"six insights driving the evolution of formularydecisions®"},{"card":{"key":"a3420a29-6dbd-4334-b470-b9529f5491e4","authorName":"Xcenda","authorCompany":null,"date":"July 2019","description":"In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-digital-innovation-drives-improved-market-access-strategies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"How Digital Innovation Drives Improved Market Access Strategies"},"categories":["affordability","analytics","commercialization","data","market access","patient support services","reimbursement","technology"],"segments":["manufacturers"],"timestamp":637000268110000000,"title":"how digital innovation drives improved market access strategies"},{"card":{"key":"70b363ea-2989-4bb9-b6ce-6d98ab692ffc","authorName":"Leigh Gallo; Victoria Loo, MPH; Scott Shields, MBA","authorCompany":"Cencora","date":"January 2024","description":"","img":{"alt":"patient care","src":"-/media/assets/amerisourcebergen/ab-doctor-patient-exam_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/addressing-barriers-to-patient-care","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Addressing Barriers to Patient Care for People Living With Atopic Dermatitis"},"categories":["market access","patient support services","research","consulting"],"segments":["manufacturers"],"timestamp":638411056450000000,"title":"addressing barriers to patient care for people living with atopic dermatitis"},{"card":{"key":"f63206e6-aa5b-4bac-93b3-ad631e48ec26","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2023","description":"","img":{"alt":"Amerisourcebergen representatives at Asembia","src":"-/media/assets/amerisourcebergen/manufacturer/asembia-hero.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/recap-asembia-2023","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Recap Asembia 2023: Our impactful contributions to the premier specialty pharmacy conference"},"categories":["commercialization","commercial supply chain","cell and gene therapy","biosimilars","consulting","distribution","specialty pharmacy"],"segments":["manufacturers"],"timestamp":638188891230000000,"title":"recap asembia 2023: our impactful contributions to the premier specialty pharmacy conference"},{"card":{"key":"9771a472-192a-457c-989f-ff05d562593f","authorName":"Xcenda","authorCompany":null,"date":"September 2019","description":"How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilars-launch-insights-from-the-field","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Biosimilars: Launch Insights From the Field"},"categories":["biosimilars","commercialization","market access"],"segments":["manufacturers"],"timestamp":637044504690000000,"title":"biosimilars: launch insights from the field"},{"card":{"key":"b12ce289-cd07-4d04-a275-0c7fb497413a","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2018","description":"How is manufacturer thinking around channel strategy changing for oral oncolytics?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/a-new-approach-to-channel-strategy-for-oncology-therapies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"A New Approach to Channel Strategy for Oncology Therapies"},"categories":["affordability","commercialization","distribution","product access","oncology"],"segments":["manufacturers"],"timestamp":636604430600000000,"title":"a new approach to channel strategy for oncology therapies"},{"card":{"key":"8230b4ef-cf62-4089-b69a-5da320bcbfc3","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"","src":"-/media/assets/amerisourcebergen/gettyimages-907066742_rgb_large.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/emerging-biopharma-benefits-from-international-commercialization","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Emerging biopharma Outlook Therapeutics shares the benefits of Cencora's international commercialization support"},"categories":["commercialization","consulting"],"segments":["manufacturers"],"timestamp":638527768800000000,"title":"emerging biopharma outlook therapeutics shares the benefits of cencora's international commercialization support"},{"card":{"key":"89f75218-3221-4a73-973e-07e99d6abfe4","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2024","description":"","img":{"alt":"Vials","src":"-/media/assets/amerisourcebergen/manufacturer/ab-pharmaceuticals-vials_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-2023-will-shape-the-us-biosimilar-space-for-2024-beyond","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Podcast: How 2023 will shape the US Biosimilar space for 2024 and beyond"},"categories":["biosimilars","consulting","managed care","market access","policy"],"segments":["manufacturers"],"timestamp":638399026590000000,"title":"podcast: how 2023 will shape the us biosimilar space for 2024 and beyond"},{"card":{"key":"3a2f7759-88de-40a8-8ebd-47bdc4a46e22","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2024","description":"","img":{"alt":"US Capitol building","src":"-/media/assets/xcenda/english/images/insights/uscapitol.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/navigating-ira-negotiations","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar Insights: Navigating the changing landscape of Inflation Reduction Act (IRA) negotiations "},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638464725600000000,"title":"webinar insights: navigating the changing landscape of inflation reduction act (ira) negotiations "},{"card":{"key":"788b98c0-441a-410e-826e-aa8711aeea95","authorName":"Sandra Siegel, DVM","authorCompany":"","date":"January 2024","description":"Empower your veterianry clients with a branded practice app that elevates their experience. See how an app enhances client engagement, compliance, and loyalty.","img":{"alt":"2 Black men walk a labrador retriever outside","src":"-/media/assets/mwianimalhealth/images/insights-images/lifestyle_bcn22_0006_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/seven-ways-to-drive-client-awareness-and-usage-of-a-branded-veterinary-practice-app","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Seven ways to drive client awareness and usage of a branded veterinary practice app"},"categories":["veterinary practices","technology"],"segments":["animal health"],"timestamp":638403999630000000,"title":"seven ways to drive client awareness and usage of a branded veterinary practice app"},{"card":{"key":"6b784958-6758-46ec-8836-3f4ae6887f87","authorName":"MWI Animal Health","authorCompany":"","date":"May 2023","description":"How can you enable client loyalty while also boosting compliance and enabling efficiency? With a client-facing app uniquely branded to your veterinary practice.","img":{"alt":"Woman with dog looking at phone","src":"-/media/assets/allydvm/images/gettyimages-1266637341-rgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/yes-your-veterinary-practice-needs-an-app","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Yes, your veterinary practice needs an app"},"categories":["technology","veterinary practices","engagement"],"segments":["animal health"],"timestamp":638193186000000000,"title":"yes, your veterinary practice needs an app"},{"card":{"key":"da274958-33cb-4426-9e50-ad5907b4620f","authorName":"MWI Animal Health","authorCompany":"","date":"March 2022","description":"Veterinary practices should leverage data to save money, increase revenue, and build more engaged relationships with clients.","img":{"alt":"Charts and graphs showing veterinary data","src":"-/media/assets/mwianimalhealth/images/insights-images/veterinary-data.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/leverage-the-untapped-potential-of-your-veterinary-data","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Leverage the untapped potential of your veterinary data"},"categories":["technology","veterinary practices"],"segments":["animal health"],"timestamp":637822386000000000,"title":"leverage the untapped potential of your veterinary data"},{"card":{"key":"0d31c624-4d6f-4301-8c73-dcdfa2e45ccf","authorName":"MWI Animal Health","authorCompany":"","date":"April 2021","description":"Order consolidation by this veterinary practice has positive environmental impacts

","img":{"alt":"Box on conveyor belt in distribution center","src":"-/media/assets/mwianimalhealth/images/insights-images/ab-dc-operations-conveyor-box_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/positive-environmental-impact-of-order-consolidation","linkText":"View the infographic","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Infographic: Positive environmental impact of order consolidation "},"categories":["veterinary practices","innovation"],"segments":["animal health"],"timestamp":637545228970000000,"title":"infographic: positive environmental impact of order consolidation "},{"card":{"key":"1879f4ed-8c59-4b99-b081-da336bdddcc1","authorName":"Jason Wernli; Scott Harper","authorCompany":"AllyDVM","date":"June 2021","description":"Leverage veterinary client communication technology to automate routine connections that keep practices humming and patients healthy.","img":{"alt":"Female doctor at computer in office","src":"-/media/assets/mwianimalhealth/images/insights-images/female-doctor-at-computer-in-office.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/the-case-for-veterinary-client-communication-platforms","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"The case for veterinary client communication platforms"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":637586675690000000,"title":"the case for veterinary client communication platforms"},{"card":{"key":"21d7a415-d7ef-44bd-a8d8-d9b6394c185d","authorName":"Distinct Advantage Partner","authorCompany":"","date":"February 2020","description":"If you decide to open a new office, whether as a relocation, new start-up practice, property purchase, or second office, having the right team in place is paramount and can make the process successful, profitable and maybe even fun!","img":{"alt":"Business team meeting","src":"-/media/assets/mwianimalhealth/images/insights-images/business-team.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/assembling-the-right-team","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Assembling the Right Team to Open a New Office"},"categories":["veterinary practices","practice management"],"segments":["animal health"],"timestamp":637161120000000000,"title":"assembling the right team to open a new office"},{"card":{"key":"2a321261-626e-44f7-b356-cfdd11163012","authorName":"MWI Animal Health","authorCompany":"","date":"July 2020","description":"","img":{"alt":"Young woman petting dog","src":"-/media/assets/mwianimalhealth/images/insights-images/dog-bath-groomer.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/four-tips-for-marketing-to-millennial-pet-parents","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Four tips for marketing to millennial pet parents"},"categories":["veterinary practices","marketing"],"segments":["animal health"],"timestamp":637314600030000000,"title":"four tips for marketing to millennial pet parents"},{"card":{"key":"3c148474-6618-4132-b7d8-fd0ec3a92985","authorName":"MWI Animal Health","authorCompany":"","date":"February 2022","description":"Veterinary practices need a client retention plan powered by technology and staff buy-in.","img":{"alt":"Woman's hand holding phone with AllyDVM's two-way texting platform displayed","src":"-/media/assets/mwianimalhealth/images/insights-images/woman_hand_phone_allydvm_texting.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/four-reasons-why-technology-helps-practices-keep-veterinary-clients","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Four reasons why technology helps practices keep veterinary clients"},"categories":["practice management","technology","veterinary practices"],"segments":["animal health"],"timestamp":637812021000000000,"title":"four reasons why technology helps practices keep veterinary clients"},{"card":{"key":"3dc87813-4d57-4ed0-a379-d37d4090e606","authorName":"MWI Animal Health","authorCompany":"","date":"September 2021","description":"The pandemic exacerbated the pace and pressure of veterinary work, shining a spotlight on burnout and exhaustion.","img":{"alt":"Stressed healthcare worker","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-1062129234.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/how-veterinarians-can-manage-burnout-and-support-well-being","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How veterinarians can manage burnout and support well-being"},"categories":["veterinary practices","engagement"],"segments":["animal health"],"timestamp":637666038000000000,"title":"how veterinarians can manage burnout and support well-being"},{"card":{"key":"65b9e041-6b54-4946-abd8-f70fa494f366","authorName":"Tim Peart","authorCompany":"Micro Technologies","date":"August 2020","description":"","img":{"alt":"ask community","src":"-/media/assets/mwianimalhealth/images/insights-images/ask-community.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/the-role-of-data-ownership-in-animal-health","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"The role of data ownership in animal health"},"categories":["data","cattle producers","technology"],"segments":["animal health"],"timestamp":637344738000000000,"title":"the role of data ownership in animal health"},{"card":{"key":"672c5396-c513-457f-9634-f71bc3e74c48","authorName":"MWI Animal Health","authorCompany":"","date":"October 2021","description":"A veterinary home delivery program can help both you and your clients, improving pet health and client retention. Here's why this service is a vital addition to your practice.","img":{"alt":"Woman opens package as dog looks on","src":"-/media/assets/mwiah-uk/images/blog/gettyimages-1224888401/home-delivery-pet-meds.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/how-can-a-veterinary-home-delivery-program-help-with-client-retention","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How can a veterinary home delivery program help with client retention?"},"categories":["veterinary practices","inventory management"],"segments":["animal health"],"timestamp":637702552230000000,"title":"how can a veterinary home delivery program help with client retention?"},{"card":{"key":"793bd9e9-32af-4dba-8e0f-da1cd502627e","authorName":"MWI Animal Health","authorCompany":"","date":"June 2021","description":"Evaluating your indirect costs, especially your labor costs, is an important aspect of managing inventory and operating a veterinary practice.","img":{"alt":"Workers carry totes at a DC","src":"-/media/assets/mwianimalhealth/images/insights-images/salt-lake-city-image-1_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/managing-indirect-costs-of-inventory-management-in-veterinary-practices","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Managing indirect costs of inventory management in veterinary practices"},"categories":["distribution","veterinary practices"],"segments":["animal health"],"timestamp":637588278000000000,"title":"managing indirect costs of inventory management in veterinary practices"},{"card":{"key":"a6d04c27-facb-46cd-ac4e-f86d948e36af","authorName":"MWI Animal Health","authorCompany":null,"date":"November 2022","description":"Veterinary preventive care plans can empower both veterinary practices and their clients. A robust program can improve your clients' pets' health while freeing up more time for your staff. Here's why.","img":{"alt":"Dog getting check-up","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-1337098603.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/empowering-your-veterinary-practice-and-customers-with-preventive-care-plans","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Empowering your veterinary practice and customers with preventive care plans"},"categories":["business performance","veterinary practices"],"segments":["animal health"],"timestamp":638051703000000000,"title":"empowering your veterinary practice and customers with preventive care plans"},{"card":{"key":"f9e8fdc9-d66b-4973-8402-b7001c67bc3d","authorName":"MWI Animal Health","authorCompany":"","date":"March 2021","description":"Veterinary practices need to leverage solutions and technologies to make compliance efforts easier and more automated.","img":{"alt":"AB-AH-Veterinarian-Dog-Exam_RGB_Large_JPG","src":"-/media/assets/mwianimalhealth/images/insights-images/ab-ah-veterinarian-dog-exam_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/improve-flea-tick-heartworm-prevention-compliance","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How to improve flea, tick, and heartworm prevention compliance"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":637504488000000000,"title":"how to improve flea, tick, and heartworm prevention compliance"},{"card":{"key":"fc337345-26bc-4bf9-80af-ab903535fa4c","authorName":"Distinct Advantage Partner","authorCompany":"","date":"July 2020","description":"","img":{"alt":"Woman and man shaking hands at job interview","src":"-/media/assets/mwianimalhealth/images/insights-images/job_interview_handshake.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/minimizing-bias-in-hiring","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Minimizing Bias in Hiring"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":637302706800000000,"title":"minimizing bias in hiring"},{"card":{"key":"f7d2dc5a-c8a4-4c8a-b8dc-7e81b13298f3","authorName":"Scott Harper","authorCompany":"","date":"June 2020","description":"","img":{"alt":"ask us tablet","src":"-/media/assets/mwianimalhealth/images/insights-images/ask-us-tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/using-technology-to-improve-communication-with-pet-parents","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Using technology to improve communication with pet parents"},"categories":["technology","practice management","marketing","engagement"],"segments":["animal health"],"timestamp":637285157530000000,"title":"using technology to improve communication with pet parents"},{"card":{"key":"7c1eae6d-08b0-4e5c-a0f1-3e55dcf9e546","authorName":"MWI Animal Health","authorCompany":"","date":"October 2023","description":"My AnimalRX increases veterinarians' bottom line with inventory management, automated price maintenance, and customizable margins","img":{"alt":"Veterinarian examines cattle","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-472652032_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/how-my-animalrx-solves-common-challenges-for-large-animal-veterinarians","linkText":"View the infographic","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Infographic: How My AnimalRx solves common challenges for large animal veterinarians"},"categories":["veterinary practices","inventory management"],"segments":["animal health"],"timestamp":638325542250000000,"title":"infographic: how my animalrx solves common challenges for large animal veterinarians"},{"card":{"key":"fb8e7a6d-efbc-489e-bcd6-93d2ce0c803b","authorName":"MWI Animal Health","authorCompany":"","date":"August 2022","description":"Utilizing the MWI Easy Care program increased compliance and helped compete with larger veterinary practices.","img":{"alt":"Veterinarian having a conversation with a client about regular pet care compliance","src":"-/media/assets/mwianimalhealth/images/insights-images/compliance-conversations.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/new-river-animal-hospital-case-study","linkText":"Read the case study","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Case study: Straightforward preventive care solution encourages staff buy-in"},"categories":["veterinary practices","value-based care"],"segments":["animal health"],"timestamp":637959027000000000,"title":"case study: straightforward preventive care solution encourages staff buy-in"},{"card":{"key":"c3959516-4171-4453-868b-222fbffd86f6","authorName":"Roxanne Hawn","authorCompany":"","date":"March 2020","description":"","img":{"alt":"phone message alert","src":"-/media/assets/mwianimalhealth/images/insights-images/phone-message-alert.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/emergency-communication","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Emergency Communication Planning"},"categories":["practice management","veterinary practices"],"segments":["animal health"],"timestamp":637197188400000000,"title":"emergency communication planning"},{"card":{"key":"f05120f0-074f-4363-91cd-2f995cc3a431","authorName":"MWI Animal Health","authorCompany":"","date":"March 2022","description":"Pet owners may have heard of preventive care plans or pet insurance but need guidance untangling the differences","img":{"alt":"lady_tablet_dog","src":"-/media/assets/mwianimalhealth/images/insights-images/lady_tablet_dog.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/wellness-plans-versus-pet-insurance","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Preventive care plans versus pet insurance: Do your clients understand the difference?"},"categories":["veterinary practices","value-based care"],"segments":["animal health"],"timestamp":637843293000000000,"title":"preventive care plans versus pet insurance: do your clients understand the difference?"},{"card":{"key":"fb2f9c08-a4f5-4907-b7dd-0fd5c2ea27da","authorName":"Brian Topper","authorCompany":"MWI Animal Health","date":"January 2021","description":"","img":{"alt":"Female veterinarian looking at tablet","src":"-/media/assets/mwianimalhealth/images/insights-images/female-veterinarian-looking-at-tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/harness-the-proper-use-of-technology-for-your-veterinary-practice","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Harness the proper use of technology for your veterinary practice"},"categories":["technology","veterinary practices"],"segments":["animal health"],"timestamp":637474161000000000,"title":"harness the proper use of technology for your veterinary practice"},{"card":{"key":"879aaf75-b80e-49e9-ab4b-e67372efeda0","authorName":"MWI Animal Health","authorCompany":"","date":"May 2024","description":"Discover how geography impacts pet healthcare access and learn how telehealth to bridges the gap.","img":{"alt":"Young people in park with dog","src":"-/media/assets/allydvm/images/lifestyle_bcn22_1600_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/who-isnt-getting-veterinary-care","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Who isn't getting veterinary care?"},"categories":["technology","veterinary practices","advocacy"],"segments":["animal health"],"timestamp":638513088600000000,"title":"who isn't getting veterinary care?"},{"card":{"key":"7559ebdf-2c70-46f0-bf12-1c8bcd795cdd","authorName":"MWI Animal Health","authorCompany":"","date":"July 2023","description":"A sustainable distribution partner will elevate your veterinary practice's commitment to the environment.","img":{"alt":"Worker at distribution center checks boxes","src":"-/media/assets/mwianimalhealth/images/insights-images/ics_lockbourn_3pl_cycle-count_035_rgb_rtchd_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/prioritizing-sustainability-in-your-veterinary-practice","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Prioritizing sustainability in your veterinary practice"},"categories":["veterinary practices","distribution"],"segments":["animal health"],"timestamp":638241705510000000,"title":"prioritizing sustainability in your veterinary practice"},{"card":{"key":"1b1965a6-1172-445d-a17f-e0ec2bb9e13c","authorName":"MWI Animal Health","authorCompany":"","date":"March 2023","description":"Selling parasiticides like flea, tick, and heartworm medication helps both the veterinary practice and the client. MWI's Jeff Hicks explains why you shouldn't overlook this valuable revenue source.","img":{"alt":"AB-AH-Veterinarian-Dog-Exam_RGB_Large_JPG","src":"-/media/assets/mwianimalhealth/images/insights-images/ab-ah-veterinarian-dog-exam_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/healthy-pets-and-healthy-business","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Healthy pets and healthy business"},"categories":["business performance","inventory management","veterinary practices"],"segments":["animal health"],"timestamp":638137250630000000,"title":"healthy pets and healthy business"},{"card":{"key":"f22faaab-f3b4-4ad2-8c6f-5ec7f439ac96","authorName":"Courtney Carter","authorCompany":"","date":"February 2023","description":"","img":{"alt":"vet looking at data analytics on his laptop","src":"-/media/assets/mwianimalhealth/images/solutions/allydvm/allydvm_analytics_solutioncard.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/the-power-of-data","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"The power of data: How it can help your veterinary practice thrive"},"categories":["analytics","data","veterinary practices"],"segments":["animal health"],"timestamp":638120632440000000,"title":"the power of data: how it can help your veterinary practice thrive"},{"card":{"key":"05e9de45-0cb7-47ad-995e-e55df072c9ba","authorName":"MWI Animal Health","authorCompany":"","date":"March 2023","description":"What makes a particular veterinary practice an attractive place to work? The answer: It's all about the culture.","img":{"alt":"two veterinarians laughing","src":"-/media/assets/mwianimalhealth/images/insights-images/business_partnership.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/building-a-veterinary-practice-culture","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Building a veterinary practice culture"},"categories":["veterinary practices","practice management"],"segments":["animal health"],"timestamp":638137084740000000,"title":"building a veterinary practice culture"},{"card":{"key":"e3dc4295-7c05-4f14-8f4c-51554629469f","authorName":"MWI Animal Health","authorCompany":"","date":"September 2023","description":"Learn the essential steps to successfully sell your veterinary practice with minimal stress. From establishing fair market value to structuring financing options, this guide covers everything you need to know for a smooth transition into retirement. ","img":{"alt":"Elderly man smiles outside","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-1034559884_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/ready-to-move-on","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Ready to move on? Preparation is paramount when selling a practice"},"categories":["practice management","veterinary practices"],"segments":["animal health"],"timestamp":638309181310000000,"title":"ready to move on? preparation is paramount when selling a practice"},{"card":{"key":"ae9b4f4b-09e8-4c61-ab99-0bd87426ee58","authorName":"Sandra Siegel, DVM","authorCompany":"","date":"March 2024","description":"As a companion animal veterinary practice, your primary focus is to provide the best possible care for your patients. In today's rapidly changing landscape, that means recognizing the evolving preferences of pet owners.","img":{"alt":"young woman with white dog against artistic background","src":"-/media/assets/mwianimalhealth/images/insights-images/lifestyle_bcn22_0556_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/pet-owner-expectations-are-changing","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Pet owner expectations are changing. Can your practice keep up?"},"categories":[],"segments":["animal health"],"timestamp":638470520410000000,"title":"pet owner expectations are changing. can your practice keep up?"},{"card":{"key":"3741b03a-5943-4d26-950c-06b57ea54986","authorName":"MWI Animal Health","authorCompany":"","date":"March 2024","description":"Veterinary equipment malfunctions and outages don't just affect your practice's revenue stream, they impact your staff, your clients, and potentially the health of your patients. That's why preventive care for your veterinary equipment is so important.","img":{"alt":"Veterinary tech works with lab equipment","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-14116602969.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/preventive-care-matters-for-your-veterinary-equipment","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Preventive care matters for your veterinary equipment, too"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":638470549590000000,"title":"preventive care matters for your veterinary equipment, too"},{"card":{"key":"0dfea69c-1924-46ed-9274-f4f1799b3cda","authorName":"Micro Technologies","authorCompany":"","date":"January 2024","description":"Our nearly 50 years of experience placing micro machines in the beef industry give us the confidence to innovate in the dairy space while, of course, respecting the inherent differences between the sectors.","img":{"alt":"","src":"-/media/assets/gettyimages-152831237_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/enhancing-efficiency-and-accuracy-with-micro-technologies-machines","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Enhancing efficiency and accuracy with Micro Technologies machines"},"categories":["technology","technical services"],"segments":["animal health"],"timestamp":638403225420000000,"title":"enhancing efficiency and accuracy with micro technologies machines"},{"card":{"key":"c13feb56-1470-4bbb-b0a1-2a8a354e106a","authorName":"MWI Animal Health","authorCompany":"","date":"July 2023","description":"Proactive communication about summertime safety will keep your clients' pets healthy and happy in the hot weather.","img":{"alt":"Dog in car carrier in back seat of car","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-1263269348.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/four-summertime-pet-travel-tips","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Four summertime pet travel tips"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":638254506620000000,"title":"four summertime pet travel tips"},{"card":{"key":"c2988318-c5cf-4b59-bb8d-fd85b4aa55c0","authorName":"MWI Animal Health","authorCompany":"","date":"February 2024","description":"Telemedicine is a valuable tool for today’s veterinary practices. It's essential to meet evolving client expectations and stay competitive in this digitally advanc","img":{"alt":"","src":"-/media/assets/gettyimages-1250595089.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/what-is-the-value-of-telemedicine-to-your-practice","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"What is the value of telemedicine to your practice?"},"categories":["technology","veterinary practices"],"segments":["animal health"],"timestamp":638440311260000000,"title":"what is the value of telemedicine to your practice?"},{"card":{"key":"a2d4ab6d-d2be-4b15-a4fc-54ada3688524","authorName":"Julia Loew","authorCompany":"MWI Animal Health","date":"January 2024","description":"Veterinary innovations that automate routine tasks smooth workflows, reduce staff stress, grow job satisfaction, and encourage more collaboration.","img":{"alt":"","src":"-/media/assets/adobestock_417768441.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/embrace-the-benefits-of-technology-for-pet-owners-and-practices","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Embrace the benefits of technology for pet owners and practices"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":638418074970000000,"title":"embrace the benefits of technology for pet owners and practices"},{"card":{"key":"e077aea9-296e-4ea8-b133-f518a7e9161c","authorName":"MWI Animal Health","authorCompany":"","date":"November 2023","description":"Discover how Wilhite and Frees Equine Hospital boosted efficiency and client satisfaction by adopting the PetPage app in our latest case study. Learn about their journey towards digital transformation.","img":{"alt":"Young woman looks at smartphone and stands next to horse","src":"-/media/assets/allydvm/images/gettyimages-838082080.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/real-world-benefits-of-the-petpage-app-in-equine-practice","linkText":"View the case study","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Case Study: Real-world benefits of the PetPage app in equine practice"},"categories":["veterinary practices","technology"],"segments":["animal health"],"timestamp":638354775120000000,"title":"case study: real-world benefits of the petpage app in equine practice"},{"card":{"key":"742484dc-d808-44f0-950d-bfc94cfad814","authorName":"MWI Animal Health","authorCompany":"","date":"May 2023","description":"Systemic strategies to empower veterinary teams to handle rude clients calmly and consistently.","img":{"alt":"veterinary customer service","src":"-/media/assets/mwianimalhealth/images/insights-images/owner-vet-talking-clinic.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/copy-of-tips-for-dealing-with-rude-veterinary-practice-clients","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Tips for dealing with rude veterinary practice clients"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":638198373000000000,"title":"tips for dealing with rude veterinary practice clients"},{"card":{"key":"a3616991-1ec5-4aca-a22b-452daa0185d6","authorName":"MWI Animal Health","authorCompany":"","date":"July 2023","description":"Learn how companion animal practices can attract and retain qualified candidates. From compensation to continuing education and student loan repayment, find out what matters most to job seekers. Plus, see how technology and staff scheduling can help increase job satisfaction and retention rates.","img":{"alt":"Female veterinarian examines black cat","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-475150033_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/where-are-all-the-veterinary-staff","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Where are all the veterinary staff?"},"categories":["business performance","veterinary practices"],"segments":["animal health"],"timestamp":638259064670000000,"title":"where are all the veterinary staff?"},{"card":{"key":"5eb83233-6b63-4e54-82d8-485a4821d1a9","authorName":"Sandra Siegel, DVM","authorCompany":"","date":"September 2023","description":"Veterinary practices need client-facing apps to stay competitive in today's digital-first environment. But practices want to ensure their new apps not only help their clients, but cut down on their workload too. Here's why the PetPage app is a great solution for both concerns.","img":{"alt":"Young woman with brown hair sits on couch while petting dog and looking at smart phone.","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-1223974159.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/answering-common-questions-veterinary-practices-have-about-client-facing-apps","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Answering common questions veterinary practices have about client-facing apps"},"categories":["technology","veterinary practices"],"segments":["animal health"],"timestamp":638301184310000000,"title":"answering common questions veterinary practices have about client-facing apps"},{"card":{"key":"15f6d32d-e55e-4acf-ba67-7125d040f8ca","authorName":"MWI Animal Health","authorCompany":null,"date":"March 2020","description":"An overview of how to use the tools Google provides for improving visibility and search engine optimization, and follow their rules for implementing. Having this basis of understanding will help your veterinary practice achieving better results with Google's algorithm.","img":{"alt":"internet search rules notebook","src":"-/media/assets/mwianimalhealth/images/insights-images/internet-search-rules-notebook.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/google-search-rules-tools","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Google Search Basics: Rules and Tools"},"categories":["veterinary practices","marketing"],"segments":["animal health"],"timestamp":637186176000000000,"title":"google search basics: rules and tools"},{"card":{"key":"1fdff14e-cffc-483d-aa68-7356c9bbcdd4","authorName":"MWI Animal Health","authorCompany":"","date":"August 2020","description":"","img":{"alt":"Bulldog on woman's lap","src":"-/media/assets/mwianimalhealth/images/insights-images/french-bulldog-couple.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/how-veterinary-practices-can-market-to-different-generations-of-potential-clients","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How veterinary practices can market to different generations of potential clients"},"categories":["marketing","technology","covid-19"],"segments":["animal health"],"timestamp":637321482000000000,"title":"how veterinary practices can market to different generations of potential clients"},{"card":{"key":"4dec7669-14d6-4f5b-87ee-7ae043cef05b","authorName":"MWI Animal Health","authorCompany":"","date":"March 2022","description":"We live in an "instant gratification" society, and your veterinary clients are no exception. You need to learn how to manage those expectations while also looking for unique solutions your clients will appreciate. Here's a look at the best solutions that you can start implementing right away.","img":{"alt":"veterinary customer service","src":"-/media/assets/mwianimalhealth/images/insights-images/owner-vet-talking-clinic.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/exceed-expectations-in-an-instant-world-with-veterinary-customer-service","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Exceed expectations in an instant world with veterinary customer service"},"categories":["veterinary practices","technology","practice management"],"segments":["animal health"],"timestamp":637825153500000000,"title":"exceed expectations in an instant world with veterinary customer service"},{"card":{"key":"5608d853-d7b2-4969-b4db-89411cd90640","authorName":"MWI Animal Health","authorCompany":"","date":"March 2022","description":"New pet owners are a receptive audience for messages about kitten or puppy wellness. Consider these strategies for effective communication about new pet education.","img":{"alt":"Young girl takes kitten to vet for new pet education","src":"-/media/assets/mwianimalhealth/images/insights-images/girl-takes-kitten-vet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/puppy-and-kitten-wellness-strategies","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Puppy and kitten wellness strategies"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":637829482850000000,"title":"puppy and kitten wellness strategies"},{"card":{"key":"4a24bf68-9326-40ca-adeb-b4d6793a86af","authorName":"MWI Animal Health","authorCompany":"","date":"March 2023","description":"Preventive care plans offer untapped potential for your veterinary practice. Here's a look at why they are not only a financially smart move for your veterinary practice, but also a great way to improve the health of your clients' pets.","img":{"alt":"vet making recommendations to pet owner","src":"-/media/assets/mwianimalhealth/images/solutions/client-engagement/customer_centric_mecp.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/why-preventive-care-plans-are-a-smart-financial-move-for-your-veterinary-practice","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Painless path to profit: Why preventive care plans are a smart financial move for your veterinary practice"},"categories":["veterinary practices","practice management"],"segments":["animal health"],"timestamp":638150022430000000,"title":"painless path to profit: why preventive care plans are a smart financial move for your veterinary practice"},{"card":{"key":"955ee196-57cd-465e-a885-f7af03dffd45","authorName":"MWI Animal Health","authorCompany":"","date":"March 2024","description":"A good culture creates a veterinary practice where people want to work.","img":{"alt":"Two yoiung women in scrubs talk and laugh","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-1323773551.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/transform-your-veterinary-practice-culture-for-better-recruitment-and-retention","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Transform your veterinary practice culture for better recruitment and retention"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":638470638000000000,"title":"transform your veterinary practice culture for better recruitment and retention"},{"card":{"key":"0ca913c9-a2d3-4503-9442-c410ab4c3eb1","authorName":"MWI Animal Health","authorCompany":"","date":"June 2021","description":"As the summer approaches, now is the time for veterinarians to alert their clients about skin issues that can develop when the weather gets warmer. This guide can help you think of topic ideas and the ideal methods for getting your message across.","img":{"alt":"Chocolate lab in field","src":"-/media/assets/mwianimalhealth/images/insights-images/chocolate-lab-field.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/summer-skin-solutions","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Summer skin solutions"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":637606440000000000,"title":"summer skin solutions"},{"card":{"key":"0d8331d5-6162-4600-8354-b14923ec169a","authorName":"MWI Animal Health","authorCompany":"","date":"July 2022","description":"Veterinary practices face multiple challenges, including workforce shortages and decreased productivity. Here are three detailed strategies to boost efficiency and productivity, even with a reduced staff.","img":{"alt":"Asian American male veterinarian uses stethoscope on white dog","src":"-/media/assets/mwianimalhealth/images/insights-images/vet-examines-white-dog.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/how-to-be-more-efficient-with-fewer-veterinary-practice-staff","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How to be more efficient with fewer veterinary practice staff"},"categories":["veterinary practices","practice management","engagement"],"segments":["animal health"],"timestamp":637944410260000000,"title":"how to be more efficient with fewer veterinary practice staff"},{"card":{"key":"1d8bfefc-5a2a-4137-8bcb-a27af2e3a4d8","authorName":"MWI Animal Health","authorCompany":"","date":"August 2022","description":"A veterinary medicine home delivery service can be a game changer, but only if your staff is excited about it too. This guide will help you educate and empower your staff as you launch your new service.","img":{"alt":"woman opens package as dog looks on","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-1417084432_rgb_web.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/creating-a-resourceful-veterinary-medicine-home-delivery-program","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Creating a resourceful veterinary medicine home delivery program"},"categories":["veterinary practices","inventory management"],"segments":["animal health"],"timestamp":637970515690000000,"title":"creating a resourceful veterinary medicine home delivery program"},{"card":{"key":"2cfc2529-4360-4525-959d-b0e2159576ad","authorName":"Katherine Garrett","authorCompany":"","date":"December 2021","description":"A conversation with Katherine Garrett, incoming vice president of the American Association of Equine Practitioners","img":{"alt":"Veterinarian uses equine diagnostic imaging on a horse's leg","src":"-/media/assets/mwianimalhealth/images/insights-images/horse-gets-leg-x-rayed.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/what-should-equine-veterinary-practices-understand-about-diagnostic-imaging","linkText":"Read the Q&A","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Q&A: What should equine veterinary practices understand about diagnostic imaging?"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":637740730680000000,"title":"q&a: what should equine veterinary practices understand about diagnostic imaging?"},{"card":{"key":"2f78ba93-eff1-4f7d-8707-9fd5e90f3255","authorName":"MWI Animal Health","authorCompany":"","date":"September 2020","description":"","img":{"alt":"DeviceLaptopDeskFemale11160006","src":"-/media/assets/amerisourcebergen/tecnhology/devicelaptopdeskfemale11160006.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/six-ways-landing-pages-differ-from-other-website-pages","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Six ways landing pages differ from other website pages"},"categories":["veterinary practices","marketing"],"segments":["animal health"],"timestamp":637360290000000000,"title":"six ways landing pages differ from other website pages"},{"card":{"key":"3b780236-0f33-49c2-a9c2-aa319774766d","authorName":"MWI Animal Health","authorCompany":"","date":"May 2021","description":"Anticipating pet owners' needs and targeting your veterinary marketing efforts based on the proper context leads to positive results.","img":{"alt":"client recommendations","src":"-/media/assets/mwianimalhealth/images/insights-images/client-recommendations.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/setting-the-right-context-for-veterinary-marketing","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Setting the right context for veterinary marketing"},"categories":["veterinary practices","engagement"],"segments":["animal health"],"timestamp":637571871000000000,"title":"setting the right context for veterinary marketing"},{"card":{"key":"4f51372a-8d14-4aa7-bc60-b3f3280b8c3a","authorName":"MWI Animal Health","authorCompany":"","date":"August 2022","description":"Learn how an animal hospital launched a robust marketing plan to encourage sign-ups for its preventive care plan.","img":{"alt":"kitten_veterinarian","src":"-/media/assets/mwianimalhealth/images/insights-images/kitten_veterinarian.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/lexington-animal-hospital-case-study","linkText":"Read the case study","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Case study: Using the preventive care program to stay competitive with larger veterinary practices"},"categories":["veterinary practices","practice management","marketing"],"segments":["animal health"],"timestamp":637959033000000000,"title":"case study: using the preventive care program to stay competitive with larger veterinary practices"},{"card":{"key":"972430c0-f2fb-45ab-8b3e-aa605f88f3fc","authorName":"MWI Animal Health","authorCompany":"","date":"August 2022","description":"To grow purchases from your veterinary e-commerce efforts, consider these trends, strategies, and messaging techniques to stand out.","img":{"alt":"Woman looks at laptop with her cat and credit card","src":"-/media/assets/mwianimalhealth/images/insights-images/woman-cat-credit-card.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/how-veterinary-practices-can-stand-out-amid-e-commerce-competition","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How veterinary practices can stand out amid e-commerce competition"},"categories":["veterinary practices","inventory management"],"segments":["animal health"],"timestamp":637952110070000000,"title":"how veterinary practices can stand out amid e-commerce competition"},{"card":{"key":"b3392186-94ba-4873-822b-9625eb3658fc","authorName":"MWI Animal Health","authorCompany":"","date":"January 2022","description":"Pet preventive care plans give veterinary practices the opportunity to promote the value of their unique expertise.","img":{"alt":"Pet owners greeted at front desk of veterinary practice","src":"-/media/assets/mwianimalhealth/images/insights-images/shutterstock_1586647927_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/why-it-makes-smart-business-sense-to-offer-pet-preventive-care-plans","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Why it makes smart business sense to offer pet preventive care plans"},"categories":["veterinary practices","practice management"],"segments":["animal health"],"timestamp":637786980000000000,"title":"why it makes smart business sense to offer pet preventive care plans"},{"card":{"key":"f00c732b-6ef0-4975-95cb-62094a7a5434","authorName":"MWI Animal Health","authorCompany":"","date":"June 2022","description":"Set up veterinary client communication topics and timelines now that educate and engage people on summertime subject.","img":{"alt":"A young woman hugs a white dog while laying on a sofa","src":"-/media/assets/mwianimalhealth/images/insights-images/young-woman-hugs-white-dog-sofa.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/hot-summer-topics","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Hot summer topics: What and how to share with pet parents"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":637921800000000000,"title":"hot summer topics: what and how to share with pet parents"},{"card":{"key":"fe5f96b1-d84b-427d-a3b2-3ad56a8d594f","authorName":"MWI Animal Health","authorCompany":"","date":"March 2021","description":"Technology platforms can result in exponential improvement for animal health services if designed and implemented for more than surface-level integrations.","img":{"alt":"Asian woman texting with dog","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-758304949_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/encouraging-better-animal-health-outcomes-through-technology","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Encourage better animal health outcomes through technology"},"categories":["veterinary practices","technology"],"segments":["animal health"],"timestamp":637521258230000000,"title":"encourage better animal health outcomes through technology"},{"card":{"key":"94bdb4a1-574f-48a1-84cd-2fbb23c39476","authorName":"MWI Animal Health","authorCompany":"","date":"April 2021","description":"Take the time to create and implement a distinct companion veterinary practice brand.

","img":{"alt":"Man on computer researching pet vaccinations","src":"-/media/assets/mwianimalhealth/images/insights-images/stressful_communication.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/understanding-branding-as-a-companion-veterinary-practice-owner","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Understanding branding as a companion veterinary practice owner"},"categories":["marketing","veterinary practices"],"segments":["animal health"],"timestamp":637535511000000000,"title":"understanding branding as a companion veterinary practice owner"},{"card":{"key":"8e86bd89-c3c7-4efe-ae80-ee23063bd360","authorName":"MWI Animal Health","authorCompany":"","date":"May 2023","description":"Systemic strategies to empower veterinary teams to handle rude clients calmly and consistently.","img":{"alt":"veterinary customer service","src":"-/media/assets/mwianimalhealth/images/insights-images/owner-vet-talking-clinic.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/tips-for-dealing-with-rude-veterinary-practice-clients","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Tips for dealing with rude veterinary practice clients"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":638198373000000000,"title":"tips for dealing with rude veterinary practice clients"},{"card":{"key":"d5162bf2-6a9a-473a-a373-a1b11300ca2d","authorName":"MWI Animal Health","authorCompany":"","date":"May 2023","description":"Boost revenue, reduce administrative burden, and keep less product on hand with an online animal health pharmacy.","img":{"alt":"Veterinarian with clipboard with cow in feedyard","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-1335930013_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/convenience-of-an-online-pharmacy","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Harness the convenience of an online pharmacy on the farm or ranch"},"categories":["cattle producers","veterinary practices"],"segments":["animal health"],"timestamp":638211535220000000,"title":"harness the convenience of an online pharmacy on the farm or ranch"},{"card":{"key":"658719d3-e63c-4290-b87a-0e1dfda033f3","authorName":"MWI Animal Health","authorCompany":"","date":"May 2022","description":"Keeping up with technology is crucial for companion animal veterinary practices. Innovative technology can also benefit practices by increasing client compliance and satisfaction, boosting practice-client communications, and growing revenue.","img":{"alt":"Black woman with small dog looks at tablet","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-601800899_nocollar-sm_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/how-veterinary-innovation-benefits-companion-animal-veterinary-practices","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How veterinary innovation benefits companion animal veterinary practices"},"categories":["marketing","veterinary practices","innovation"],"segments":["animal health"],"timestamp":637874235000000000,"title":"how veterinary innovation benefits companion animal veterinary practices"},{"card":{"key":"89b78b26-7993-4966-80fe-07e2399b8b7c","authorName":"MWI Animal Health","authorCompany":null,"date":"November 2022","description":"Respect clients' time with veterinary home delivery services

","img":{"alt":"Black woman looks at laptop with small dog by her side","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-601800907.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/how-to-market-veterinary-home-delivery","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How to market veterinary home delivery"},"categories":["veterinary practices","technology"],"segments":["animal health"],"timestamp":638046758030000000,"title":"how to market veterinary home delivery"},{"card":{"key":"0c76c10c-dcbb-4fc6-81a9-b79b7c5b8238","authorName":"MWI Animal Health","authorCompany":"","date":"November 2023","description":"Discover the right veterinary practice technologies for your clinic with these 10 questions. Find a partner who listens to your needs, prioritizes data security, saves you time and money, and helps you connect with pet parents.","img":{"alt":"Front desk staff","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-1497276623.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/right-software-right-clinic-right-time","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Right software, right clinic, right time"},"categories":["technology","veterinary practices"],"segments":["animal health"],"timestamp":638367678000000000,"title":"right software, right clinic, right time"},{"card":{"key":"0b1e68a6-18ee-485f-ba15-51f2b9c1e164","authorName":"MWI Animal Health","authorCompany":"","date":"April 2022","description":"Do you want your veterinarian practice to be more client-focused but aren't sure where to start? Consider fine-tuning your communication marketing, while taking a closer look at the new services your clients enjoy the most. This guide can help you get started.","img":{"alt":"Woman looks at phone with her dog","src":"-/media/assets/mwianimalhealth/images/insights-images/woman-looks-at-phone-with-dog.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/finding-the-right-channels-to-reach-pet-owners","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Finding the right channels to reach pet owners"},"categories":[],"segments":["animal health"],"timestamp":637849291940000000,"title":"finding the right channels to reach pet owners"},{"card":{"key":"0da157f6-c943-4683-a3b8-60091bca53a5","authorName":"MWI Animal Health","authorCompany":"","date":"December 2021","description":"Veterinarians can leverage equine core vaccines to increase wellness plan enrollment

","img":{"alt":"White male veterinarian examines horse to administer equine core vaccines","src":"-/media/assets/mwianimalhealth/images/insights-images/vet-examines-horse.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/equine-practices-deliver-essential-care-through-vaccinations","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Equine practices deliver essential care through vaccinations"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":637740668530000000,"title":"equine practices deliver essential care through vaccinations"},{"card":{"key":"16d38a6b-f1d1-4174-852b-463529eb5b98","authorName":"Roxanne Hawn","authorCompany":"","date":"January 2023","description":"Millions of pets do not receive adequate veterinary care because the costs are beyond the family's ability to pay. This may be the most significant animal welfare crisis affecting owned pets in the United States.","img":{"alt":"Veterinary clinic lobby","src":"-/media/assets/mwianimalhealth/images/veterinary-practices-images/veterinary_clinic_lobby.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/understanding-discrepancies-in-access-to-animal-health-services","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Understanding discrepancies in access to animal health services"},"categories":["veterinary practices"],"segments":["animal health"],"timestamp":638103473160000000,"title":"understanding discrepancies in access to animal health services"},{"card":{"key":"2cbc2956-8531-4e39-b679-4a7cf6c88aac","authorName":"MWI Animal Health","authorCompany":"","date":"January 2022","description":"Female veterinarians are 3.5 times more likely to die by suicide than the general population. By focusing attention on mental wellness and stopping the stigma around talking about suicide, those in crisis will no longer feel alone.","img":{"alt":"Stressed female veterinarian takes a break","src":"-/media/assets/mwianimalhealth/images/insights-images/gettyimages-1220240541.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/out-of-the-darkness","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Out of the darkness"},"categories":["veterinary practices","practice management"],"segments":["animal health"],"timestamp":637792312200000000,"title":"out of the darkness"},{"card":{"key":"35da708f-fc19-4af7-8aa4-5faa7f7c3263","authorName":"Brian Topper","authorCompany":"MWI Animal Health","date":"September 2020","description":"","img":{"alt":"Man and woman at computer","src":"-/media/assets/mwianimalhealth/images/insights-images/computer-analyst.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/how-to-pick-the-best-software-for-your-veterinary-practice","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How to pick the best software for your veterinary practice"},"categories":["technology","veterinary practices"],"segments":["animal health"],"timestamp":637356690000000000,"title":"how to pick the best software for your veterinary practice"},{"card":{"key":"956792dd-95ca-4c5c-868e-3b9a7211c317","authorName":"MWI Animal Health","authorCompany":"","date":"September 2021","description":"There is no one-size-fits-all strategy for business growth in animal health services.

","img":{"alt":"Female veterinarian examines cat","src":"-/media/assets/mwianimalhealth/images/insights-images/female-veterinarian-examines-cat.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/adding-new-animal-health-services-enhances-your-practice","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Adding new animal health services enhances your practice"},"categories":["veterinary practices","business performance"],"segments":["animal health"],"timestamp":637677353700000000,"title":"adding new animal health services enhances your practice"},{"card":{"key":"9ff7a20a-db63-4afa-bdf7-474e8ca2dbc9","authorName":"Distinct Advantage Partner","authorCompany":"","date":"June 2020","description":"In light of the coronavirus outbreak, your hospital’s protocols are changing day by day, even hour by hour. In this article, PawsTime shares a few building blocks for your effectively communicating with clients and with your staff.","img":{"alt":"Nurses using phones to communicate with clients","src":"-/media/assets/mwianimalhealth/images/insights-images/nurse-communications.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/9-ways-to-help-manage-client-communication-during-coronavirus","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"9 Ways to Help Manage Client Communication During Coronavirus"},"categories":["veterinary practices","practice management","marketing"],"segments":["animal health"],"timestamp":637266339600000000,"title":"9 ways to help manage client communication during coronavirus"},{"card":{"key":"afe9e8d7-9ce9-4442-9557-53b0ebc1ea7b","authorName":"MWI Animal Health; Will Stirling","authorCompany":"","date":"May 2021","description":"The 7 Ps of marketing are a useful framework for examining your veterinary marketing practices.","img":{"alt":"internet search rules notebook","src":"-/media/assets/mwianimalhealth/images/insights-images/internet-search-rules-notebook.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/how-to-use-the-7-ps-in-veterinary-marketing","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How to use the 7 Ps in veterinary marketing"},"categories":["engagement","veterinary practices"],"segments":["animal health"],"timestamp":637565981330000000,"title":"how to use the 7 ps in veterinary marketing"},{"card":{"key":"b78c98e4-81bc-4dd9-a2ce-4804bc576dac","authorName":"MWI Animal Health","authorCompany":"","date":"July 2022","description":"In emergency care, veterinary practices need a distributor who is responsive, offers a good array of options, and gets them their orders quickly.","img":{"alt":"Female veterinarian examines cat","src":"-/media/assets/mwianimalhealth/images/insights-images/female-veterinarian-examines-cat.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/opening-the-door-to-emergency-medicine","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Opening the door to emergency medicine"},"categories":["veterinary practices","practice management"],"segments":["animal health"],"timestamp":637937697970000000,"title":"opening the door to emergency medicine"},{"card":{"key":"b865db3b-9556-4a2a-a241-74097362e984","authorName":"Micro Technologies","authorCompany":"","date":"August 2022","description":"Drone technology in cattle feedyards provides fast, accurate head counts while freeing employees to do other tasks. And that's just for starters.","img":{"alt":"drone in sky","src":"-/media/assets/microtechnologies/images/insights/drone_insights.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/how-drones-for-livestock-management-grow-efficiency","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How drones for livestock management grow efficiency"},"categories":["cattle producers","technology"],"segments":["animal health"],"timestamp":637963472400000000,"title":"how drones for livestock management grow efficiency"},{"card":{"key":"d9fde5ba-2c89-4f2e-a8dc-8034ecc0e2e6","authorName":"MWI Animal Health","authorCompany":"","date":"April 2021","description":"Forward-looking veterinary practice owners and managers can establish practice cultures that allow others' leadership to shine.

","img":{"alt":"Diverse young coworkers at business meeting","src":"-/media/assets/mwianimalhealth/images/insights-images/diverse-young-coworkers-at-business-meeting.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/5-ways-veterinary-staff-can-lead-by-example","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Five ways veterinary staff can lead by example"},"categories":["practice management","veterinary practices","engagement"],"segments":["animal health"],"timestamp":637550407370000000,"title":"five ways veterinary staff can lead by example"},{"card":{"key":"a280eb4e-a846-42d7-9ab9-2a20e36e52e8","authorName":"Zachary Melton","authorCompany":"","date":"June 2023","description":"It's natural to want to raise prices when inflation hits. But instead, try investing in certain technologies. These investments can actually save your practice more money in the long run while helping promote client loyalty and compliance. Here's why.","img":{"alt":"Female veterinarian looking at tablet","src":"-/media/assets/mwianimalhealth/images/insights-images/female-veterinarian-looking-at-tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/lower-your-veterinary-practice-inflation-stress-levels","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Lower your veterinary practice's inflation stress levels"},"categories":["technology","veterinary practices"],"segments":["animal health"],"timestamp":638235485820000000,"title":"lower your veterinary practice's inflation stress levels"},{"card":{"key":"ac03642d-5be9-4ae5-8865-dc254d3e025d","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2020","description":"As pharmaceutical manufacturers navigate new and looming legislation related to drug pricing and other policies, distributors can help them adapt and thrive.","img":{"alt":"health policy flag stethoscope","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/health-policy-flag-stethoscope.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/infographic-navigating-health-policy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Infographic: navigating health policy"},"categories":["distribution","policy","our role in healthcare"],"segments":["manufacturers"],"timestamp":637378605010000000,"title":"infographic: navigating health policy"},{"card":{"key":"581d0467-58c2-4de5-b1db-dd2531218399","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2019","description":"100+ physicians shared their perspectives on biosimilar utilization, cost and barriers to adoption in a recent survey. Get a quick glimpse at the results in this infographic.","img":{"alt":"biosims_micro","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/biosims_micro.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/infographic-physician-perspectives-on-biosimilars","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Infographic: Physician Perspectives on Biosimilars"},"categories":["biosimilars","commercialization"],"segments":["manufacturers","physician practices"],"timestamp":637123686110000000,"title":"infographic: physician perspectives on biosimilars"},{"card":{"key":"cf408002-cb82-45b2-8f44-65c9884732f5","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2023","description":"","img":{"alt":"How to effectively navigate promotional compliance for pharmaceutical products in US, Canada, and Europe","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/webinar-snip.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-effectively-navigate-promotional-compliance-for-pharmaceutical-products","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How to effectively navigate promotional compliance for pharmaceutical products in US, Canada, and Europe"},"categories":[],"segments":["manufacturers"],"timestamp":638354924530000000,"title":"how to effectively navigate promotional compliance for pharmaceutical products in us, canada, and europe"},{"card":{"key":"e12e480c-499d-454b-a748-a000b99708b0","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2023","description":"","img":{"alt":"Cell and gene therapy commercialization","src":"-/media/assets/amerisourcebergen/manufacturer/cgt-commercialization.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/3-questions-biopharma-companies-must-ask-when-building-a-cell-and-gene-commercialization-strategy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Three questions biopharma companies must ask when building a cell and gene commercialization strategy"},"categories":["cell and gene therapy","market access","distribution","commercialization"],"segments":["manufacturers"],"timestamp":638119792560000000,"title":"three questions biopharma companies must ask when building a cell and gene commercialization strategy"},{"card":{"key":"e0ac7919-2a76-42e3-8051-70f555ed16bb","authorName":"Christie Smith, PharmD, MBA","authorCompany":"Specialty Physician Services & Solutions","date":"June 2024","description":"","img":{"alt":"","src":"-/media/assets/sps/abstract-sps.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/7-questions-with-christie-smith","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"7 questions with Dr. Christie Smith"},"categories":["formulary solutions"],"segments":["manufacturers"],"timestamp":638539004400000000,"title":"7 questions with dr. christie smith"},{"card":{"key":"9b130556-cde8-473e-a8b0-42a777b6e975","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2023","description":"","img":{"alt":"insights into the workings of the JCA process","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pharmaphorum_podcast-episode-90a_0-cropped.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/collaborative-perseverance-to-bring-change-to-medicine-access","linkText":"Listen now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Podcast: Collaborative perseverance to bring change to medicine access"},"categories":["commercialization","consulting","policy","regulatory"],"segments":["manufacturers"],"timestamp":638265026150000000,"title":"podcast: collaborative perseverance to bring change to medicine access"},{"card":{"key":"92fb97f3-a9bb-4954-930e-43e4ab031c11","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2024","description":"","img":{"alt":"consulting","src":"-/media/assets/adobestock_566596170-smaller.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/is-nices-disease-severity-classification-at-risk","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Is NICE’s disease severity classification at risk?"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638454312620000000,"title":"is nice’s disease severity classification at risk?"},{"card":{"key":"3108a61a-e890-4277-94f0-7e6115e43008","authorName":"Lash Group","authorCompany":null,"date":"August 2019","description":"Innovative therapies make innovative patient services essential. Learn how Lash Group helped one manufacturer improve speed and access to therapy with an electronic provider portal for benefit verification and prior authorization.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/case-study-improving-speed-to-therapy-with-provider-portals","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Case Study: Improving Speed to Therapy With Provider Portals"},"categories":["commercialization","patient support services","technology"],"segments":["manufacturers"],"timestamp":637027904170000000,"title":"case study: improving speed to therapy with provider portals"},{"card":{"key":"8f2faabf-6ec6-40b4-a141-0cfc7db23d13","authorName":"Lash Group","authorCompany":null,"date":"October 2018","description":"The evolving needs of the patient and historic approaches to non-adherence.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-power-of-patient-activation-part-one","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Power of Patient Activation: Part One"},"categories":["affordability","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":636741887760000000,"title":"the power of patient activation: part one"},{"card":{"key":"af7054df-ed69-471e-a073-ce1206d89dbf","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"In this edition, we continue the series on preparations for European Union (EU) HTA now the draft implementing act on procedural rules for Joint Clinical Assessment (JCA) of medicinal products has been published. Additionally, two country-specific analyses consider the impact of AMNOG benefit assessment on drug pricing in Germany, and the impact of participation in the UK’s Early Access to Medicines Scheme (EAMS) on recommendations from the National Institute for Health and Care Excellence (NICE).","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-summer-2024-summary","linkText":"Read more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"HTAQ Summer 2024"},"categories":["consulting","regulatory"],"segments":["manufacturers"],"timestamp":638507770800000000,"title":"htaq summer 2024"},{"card":{"key":"1c254c3f-584a-45e2-a0ad-4288091a02a2","authorName":"World Courier","authorCompany":null,"date":"October 2023","description":"Despite growth in the CGT field, limited approved therapies and unique logistical challenges can leave CROs inexperienced. Our white paper, developed in collaboration with IQVIA, explores the crucial partnership between CROs and specialty logistics in CGT clinical trials, unveiling strategies and insights for success in this rapidly evolving field of cell therapy logistics.","img":{"alt":"Changing the OBA landscape","src":"-/media/assets/amerisourcebergen/manufacturer/cgt/lp-changing-landscape.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-synergy-of-cro-and-specialty-logistics-collaboration","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Cell and gene therapy trials — The synergy of CRO and specialty logistics collaboration"},"categories":["cell and gene therapy","market access"],"segments":["manufacturers"],"timestamp":638324280000000000,"title":"cell and gene therapy trials — the synergy of cro and specialty logistics collaboration"},{"card":{"key":"7ca885e8-acff-499d-b17a-c5b57dbea2c5","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2024","description":"","img":{"alt":"A smiling woman talks on the phone while looking at her computer.","src":"-/media/assets/worldcourier/english/images/corporate-setting/customer-service-rep_brazil.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/best-practice-strategies-for-your-emerging-biopharma-field-team","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Best practice strategies for your emerging biopharma field team search"},"categories":["commercialization","field support"],"segments":["manufacturers"],"timestamp":638481855910000000,"title":"best practice strategies for your emerging biopharma field team search"},{"card":{"key":"8149e3ca-0976-41b5-acc9-0dca9f6c1353","authorName":"World Courier","authorCompany":null,"date":"June 2019","description":"Should the clinical supply chain be the same as the commercial supply chain for advanced therapies? Find out here. ","img":{"alt":"woman looking through microscope","src":"-/media/assets/worldcourier/english/images/article-images/woman-looking-through-microscope.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/advanced-therapies-commercial-supply-chain-lesson-for-clinical-trial-success","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Article: Advanced Therapy Commercial Supply Chain Lessons for Clinical Trial Success"},"categories":["clinical trial logistics","cell and gene therapy","commercial supply chain"],"segments":[],"timestamp":636965301160000000,"title":"article: advanced therapy commercial supply chain lessons for clinical trial success"},{"card":{"key":"46774686-765c-4778-87e4-2926576a1411","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2023","description":"A manufacturer's launch guide for making the most of the drug commercialization process, including solutions you'll need at every step and checklists for finding the right commercialization partner.","img":{"alt":"abstract-brand-colors-texture","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/abstract-brand-colors-texture.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/guide-to-drug-commercialization","linkText":"Get the guide","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The essential guide to drug commercialization"},"categories":["clinical trial logistics","commercialization","distribution","innovation","market access","medication adherence","patient support services","product access","reimbursement","technology","data"],"segments":["manufacturers"],"timestamp":638126795400000000,"title":"the essential guide to drug commercialization"},{"card":{"key":"8e016a3b-1cc8-4ef3-b241-4e80800ac908","authorName":"AmerisourceBergen","authorCompany":"","date":"June 2023","description":"An investment in learning solutions is more than an investment in your product. It's a signal that your biopharma company cares about its people, not just its profits.","img":{"alt":"Middle-aged woman in wheelchair draws on a white board","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/gettyimages-925340672_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/empower-your-people-and-brand-with-biopharma-learning-solutions","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Empower your people and brand with biopharma learning solutions "},"categories":["commercialization","consulting","engagement"],"segments":["manufacturers"],"timestamp":638231310000000000,"title":"empower your people and brand with biopharma learning solutions "},{"card":{"key":"78b5e5f6-beec-46fc-bfa5-68db61d75f50","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2023","description":"The recent CAR-TCR conference, a gathering of experts in the field of Cell and Gene Therapy (CGT) held in Boston from August 29, 2023 to September 1, 2023, provided a platform for in-depth discussions on the challenges and opportunities facing this innovative sector of healthcare. Dale Hanna, Director, Cell and Gene Therapy, at Cencora, shares valuable insights on the conference's key takeaways, particularly regarding the digital transformation of CGT.","img":{"alt":"Advancing Cell and Gene Therapy","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/advancing-cell-and-gene-therapy.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/advancing-cell-and-gene-therapy-access","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Advancing Cell and Gene Therapy (CGT) Access: Insights from CAR-TCR 2023"},"categories":["cell and gene therapy","market access"],"segments":["manufacturers"],"timestamp":638315019310000000,"title":"advancing cell and gene therapy (cgt) access: insights from car-tcr 2023"},{"card":{"key":"5791c473-ddc2-4180-95ee-186af814db26","authorName":"Lung-I Cheng","authorCompany":"Biopharma Services","date":"April 2023","description":"","img":{"alt":"insights","src":"-/media/assets/amerisourcebergen/insights/gettyimages-1158524088-rt-rgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/three-opportunities-and-three-challenges-in-the-cell-and-gene-therapy-market","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Three opportunities and three challenges in the cell and gene therapy market"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638180419180000000,"title":"three opportunities and three challenges in the cell and gene therapy market"},{"card":{"key":"faea71af-fdfe-4c5b-90a0-006725697177","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2020","description":"Three major challenges must be prepared for: constantly shifting travel restrictions, maintaining shipment integrity in the face of those restrictions, and ensuring trial data can be relied upon.","img":{"alt":"Shipments","src":"-/media/assets/worldcourier/english/images/article-images/180321_wc-2199.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-impact-of-lockdown-and-restrictions-on-covid-19-treatment-trials","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Article: The Impact of Lockdown and Restrictions on COVID-19 Treatment Trials"},"categories":["covid-19","pharmaceutical storage and transport management"],"segments":[],"timestamp":637350837000000000,"title":"article: the impact of lockdown and restrictions on covid-19 treatment trials"},{"card":{"key":"dd477116-a204-4905-8c23-08ffd2631d1a","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"Learn more about the benefits of working with a single commercialization services partner in this Q&A with one of AmerisourceBergen's pharmaceutical manufacturer partners.","img":{"alt":"AB new brand magenta texture","src":"-/media/assets/amerisourcebergen/insights/ab-new-brand-magenta-texture.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/mcs-qa","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The hidden value of integrated commercialization services: A manufacturer’s perspective"},"categories":["commercialization","distribution","market access","product access","third party logistics"],"segments":["manufacturers"],"timestamp":637544563500000000,"title":"the hidden value of integrated commercialization services: a manufacturer’s perspective"},{"card":{"key":"a3764656-3ab1-42a3-be51-6811fdca06f2","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2024","description":"In the ever-evolving landscape of healthcare, ensuring timely access to innovative therapies is a top priority. One promising approach that holds the potential to expedite patient access is the Joint Clinical Assessment (JCA). JCA aims to harmonize the evaluation and decision-making processes for new interventions across European member states, streamlining the path from development to market.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/bright-tubes/microsoftteams-image-(17).png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/ispor-us-forging-ahead","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Forging ahead with US and EU healthcare policy changes: balancing sustainability, innovation and patient access in the era of IRA and EU HTA"},"categories":["consulting","regulatory"],"segments":["manufacturers"],"timestamp":638537115600000000,"title":"forging ahead with us and eu healthcare policy changes: balancing sustainability, innovation and patient access in the era of ira and eu hta"},{"card":{"key":"f8ae47be-b6f8-40fc-9185-b68daa30a96c","authorName":"Jennifer Fenwick","authorCompany":"World Courier","date":"December 2022","description":"","img":{"alt":"GettyImages-1198271727_RGB_Large_JPG","src":"-/media/assets/worldcourier/english/images/gettyimages-1198271727_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/preserving-cell-and-gene-integrity-in-the-supply-chain","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Preserving cell and gene integrity in the supply chain"},"categories":["secure supply chain","cell and gene therapy","temperature control solutions"],"segments":[],"timestamp":638055312650000000,"title":"preserving cell and gene integrity in the supply chain"},{"card":{"key":"95ad467e-306e-47bc-a61a-bcd9bd5d44ce","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"February 2023","description":"Cell and gene therapies (CGTs) hold promise in curing diseases by addressing root causes. Logistics partners are crucial for secure and compliant delivery to patients globally.","img":{"alt":"Regulatory article 3","src":"-/media/assets/worldcourier/english/images/cell-and-gene/regulatory-article-3.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/regulators-tightening-cgt-logistics-controls-to-assure-patient-safety-and-security","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Regulators tighten CGT logistics for patient safety and security"},"categories":["cell and gene therapy","regulatory"],"segments":[],"timestamp":638131900480000000,"title":"regulators tighten cgt logistics for patient safety and security"},{"card":{"key":"aaead591-86a9-4a2c-9558-af8f609030c7","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"February 2023","description":"Time to adapt Europe’s evolving cell and gene therapy regulatory framework before it prevents patient access due to logistics hurdles","img":{"alt":"Image of European Medicines Agency head office sign","src":"-/media/assets/worldcourier/english/images/cell-and-gene/european-medicines-agency.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/time-to-adapt-europes-evolving-cgt-regulatory-framework","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Cell and gene therapy regulatory framework in Europe"},"categories":["cell and gene therapy","regulatory"],"segments":[],"timestamp":638131896000000000,"title":"cell and gene therapy regulatory framework in europe"},{"card":{"key":"8bc01a9b-dba8-4edd-9ea4-111a853800df","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2023","description":"Brian Biehn, senior director of biosimilar commercialization at Cencora, makes predictions for how big regulatory approvals in 2023 will shape the biosimilar space going forward.","img":{"alt":"Manufacturer of biosimilars","src":"-/media/assets/amerisourcebergen/biosimilars-page/manufacturer-of-biosimilars.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/forecasts-big-changes-for-the-us-biosimilar-space","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Cencora's Brian Biehn Forecasts Big Changes for the US Biosimilar Space"},"categories":["biosimilars"],"segments":["manufacturers"],"timestamp":638377632000000000,"title":"cencora's brian biehn forecasts big changes for the us biosimilar space"},{"card":{"key":"909e393a-afad-438b-8692-d975c2a3175c","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2020","description":"With the potential of 40+ groundbreaking cell and gene therapy products FDA-approved by 2024, manufacturers are looking for innovative ways to successfully bring these therapies to market. Join AmerisourceBergen experts as they discuss commercialization considerations that manufacturers should know.","img":{"alt":"Lab tech with DNA","src":"-/media/assets/xcenda/english/images/expertise/cgt-dna_bw.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/cell-and-gene-therapy-session","linkText":"Watch the webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Cell and gene therapies: bringing innovation to market"},"categories":["cell and gene therapy","commercialization","market access"],"segments":["manufacturers"],"timestamp":637432167000000000,"title":"cell and gene therapies: bringing innovation to market"},{"card":{"key":"b1b60889-3d67-4b92-bb2b-049dd9f8c165","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2023","description":"In the ever-evolving landscape of healthcare, ensuring timely access to innovative therapies is a top priority. One promising approach that holds the potential to expedite patient access is the Joint Clinical Assessment (JCA). JCA aims to harmonize the evaluation and decision-making processes for new interventions across European member states, streamlining the path from development to market.","img":{"alt":"bright tubes","src":"-/media/assets/amerisourcebergen/insights/bright-tubes.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/unlocking-the-potential-of-joint-clinical-assessment-in-europe","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Unlocking the Potential of Joint Clinical Assessment (JCA) in Europe: Insights from Industry Leaders and Experts"},"categories":["consulting","regulatory"],"segments":["manufacturers"],"timestamp":638374023970000000,"title":"unlocking the potential of joint clinical assessment (jca) in europe: insights from industry leaders and experts"},{"card":{"key":"99676027-aaf2-4ee2-a205-41f94f08850f","authorName":"Lash Group","authorCompany":null,"date":"November 2019","description":"How do nurses make a difference when it comes to patient-centric adherence programs? A Lash Group nurse shares how she offers personal support for rare disease patients.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/nurse-stories-amy","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Nurse Stories: Amy"},"categories":["commercialization","engagement","medication adherence","patient care","patient support services"],"segments":["manufacturers"],"timestamp":637091946070000000,"title":"nurse stories: amy"},{"card":{"key":"07e9f70b-70b7-4d8e-89e2-65309af77c41","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2018","description":"How can FTZs help with commercialization success? What should manufacturers consider when evaluating a FTZ and 3PL partner?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-role-of-foreign-trade-zones-in-pharmaceutical-manufacturing-success-part-two","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Role of Foreign Trade Zones in Pharmaceutical Manufacturing Success: Part Two"},"categories":["commercialization","third party logistics"],"segments":["manufacturers"],"timestamp":636719335750000000,"title":"the role of foreign trade zones in pharmaceutical manufacturing success: part two"},{"card":{"key":"d11626d9-1c1b-4058-ae9d-ca602fec78f4","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"female patient and female doctor","src":"-/media/assets/xcenda/english/images/solutions/patient_doctor.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-power-of-patient-engagement-with-cgt-innovation","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The power of patient engagement with CGT innovation"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638554663890000000,"title":"the power of patient engagement with cgt innovation"},{"card":{"key":"dec08329-91cb-4baf-9ae4-6ef037eadf11","authorName":"Xcenda","authorCompany":null,"date":"November 2022","description":"In this issue our editors provide insights on the new European Union Health Technology Assessment regulation, the United Kingdom's Innovative Licensing and Access Pathway, and the drug reimbursement environment in Canada.","img":{"alt":"HTA Quarterly Logo","src":"-/media/assets/xcenda/german/images/home---about-us/xcenda_2_3_card-02.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-summer-2023-summary-page","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"HTA Quarterly | Summer 2023"},"categories":["market access","regulatory","reimbursement","commercialization"],"segments":["manufacturers"],"timestamp":638035219200000000,"title":"hta quarterly | summer 2023"},{"card":{"key":"dbefd793-5bbe-4820-808b-62c165aade20","authorName":"Tanya Mericle","authorCompany":"AmerisourceBergen","date":"May 2022","description":"Happy employees go above and beyond for customers","img":{"alt":"A customer laughing joyfully as a pharmacist helps her find the medication she needs","src":"-/media/assets/gnp/images/gnp-insights-patient-satisfaction.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/keeping-patients-satisfied-when-your-pharmacy-is-short-staffed","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Keeping patients satisfied when your pharmacy is short staffed"},"categories":["good neighbor pharmacy","pharmacy operations","patient care"],"segments":[],"timestamp":637879437940000000,"title":"keeping patients satisfied when your pharmacy is short staffed"},{"card":{"key":"7b294fc9-ca69-480e-9713-1b15d21a0798","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2021","description":"Novel cell and gene therapies require a different approach to the clinical supply chain. AmerisourceBergen and TrakCel experts will discuss key considerations for product owners during clinical development. Hear lessons learned from the latest cell and gene therapy clinical trials and insights on what you need to know about the clinical development journey.","img":{"alt":"optimal cell and gene therapy supply chain and tracking outcomes","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/cell-and-gene-therapies-clinical-supply-chain-considerations.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/cell-and-gene-therapies-clinical-supply-chain-considerations","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar | Cell and gene therapies: Clinical supply chain considerations"},"categories":["cell and gene therapy","clinical trial logistics","commercial supply chain","commercialization","distribution","secure supply chain"],"segments":["manufacturers"],"timestamp":637635945480000000,"title":"webinar | cell and gene therapies: clinical supply chain considerations"},{"card":{"key":"579b0fbe-5dd9-4e01-8183-29f52a4fe998","authorName":"Xcenda","authorCompany":null,"date":"August 2020","description":"What are the myths that could be impacting access to your products, and how could the right field services partner help?","img":{"alt":"female_doctor_virtual_visit","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/doctor_female_telehealth.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rethink-field-services","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Rethink field services: Three myths keeping access barriers in front of your product"},"categories":["commercialization","covid-19","market access","patient support services","product access"],"segments":["manufacturers"],"timestamp":637341528710000000,"title":"rethink field services: three myths keeping access barriers in front of your product"},{"card":{"key":"18546673-aeef-49b2-bc38-f8b820f74673","authorName":"Corey Ford, MHA","authorCompany":"","date":"July 2023","description":"Discussing the transition of going from platform users to employees of FormularyDecisions with the power to affect change.","img":{"alt":"Coworkers at meeting","src":"-/media/assets/xcenda/english/images/insights/gettyimages-1179568324_srgb_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/whats-next-for-biopharma-under-the-inflation-reduction-act","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"What's next for biopharma under the inflation reduction act"},"categories":["legislation","market access"],"segments":["manufacturers"],"timestamp":638259700200000000,"title":"what's next for biopharma under the inflation reduction act"},{"card":{"key":"b33eb5ae-234c-4fe7-bc78-000e13ddeeb1","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2024","description":"Video from Brenda Gryfe, Director Regulatory Affairs, details the regulatory considerations that can make or break your entry into Canada’s pharmaceutical market — including critical data requirements and adapting foreign dossiers for this market","img":{"alt":"Doctor ","src":"-/media/assets/innomarstrategies/insights/video-1-graphic.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/regulatory-compliance-navigating-the-canadian-landscape-for-specialty-products","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Regulatory compliance: Navigating the Canadian landscape for specialty products"},"categories":["our role in healthcare"],"segments":["manufacturers"],"timestamp":638616817200000000,"title":"regulatory compliance: navigating the canadian landscape for specialty products"},{"card":{"key":"727bb293-7010-4c1e-b1f8-21f9dfc6bb29","authorName":"Lash Group","authorCompany":null,"date":"March 2021","description":"Automating the benefits verification process is one of the most effective ways to speed access to therapy. Learn how to harness AI-powered digital assistant technology for real-time eBV.","img":{"alt":"AI_technology_innovation","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ai_technology_innovation.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/harnessing-the-power-of-a-digital-assistant-to-accelerate-patient-access","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Harnessing the power of a digital assistant to accelerate patient access"},"categories":["affordability","patient support services","product access","technology","commercialization"],"segments":["manufacturers"],"timestamp":637521978000000000,"title":"harnessing the power of a digital assistant to accelerate patient access"},{"card":{"key":"2ec87069-3afa-40c8-9c7d-29e7fbf11265","authorName":"Bill Smith","authorCompany":"Biopharma Services","date":"August 2020","description":"Executive Q&A: Lash Group's Bill Smith explains how a patient support provider's operational makeup impacts the manufacturer and patient experience.","img":{"alt":"whiteboard","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/whiteboard.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/what-a-unified-approach-to-business-excellence-means-for-patient-support-program-success","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"What a unified approach to business excellence means for patient support program success"},"categories":["commercialization","patient support services"],"segments":["manufacturers"],"timestamp":637329453720000000,"title":"what a unified approach to business excellence means for patient support program success"},{"card":{"key":"2752693b-2b1e-485a-8efc-21c60adfbb99","authorName":"Brenda Agnew","authorCompany":"","date":"April 2022","description":"Caregivers play a critical role in Canadian healthcare. In a survey conducted by The Ontario Caregiver Association, 35 percent of the workforce provides unpaid care to a family member or friend. This number has gone up 22 percent as a result of COVID-19, and 52 percent of Canada’s 7.8 million caregivers say balancing work and caregiving is more challenging due to the pandemic.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/a-caregivers-story--how-to-support-caregiving-employees-and-their-families","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Insight","headline":"A caregiver's story: How to support caregiving employees and their families"},"categories":["advocacy","engagement","patient care","patient support services","technology"],"segments":[],"timestamp":637866790230000000,"title":"a caregiver's story: how to support caregiving employees and their families"},{"card":{"key":"72277bc6-af67-4d9c-99b6-0d96f4d48d71","authorName":"Lung-I Cheng","authorCompany":"Biopharma Services","date":"June 2023","description":"","img":{"alt":"podcast","src":"-/media/assets/amerisourcebergen/insights/microphone-true-blue-no-wave.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-future-is-cgt-podcast","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Podcast: The future is bright; the future is CGT"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638228702750000000,"title":"podcast: the future is bright; the future is cgt"},{"card":{"key":"f8c10294-4f97-4573-826e-2839d4510d88","authorName":"Glen Martin","authorCompany":"AmerisourceBergen","date":"March 2021","description":"Bringing a new therapy to market is no easy task, and making sure it's a commercial success is even harder. Manufacturers need to have the right commercialization services and partner at each stage of the commercialization process.","img":{"alt":"AmerisourceBergen manufacturer commercialization strategies","src":"-/media/assets/amerisourcebergen/insights/bright-tubes.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-make-the-most-of-integrated-commercialization-solutions","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How to make the most of integrated commercialization solutions"},"categories":["commercialization","clinical trial logistics","distribution","innovation","market access","medication adherence","our role in healthcare","patient support services","pharmaceutical storage and transport management","product access","reimbursement","technology","third party logistics"],"segments":["manufacturers"],"timestamp":637517820100000000,"title":"how to make the most of integrated commercialization solutions"},{"card":{"key":"22358fe9-2dfd-4266-9d29-cb6fb80bb037","authorName":"Xcenda","authorCompany":null,"date":"November 2020","description":"An in-depth look into the work of the pharma industry's field access manager — from relationships with sales reps and providers to the extra steps they take to improve patient access.","img":{"alt":"insurance card and tablet","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/insurance-card-and-tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharma-in-the-field-tierra","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pharma in the field: Tierra's story"},"categories":["affordability","commercialization","market access","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637405393790000000,"title":"pharma in the field: tierra's story"},{"card":{"key":"8d97f901-9efc-4c4d-85b6-09fbb12ecb4a","authorName":"Sean McGowan; Rick Lozano ","authorCompany":"AmerisourceBergen","date":"September 2019","description":"The growth of biosimilars presents a significant opportunity to reduce the cost of care and provide patients with greater access to affordable treatments. Our experts assess the current state and future of the biosimilars market.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilars-market-insights-and-growth-factors","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Biosimilars: Market Insights and Growth Factors"},"categories":["biosimilars","commercialization","market access"],"segments":["manufacturers"],"timestamp":637045170800000000,"title":"biosimilars: market insights and growth factors"},{"card":{"key":"76552b9f-1d99-4f0e-b2a9-4c0890961237","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2023","description":"","img":{"alt":"policy impacts on pharma","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/policy-impacts-on-pharma.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/annual-benefit-reverification-enhanced-by-technology-solutions","linkText":"Download the case study","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case Study: Annual benefit reverification enhanced by technology solutions"},"categories":["patient care","patient support services","pharmacy operations"],"segments":["manufacturers"],"timestamp":638324730180000000,"title":"case study: annual benefit reverification enhanced by technology solutions"},{"card":{"key":"977ca7ab-e834-4780-b495-b3f877be1566","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2024","description":"","img":{"alt":"abstract lines ","src":"-/media/assets/xcenda/english/images/insights/ab-colors-abstract-lines.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/government-reliance-on-value-assessments-in-medicare","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Government Reliance on Value Assessments in Medicare Part B"},"categories":["consulting","regulatory"],"segments":["manufacturers"],"timestamp":638483622000000000,"title":"government reliance on value assessments in medicare part b"},{"card":{"key":"8ce046d7-ae06-4976-8867-36e3f8efe7a7","authorName":"Jo Watts-James, MBA","authorCompany":"Cencora","date":"November 2023","description":"","img":{"alt":"NICE DHT's","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/nice-app.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-winter-2023-how-nice-theres-an-app-for-that","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How NICE there’s an app for that! "},"categories":["market access","regulatory","technology"],"segments":["manufacturers"],"timestamp":638344435200000000,"title":"how nice there’s an app for that! "},{"card":{"key":"3d1f2791-39d3-4463-8398-21126d21410f","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"thinklive","src":"-/media/assets/amerisourcebergen/thinklive-cgt-small.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/takeaways-from-cencora-inaugural-cgt-summit","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Takeaways from Cencora’s inaugural Cell and Gene Therapy Summit"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638572585610000000,"title":"takeaways from cencora’s inaugural cell and gene therapy summit"},{"card":{"key":"536e851a-c281-477c-a468-b1c35852745d","authorName":"Lung-I Cheng","authorCompany":"Biopharma Services","date":"December 2023","description":"","img":{"alt":"pre-launch","src":"-/media/assets/innomarstrategies/who-we-support/manufacturers/placeholder-images/pre-launch.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/avoiding-cgt-commercialization-pitfalls","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Avoiding CGT commercialization pitfalls "},"categories":["cell and gene therapy","market access","patient support services"],"segments":["manufacturers"],"timestamp":638374840200000000,"title":"avoiding cgt commercialization pitfalls "},{"card":{"key":"e292b7e8-9dbf-41a8-a0bc-c740e65c4e7e","authorName":"AmerisourceBergen","authorCompany":"","date":"October 2022","description":"An indicator of a rapidly changing healthcare landscape, innovative payer-manufacturer contracts aim to reduce costs while improving outcomes amid a crowded market of emerging and perceivably unproven therapies.","img":{"alt":"vaccines on top of US dollars","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-summer-2021/htaq_vaccines.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/improve-outcomes-and-reduce-costs-for-emerging-therapies","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Improve outcomes and reduce costs for emerging therapies"},"categories":["affordability","reimbursement","value-based care"],"segments":["manufacturers"],"timestamp":638006776060000000,"title":"improve outcomes and reduce costs for emerging therapies"},{"card":{"key":"9d29f778-e072-4971-b307-96e3789000f9","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2024","description":"","img":{"alt":"ifs","src":"-/media/assets/amerisourcebergen/call_center-1.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/improve-the-effectiveness-of-field-reimbursement-support","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case Study: Improve the effectiveness of field reimbursement support"},"categories":["field support","reimbursement"],"segments":["manufacturers"],"timestamp":638421525940000000,"title":"case study: improve the effectiveness of field reimbursement support"},{"card":{"key":"28f8d2b9-8e4f-4741-b290-bc1e562ec732","authorName":"Dale Hanna","authorCompany":"Lash Group","date":"November 2020","description":"Executive Q&A: Dale Hanna, Product Director, and Andrea Windich, Director of Nursing, discuss how Lash Group is adapting patient support programs to address the medication adherence barriers patients are facing during the COVID-19 pandemic.","img":{"alt":"stethoscope medication adherence","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/telehealth_phone_steth.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/overcoming-medication-adherence-barriers-during-the-covid-19-pandemic","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Overcoming medication adherence barriers during the covid-19 pandemic"},"categories":["medication adherence","patient support services","covid-19"],"segments":["manufacturers"],"timestamp":637415006400000000,"title":"overcoming medication adherence barriers during the covid-19 pandemic"},{"card":{"key":"b1f4f84e-df17-43ad-bd50-c5590411ee9c","authorName":"Xcenda","authorCompany":null,"date":"June 2020","description":"FormularyDecisions is a secure, online platform facilitating the bi-directional exchange of information between life sciences companies and over 2,100 qualified, active healthcare decision-makers. From pre-approval to post-launch, get unrivaled insight into what payers think of your product and those of your competitors, and gain feedback to better inform your market access strategies. ","img":{"alt":"CircularModule_TYPage_Refresh","src":"-/media/assets/xcenda/english/images/paid-media/circularmodule_typage_refresh.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/formularydecisions-amcp-pie-webinar-june-3-2020","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Effective Pre-Approval Communication With Payers"},"categories":[],"segments":["manufacturers"],"timestamp":637269601800000000,"title":"webinar: effective pre-approval communication with payers"},{"card":{"key":"48687435-1524-4342-88d0-56d5f00240f4","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2024","description":"","img":{"alt":"Man with beard and headphones sitting in front of computer in office","src":"-/media/assets/amerisourcebergen/manufacturer/cor_gettyimages-863549118_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/race-to-develop-innovative-products-and-supply-chain-solutions","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Podcast: The race to develop innovative products and supply chain solutions "},"categories":["commercialization","commercial supply chain","market access"],"segments":["manufacturers"],"timestamp":638398863070000000,"title":"podcast: the race to develop innovative products and supply chain solutions "},{"card":{"key":"d7d34dff-7c58-4afb-b6fe-97fcad9bf22b","authorName":"Xcenda","authorCompany":null,"date":"April 2021","description":"Xcenda’s FormularyDecision team conducted a study to assess the current use of CEAs by US decision-makers, the challenges that they currently face in using CEAs, and the ways in which these could resolved. ","img":{"alt":"Woman with tablet and computer","src":"-/media/assets/xcenda/english/images/insights/payer_cea_computer_tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/are-us-payers-getting-to-grips-with-cost-effectiveness-analysis","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Are US payers getting to grips with cost-effectiveness analysis?"},"categories":["analytics","financial management"],"segments":[],"timestamp":637551341280000000,"title":"are us payers getting to grips with cost-effectiveness analysis?"},{"card":{"key":"53f38745-3b0a-4ff5-942d-f1f345f50415","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"Communicating With Your Payers_467x250","src":"-/media/assets/ion/images/communicating-with-your-payers_467x250.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilars-roadmap","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"A Biosimilars Roadmap: Understanding Payer Perceptions"},"categories":["biosimilars","formulary solutions"],"segments":["manufacturers"],"timestamp":638514633600000000,"title":"a biosimilars roadmap: understanding payer perceptions"},{"card":{"key":"b923f0f7-a8b3-4eec-b963-87e89d879345","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2024","description":"","img":{"alt":"","src":"-/media/assets/xcenda/english/images/insights/uscapitol/microsoftteams-image-(11)/amcp.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/amcp-webinar-2024","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Leveraging the Pre-Approval Information Safe Harbor to Accelerate Patient Access"},"categories":["formulary solutions"],"segments":["manufacturers"],"timestamp":638463861600000000,"title":"leveraging the pre-approval information safe harbor to accelerate patient access"},{"card":{"key":"0a75e007-a760-49cf-8077-524764bdfe3b","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2018","description":"What information do payers and providers want from pharma?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/information-exchange-with-payers-and-providers","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Information Exchange With Payers and Providers"},"categories":["commercialization","data","analytics","reimbursement","engagement"],"segments":["manufacturers"],"timestamp":636516438730000000,"title":"information exchange with payers and providers"},{"card":{"key":"9feaec27-76e0-45b1-aaf5-37859c5c43fd","authorName":"AmerisourceBergen","authorCompany":"","date":"September 2022","description":"Learn best practices on using HEOR in rare drug development

","img":{"alt":"Male and female coworker at conference table","src":"-/media/assets/xcenda/english/images/insights/gettyimages-1180036737_srgb_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/answering-the-challenges-of-rare-disease-market-access-with-heor","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Answering the challenges of rare disease market access with HEOR"},"categories":["commercialization","market access","clinical trial logistics","research"],"segments":["manufacturers"],"timestamp":637976439000000000,"title":"answering the challenges of rare disease market access with heor"},{"card":{"key":"a7ec9e2b-05af-4b34-a640-31e3604f2f63","authorName":"David Senior","authorCompany":"AmerisourceBergen","date":"October 2022","description":"","img":{"alt":"Reimbursement models for CGT","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/rgb-youngfemaledoctorininfusionconcept_png-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/alternative-reimbursement-models-to-craft-a-sustainable-business-model-for-cgts","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Evaluating alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies"},"categories":["cell and gene therapy","commercialization","innovation","reimbursement","value-based care"],"segments":["manufacturers"],"timestamp":638023875190000000,"title":"evaluating alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies"},{"card":{"key":"8242ab08-4bc6-4f1d-8606-330a85d7bc73","authorName":"AmerisourceBergen","authorCompany":"","date":"October 2023","description":"Expert tips for biopharma companies preparing to bring their biosimilars to market

","img":{"alt":"Family plays cat's cradle","src":"-/media/assets/amerisourcebergen/insights/gettyimages-1076658604.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/untangle-the-complexities-of-launching-a-biosimilar","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Untangle the complexities of launching a biosimilar"},"categories":["biosimilars","business performance","commercialization"],"segments":["manufacturers"],"timestamp":638321025000000000,"title":"untangle the complexities of launching a biosimilar"},{"card":{"key":"25e07e32-474e-4b1a-a5c3-ebf13f92a5ab","authorName":"Kyle Noonan, PharmD, MS","authorCompany":"Cencora","date":"May 2024","description":"","img":{"alt":"meeting","src":"-/media/assets/business_bcn22_0504_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/6-questions-with-kyle-noonan","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"6 questions with Kyle Noonan"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638518309260000000,"title":"6 questions with kyle noonan"},{"card":{"key":"4a0a41dc-f007-4765-b1c0-cd54cc76226c","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2023","description":"","img":{"alt":"New Pan-EU HTA","src":"-/media/assets/amerisourcebergen/manufacturer/new-pan-eu-hta.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/new-pan-eu-hta-how-can-biopharma-navigate-the-joint-clinical-assessment","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"New pan-EU HTA: How can biopharma navigate the joint clinical assessment?"},"categories":["commercialization","consulting","legislation","market access"],"segments":["manufacturers"],"timestamp":638106880480000000,"title":"new pan-eu hta: how can biopharma navigate the joint clinical assessment?"},{"card":{"key":"b1aa8a05-8e9a-48e1-a0ee-a62d8907c9dc","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"team","src":"-/media/assets/amerisourcebergen/team-members---fierce-article.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/exploring-strategic-partnerships","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Exploring strategic partnerships: A conversation with Cencora leadership"},"categories":["our role in healthcare"],"segments":["manufacturers"],"timestamp":638508824410000000,"title":"exploring strategic partnerships: a conversation with cencora leadership"},{"card":{"key":"ebd2f623-f2ab-438f-b57a-e81f5ac39df2","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2023","description":"","img":{"alt":"IRA Webinar","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/gettyimages-1343769556_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/march-2023-ira-webinar","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Available on-demand webinar: IRA Update: Key considerations for 2023"},"categories":[],"segments":["manufacturers"],"timestamp":638145944400000000,"title":"available on-demand webinar: ira update: key considerations for 2023"},{"card":{"key":"9780142e-d941-4bce-8e81-725c194d7cbf","authorName":"David Senior","authorCompany":"AmerisourceBergen","date":"December 2022","description":"Access the recording to learn more about the key features of successful innovative pricing and reimbursement models, and outcomes-based agreements in particular, and about the ways to advance those strategies for cell and gene therapies.","img":{"alt":"Cell and Gene therapy alternative reimbursement models","src":"-/media/assets/amerisourcebergen/manufacturer/cgt/gettyimages-907066340_srgb_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/evaluate-alternative-reimbursement-models-to-craft-a-sustainable-cgt-business-model","linkText":"Watch webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Evaluate alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies"},"categories":["cell and gene therapy","market access","value-based care"],"segments":["manufacturers"],"timestamp":638058729590000000,"title":"webinar: evaluate alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies"},{"card":{"key":"1ac24cdf-cb2a-44ee-8af0-98e8011744c1","authorName":"David Ringger; Erika Wissinger, PhD","authorCompany":"Cencora","date":"May 2024","description":"","img":{"alt":"EAMS","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/htaq-eams.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-summer-2024-eams-evidence","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"EAMS evidence: A key player in drug value proposition and NICE approval?"},"categories":["consulting","regulatory"],"segments":["manufacturers"],"timestamp":638507784000000000,"title":"eams evidence: a key player in drug value proposition and nice approval?"},{"card":{"key":"db9a7bbd-9bb6-4aaf-9f66-3788135f7e2e","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2024","description":"","img":{"alt":"iStock-501041955","src":"-/media/assets/intrinsiq/images/istock-501041955.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/regulations-will-require-biopharma-to-look-to-knowledgeable-partners","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"A tsunami of regulations will require biopharma to look to the high ground of knowledgeable partners"},"categories":["distribution","our role in healthcare"],"segments":["manufacturers"],"timestamp":638536366040000000,"title":"a tsunami of regulations will require biopharma to look to the high ground of knowledgeable partners"},{"card":{"key":"b4c605ef-aac5-439e-8f55-cd0601946d55","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2023","description":"","img":{"alt":"handshake between vet and business partner","src":"-/media/assets/securos/why-securos/handshake_doctor_color.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/when-supplementing-your-field-reimbursement-and-access-team-benefits-you-most","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"When supplementing your field reimbursement and access team benefits you most"},"categories":["field support","patient care","reimbursement","product access"],"segments":["manufacturers"],"timestamp":638370473520000000,"title":"when supplementing your field reimbursement and access team benefits you most"},{"card":{"key":"fa00f5ed-92a7-47ab-b4af-37823dc30339","authorName":"Alvana Maliqi","authorCompany":"Cencora","date":"June 2024","description":"","img":{"alt":"Legislation","src":"-/media/assets/amerisourcebergen/topic-thumbnails/legislation.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/leveraging-pre-approval-information-exchange-to-accelerate-product-success-and-patient-access","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Leveraging Pre-Approval Information Exchange to Accelerate Product Success and Patient Access"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638542470000000000,"title":"leveraging pre-approval information exchange to accelerate product success and patient access"},{"card":{"key":"bf7538f2-48dd-40b6-80ee-7a1e8257a7aa","authorName":"Kimberly Westrich, MA; Lisabeth Buelt, MPH","authorCompany":"Cencora","date":"November 2023","description":"ICER’s final value assessment framework includes only minor changes to its assessment methods and processes but leaves the door open for more significant changes in the future. ","img":{"alt":"ICERs update VAF","src":"-/media/assets/amerisourcebergen/manufacturer/htaq-winter-2023-icer.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-winter-2023-reviewing-icers-revised-value-assessment-framework","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The more things change, the more they stay the same? Reviewing ICER's revised value assessment framework"},"categories":["market access","policy","regulatory"],"segments":["manufacturers"],"timestamp":638344437000000000,"title":"the more things change, the more they stay the same? reviewing icer's revised value assessment framework"},{"card":{"key":"59b0eff6-66a9-4160-bc04-88e71adc8639","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2023","description":"","img":{"alt":"jca","src":"-/media/assets/amerisourcebergen/global-jca.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/exploring-the-implications","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Exploring the Implications of Differing PICO Criteria for Oncology Drug Assessments in Europe"},"categories":["consulting","market access","patient support services","research"],"segments":["manufacturers"],"timestamp":638374991250000000,"title":"exploring the implications of differing pico criteria for oncology drug assessments in europe"},{"card":{"key":"6113059b-0b36-4c93-921e-d5bea578a13f","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2023","description":"What should your commercialization partner be
focused on post-launch? Effective partners optimize
programs and solutions as needed to remove access
and adherence barriers and ensure products reach
their full potential.","img":{"alt":"Post-launch checklist","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/post-launch-checklist.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/post-launch-checklist","linkText":"Download checklist","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Post-launch checklist: What to look for in a commercialization partner"},"categories":["business performance","commercialization","commercial supply chain","data","distribution","medication adherence"],"segments":["manufacturers"],"timestamp":638224537200000000,"title":"post-launch checklist: what to look for in a commercialization partner"},{"card":{"key":"2d289ef4-9574-4b48-b87d-43801445cd3e","authorName":"Scott Shields, MBA","authorCompany":"Cencora","date":"March 2024","description":"The Inflation Reduction Act (IRA) allows the federal government to negotiate US drug prices for the first time. This article considers how the US system may evolve, based on comparison with established price negotiation processes in Canada, France, and Germany.","img":{"alt":"Advanced therapies week","src":"-/media/assets/amerisourcebergen/manufacturer/advanced-therapies-week.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-spring-2024-comparing-the-inflation-reduction-act-to-drug-pricing-programs-in-other-countries","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Apples to apples, or apples to oranges? Comparing the Inflation Reduction Act to drug-pricing programs in other countries"},"categories":["consulting","policy","regulatory"],"segments":["manufacturers"],"timestamp":638453424600000000,"title":"apples to apples, or apples to oranges? comparing the inflation reduction act to drug-pricing programs in other countries"},{"card":{"key":"12c6271e-6c58-4f02-9128-45936f301378","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2024","description":"","img":{"alt":"Cryogenic CGT logistics ","src":"-/media/assets/amerisourcebergen/manufacturer/cgt/cold-hard-facts.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/discussing-the-thinklive-cell-and-gene-therapy-summit","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Discussing the ThinkLive Cell and Gene Therapy Summit"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638532143640000000,"title":"discussing the thinklive cell and gene therapy summit"},{"card":{"key":"741be715-e452-42f6-a4c5-1fcc278289a1","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2024","description":"","img":{"alt":"as patient and partner needs grow_center","src":"-/media/assets/innomarstrategies/who-we-support/manufacturers/as-patient-and-partner-needs-grow_center.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/5-questions-to-ask-a-potential-patient-support-partner-for-established-biopharma-companies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"5 questions to ask a potential patient support partner if you’re an established biopharma company"},"categories":["affordability","commercialization","innovation","medication adherence","patient support services","product access","technology"],"segments":["manufacturers"],"timestamp":638588155190000000,"title":"5 questions to ask a potential patient support partner if you’re an established biopharma company"},{"card":{"key":"7b9ba7be-1d46-4028-8121-b0e905501394","authorName":"Xcenda","authorCompany":null,"date":"February 2021","description":"More and more manufacturers recognize that the key to improving patient access and speed to therapy is to deploy an experienced field services team. Learn how Xcenda can help. ","img":{"alt":"xcenda field services working on project","src":"-/media/assets/xcenda/english/images/01-home-page-new-images/xcenda_1upcard_03.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/checklist-four-things-to-look-for-in-a-field-services-partner","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Checklist: Four things to look for in a field services partner"},"categories":["reimbursement","market access","commercialization","field support"],"segments":["manufacturers"],"timestamp":637486886930000000,"title":"checklist: four things to look for in a field services partner"},{"card":{"key":"822a4b9c-ba04-4b6c-9316-9561bf05f858","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"amcp","src":"-/media/assets/amerisourcebergen/amcp-2024-innovation-and-impact-award.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/recap-amcp-2024-our-thought-leadership-in-action","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Recap AMCP 2024: Our thought leadership in action"},"categories":["cell and gene therapy","consulting","commercialization","formulary solutions","innovation","managed care","market access","policy","regulatory"],"segments":["manufacturers"],"timestamp":638518149000000000,"title":"recap amcp 2024: our thought leadership in action"},{"card":{"key":"054cf79c-26d1-4317-a20d-98d9c12e8a9f","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2021","description":"Xcenda and FormularyDecisions joined AMCP for a live webinar on June 9, 2021 titled, “The Rise in Digital Information Dissemination: Communication Trends in Managed Care.”","img":{"alt":"AB-Business-Meeting-2_RGB_card","src":"-/media/assets/sustainability/images/ab-business-meeting-2_rgb_card.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/webinar-rise-of-digital-information-dissemination-communication-trends-in-managed-care","linkText":"Download slides","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: the rise of digital information dissemination: communication trends in managed care"},"categories":[],"segments":["manufacturers"],"timestamp":637590173480000000,"title":"webinar: the rise of digital information dissemination: communication trends in managed care"},{"card":{"key":"54c8eead-819a-4a23-a160-1c1da95e126c","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2019","description":"","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/lash-group-tech-enabled-webinar","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Achieve Better Patient Outcomes with Clinically Supported, Tech-Enabled Adherence Programs"},"categories":[],"segments":["manufacturers"],"timestamp":637026873000000000,"title":"webinar: achieve better patient outcomes with clinically supported, tech-enabled adherence programs"},{"card":{"key":"2d19ecef-8bf1-455b-9429-2ffb8e8ff1e4","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2020","description":"Ideas that matter from PAP 2020: As the larger healthcare system looks for ways to alleviate challenges brought on by the coronavirus, patient support providers are shifting how they work with manufacturers to increase impact and provide ongoing support for patients.","img":{"alt":"blue face masks on yellow background tiled","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/face-masks-tiled.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pap-2020-panel-recap-navigating-covid-19","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"PAP 2020 panel recap: Navigating COVID-19"},"categories":["affordability","covid-19","commercialization","product access"],"segments":["manufacturers"],"timestamp":637387221350000000,"title":"pap 2020 panel recap: navigating covid-19"},{"card":{"key":"0f8fa7b7-1771-4794-824e-bc2d934b2804","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2022","description":"","img":{"alt":"innovative agreements","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/1000x150-tlc-fierce-biopharma-services.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/innovative-agreements-exploring-alternative-payment-models","linkText":"Watch on demand","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Innovative agreements: Exploring alternative payment models"},"categories":["value-based care","reimbursement","product access","market access"],"segments":["manufacturers"],"timestamp":637940279410000000,"title":"innovative agreements: exploring alternative payment models"},{"card":{"key":"71534c9e-35cf-4494-9674-c79230e206a1","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2019","description":"Download this new white paper from IHOC - Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies - to learn the key insights about the role HSSPs play in improving the patient experience and why patient and provider satisfaction are important data points for both payers and manufacturers to consider when deciding to include HSSPs in their networks.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/value-of-patient-and-provider-satisfaction","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies"},"categories":["analytics","specialty pharmacy","product access","market access"],"segments":["health systems","manufacturers"],"timestamp":636911312100000000,"title":"coordinated care: the value of patient and provider satisfaction within health system specialty pharmacies"},{"card":{"key":"2b4556ca-e7ec-46e9-a46c-b3ab8875b6e1","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"call centre support 4","src":"-/media/assets/healthforward/images/colour/call-centre-support-3.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/prepare-your-patient-support-program-for-ira-impact","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Prepare your patient support program for IRA's impact"},"categories":["patient support services","patient care"],"segments":["manufacturers"],"timestamp":638521625200000000,"title":"prepare your patient support program for ira's impact"},{"card":{"key":"247447cd-68c3-44e6-9807-e9f6fc3742e2","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2022","description":"","img":{"alt":"Interchangeable biosimilars","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/podcast-interchangeable-biosimilars.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/podcast-conversations-around-interchangeability-and-biosimilar-entries-in-new-therapeutic-categories","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Podcast: Conversations around interchangeability and biosimilar entries in new therapeutic categories"},"categories":["biosimilars","affordability","market access","regulatory"],"segments":["manufacturers"],"timestamp":637980984230000000,"title":"podcast: conversations around interchangeability and biosimilar entries in new therapeutic categories"},{"card":{"key":"328f08c7-d81a-4d0c-9a26-3b052ec5c00b","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2019","description":"We asked 100 physicians to share their perspectives on biosimilar utilization, cost savings, and adoption barriers. See what they said and what it means for the market and manufacturers.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilar-physician-insights-survey","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Biosimilars Check Up: Physician Survey Results"},"categories":["biosimilars"],"segments":["manufacturers","pharmacies"],"timestamp":637037227980000000,"title":"biosimilars check up: physician survey results"},{"card":{"key":"49e8eccf-c16a-47ec-9b3d-86c0747981e1","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2021","description":"Health policy experts discuss politics, policy, and the impact on manufacturers heading into 2022.","img":{"alt":"AB-health-policy","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/health-policy-flag-stethoscope/ab-health-policy.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/health-policy-and-the-political-landscape","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Health policy and the political landscape"},"categories":["advocacy","affordability","policy","regulatory"],"segments":["manufacturers"],"timestamp":637705147390000000,"title":"health policy and the political landscape"},{"card":{"key":"6df65be6-2d53-4fb8-8f34-ba49404047da","authorName":"Lash Group","authorCompany":null,"date":"August 2021","description":"Lash Group experts share strategies for commercializing digital therapies and supporting patients who use them in this ebook developed in partnership with Pharmaceutical Executive.","img":{"alt":"woman using smartphone on yellow couch","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/woman-using-smartphone-on-yellow-couch.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/bringing-innovation-to-market-with-digital-therapeutics-ebook","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"eBook: Bringing innovation to market with digital therapeutics"},"categories":["affordability","commercialization","data","market access","medication adherence","patient support services","innovation","product access","reimbursement","technology"],"segments":["manufacturers"],"timestamp":637655118740000000,"title":"ebook: bringing innovation to market with digital therapeutics"},{"card":{"key":"cc486548-df94-4d99-966d-c9670ce89b09","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"regulatory services_top banner","src":"-/media/assets/innomarstrategies/services/regulatory-services/regulatory-services_top-banner.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/navigating-the-launch-of-atmps-in-europe","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Q&A Interview: Navigating the launch of ATMPs in Europe"},"categories":["cell and gene therapy","consulting","regulatory"],"segments":[],"timestamp":638509663780000000,"title":"q&a interview: navigating the launch of atmps in europe"},{"card":{"key":"ca3a973d-a779-4eb1-b513-cf020abd6e85","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2024","description":"","img":{"alt":"Strategic partnerships for unlocking product potential ebook","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/strategic-partnerships-for-unlocking-product-potential.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-biopharma-can-engage-successfully-with-complex-sites-of-care","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How biopharma can engage successfully with complex sites of care"},"categories":["field support"],"segments":["manufacturers"],"timestamp":638587423470000000,"title":"how biopharma can engage successfully with complex sites of care"},{"card":{"key":"64d28c6e-027a-4c32-b37a-07c3aeaabb9a","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2021","description":"Melissa Mulchaney, Vice President of Field Services Client Engagement and Business Development at Xcenda, weighs in on the most important qualities to look for when building a field services team.","img":{"alt":"health insurance claim form","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/health-insurance-claim-form.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/building-your-field-reimbursement-and-access-team","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Building your field reimbursement and access team: The translational experience and skills that matter most"},"categories":["affordability","commercialization","market access","reimbursement","product access","field support"],"segments":["manufacturers"],"timestamp":637672436550000000,"title":"building your field reimbursement and access team: the translational experience and skills that matter most"},{"card":{"key":"2fa38be8-99e9-4b5c-b681-a66fbb34b47e","authorName":"Lash Group","authorCompany":null,"date":"April 2021","description":"The manufacturer of a leading biologic therapy used digital communications to improve medication adherence among targeted patient groups as they enrolled in a patient support program for the therapy.","img":{"alt":"digital companion medication adherence solutions","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ab-brand-abstract-swirls.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/case-study-improving-medication-adherence-with-a-digital-companion","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case study: Improving medication adherence with a digital companion"},"categories":["medication adherence","patient support services","innovation","commercialization"],"segments":["manufacturers"],"timestamp":637544736000000000,"title":"case study: improving medication adherence with a digital companion"},{"card":{"key":"9e15ca31-9c7a-4d72-9257-215a8279630d","authorName":"Lash Group","authorCompany":null,"date":"July 2020","description":"Executive Q&A: Troy Ward, Chief Operations Officer at Lash Group, shares how his team sustains operational excellence during times of uncertainty, such as the current COVID-19 pandemic.","img":{"alt":"callcenter remote female","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/callcenter-remote-female.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/patient-support-program-operations","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Patient support program operations: A peek behind the curtain"},"categories":["patient support services"],"segments":["manufacturers"],"timestamp":637318102760000000,"title":"patient support program operations: a peek behind the curtain"},{"card":{"key":"5ac79eee-996e-4f4a-8c18-5d07c5258429","authorName":"Xcenda","authorCompany":null,"date":"December 2020","description":"A look at the modern field reimbursement and access program. Why pharmaceutical manufacturers should rethink their approach in the face of COVID-19 and a changing healthcare landscape.","img":{"alt":"field-services-patient-access-meeting","src":"-/media/assets/xcenda/english/images/paid-media/circularmodule_typage_refresh.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/evaluating-the-modern-field-reimbursement-and-access-program-key-considerations","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Evaluating the modern field reimbursement and access program: key considerations"},"categories":["product access","reimbursement","covid-19"],"segments":["manufacturers"],"timestamp":637438559390000000,"title":"evaluating the modern field reimbursement and access program: key considerations"},{"card":{"key":"bdacd407-6cfb-43c5-a87d-64ea5ce89cfb","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2021","description":"How two AmerisourceBergen companies are partnering to deliver an innovative clinical trial solution during the COVID-19 pandemic and beyond.","img":{"alt":"nurse and patient in home","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/nurse-and-patient-in-home.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/adding-nursing-support-to-at-home-clinical-trials","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Innovation spotlight: Adding nursing support to at-home clinical trials"},"categories":["clinical trial logistics","covid-19","direct-to-patient","medication adherence","innovation","consulting"],"segments":["manufacturers"],"timestamp":637515970580000000,"title":"innovation spotlight: adding nursing support to at-home clinical trials"},{"card":{"key":"3a48e668-d468-4c82-be8a-6a4e37cd59d9","authorName":"Shemeka Johnson","authorCompany":"Lash Group","date":"March 2021","description":"Shemeka Johnson, Senior Director of Operations at Lash Group, discusses how social determinants of health impact patient access to medication and explains why it's important for manufacturers to develop a deep understanding of the patients they serve.","img":{"alt":"woman at desk","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/woman-at-desk.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/addressing-health-disparities-through-understanding","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Addressing health disparities through understanding"},"categories":["affordability","patient support services","health equity","product access"],"segments":["manufacturers"],"timestamp":637526343540000000,"title":"addressing health disparities through understanding"},{"card":{"key":"05c689e8-b78f-4c98-b696-d09babac3fa0","authorName":"World Courier","authorCompany":null,"date":"September 2020","description":"Based on World Courier’s experience of maintaining supply channels during times of public health crises and transport disruption, we’ve outlined key logistics considerations that apply to COVID-19 vaccine development and distribution.","img":{"alt":"Trials","src":"-/media/assets/worldcourier/english/images/article-images/patient_needs.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-logistics-of-covid-19-vaccine-trials","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Article: The Logistics of COVID-19 Vaccine Trials"},"categories":["covid-19","secure supply chain"],"segments":["manufacturers"],"timestamp":637350738600000000,"title":"article: the logistics of covid-19 vaccine trials"},{"card":{"key":"c5d69830-4114-46c1-a9b6-f96cb111962f","authorName":"Kim McLeod, MPH","authorCompany":"Xcenda","date":"February 2020","description":"New ways manufacturers are gathering data that supports their product value story, both pre- and post-launch.","img":{"alt":"MindtheGap","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/mindthegap.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/mind-the-evidence-gap","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Mind the (Evidence) Gap"},"categories":["commercialization","data","legislation","market access","orphan drugs","policy","regulatory","technology"],"segments":["manufacturers"],"timestamp":637163352000000000,"title":"mind the (evidence) gap"},{"card":{"key":"c6b5bb3f-350e-46a9-ae4a-0d52abb0287c","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2023","description":"","img":{"alt":"jca eu hta","src":"-/media/assets/amerisourcebergen/insights/panel-explores-insights-and-implications-of-eu-jca/jca_eu_hta.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/panel-explores-insights-and-implications-of-the-game-changing-eu-jca","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Panel explores insights and implications of the game-changing EU JCA"},"categories":["commercialization","consulting","affordability","legislation"],"segments":[],"timestamp":638260009470000000,"title":"panel explores insights and implications of the game-changing eu jca"},{"card":{"key":"91ceebc6-33d3-4ffd-bac3-882e46de0790","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2024","description":"","img":{"alt":"US capitol color","src":"-/media/assets/amerisourcebergen/addressing-public-policy/us-capitol-color.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/access-usa-2024-state-of-industry-session-download","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"State of the Industry: The Changing Landscape of Healthcare Coverage and Access"},"categories":["patient care","patient support services"],"segments":["manufacturers"],"timestamp":638471669440000000,"title":"state of the industry: the changing landscape of healthcare coverage and access"},{"card":{"key":"6722a2f0-f0fa-4f9f-9603-054153a8c7c5","authorName":"World Courier","authorCompany":null,"date":"October 2022","description":"","img":{"alt":"GettyImages-1161024014-RGB_PNG","src":"-/media/assets/worldcourier/english/images/gettyimages-1161024014-rgb_png.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/cold-hard-facts-about-cryogenic-cell-and-gene-therapy-logistics","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Cold hard facts about cryogenic cell and gene therapy logistics"},"categories":["cell and gene therapy"],"segments":[],"timestamp":638006755480000000,"title":"cold hard facts about cryogenic cell and gene therapy logistics"},{"card":{"key":"5e88f332-edeb-4d71-a0fb-2954ac429912","authorName":"Jane Ha, PharmD, MS","authorCompany":"Cencora","date":"June 2024","description":"","img":{"alt":"","src":"-/media/assets/amerisourcebergen/meeting---opt-2/jane-ha.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/unsupported-policy-information","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Unsupported policy information: Insights from Jane Ha"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638544954000000000,"title":"unsupported policy information: insights from jane ha"},{"card":{"key":"65c789fc-57bd-4850-8c61-23709f2c91ea","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2024","description":"A global biotechnology company approached Innomar with a request to become their quality unit for Canadian importation. They expressed dissatisfaction with their current contracted quality consultants.","img":{"alt":"Female scientist working with a digital tablet in the laboratory","src":"-/media/assets/innomarstrategies/insights/female-lab-coat-tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/achieving-quality-assurance-excellence-for-a-client","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Achieving quality assurance excellence for a client"},"categories":[],"segments":["manufacturers"],"timestamp":638484544930000000,"title":"achieving quality assurance excellence for a client"},{"card":{"key":"261ff1ab-b4d7-419a-984d-e10e39c8fc39","authorName":"Xcenda","authorCompany":null,"date":"August 2020","description":"By the numbers: Field reimbursement and access support for pharmaceutical products in the new normal of COVID-19.","img":{"alt":"Male doctor speaking to patient on a tablet","src":"-/media/assets/xcenda/english/images/insights/telehealth.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/solving-access-reimbursement-and-pap-awareness-problems","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Solving access, reimbursement, and PAP awareness problems"},"categories":["reimbursement","patient support services","covid-19","product access","market access"],"segments":["manufacturers"],"timestamp":637338783070000000,"title":"solving access, reimbursement, and pap awareness problems"},{"card":{"key":"b67421db-a6bb-4fcf-9cb2-fcfa5214f63a","authorName":"Corey Ford, MHA; Myra Reinhardt","authorCompany":"","date":"July 2019","description":"Two experts in health economics and patient support team up to offer insight on how manufacturers can prepare for the impact of copay accumulators.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/copay-accumulators-are-your-patients-really-at-risk","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Copay Accumulators: Are Your Patients Really at Risk?"},"categories":["affordability","patient support services"],"segments":["manufacturers"],"timestamp":636995871930000000,"title":"copay accumulators: are your patients really at risk?"},{"card":{"key":"1ef87f74-c209-4160-a56c-423a35e81d95","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"March 2023","description":"","img":{"alt":"shutterstock_524319070","src":"-/media/assets/worldcourier/english/images/cell-and-gene/shutterstock_524319070.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-cryogenic-logistics-overcome-the-low-tolerance-for-deviations-of-cell-and-gene-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Infographic: How cryogenic logistics overcome the low tolerance for deviations of cell and gene therapies"},"categories":["cell and gene therapy"],"segments":[],"timestamp":638148780000000000,"title":"infographic: how cryogenic logistics overcome the low tolerance for deviations of cell and gene therapies"},{"card":{"key":"81c679a6-ebf6-46aa-8320-be8de994cfa5","authorName":"Innomar Strategies","authorCompany":null,"date":"December 2019","description":"A recap of InnomarLive 2019, including highlights from speakers and panel discussions on key considerations for commercializing pharmaceutical products in Canada.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/innomarlive-2019-summary-commercializing-in-canada","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"InnomarLive 2019: Commercializing in Canada"},"categories":["commercialization","product access","market access","regulatory"],"segments":["manufacturers"],"timestamp":637118653800000000,"title":"innomarlive 2019: commercializing in canada"},{"card":{"key":"8d954054-d4f2-4e2e-b2fb-3120878e0e7e","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2024","description":"","img":{"alt":"pharmacy","src":"-/media/assets/amerisourcebergen/pharmacy_bcn22_0599_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharmacy-network-strategies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pharmacy Network Strategies"},"categories":["distribution","patient support services"],"segments":["manufacturers"],"timestamp":638496688870000000,"title":"pharmacy network strategies"},{"card":{"key":"c322aaee-ffc0-4497-a8f4-81435dc5547d","authorName":"Xcenda","authorCompany":null,"date":"July 2022","description":"Why FormularyDecisions is the right choice for enterprise biopharma payer engagement. The secure, online platform connects biopharma companies and payers to share information bi-directionally","img":{"alt":"formulary decisions enterprise man working on computer","src":"-/media/assets/xcenda/english/images/formularydecisions/formularydecisions-hero-3840x2194.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/formularydecisions-enterprise-biopharma-payer-engagement","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Why FormularyDecisions® is the right choice for enterprise biopharma payer engagement "},"categories":["commercialization","market access","technology"],"segments":["manufacturers"],"timestamp":637931438910000000,"title":"why formularydecisions® is the right choice for enterprise biopharma payer engagement "},{"card":{"key":"83ac9a24-aa8d-4113-936c-b3d3f0b7e795","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2022","description":"","img":{"alt":"GettyImages-483533237_RGB_Large_JPG (1)","src":"-/media/assets/amerisourcebergen/01-home-page-new-images/gettyimages-483533237_rgb_large_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/podcast-emerging-cell-and-gene-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Podcast: Emerging cell and gene therapies, complex logistics eco-systems, and the need for greater industry collaboration"},"categories":["cell and gene therapy"],"segments":[],"timestamp":637847035150000000,"title":"podcast: emerging cell and gene therapies, complex logistics eco-systems, and the need for greater industry collaboration"},{"card":{"key":"dae7391b-497b-48bd-8081-b8e786f71125","authorName":"Alex Guite","authorCompany":"World Courier","date":"November 2020","description":"","img":{"alt":"WC_China_2016_0056-rev_RGB_Large_JPG LR","src":"-/media/assets/worldcourier/english/images/rebrand/wc_china_2016_0056-rev_rgb_large_jpg-lr.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/key-strategies-for-cell-and-gene-therapy-in-china","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Whitepaper: Key Strategies for Cell and Gene Therapy in China"},"categories":["cell and gene therapy","commercialization"],"segments":[],"timestamp":637420507460000000,"title":"whitepaper: key strategies for cell and gene therapy in china"},{"card":{"key":"c1d2d656-4b52-4bf6-88ca-b40a090525c3","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2022","description":"","img":{"alt":"CGT cells","src":"-/media/assets/worldcourier/english/images/cell-and-gene/cgt-cells.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/report-building-successful-cell-and-gene-therapy-supply-chains","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Report: Building successful cell and gene therapy supply chains"},"categories":["cell and gene therapy"],"segments":[],"timestamp":637873651930000000,"title":"report: building successful cell and gene therapy supply chains"},{"card":{"key":"62264298-00b0-460b-8d81-c7d4521e72bc","authorName":"Kelly Frend","authorCompany":"World Courier","date":"February 2021","description":"","img":{"alt":"lungs covid19","src":"-/media/assets/worldcourier/english/images/article-images/lungs-covid19.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/webinar-on-demand-cryo-network-post-covid-day","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Webinar on-demand: Partnering in a pandemic, a case study by World Courier and Pluristem"},"categories":["cell and gene therapy"],"segments":[],"timestamp":637490864900000000,"title":"webinar on-demand: partnering in a pandemic, a case study by world courier and pluristem"},{"card":{"key":"1d935886-dbff-401c-90a6-ae92adcc65cb","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"pharmacy","src":"-/media/assets/amerisourcebergen/pharmacy_bcn22_1249_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/enhancing-your-patient-assistance-programs-efficiency-with-innovative-digital-solutions","linkText":"Get the white paper","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":" Enhancing your patient assistance program’s efficiency with innovative digital solutions"},"categories":["patient support services"],"segments":["manufacturers"],"timestamp":638572795930000000,"title":" enhancing your patient assistance program’s efficiency with innovative digital solutions"},{"card":{"key":"fbc49006-8536-464a-bd37-5eca3ee1d35c","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2022","description":"","img":{"alt":"GettyImages-1251485261_sRGB_JPG","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/gettyimages-1251485261_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/nine-questions-about-rare-and-orphan-drug-commercialization","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Nine questions about rare and orphan drug commercialization"},"categories":["orphan drugs","commercialization","distribution"],"segments":["manufacturers"],"timestamp":637811347780000000,"title":"nine questions about rare and orphan drug commercialization"},{"card":{"key":"aff87206-0cc8-4d26-a948-4aa9b6f1ee05","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2023","description":"Use this checklist to help you decide which skills are core, non-negotiable, translational attributes for a field reimbursement and access specialist -- and which ones can be learned in product-specific training.","img":{"alt":"female speaking to medical audience","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/female-speaking-to-medical-audience.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/essential-skills-for-outsourced-field-solutions-teams","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Essential skills for outsourced field solutions teams"},"categories":["affordability","commercialization","innovation","market access","product access","reimbursement","field support"],"segments":["manufacturers"],"timestamp":638367050400000000,"title":"essential skills for outsourced field solutions teams"},{"card":{"key":"222804c5-d9f3-4f5b-b4d9-ff971d55b0e2","authorName":"Lash Group","authorCompany":null,"date":"April 2021","description":"Watch the Lash Group PAP 2021 webinar online: Forging a better path for patients in the wake of a pandemic","img":{"alt":"lash group medication patient","src":"-/media/assets/amerisourcebergen/about-us/ab_1card_03.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pap-forging-a-better-path-2021","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Webinar: Forging a better path for patients in the wake of a pandemic"},"categories":["patient support services","product access","medication adherence","covid-19"],"segments":[],"timestamp":637544573830000000,"title":"webinar: forging a better path for patients in the wake of a pandemic"},{"card":{"key":"eab4edcf-423a-47b5-8404-d52080de7ac6","authorName":"Dave Picard","authorCompany":"AmerisourceBergen","date":"September 2017","description":"What should biosimilar manufacturers focus on for commercialization success?","img":{"alt":"Female researcher with test tube","src":"-/media/assets/amerisourcebergen/lab/lab_testtube_rsrch_fm_003.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-growth-of-biosimilars-in-the-oncology-pipeline","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Manufacturers","headline":"The Growth of Biosimilars in the Oncology Pipeline"},"categories":["biosimilars","commercialization","oncology"],"segments":["manufacturers"],"timestamp":636420538080000000,"title":"the growth of biosimilars in the oncology pipeline"},{"card":{"key":"b1fb5866-2a26-4628-b845-7ebe71275708","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2023","description":"","img":{"alt":"Hands and blocks building strategy","src":"-/media/assets/xcenda/german/images/expertise/buildingblocksstrategy.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-dutch-lock-procedure-for-reimbursement","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The Dutch Lock Procedure for Reimbursement: Ensuring Effective and Affordable Healthcare"},"categories":["consulting","market access","patient support services","research"],"segments":["manufacturers"],"timestamp":638393043500000000,"title":"the dutch lock procedure for reimbursement: ensuring effective and affordable healthcare"},{"card":{"key":"ce1434e2-5736-4bce-a565-70990a02b107","authorName":"Corey Ford, MHA","authorCompany":"","date":"April 2020","description":"Executive Q&A: Patient assistance programs improve access to medication for today’s chronic, life-altering and difficult-to-manage diseases. Xcenda’s Corey Ford explains how COVID-19 could impact patient access and the programs supporting these patients.","img":{"alt":"shutterstock_1620672310","src":"-/media/assets/amerisourcebergen/insights/covid19/shutterstock_1620672310.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-covid-19-will-impact-patient-support","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How COVID-19 Will Impact Patient Support"},"categories":["covid-19","affordability","medication adherence","patient support services","product access"],"segments":["manufacturers"],"timestamp":637219767960000000,"title":"how covid-19 will impact patient support"},{"card":{"key":"1960c826-ad6b-4327-93c8-8e016f28d2aa","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2023","description":"World Courier ensures timely and safe delivery of life-saving gene therapy for SMA patient, using advanced tracking technology.","img":{"alt":"shutterstock_1088838263LR","src":"-/media/assets/worldcourier/english/images/direct-to-patient/shutterstock_1088838263lr.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/spinal-muscular-atrophy-case-study","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Amelia's journey with spinal muscular atrophy "},"categories":["cell and gene therapy","direct-to-patient","patient safety"],"segments":[],"timestamp":638140569600000000,"title":"amelia's journey with spinal muscular atrophy "},{"card":{"key":"53ad7bba-00cb-4848-a6f7-840a00386c53","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"August 2022","description":"","img":{"alt":"shutterstock_1241172154 LR","src":"-/media/assets/worldcourier/english/images/cell-and-gene/shutterstock_1241172154-lr.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/to-freeze-or-not-to-freeze---insights","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Fresh or frozen: the supply chain needs of your cell and gene therapy"},"categories":["cell and gene therapy"],"segments":[],"timestamp":637956374400000000,"title":"fresh or frozen: the supply chain needs of your cell and gene therapy"},{"card":{"key":"23882d83-5d2d-4425-989e-10c36bb6155e","authorName":"Innomar Strategies","authorCompany":null,"date":"April 2020","description":"Executive Q&A: Justin Evans, Director of Regulatory Operations at Innomar Strategies, discusses how his team works with clients to meet Health Canada's rigorous standards on the path to commercialization.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/3-questions-with---publishing-and-submissions","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"Commercializing in Canada: Regulatory Publishing and Submissions"},"categories":["commercialization","regulatory"],"segments":["manufacturers"],"timestamp":637227180000000000,"title":"commercializing in canada: regulatory publishing and submissions"},{"card":{"key":"59a3cbc6-55c8-431d-be87-3931bd72f592","authorName":"AmerisourceBergen","authorCompany":"","date":"September 2022","description":"Heightened collaboration among all stakeholders, including payers and biopharma companies, is critical to close the pre-approval information gaps and maximize the opportunities that PIE presents.","img":{"alt":"AB color abstract ","src":"-/media/assets/xcenda/english/images/01-home-page-new-images/gettyimages-1299992609-rgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/closing-the-gap-in-preapproval-information-exchange","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Closing the gaps in pre-approval information exchange to accelerate product success and patient access"},"categories":["commercialization","data","policy","regulatory","market access"],"segments":["manufacturers"],"timestamp":637976490910000000,"title":"closing the gaps in pre-approval information exchange to accelerate product success and patient access"},{"card":{"key":"e82238a9-92f5-4e47-baf5-bd9198c57251","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2024","description":"","img":{"alt":"banner","src":"-/media/assets/innomarstrategies/services/pharmacoviglance/pharmacovigilance_top-banner.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/streamlining-ae-management-with-automated-solutions","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Streamlining AE Management with Automated Solutions"},"categories":[],"segments":["manufacturers"],"timestamp":638609836310000000,"title":"streamlining ae management with automated solutions"},{"card":{"key":"819cad81-658d-4c26-a067-724041abd412","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2024","description":"Enrollment is the first key step providers take to get patients access to a patient support program (PSP). However, the enrollment process is the source of several challenges that limit the utilization and efficacy of PSPs. ","img":{"alt":"PSP_top banner","src":"-/media/assets/innomarstrategies/services/patient-support-programs/psp_top-banner.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/infographic-patient-support-program-enrollment-process-comparison","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Infographic: Patient support program enrollment process comparison"},"categories":["patient support services"],"segments":[],"timestamp":638615071200000000,"title":"infographic: patient support program enrollment process comparison"},{"card":{"key":"6b32d640-3595-4b07-aaed-50b067a183a9","authorName":"Michael Hennig, PhD","authorCompany":"PharmaLex, part of Cencora","date":"July 2024","description":"","img":{"alt":"Market research images on ipad","src":"-/media/assets/innomarstrategies/services/consulting-services/market-access-strategy-graphs.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/eu-hta-2025-key-methodological-updates-and-practical-tips-on-statistical-guidelines","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"EU HTA 2025 readiness: Key methodological updates and practical tips on statistical guidelines"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638572614690000000,"title":"eu hta 2025 readiness: key methodological updates and practical tips on statistical guidelines"},{"card":{"key":"156c1aec-ed72-4d5f-bbd5-b5feae09468d","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2024","description":"","img":{"alt":"Two people having a discussion","src":"-/media/assets/xcenda/english/images/solutions/fieldconsulting.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/clinical-specialists-and-field-reimbursement","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Better together: Clinical specialists and field reimbursement and access specialists"},"categories":["field support"],"segments":["manufacturers"],"timestamp":638586525640000000,"title":"better together: clinical specialists and field reimbursement and access specialists"},{"card":{"key":"04c5d069-cc2c-4020-a7ea-d092dd7fde53","authorName":"World Courier","authorCompany":null,"date":"March 2022","description":"","img":{"alt":"ICS_Brooks_3PL_Cryogenic_074_rgb_rtchd LR","src":"-/media/assets/worldcourier/english/images/cell-and-gene/ics_brooks_3pl_cryogenic_074_rgb_rtchd-lr.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/advanced-therapies-time-is-now","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"The time is now: why it pays to be prepared for the commercialization of advanced therapies "},"categories":["cell and gene therapy","pharmaceutical storage and transport management"],"segments":[],"timestamp":637831342980000000,"title":"the time is now: why it pays to be prepared for the commercialization of advanced therapies "},{"card":{"key":"b30dbf63-9cea-41c5-8bf7-781b9df3bb8b","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2020","description":"Manufacturers today have more options than ever for electronic benefit verification. What type of eBV solution is best for you?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-evaluate-an-ebv-product","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Insight","headline":"How to Evaluate an eBV Product"},"categories":[],"segments":[],"timestamp":637142249930000000,"title":"how to evaluate an ebv product"},{"card":{"key":"106d115b-a8c6-4c4b-8b78-3d953dab6d05","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2022","description":"Cell and gene therapies are currently at the forefront of scientific innovation. They hold great promise for patients suffering from a range of serious ailments. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/commercializing-cell-and-gene-therapies-in-canada","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Commercializing cell and gene therapies in Canada"},"categories":["commercialization","patient support services","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637804260000000000,"title":"commercializing cell and gene therapies in canada"},{"card":{"key":"0c4233b7-7e0a-4a6a-bc8c-d35a69085bcb","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2024","description":"","img":{"alt":"digital enrolment_square","src":"-/media/assets/innomarstrategies/services/avidityhealth/digital-enrolment_square.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/access-usa-2024-patient-support-session-download","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Digital-First Patient Support: The Art of the Possible to Optimize Outcomes"},"categories":["patient care","patient support services","technical services"],"segments":["manufacturers"],"timestamp":638471683480000000,"title":"digital-first patient support: the art of the possible to optimize outcomes"},{"card":{"key":"413fd60a-6611-46b4-b891-665650dd6752","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2022","description":"Prescription digital therapeutics (PDTs) consist of evidence-based, clinically evaluated software that goes through a development and approval process similar to medications and medical devices.","img":{"alt":"asian woman on smartphone at home","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/asian-woman-on-smartphone-at-home.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/time-is-right-for-commercializing-prescription-digital-therapeutics","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The time is right for commercializing prescription digital therapeutics "},"categories":["data","engagement","medication therapy management","patient support services"],"segments":["manufacturers"],"timestamp":638036903980000000,"title":"the time is right for commercializing prescription digital therapeutics "},{"card":{"key":"29759932-6986-4341-8d22-32fe3afc4d64","authorName":"Heather Zenk, RPh, PharmD","authorCompany":"Cencora","date":"April 2020","description":"What providers and pharmacies need to know about the distribution of high-demand inventory during the COVID-19 pandemic.","img":{"alt":"Dist_Drug_A-Frame_Bottles_016_grey","src":"-/media/assets/amerisourcebergen/distribution/dist_drug_a-frame_bottles_016_grey.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-do-allocations-work-for-the-pharma-supply-chain","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How Do Allocations Work for the Pharma Supply Chain?"},"categories":["covid-19","distribution","inventory management","product access"],"segments":["pharmacies","health systems"],"timestamp":637226482110000000,"title":"how do allocations work for the pharma supply chain?"},{"card":{"key":"6f435d68-6dc8-4bf7-b007-a05eb5be839a","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2023","description":"","img":{"alt":"Four people working on computers","src":"-/media/assets/besse/images/general/four-people-working-computers.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biopharma-economic-challenges-and-solutions","linkText":"Download the report","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Top 4 current economic challenges faced by biopharma companies"},"categories":["formulary solutions"],"segments":["manufacturers"],"timestamp":638260760410000000,"title":"top 4 current economic challenges faced by biopharma companies"},{"card":{"key":"1eefad8f-0a7e-450f-812a-5c3df8ab0e30","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2017","description":"In supply chain decisions, a wholly new type of product demands a wholly new definition for supply chain expertise and effective support.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/logistics-decisions-will-impact-the-success-of-new-cell-and-gene-therapies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Logistics Decisions Will Impact the Success of New Cell and Gene Therapies"},"categories":["cell and gene therapy","commercialization","third party logistics"],"segments":["manufacturers"],"timestamp":636359181000000000,"title":"logistics decisions will impact the success of new cell and gene therapies"},{"card":{"key":"4fb71974-dd87-4f81-9fab-91fcf238c279","authorName":"Lash Group","authorCompany":null,"date":"December 2021","description":"What three things do manufacturers need to know as they build the copay solution of the future? Lash Group simplifies the complex future of copay.","img":{"alt":"piggy bank","src":"-/media/assets/amerisourcebergen/insights/piggy-bank.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/three-considerations-for-patient-forward-copay-solutions","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Patient-forward copay solutions: Three considerations for building effective support"},"categories":["affordability","commercialization","patient support services"],"segments":["manufacturers"],"timestamp":637751051050000000,"title":"patient-forward copay solutions: three considerations for building effective support"},{"card":{"key":"ff0c67fa-11ab-4f95-9e1c-8cf9413fc794","authorName":"Tasmina Hydery","authorCompany":"","date":"June 2022","description":"Download the webinar slides from the Xcenda and FormularyDecisions discussion: “Navigating Reimbursement and Access Challenges for Novel Cell and Gene Therapies.” ","img":{"alt":"abstract lines ","src":"-/media/assets/xcenda/english/images/insights/ab-colors-abstract-lines.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/webinar-slides-navigating-reimbursement-and-access-challenges-for-novel-cell-and-gene-therapies","linkText":"Download slides","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar slides: Navigating Reimbursement and Access Challenges for Novel Cell and Gene Therapies"},"categories":["cell and gene therapy","commercialization","market access"],"segments":["manufacturers"],"timestamp":637914326220000000,"title":"webinar slides: navigating reimbursement and access challenges for novel cell and gene therapies"},{"card":{"key":"fd5317ec-b197-48f8-9847-a64944a20132","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2023","description":"","img":{"alt":"Biosimilars gears htaq","src":"-/media/assets/xcenda/english/images/biosimilars-gears-htaq.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/will-the-ira-hinder-the-potential-of-biosimilars","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Will the IRA hinder the potential of Biosimilars?"},"categories":["consulting","market access","patient support services","research"],"segments":["manufacturers"],"timestamp":638381734730000000,"title":"will the ira hinder the potential of biosimilars?"},{"card":{"key":"c419bf8b-f651-4083-a197-91d7becd4c36","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2024","description":"","img":{"alt":"US Capitol building","src":"-/media/assets/xcenda/english/images/insights/uscapitol.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/whats-next-with-inflation-reduction-act","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Executive Insights: What's next with the Inflation Reduction Act (IRA)"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638443125600000000,"title":"executive insights: what's next with the inflation reduction act (ira)"},{"card":{"key":"e1dd098b-3c77-4f7c-bebc-7091178e05dc","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2024","description":"Sandra Anderson, SVP of international commercialization at Cencora, discusses the complexities of planning for a global launch and the common mistakes companies make that cause problems along the way.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/01-home-page-new-images/thinklive-web-hero-background-1200x800/sa-headshot/sa-2-23-24.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/planning-for-the-world-with-sandra-anderson","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Planning for the World: Q&A With Sandra Anderson, SVP of International Commercialization at Cencora"},"categories":["commercialization","consulting","market access"],"segments":["manufacturers"],"timestamp":638442318600000000,"title":"planning for the world: q&a with sandra anderson, svp of international commercialization at cencora"},{"card":{"key":"046dadef-e3cf-40dc-b556-c9897023ebe0","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2018","description":"Much of the complexity of the cell and gene supply chain comes from how dependent the commercialization phase is on the clinical phase. What does integration look like, and how can the right logistics partner help?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-supply-chain-redefined-cgt","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Supply Chain Redefined: Cell and Gene Therapies"},"categories":["cell and gene therapy","third party logistics","commercialization","commercial supply chain"],"segments":["manufacturers"],"timestamp":636686495650000000,"title":"the supply chain redefined: cell and gene therapies"},{"card":{"key":"e9cb6786-fbd3-4179-b336-531619cc13ab","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2022","description":"","img":{"alt":"pharma marketing promotional programs","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pharma-marketing-promotional-programs.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-reach-customers-and-cut-through-the-noise-webinar","linkText":"Watch on demand","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: How to reach customers and cut through the noise"},"categories":["business performance","data","marketing"],"segments":["manufacturers"],"timestamp":637891690320000000,"title":"webinar: how to reach customers and cut through the noise"},{"card":{"key":"355ff791-8954-40a3-8577-7c3dab8252a8","authorName":"Dale Hanna","authorCompany":"Lash Group","date":"August 2019","description":"What are the elements of innovative, effective medication adherence programs -- and how do they address the underlying causes of non-adherence?","img":{"alt":"PageDesign_Patient_Doc","src":"-/media/assets/lash/images/pagedesign_patient_doc.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/uncommon-commonalities-part-two","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Manufacturers","headline":"Uncommon Commonalities: A Patient-Centric Strategy for Improving Medication Adherence"},"categories":["commercialization","data","engagement","medication adherence","patient support services","technology","analytics"],"segments":["manufacturers"],"timestamp":637027524000000000,"title":"uncommon commonalities: a patient-centric strategy for improving medication adherence"},{"card":{"key":"85719e40-bd19-4fc1-83eb-4a644b30ad8f","authorName":"Dale Hanna","authorCompany":"Lash Group","date":"September 2022","description":"Why do patients struggle with medication adherence even when they know it will help them? In part one of a two-part article series from Lash Group, discover how the most advanced patient support programs use behavioral science to unlock adherence.","img":{"alt":"Physician discussing medication bedside","src":"-/media/assets/amerisourcebergen/patient-care_physicians/hs_patcare_bedside_fmphys_mpat_meds_006-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/uncommon-commonalities-part-one","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Manufacturers","headline":"Uncommon commonalities: Applying behavioral economics to medication adherence"},"categories":["medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":637981693200000000,"title":"uncommon commonalities: applying behavioral economics to medication adherence"},{"card":{"key":"dfc88c34-0e9c-4822-80b0-e17c8dfff6be","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2023","description":"There is widespread agreement across healthcare that the Joint Clinical Assessment (JCA) has good intentions – to accelerate the process of bringing innovative medicinal products to patients, strive for equal access, and reduce bureaucracy . The more pertinent question, however, is how will the new process, which is a key pillar of the European Union’s Regulation on Health Technology Assessment (HTAR), truly impact patients across the EU?","img":{"alt":"Does EU HTAR put patients at the center","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/does-eu-htar-put-patients-at-the-center.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/does-the-eu-htar-really-put-patients-at-the-center","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Does the EU HTAR really put patients at the center?"},"categories":["consulting","market access","regulatory","policy"],"segments":["manufacturers"],"timestamp":638352454790000000,"title":"does the eu htar really put patients at the center?"},{"card":{"key":"f3317fe3-12c9-4308-8530-87868e213144","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2022","description":"AmerisourceBergen has the most diversified set of assets and businesses that can truly help biopharma companies successfully commercialize a product," says Tom Doyle, Senior Vice President of Sales, Chief Customer Officer, Biopharma Services.","img":{"alt":"Coworkers at meeting","src":"-/media/assets/xcenda/english/images/insights/gettyimages-1179568324_srgb_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/culture-people-and-an-investment-in-innovation-set-amerisourcebergen-apart","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Culture, people, and an investment in innovation set AmerisourceBergen apart"},"categories":["business performance","commercialization","our role in healthcare"],"segments":["manufacturers"],"timestamp":637938554430000000,"title":"culture, people, and an investment in innovation set amerisourcebergen apart"},{"card":{"key":"41117729-a208-4482-9a49-3597d36d3194","authorName":"Shanna Barnes; Myra Reinhardt","authorCompany":"Lash Group","date":"May 2020","description":"","img":{"alt":"Screen Shot 20200501 at 25749 PM","src":"-/media/assets/lashgroup/images/9-news-events/screen-shot-20200501-at-25749-pm.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/2020-webinar---part-2-leveraging-ai-within-ebv","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar Part 2: Leveraging AI within eBV to speed access to therapy"},"categories":["patient support services","affordability","product access","commercialization","technology"],"segments":["manufacturers"],"timestamp":637254036000000000,"title":"webinar part 2: leveraging ai within ebv to speed access to therapy"},{"card":{"key":"43f4e1a9-024e-438a-80e5-c5aad4477d31","authorName":"Xcenda","authorCompany":null,"date":"September 2022","description":"","img":{"alt":"Patient support services","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/gettyimages-1055509742_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/youve-created-a-good-patient-support-program-now-make-it-great","linkText":"Watch on demand","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On-demand webinar: You’ve created a good patient support program, now make it great"},"categories":["commercialization","marketing","patient support services"],"segments":["manufacturers"],"timestamp":638001437840000000,"title":"on-demand webinar: you’ve created a good patient support program, now make it great"},{"card":{"key":"3e5efdef-91de-483f-bee8-4bc4110e6ebb","authorName":"Lash Group","authorCompany":null,"date":"June 2019","description":"How adherence solutions are evolving -- with some high-tech help. Originally published on FiercePharma.com.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/2019-hightech-trends-how-patient-adherence-and-engagement-solutions-are-evolving","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"High-Tech Trends: How Patient Adherence and Engagement Solutions Are Evolving"},"categories":["engagement","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":636950863200000000,"title":"high-tech trends: how patient adherence and engagement solutions are evolving"},{"card":{"key":"f5f20fd3-acd8-44c9-8884-5b09eb630e64","authorName":"Lash Group","authorCompany":null,"date":"May 2020","description":"Patient support providers are a vital link that enables the type of industry-wide collaboration that is needed to address access, affordability, and adherence issues now to make a substantial impact in the future. Hear from Tommy Bramley, PhD, on we can achieve better equilibrium across healthcare’s tension points and simplify the path to better outcomes.","img":{"alt":"lash-group-mk027-copy-(2)","src":"-/media/assets/lashgroup/images/9-2-leadership-associates/lash-group-mk025-copy-(2)/lash-group-mk027-copy-(2).png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/2020-simplifying-the-path-to-better-patient-outcomes---tommy-bramley","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Simplifying the Path to Better Patient Outcomes"},"categories":["commercialization","patient support services","affordability","product access","technology"],"segments":["manufacturers"],"timestamp":637244636400000000,"title":"simplifying the path to better patient outcomes"},{"card":{"key":"92b69e38-5ce0-46d9-a791-fb5b9f5b027f","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2015","description":"Successful commercialization demands that manufacturers address three critical areas of opportunity — evidence, access and adherence. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-fundamentals-of-commercialization-strategy","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Fundamentals of Commercialization Strategy"},"categories":["commercialization","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":635585847600000000,"title":"the fundamentals of commercialization strategy"},{"card":{"key":"0d88a470-1dde-442d-b85c-be1598f8a040","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2018","description":"Insights from managed care executives on the future of coverage and outcomes evaluation.","img":{"alt":"Rethink: Payer Strategies for Commercializing Cell and Gene Therapies","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/lab_microscope_rsrch_007.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/payer-strategies-for-commercializing-cell-and-gene-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Rethink: Payer Strategies for Commercializing Cell and Gene Therapies"},"categories":["cell and gene therapy","reimbursement","commercialization"],"segments":["manufacturers"],"timestamp":636590666680000000,"title":"rethink: payer strategies for commercializing cell and gene therapies"},{"card":{"key":"79f25915-adcf-4cc9-bedb-eee542ab18db","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2023","description":"The clock is ticking down to the implementation of the EU JCA, yet many questions remain. What do we know and how can we prepare for what comes next?","img":{"alt":"implementation of the new EU JCA","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/implementation-of-the-new-eu-jca.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-fall-2023-implementation-of-the-new-eu-jca","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Only 17 months until the implementation of the new EU JCA—Latest developments and remaining uncertainties"},"categories":["consulting","policy","market access"],"segments":["manufacturers"],"timestamp":638271948140000000,"title":"only 17 months until the implementation of the new eu jca—latest developments and remaining uncertainties"},{"card":{"key":"c8b4f2d4-96bf-434e-be85-8ca1a18c8187","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"Video from Michael Lee, Director, Quality Assurance GMP, that describes the capabilities and licences that Innomar Strategies holds to help you stay worry-free and compliant with Health Canada’s standards.","img":{"alt":"your fully licensed importer2","src":"-/media/assets/innomarstrategies/services/3pl-and-importation/your-fully-licensed-importer2.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/qa-and-3pl-licences-helping-you-stay-compliant","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"QA and 3PL licences: Helping you stay compliant"},"categories":["our role in healthcare"],"segments":["manufacturers"],"timestamp":638557939800000000,"title":"qa and 3pl licences: helping you stay compliant"},{"card":{"key":"51b5ec63-539b-4217-a0ae-d2ca4857f282","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2024","description":"","img":{"alt":"Rainbow-Abstract","src":"-/media/assets/amerisourcebergen/rainbow-abstract.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/essential-guide-to-cell-and-gene-therapy-commercialization","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Essential guide to cell and gene therapy (CGT) commercialization"},"categories":["cell and gene therapy","commercialization"],"segments":["manufacturers"],"timestamp":638488144200000000,"title":"essential guide to cell and gene therapy (cgt) commercialization"},{"card":{"key":"98a19382-46a6-4e1f-8816-9c61d9212100","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2024","description":"Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options.","img":{"alt":"access network","src":"-/media/assets/amerisourcebergen/gettyimages-529400769_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/biosimilars-pipeline-report-for-understanding-the-growing-market","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Biosimilars pipeline report: A guide for understanding the growing market "},"categories":["biosimilars"],"segments":["physician practices"],"timestamp":638608203600000000,"title":"biosimilars pipeline report: a guide for understanding the growing market "},{"card":{"key":"ad844a5b-3939-41b0-8750-37624c92e753","authorName":"Xcenda","authorCompany":null,"date":"October 2020","description":"","img":{"alt":"Republican Democrat Healthcare","src":"-/media/assets/xcenda/english/images/insights/rep_dem_election_healthcare.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/lets-ditch-2020-and-plan-for-2021-election-what-ifs","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Let's Ditch 2020 and Plan for 2021: Election What-Ifs"},"categories":["legislation","managed care","policy","regulatory"],"segments":[],"timestamp":637390602000000000,"title":"let's ditch 2020 and plan for 2021: election what-ifs"},{"card":{"key":"00ba62fe-a060-46c1-89a8-20511ce9434d","authorName":"Rita Norton","authorCompany":"","date":"December 2021","description":"Specialty physician practices are facing up to a 9.75 percent cut in their Medicare reimbursement next year.","img":{"alt":"Consultant and doctor with tablet computer","src":"-/media/assets/besse/images/general/consultant-tablet-doctor.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/the-dangers-of-pending-medicare-cuts-and-what-practices-can-expect-in-2022","linkText":"Read the Q&A","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Q&A: The dangers of pending Medicare cuts and what practices can expect in 2022"},"categories":[],"segments":["physician practices"],"timestamp":637744698000000000,"title":"q&a: the dangers of pending medicare cuts and what practices can expect in 2022"},{"card":{"key":"e77bfc68-4d30-4cb1-9201-5e0d1afe8add","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2020","description":"","img":{"alt":"iStock-995485400Blur","src":"-/media/assets/intrinsiq/images/istock-995485400blur.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/cybersecurity-and-working-virtually-during-the-pandemic","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Cybersecurity and Working Virtually During the Pandemic"},"categories":["technology","regulatory"],"segments":["physician practices"],"timestamp":637208506800000000,"title":"cybersecurity and working virtually during the pandemic"},{"card":{"key":"f0c4d727-a284-4620-99df-358d0e381659","authorName":"Featured article","authorCompany":null,"date":"April 2020","description":"","img":{"alt":"IQSS_Blog_PracticeTips","src":"-/media/assets/intrinsiq/images/iqss_blog_practicetips.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/tips-for-practices-to-keep-patients-and-staff-healthy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Tips for Practices to Keep Patients and Staff Healthy"},"categories":["covid-19","patient safety","practice management"],"segments":["physician practices"],"timestamp":637218033180000000,"title":"tips for practices to keep patients and staff healthy"},{"card":{"key":"0ffe5aff-d981-486e-93bf-37f1a05ca392","authorName":"Featured article","authorCompany":null,"date":"April 2020","description":"","img":{"alt":"iStock-1166115050","src":"-/media/assets/intrinsiq/images/istock-1166115050.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/how-covid-19-is-altering-telehealth","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"How COVID-19 is Altering Telehealth"},"categories":["managed care","patient care","practice management","regulatory"],"segments":["physician practices"],"timestamp":637214339940000000,"title":"how covid-19 is altering telehealth"},{"card":{"key":"6a2c6d81-3bf7-47bc-8563-4dc5dbe800d0","authorName":"AmerisourceBergen","authorCompany":"","date":"December 2021","description":"Our reach into all facets of the healthcare industry means AmerisourceBergen can rely on collective resources to meet the goal of narrowing cancer care disparities.","img":{"alt":"Elderly Black man with community oncology doctor","src":"-/media/assets/ion/images/elderly-black-man-with-doctor.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/community-oncology-practices-build-more-equitable-access-and-outcomes","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Community oncology practices build more equitable access and outcomes"},"categories":[],"segments":["physician practices"],"timestamp":637744662000000000,"title":"community oncology practices build more equitable access and outcomes"},{"card":{"key":"ba76dd46-c502-4a79-a1f9-2a2378efefb5","authorName":"Rita Norton","authorCompany":"","date":"June 2022","description":"","img":{"alt":"doctors with ipad","src":"-/media/assets/besse/images/general/docs-ipad-thumb.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/q-and-a-with-the-amerisourcebergen-office-of-government-affairs-and-public-policy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Q&A with the AmerisourceBergen Office of Government Affairs and Public Policy (AB GA&P)"},"categories":[],"segments":["physician practices"],"timestamp":637904623510000000,"title":"q&a with the amerisourcebergen office of government affairs and public policy (ab ga&p)"},{"card":{"key":"abbbb6c0-559e-4e82-989f-f5eca254280b","authorName":"Christie Smith, PharmD, MBA","authorCompany":"Specialty Physician Services & Solutions","date":"March 2023","description":"In the oncology space, how might reducing pharmacy waste benefit community practices? AmerisourceBergen’s Christie Smith shares insights from the company’s partnership with Prime Therapeutics’ IntegratedRx™-Oncology program.","img":{"alt":"patient holding prescription bottle","src":"-/media/assets/amerisourcebergen/product/patient-holding-prescription-bottle.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/realizing-cost-savings-through-medically-integrated-dispensing","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Realizing cost savings through medically integrated dispensing"},"categories":["medication adherence","oncology","specialty pharmacy"],"segments":["physician practices"],"timestamp":638156190830000000,"title":"realizing cost savings through medically integrated dispensing"},{"card":{"key":"dd4a54c6-6989-4596-9aef-66be2c70c820","authorName":"Brad Tallamy","authorCompany":"AmerisourceBergen","date":"September 2021","description":"Practices should prepare for reductions to Medicare payments beginning January 1, 2021","img":{"alt":"iStock-1129810557","src":"-/media/assets/intrinsiq/images/istock-1129810557.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/how-specialty-practices-can-prepare-for-coming-changes-to-reimbursement","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"How specialty practices can prepare for coming changes to reimbursement"},"categories":["practice management","cash flow management","business performance"],"segments":["physician practices"],"timestamp":637667085610000000,"title":"how specialty practices can prepare for coming changes to reimbursement"},{"card":{"key":"05fdaac1-af1b-4194-a5d4-52976b3f52c2","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2020","description":"","img":{"alt":"iStock-1072311118","src":"-/media/assets/intrinsiq/images/istock-1072311118.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/the-importance-of-marketing-and-communications-for-community-practices","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Roundtable: The importance of marketing and communications for community practices"},"categories":["covid-19","marketing","practice management"],"segments":["physician practices"],"timestamp":637280352000000000,"title":"roundtable: the importance of marketing and communications for community practices"},{"card":{"key":"6124a682-764e-4bce-a0af-43767bedf5ad","authorName":"Rick Lozano and Susan Weidner","authorCompany":"","date":"June 2020","description":"","img":{"alt":"Masked healthcare professional watching computer","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/masked-healthcare-professional-watching-computer.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/data-analysis-for-smart-business-decisions","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"The now normal, part 1: Data analysis for smart business decisions"},"categories":["analytics","practice management","practice data"],"segments":["physician practices"],"timestamp":637284509520000000,"title":"the now normal, part 1: data analysis for smart business decisions"},{"card":{"key":"159d1988-8b0b-44b9-bb7c-f297058c745a","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2016","description":"New England Cancer Specialists demonstrates why staying the same simply isn't an option when it comes to cancer care.","img":{"alt":"Female patient with Doctor","src":"-/media/assets/amerisourcebergen/patient-care_physicians/examconsultdrmpatientf1116010.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/the-metamorphosis-of-a-community-oncology-practice","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Physician Practices","headline":"The Metamorphosis of a Community Oncology Practice"},"categories":["practice management","oncology"],"segments":["physician practices"],"timestamp":636132761400000000,"title":"the metamorphosis of a community oncology practice"},{"card":{"key":"a572bacb-fc0c-4432-823a-e465af81c19e","authorName":"Tim Navin","authorCompany":"","date":"April 2021","description":"Pre-ordering is a critical component of the flu distribution model. A phased approach sends product to as many sites of care as possible early in the flu season so they can start to vaccinate patients.","img":{"alt":"Woman getting vaccine","src":"-/media/assets/besse/images/general/woman-getting-vaccine.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/supporting-flu-vaccine-access","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Supporting flu vaccine access"},"categories":["distribution","immunizations"],"segments":["physician practices"],"timestamp":637552139420000000,"title":"supporting flu vaccine access"},{"card":{"key":"360e0d65-ce89-448f-8c4b-971b6a2564ec","authorName":"AmerisourceBergen","authorCompany":"","date":"November 2022","description":"Answering specialty physicians basic questions about this drug class","img":{"alt":"woman infusion","src":"-/media/assets/besse/images/general/infusion-woman.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/seven-questions-about-biosimilars","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Seven questions about biosimilars"},"categories":[],"segments":["physician practices"],"timestamp":638036123400000000,"title":"seven questions about biosimilars"},{"card":{"key":"2ec09251-1b6f-4f89-a70d-d2db9fb794b4","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2020","description":"","img":{"alt":"Doctor looking at iPad","src":"-/media/assets/intrinsiq/images/istock-1035963640_crop.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/working-together-in-response-to-covid-19-roundtable","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Roundtable: Working together in response to COVID-19"},"categories":["covid-19","practice management","advocacy"],"segments":["physician practices"],"timestamp":637213824000000000,"title":"roundtable: working together in response to covid-19"},{"card":{"key":"40d0064c-d696-4fff-9777-3cf224d1cca8","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2020","description":"","img":{"alt":"AdobeStock_336406836","src":"-/media/assets/amerisourcebergen/insights/adobestock_336406836.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/minimizing-the-impact-of-covid-19-on-practice-operations-roundtable","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Roundtable: Minimizing the impact of COVID-19 on practice operations "},"categories":["advocacy","covid-19","practice management"],"segments":["physician practices"],"timestamp":637236852600000000,"title":"roundtable: minimizing the impact of covid-19 on practice operations "},{"card":{"key":"2c705a80-78f4-44aa-b369-39cb1fc7e9e5","authorName":"Christie Smith","authorCompany":"","date":"September 2022","description":"Introducing the potential benefits of an integrated oncolytic dispensing model. ","img":{"alt":"Doctors examining notes","src":"-/media/assets/oncologysupply/images/general/doctors-examining-notes.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/clinically-integrated-oncolytic-dispensing","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Clinically integrated oncolytic dispensing: The next frontier in cancer care "},"categories":["oncology","specialty pharmacy","patient care"],"segments":[],"timestamp":637987169130000000,"title":"clinically integrated oncolytic dispensing: the next frontier in cancer care "},{"card":{"key":"cadff82a-6dab-41ff-9a4f-cf27f05a8f69","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2020","description":"IntrinsiQ Specialty Solutions COVID19 Virtual Roundtable Resources and Webinar recordings","img":{"alt":"COVID 19 Virtual Round Table Carousel_IQSS","src":"-/media/assets/intrinsiq/images/covid-19-virtual-round-table-carousel_iqss.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/covid-19-roundtable","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"COVID-19 Resources"},"categories":["covid-19","patient care","practice management","regulatory"],"segments":["physician practices"],"timestamp":637238594810000000,"title":"covid-19 resources"},{"card":{"key":"460fec10-62ab-494f-ba01-46e77826eac2","authorName":"Alana Vaughn","authorCompany":"ION Solutions","date":"November 2016","description":"Like a slowly dripping faucet or an improperly insulated window, gaps and inefficiencies in a business allow profits to seep out over time. Even one leak—while seemingly small—can have damaging effects on a company’s financial health. Oncology practices are no different.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/physician-practices/plugging-profit-leaks","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Physician Practices","headline":"Plugging Profit Leaks"},"categories":["financial management","practice management","reimbursement","oncology"],"segments":["physician practices"],"timestamp":636137974200000000,"title":"plugging profit leaks"},{"card":{"key":"5671e462-f97a-4f5c-8036-374ac2b9ddb0","authorName":"Besse Medical","authorCompany":"","date":"June 2021","description":"Picking a medication delivery platform that easily integrates with other technologies allows you to streamline inventory processes while improving both the provider and the patient experience.","img":{"alt":"iStock-1069859094","src":"-/media/assets/intrinsiq/images/istock-1069859094.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/streamline-the-infusion-inventory-process-with-technology","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Streamline the infusion inventory process with technology"},"categories":["practice management","technology","inventory management"],"segments":["physician practices"],"timestamp":637592811000000000,"title":"streamline the infusion inventory process with technology"},{"card":{"key":"9e793e1f-86fc-4c0c-ae53-ee33534b35b8","authorName":"Christie Smith","authorCompany":"","date":"March 2021","description":"","img":{"alt":"Black female doctor looks at iPad","src":"-/media/assets/besse/images/general/black-female-doctor-looks-at-ipad.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/healthcare-payer-trends-in-2021","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Healthcare payer trends in 2021"},"categories":["affordability","dir fees","reimbursement"],"segments":["physician practices"],"timestamp":637509165180000000,"title":"healthcare payer trends in 2021"},{"card":{"key":"7c0d490e-43dd-4805-bfd8-eed372275bc3","authorName":"Michael (Mick) Besse; Lisa Harrison","authorCompany":"","date":"July 2020","description":"","img":{"alt":"Masked patient and masked nurse in conversation","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/masked-patient-and-masked-nurse-in-conversation.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/the-vital-role-of-community-practices-in-delivering-care-through-a-pandemic","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"The Vital Role of Community Practices in Delivering Care Through a Pandemic"},"categories":["covid-19","financial management","practice management"],"segments":["physician practices"],"timestamp":637292046120000000,"title":"the vital role of community practices in delivering care through a pandemic"},{"card":{"key":"802c3fd7-20cc-4ad0-9bb8-19ee0ce2b746","authorName":"AmerisourceBergen","authorCompany":"","date":"May 2022","description":"There are many aspects to the success of offering buy-and-bill services","img":{"alt":"AB-HH-HS-Doctor-Medication-1_RGB_Large_JPG","src":"-/media/assets/intrinsiqanalytics/images/ab-hh-hs-doctor-medication-1_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/navigating-buy-and-bill","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Navigating buy-and-bill: What every practice should monitor and how data analytics can help"},"categories":["analytics","practice management"],"segments":["physician practices"],"timestamp":637892532000000000,"title":"navigating buy-and-bill: what every practice should monitor and how data analytics can help"},{"card":{"key":"002d41d3-eced-445a-91d1-2c107c3d238d","authorName":"Lisa Harrison","authorCompany":"","date":"June 2022","description":"","img":{"alt":"doctor with patient","src":"-/media/assets/besse/images/what-matters-patient-doc.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/what-matters-series-volume-1","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Evolving with our customers: Putting patients first through specialty distribution"},"categories":[],"segments":["physician practices"],"timestamp":637904656040000000,"title":"evolving with our customers: putting patients first through specialty distribution"},{"card":{"key":"23c076d8-cdb0-444c-988f-b5c96718e800","authorName":"AmerisourceBergen","authorCompany":"","date":"September 2022","description":"Legislative updates to help practices prepare for 2023 and beyond. ","img":{"alt":"US capitol building","src":"-/media/assets/besse/images/general/capitol-building.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/policy-updates-from-the-inflation-reduction-act-to-the-enhancing-oncology-model","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Policy updates: From the Inflation Reduction Act to the Enhancing Oncology Model"},"categories":["policy","advocacy","legislation"],"segments":[],"timestamp":637986831170000000,"title":"policy updates: from the inflation reduction act to the enhancing oncology model"},{"card":{"key":"2ea5462f-5d36-4517-ab93-c3dc21502f31","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2020","description":"","img":{"alt":"Group Physicians Wearing Masks","src":"-/media/assets/amerisourcebergen/insights/group-physicians-wearing-masks.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/the-road-ahead-for-community-practices-roundtable","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Roundtable: The road ahead for community practices "},"categories":["advocacy","covid-19","practice management"],"segments":["physician practices"],"timestamp":637260480000000000,"title":"roundtable: the road ahead for community practices "},{"card":{"key":"9e9988cd-dfa9-4e12-bbd1-4033591c2327","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2022","description":"Our experts weigh in on what policy changes physicians can expect—and how to prepare.","img":{"alt":"US capitol color","src":"-/media/assets/amerisourcebergen/addressing-public-policy/us-capitol-color.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/physician-fee-cuts-and-policy-updates","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Physician fee cuts and policy updates: What's at stake for practices in 2023 "},"categories":["practice management","policy"],"segments":["physician practices"],"timestamp":638040302400000000,"title":"physician fee cuts and policy updates: what's at stake for practices in 2023 "},{"card":{"key":"7fa42280-7a9c-4e62-a231-9ef3eff74eec","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2020","description":"","img":{"alt":"Doctor on video call with colleagues","src":"-/media/assets/intrinsiq/images/iqss_blog_commpract.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/practice-innovations-in-covid","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"How Community and Specialty Physician Practices Are Confronting COVID-19 Challenges"},"categories":["covid-19","distribution","practice management"],"segments":["physician practices"],"timestamp":637275790620000000,"title":"how community and specialty physician practices are confronting covid-19 challenges"},{"card":{"key":"d1265fbc-8e12-4e62-8754-44ef092b65be","authorName":"Alana Vaughn","authorCompany":"ION Solutions","date":"July 2020","description":"","img":{"alt":"Doctor talking to patient","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/doctor-talking-to-patient.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/proactive-communications-for-practice-success","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"The now normal, part 3: Proactive communications for practice success"},"categories":["marketing","patient safety","practice management"],"segments":["physician practices"],"timestamp":637297220170000000,"title":"the now normal, part 3: proactive communications for practice success"},{"card":{"key":"70d5ca1e-6301-4427-9166-e81604d23250","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2020","description":"","img":{"alt":"virtual training_female","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/virtual-training_female.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/the-early-impact-of-covid-19-on-community-practices","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Roundtable: The early impact of COVID-19 on community practices"},"categories":["covid-19","patient care","practice management"],"segments":["physician practices"],"timestamp":637315546560000000,"title":"roundtable: the early impact of covid-19 on community practices"},{"card":{"key":"540260ea-a4cc-4cb0-954c-9f5aeb2a704e","authorName":"IntrinsiQ Specialty Solutions","authorCompany":"","date":"August 2020","description":"","img":{"alt":"Doctor looks at laptop and takes notes","src":"-/media/assets/intrinsiq/images/istock-996290796.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/billing-and-payer-reimbursement-for-telemedicine","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"How to thrive with telemedicine"},"categories":["covid-19","technology","reimbursement"],"segments":["physician practices"],"timestamp":637327512000000000,"title":"how to thrive with telemedicine"},{"card":{"key":"8b210f7c-5dc9-43a0-9b25-5b879fa7d37e","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2020","description":"","img":{"alt":"Lab tech in protective gear checks patient in car","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/lab-tech-in-protective-gear-checks-patient-in-car.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/getting-your-practice-future-ready","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"The now normal, part 2: Getting your practice future-ready"},"categories":["financial management","practice management","patient safety"],"segments":["physician practices"],"timestamp":637292289490000000,"title":"the now normal, part 2: getting your practice future-ready"},{"card":{"key":"3c7bb4cb-13a8-484a-9d73-724edaf48cc1","authorName":"AmerisourceBergen","authorCompany":"","date":"April 2023","description":"Good news for manufacturers, pharmacies, and all healthcare stakeholders: you don't need to feel overwhelmed by the DSCSA. This guide will help you better understand what to expect and how to prepare.","img":{"alt":"People","src":"-/media/assets/amerisourcebergen/dscsa-vials.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/3-ways-your-distributor-can-help-you-prepare-for-dscsa-compliance","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"3 ways your distributor can help you prepare for DSCSA compliance"},"categories":["data","dscsa","distribution","policy","regulatory","secure supply chain"],"segments":["pharmacies","health systems","physician practices","manufacturers"],"timestamp":638170596000000000,"title":"3 ways your distributor can help you prepare for dscsa compliance"},{"card":{"key":"0b6f1e87-0a24-46a5-966f-735448331179","authorName":"MWI Animal Health","authorCompany":"","date":"June 2022","description":"Aligning on single-source vendors like MWI Office Supply with the associated price savings benefits practices. ","img":{"alt":"business planning couple","src":"-/media/assets/mwianimalhealth/images/insights-images/business-planning-couple.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/how-destination-pet-redefined-practice-autonomy","linkText":"Read the case study","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How Destination Pet redefined practice autonomy for its financial benefit"},"categories":["veterinary practices","distribution","inventory management"],"segments":["animal health"],"timestamp":637913691520000000,"title":"how destination pet redefined practice autonomy for its financial benefit"},{"card":{"key":"ffe5ed39-7862-4c33-9a1f-deec752d0338","authorName":"Lisa Harrison; Beth Mitchell","authorCompany":"","date":"September 2023","description":"","img":{"alt":"People","src":"-/media/assets/amerisourcebergen/dscsa-vials.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/navigating-cms-cy-2024---part-1","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Navigating the CMS CY 2024 proposed rule: part 1"},"categories":[],"segments":[],"timestamp":638315748000000000,"title":"navigating the cms cy 2024 proposed rule: part 1"},{"card":{"key":"28ecfff1-51d1-49a8-afe0-d31f54ecb501","authorName":"Xcenda","authorCompany":null,"date":"March 2023","description":"From delivering a repeat training on developing a comprehensive HCEI strategy to incorporating value framework assessments in coverage discussions to award-winning research, AmerisourceBergen was a proud supporter of this year's conference.

Explore some of our expert contributions, media coverage, and related content that showcased our commitment to helping our biopharma partners accelerate product success. ","img":{"alt":"Team members at the AMCP 2023 exhibit","src":"-/media/assets/xcenda/english/images/insights/amcp2023-booth.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/recap-amcp-2023-our-thought-leadership-in-action","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Recap AMCP 2023: Our thought leadership in action"},"categories":["consulting","cell and gene therapy","commercialization","formulary solutions","innovation","managed care","market access","policy","regulatory"],"segments":["manufacturers"],"timestamp":638157335490000000,"title":"recap amcp 2023: our thought leadership in action"},{"card":{"key":"76249e30-305d-4e08-a94e-db77a5afaa9f","authorName":"Corey Ford, MHA","authorCompany":"","date":"August 2023","description":"","img":{"alt":"Washington DC Capital ","src":"-/media/assets/worldcourier/english/images/ics-images/images/washington-dc-2.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/inflation-reduction-act-implementation-update","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"First 10 drugs for Medicare price negotiation announced under IRA"},"categories":["commercialization","consulting","legislation","managed care","market access","policy","reimbursement","regulatory"],"segments":["manufacturers"],"timestamp":638289312180000000,"title":"first 10 drugs for medicare price negotiation announced under ira"},{"card":{"key":"d3177ccb-08bd-415a-a62c-9db01f358b89","authorName":"Cathy Madson","authorCompany":"Preventive Vet","date":"November 2022","description":"Virtual dog training offers a solution for dog owners all over the world who may not have access to these services in their local area and at an affordable price.","img":{"alt":"Young woman laughs with pug at laptop","src":"-/media/assets/mwianimalhealth/images/insights-images/women-pug-laptop.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/meet-client-needs-with-mutually-beneficial-online-recommendations","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"Going virtual with dog training and behavior consults"},"categories":["veterinary practices","business performance"],"segments":["animal health"],"timestamp":638035002000000000,"title":"going virtual with dog training and behavior consults"},{"card":{"key":"d8cd9183-5f58-4bdc-bf43-dc63ca04e457","authorName":"FirstView","authorCompany":"","date":"March 2023","description":"","img":{"alt":"whitepaper","src":"-/media/assets/firstview/images/digital-pharmacy-case-study-cover-image.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/digital-pharmacy-advanced-strategies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Digital Pharmacy: Advanced strategies to reduce barriers to patient access"},"categories":["financial management"],"segments":[],"timestamp":638143332600000000,"title":"digital pharmacy: advanced strategies to reduce barriers to patient access"},{"card":{"key":"64fcfb06-af18-4d5f-9a6f-163c4029fed5","authorName":"Specialty Physician Services","authorCompany":"","date":"January 2023","description":"","img":{"alt":"GettyImages-1165979798","src":"-/media/assets/besse/images/gettyimages-1165979798.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/what-matters-series-volume-3","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"What matters most: Building meaningful distribution partnerships"},"categories":[],"segments":[],"timestamp":638097363110000000,"title":"what matters most: building meaningful distribution partnerships"},{"card":{"key":"86a81f48-3d88-4d88-ab14-d8d93c559501","authorName":"Xcenda","authorCompany":null,"date":"September 2020","description":"In the competitive world of pharmaceutical market access, payers are preparing their budgets and forecasts well ahead of new product launches. That means they’re reviewing product information earlier in the pre-approval stage.

The importance of connecting with payers early, understanding their needs and requirements, and delivering the product information they’re looking for has never been greater. Learn how one manufacturer used the FormularyDecisions platform to meet payers where and when they’re looking for pre-approval information.","img":{"alt":"businessman with laptop reviewing a dashboard","src":"-/media/assets/xcenda/english/images/paid-media/circle.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/case-study-gaining-payer-attention-through-digital-innovation","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Case study: Gaining payer attention through digital innovation"},"categories":["affordability","analytics","commercialization","data","market access","marketing","product access","reimbursement"],"segments":[],"timestamp":637346767800000000,"title":"case study: gaining payer attention through digital innovation"},{"card":{"key":"7c3a70fd-f41b-48b7-aab9-87d69a919466","authorName":"Sean McGowan; Steve Miller; David Senior","authorCompany":"AmerisourceBergen","date":"October 2020","description":"In the inaugural episode of the AmerisourceBergen Insights podcast, we’re looking at the biosimilars market. Sean McGowan, Senior Director of Biosimilars at AmerisourceBergen, will be joined by David Senior and Steve Miller about the policy and reimbursement issues that impact our customers and the overall growth of biosimilars. These three experts will discuss how different policy issues can slow market growth, with actionable guidance for providers on how to confront reimbursement-related challenges. ","img":{"alt":"microphone","src":"-/media/assets/amerisourcebergen/insights/microphone.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/podcast-oct-2020","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Health Systems","headline":"Biosimilars: Patents, policy, and reimbursement"},"categories":["biosimilars","policy","regulatory","reimbursement"],"segments":["health systems","manufacturers","physician practices"],"timestamp":637387830000000000,"title":"biosimilars: patents, policy, and reimbursement"},{"card":{"key":"4fff1242-de63-4ab4-aa8a-f9a055aa208f","authorName":"Marc Johnson","authorCompany":"AmerisourceBergen","date":"April 2020","description":"Long-term care isn't slowing down. Here's how your pharmacy can keep up as demands for LTC pharmacy grow.","img":{"alt":"PageDesign_Patient_Caregiver","src":"-/media/assets/lash/images/pagedesign_patient_caregiver.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/six-steps-to-growing-a-long-term-care-pharmacy-business","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Six Steps to Growing a Long-Term Care Pharmacy Business"},"categories":["long term care","pharmacy operations"],"segments":["pharmacies"],"timestamp":637214533200000000,"title":"six steps to growing a long-term care pharmacy business"},{"card":{"key":"bfa9efcf-5805-4020-9b35-ef78c929deb4","authorName":"Gold Eneyo, PharmD; Phyllis Houston, MSOL ; Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"March 2022","description":"Innovative PSAOs are helping independent pharmacies evolve for the future, allowing them to compete and thrive in a dynamic market. Here's how.","img":{"alt":"GettyImages-1077578340","src":"-/media/assets/amerisourcebergen/insights/gettyimages-1077578340.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/5-benefits-of-an-innovative-psao","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Five benefits of an innovative PSAO"},"categories":["business performance","dir fees","good neighbor pharmacy","immunizations","innovation","pharmacy operations","reimbursement"],"segments":["pharmacies"],"timestamp":637841751850000000,"title":"five benefits of an innovative psao"},{"card":{"key":"6cbb66a7-250e-4307-a27d-2103f2b7f9a9","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2017","description":"Thinking about retirement? Explore five considerations to preserve the legacy of independent pharmacy for future generations. ","img":{"alt":"Pharmacist superhero flying","src":"-/media/assets/gnp/images/gnp-insights-guardians-of-the-pharmacy.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/guardians-of-the-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Pharmacies","headline":"Guardians of the Pharmacy"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":636492834000000000,"title":"guardians of the pharmacy"},{"card":{"key":"19405f9c-501d-485c-a2a9-3d813760144b","authorName":"Jordan Cupo","authorCompany":"Good Neighbor Pharmacy","date":"May 2022","description":"Improving your search ranking will drive additional customers to your pharmacy and help boost your bottom line.","img":{"alt":"An older male pharmacist educating a younger female pharmacist while holding up a pill bottle","src":"-/media/assets/gnp/images/gnp-insights-preserving-the-legacy.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/tips-for-ranking-higher-on-google","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"How can independent pharmacies rank higher in Google search?"},"categories":["marketing","pharmacy operations","good neighbor pharmacy"],"segments":[],"timestamp":637872648200000000,"title":"how can independent pharmacies rank higher in google search?"},{"card":{"key":"7c249967-0a7c-4fee-8466-164a161e20da","authorName":"Kevin Ban; Jenni Zilka","authorCompany":"","date":"June 2022","description":"","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/patients-lose-if-we-dont-continue-to-expand-pharmacy-based-clinical-care-in-the-us","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Insight","headline":"Patients lose if we don't continue to expand pharmacy-based clinical care in the U.S."},"categories":["good neighbor pharmacy","patient care","regulatory"],"segments":[],"timestamp":637902139980000000,"title":"patients lose if we don't continue to expand pharmacy-based clinical care in the u.s."},{"card":{"key":"bd28dae2-46bf-4035-8528-eb9277e338b4","authorName":"Sasha Juenemann","authorCompany":"Good Neighbor Pharmacy","date":"May 2020","description":"You have many different options on how to promote your pharmacy, but finding a successful balance that suits your community will ensure your current and prospective patients are fully aware of all your store has to offer.","img":{"alt":"A person reviewing a variety of colorful charts set out on a rustic table","src":"-/media/assets/gnp/images/gnp-insights-marketing-budget.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-make-the-most-of-your-pharmacy-marketing-budget","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to Make the Most of Your Pharmacy’s Marketing Budget"},"categories":["marketing"],"segments":["pharmacies"],"timestamp":637256012400000000,"title":"how to make the most of your pharmacy’s marketing budget"},{"card":{"key":"4d2d6881-ad9c-4fd4-b1e5-49bbeff1afb6","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2018","description":"The high-touch, high-quality, personalized care independent pharmacies provide creates a unique value proposition in a healthcare market where more chronically ill patients need accessible care. As payers are prioritizing improved patient outcomes and a reduction in overall healthcare costs, they need to also consider new reimbursement models for these pharmacy services, a framework under which independent pharmacies are uniquely positioned to excel. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/delivering-care-beyond-prescriptions-a-marketplace-opportunity-for-independent-pharmacies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Delivering Care Beyond Prescriptions: A Marketplace Opportunity for Independent Pharmacies"},"categories":["good neighbor pharmacy","patient care","reimbursement"],"segments":["pharmacies"],"timestamp":636794522340000000,"title":"delivering care beyond prescriptions: a marketplace opportunity for independent pharmacies"},{"card":{"key":"6b458e14-4f2d-437d-80f0-b33781615328","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2019","description":"Political advocacy can be intimidating, but it doesn’t need to be. Here are a few tips to help you get started. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/eight-impact-making-advocacy-tips-for-pharmacists","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Eight Impact Making Advocacy Tips for Pharmacists"},"categories":["dir fees","legislation","policy","advocacy"],"segments":["pharmacies"],"timestamp":636995926800000000,"title":"eight impact making advocacy tips for pharmacists"},{"card":{"key":"1e6ad45c-b174-4b9e-aa0a-0d81336070c7","authorName":"Lara Knudsen","authorCompany":"AmerisourceBergen","date":"July 2020","description":"There's an unprecedented opportunity to start serving pets in your pharmacy. Here's how to put pet health into practice and provide more comprehensive care to the people in your community who have companion animals at home.","img":{"alt":"A person petting the underside of a cat's chin","src":"-/media/assets/gnp/images/gnp-insights-caring-for-every-member-of-the-family.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/caring-for-every-member-of-the-family","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Caring for Every Member of the Family, Including the Ones with Four Legs"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":637302553200000000,"title":"caring for every member of the family, including the ones with four legs"},{"card":{"key":"fd2a8f26-ca91-4944-b248-737228fbcc2d","authorName":"Michael Amante","authorCompany":"AmerisourceBergen","date":"August 2021","description":"Healthcare distributors must understand the large retail pharmacy to successfully serve these customers and their patients. Learn what to look for in a distribution partner.","img":{"alt":"DIst_Drug_AFrame_Loading_Roanoke_2012_001","src":"-/media/assets/amerisourcebergen/distribution/dist_drug_aframe_loading_roanoke_2012_001.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/four-things-large-retail-pharmacies-should-look-for-in-a-distribution-partner","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Four things large retail pharmacies should look for in a distribution partner"},"categories":["business performance","distribution","innovation","inventory management","large retail pharmacy","patient care","pharmacy operations","product access"],"segments":["pharmacies"],"timestamp":637642994420000000,"title":"four things large retail pharmacies should look for in a distribution partner"},{"card":{"key":"d03b2603-d223-4be4-ad0c-edafa04b762f","authorName":"Jim McCaslin; Tanya Mericle","authorCompany":"AmerisourceBergen","date":"April 2022","description":"As highly accessible and trusted experts on medication usage, independent pharmacies are ideally positioned to positively influence medication adherence. Learn how you can get patients on an adherent path.","img":{"alt":"asian woman on smartphone at home","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/asian-woman-on-smartphone-at-home.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/getting-through-to-non-adherent-patients","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Getting through to non-adherent patients"},"categories":["data","good neighbor pharmacy","medication adherence","patient care","star ratings"],"segments":["pharmacies"],"timestamp":637846911560000000,"title":"getting through to non-adherent patients"},{"card":{"key":"1129f1a5-018e-4ae1-a76b-89090e5614dc","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2022","description":"In honor of Women’s History Month, we are highlighting four female pharmacists and sharing their insights about their pharmacy careers.","img":{"alt":"Women in Pharmacy","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/women-in-pharmacy/women-in-pharmacy.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/celebrating-women-in-pharmacy-march-2022","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Celebrating women in pharmacy"},"categories":["good neighbor pharmacy","pharmacy transformation","pharmacy ownership"],"segments":["pharmacies"],"timestamp":637818348130000000,"title":"celebrating women in pharmacy"},{"card":{"key":"3fdf8477-efa1-471e-918f-2a7bc740bc2a","authorName":"Beth Mitchell","authorCompany":"AmerisourceBergen","date":"June 2020","description":"Until social distancing measures are phased out, store owners who want to make a difference in independent pharmacy can and should leverage technology to connect with legislators virtually.","img":{"alt":"A pharmacist hosts a virtual meeting with an elected official on her tablet","src":"-/media/assets/gnp/images/gnp-insights-elected-officials.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-engage-with-elected-officials-when-you-cant-meet-face-to-face","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to Engage with Elected Officials When You Can't Meet Face to Face"},"categories":["marketing"],"segments":["pharmacies"],"timestamp":637279995600000000,"title":"how to engage with elected officials when you can't meet face to face"},{"card":{"key":"01da0cbd-834f-4da8-a213-7a084ada7e2a","authorName":"Good Neighbor Pharmacy","authorCompany":null,"date":"February 2020","description":"The basics of Collaborative Practice Agreements and how they can help eliminate some of the biggest challenges faced by independent pharmacy owners today. ","img":{"alt":"GNPConnect","src":"-/media/assets/gnp/icons/gnpconnect.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/gnp-connect-podcast-collaborative-practice-agreements-101","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"GNP Connect Podcast: Collaborative Practice Agreements 101"},"categories":["patient care","pharmacy operations","pharmacy ownership","good neighbor pharmacy"],"segments":["pharmacies"],"timestamp":637163208000000000,"title":"gnp connect podcast: collaborative practice agreements 101"},{"card":{"key":"3e7ecb95-0f06-4e13-8f4f-bdcb40e16280","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2018","description":"Take our quiz to find out what superpower lies behind the white coat.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/what-pharmacy-superhero-are-you-quiz","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"QUIZ: What Pharmacy Superhero Are You?"},"categories":["patient care"],"segments":["pharmacies"],"timestamp":636760702040000000,"title":"quiz: what pharmacy superhero are you?"},{"card":{"key":"561a78d6-8290-433f-b65b-eb192d1c4782","authorName":"Peter Kounelis","authorCompany":"AmerisourceBergen","date":"July 2019","description":"Working together, you and your PSAO can mitigate or avoid PBMs’ bias toward commoditization.","img":{"alt":"Umbrella","src":"-/media/assets/gnp/images/gnp-insights-how-to-respond-to-pharmacy-reimbursement-threats.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-respond-to-pharmacy-reimbursement-threats","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to Respond to Pharmacy Reimbursement Threats"},"categories":["managed care"],"segments":["pharmacies"],"timestamp":636979290600000000,"title":"how to respond to pharmacy reimbursement threats"},{"card":{"key":"3f858da9-d985-40f4-a77e-e78adf50a56f","authorName":"Carla Frehn","authorCompany":"AmerisourceBergen ","date":"March 2019","description":"Google is the first place people go when they want to find a pharmacy, so it’s absolutely vital to have a robust Google listing with up-to-date business , but having a great listing isn’t enough though. Learn what an independent pharmacy needs to do to ensure their business appears in the search results.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/convert-from-search-turn-online-traffic-into-foot-traffic","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Convert from Search: Turn Online Traffic into Foot Traffic"},"categories":["marketing","good neighbor pharmacy","pharmacy operations"],"segments":["pharmacies"],"timestamp":636892954430000000,"title":"convert from search: turn online traffic into foot traffic"},{"card":{"key":"ca19be24-cc9c-495f-8b68-8bedc0f0e0de","authorName":"George Rafferty","authorCompany":"AmerisourceBergen","date":"August 2020","description":"The Corporate Partnerships team at AmerisourceBergen services 20 of AmerisourceBergen’s largest and most strategic customers, including Express Scripts, Costco, Walgreens, Kaiser Permanente and Humana to name a few. Learn how the team has evolved its strategy and service model to better serve these customers.","img":{"alt":"NDCStagingArea117257","src":"-/media/assets/amerisourcebergen/stories/ndcstagingarea117257.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/spotlight-on-the-corporate-partnerships-model","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Spotlight: The corporate partnerships model"},"categories":["large retail pharmacy","covid-19","distribution","our role in healthcare"],"segments":["pharmacies"],"timestamp":637324226160000000,"title":"spotlight: the corporate partnerships model"},{"card":{"key":"1084aad2-f260-4cfd-a9f4-628c42ea2760","authorName":"Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"August 2021","description":"The facts on Medicare Open Enrollment, a helpful guide for pharmacists and their patients. ","img":{"alt":"Pharmacy consultation","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ab-pharmacy-front-consult-1_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/medicare-part-d-open-enrollment","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Pharmacies","headline":"Medicare Part D open enrollment: What your patients need to know"},"categories":["open enrollment","patient care","good neighbor pharmacy"],"segments":["pharmacies"],"timestamp":637649104800000000,"title":"medicare part d open enrollment: what your patients need to know"},{"card":{"key":"b80129ca-5b97-4916-8ef6-f25926494d08","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2018","description":"Independent pharmacists share what it means to be independent and why independent pharmacy is worth protecting. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/guardians-of-the-pharmacy-vol-2","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Guardians of the Pharmacy Vol. 2"},"categories":["pharmacy ownership","pharmacy ownership"],"segments":["pharmacies"],"timestamp":636554307190000000,"title":"guardians of the pharmacy vol. 2"},{"card":{"key":"85e49dea-4b45-4648-8c02-46ca68ccfc04","authorName":"Michael Amante","authorCompany":"AmerisourceBergen","date":"July 2020","description":"Executive Q&A: What is the role of Strategic Solutions at AmerisourceBergen? Learn how this team helps us cultivate a deep understanding of our pharmacy customers.","img":{"alt":"Dist_Drug_Conv_Belt_Roanoke_020","src":"-/media/assets/amerisourcebergen/distribution/dist_drug_conv_belt_roanoke_020.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/driving-deeper-customer-relationships","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Driving deeper customer relationships"},"categories":["large retail pharmacy","distribution"],"segments":["pharmacies"],"timestamp":637317394770000000,"title":"driving deeper customer relationships"},{"card":{"key":"ffd5f740-3924-4b15-ac1c-54787f9a381d","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2021","description":"Perhaps you’ve heard of the benefits of 340B from a friend, colleague, or pharmacy association. Maybe you’ve been trying to find a potential 340B partnership. How to become a 340B contract pharmacy is one of the most common questions our 340B Advisory Team receives. And although there isn’t an easy answer, our road map will help you understand whether 340B makes sense for your pharmacy. From there, you can identify, evaluate, and engage with the right covered entity partner. ","img":{"alt":"roadmap_magenta","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/roadmap_magenta.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/feeling-left-out-of-340b","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Feeling left out of 340B?"},"categories":["340b","pharmacy operations"],"segments":["pharmacies"],"timestamp":637556681950000000,"title":"feeling left out of 340b?"},{"card":{"key":"9c8355c1-02be-406c-9836-3910c5281910","authorName":"US Bioservices","authorCompany":null,"date":"June 2018","description":"Our experts explain how specialty pharmacy can emerge as the centerpiece of clinically-integrated, patient-centered care that minimizes obstacles and optimizes outcomes.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/why-specialty-pharmacy-is-key-to-collaborative-care","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Physician Practices","headline":"Why Specialty Pharmacy is Key to Collaborative Care"},"categories":["specialty pharmacy","medication adherence","medication therapy management","population health management","readmissions","transitional care"],"segments":["physician practices"],"timestamp":636639813270000000,"title":"why specialty pharmacy is key to collaborative care"},{"card":{"key":"c51ce046-694a-4da2-b6c6-32842b1e9eb2","authorName":"Jim McCaslin","authorCompany":"AmerisourceBergen","date":"December 2016","description":"Ways independent pharmacies can ensure their patients maintain their medication regimens.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/nine-tips-for-medication-adherence","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Nine Tips for Improving Medication Adherence"},"categories":["medication adherence"],"segments":["pharmacies"],"timestamp":636166395000000000,"title":"nine tips for improving medication adherence"},{"card":{"key":"0a54f46a-53f9-4677-8c12-41741db1725d","authorName":"Marc Johnson","authorCompany":"AmerisourceBergen","date":"August 2020","description":"As essential healthcare providers to the most vulnerable populations, it's critical that long-term care pharmacies have a plan in case an employee tests positive for COVID-19. These five steps will help ensure your LTC pharmacy keeps employees and patients healthy and safe.","img":{"alt":"pharmacist in mask","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ltc-pharmacist-in-mask.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/covid-19-and-long-term-care","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"COVID-19 and long-term care: An action plan for responding to a positive coronavirus test"},"categories":["covid-19","long term care"],"segments":["pharmacies"],"timestamp":637320817220000000,"title":"covid-19 and long-term care: an action plan for responding to a positive coronavirus test"},{"card":{"key":"11ea15ad-847a-4f7e-9131-b218d532639b","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2023","description":"","img":{"alt":"Group Physicians Wearing Masks","src":"-/media/assets/amerisourcebergen/insights/group-physicians-wearing-masks.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/multistakeholder-perspectives-on-joint-clinical-assessment-in-europe","linkText":"Read article","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Multistakeholder perspectives on Joint Clinical Assessment in Europe"},"categories":["consulting","legislation","market access","policy"],"segments":["manufacturers"],"timestamp":638264935760000000,"title":"multistakeholder perspectives on joint clinical assessment in europe"},{"card":{"key":"7ecbcede-dd59-4e2c-a890-0a130f9b83d0","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2023","description":"","img":{"alt":"SPS-abstract2","src":"-/media/assets/amerisourcebergen/01-home-page-new-images/sps-abstract2.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/driving-robust-healthcare-decision-maker-engagement","linkText":"Download case study","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case study: Driving robust healthcare decision maker engagement"},"categories":["formulary solutions"],"segments":["manufacturers"],"timestamp":638255504230000000,"title":"case study: driving robust healthcare decision maker engagement"},{"card":{"key":"79672999-10fb-49b7-ae41-86faa2f5237b","authorName":"AmerisourceBergen","authorCompany":"","date":"May 2023","description":"Race, age, geography, and economic status all factor into the dynamics of cancer care. In 2022, AmerisourceBergen hosted its first Disparities in Cancer Care Summit to address the need for the industry to work together to diminish these evident disparities. Dr. Kashyap Patel, MD, launched a nonprofit foundation in 2021 to do just that. In his presentation, Dr. Patel shared his experience in working to alleviate these challenges within his community and offered key insights from his research. ","img":{"alt":"Black female nurse uses stethoscope on older Black female patient","src":"-/media/assets/intrinsiqanalytics/images/gettyimages-950886826_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/addressing-disparities-in-cancer-care","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Addressing disparities in cancer care"},"categories":["oncology","specialty pharmacy","health equity","patient care"],"segments":["physician practices"],"timestamp":638185878000000000,"title":"addressing disparities in cancer care"},{"card":{"key":"e8fde5bf-8e85-4d95-84ca-803f403de4fe","authorName":"Matt Sarnes, PharmD","authorCompany":"Biopharma Services","date":"May 2021","description":"AmerisourceBergen recently hosted its first-ever manufacturer summit dedicated to commercialization strategy and market access. In this episode of the AmerisourceBergen Insights podcast, hear highlights from the event. ","img":{"alt":"audience","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/audience.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/podcast-may-2021","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Podcast: ThinkLive Commercialization 2021"},"categories":["affordability","commercialization","innovation","market access","medication adherence","patient support services","product access","technology"],"segments":["manufacturers"],"timestamp":637564950000000000,"title":"podcast: thinklive commercialization 2021"},{"card":{"key":"9699e7b7-2e03-495c-9aa7-c06e105f6d75","authorName":"Specialty Physician Services","authorCompany":"","date":"March 2023","description":"","img":{"alt":"US Capitol","src":"-/media/assets/besse/images/general/us-capitol.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/government-affairs-q-and-a-the-latest-on-medicare-part-b","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Government Affairs Q&A: The latest on Medicare Part B"},"categories":[],"segments":[],"timestamp":638140701630000000,"title":"government affairs q&a: the latest on medicare part b"},{"card":{"key":"8655e132-bad4-4106-8c45-3e4cdd2720b4","authorName":"AmerisourceBergen","authorCompany":"","date":"August 2022","description":"The Inflation Reduction Act (IRA) will have a substantial impact on Medicare. Learn how the bill will affect drug pricing, reimbursement strategies, and patient assistance program designs.","img":{"alt":"vaccines on top of US dollars","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-summer-2021/htaq_vaccines.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/how-will-the-inflation-reduction-act-affect-the-biopharma-industry","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How will the Inflation Reduction Act affect the biopharma industry? "},"categories":["legislation","market access"],"segments":["manufacturers"],"timestamp":637975608600000000,"title":"how will the inflation reduction act affect the biopharma industry? "},{"card":{"key":"cc0cc2dc-1614-4d1c-b537-4450fd7e236c","authorName":"AmerisourceBergen","authorCompany":"","date":"November 2022","description":"","img":{"alt":"AB-Doctor-Patient-Consult-2_RGB_Large (1)","src":"-/media/assets/amerisourcebergen/insights/ab-doctor-patient-consult-2_rgb_large-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/what-matters-series-volume-2","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"What matters most: Understanding our customer's experience"},"categories":["innovation","oncology","patient care"],"segments":["physician practices"],"timestamp":638035640920000000,"title":"what matters most: understanding our customer's experience"},{"card":{"key":"433e299e-0844-4ccb-9f7e-99f26117a744","authorName":"Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"January 2022","description":"How should the right PSAO be investing in and advocating for independent pharmacies? Peter Kounelis, Vice President of Elevate Provider Network at AmerisourceBergen, joins us to continue our discussion on the evolution of the PSAO.","img":{"alt":"microphone","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/microphone.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/podcast-elevate-provider-network-part-2","linkText":"Listen now","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Podcast: Investing in independents"},"categories":["good neighbor pharmacy","innovation","managed care","patient care","our role in healthcare","pharmacy operations","reimbursement","dir fees"],"segments":["pharmacies"],"timestamp":637783062000000000,"title":"podcast: investing in independents"},{"card":{"key":"a010290d-a806-48d8-997f-57f196933cdc","authorName":"Lisa Harrison; Beth Mitchell","authorCompany":"","date":"March 2024","description":"","img":{"alt":"People","src":"-/media/assets/amerisourcebergen/dscsa-vials.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/q-and-a-hr5526","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Q&A: The Seniors’ Access to Critical Medications Act of 2023 (H.R. 5526/S. 3458)"},"categories":[],"segments":[],"timestamp":638474724000000000,"title":"q&a: the seniors’ access to critical medications act of 2023 (h.r. 5526/s. 3458)"},{"card":{"key":"0dba0859-d9ab-4c7b-b9b8-d390ad994119","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2023","description":"Ensure you are prepared and understand the Drug Supply Chain Security Act (DSCSA) requirements. Click to learn more.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/dscsa/pharmacy_bcn22_0599_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/navigating-dscsa-compliance","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Navigating DSCSA compliance"},"categories":["dscsa"],"segments":["pharmacies","physician practices"],"timestamp":638090784000000000,"title":"navigating dscsa compliance"},{"card":{"key":"24a66369-09a7-440e-9ae2-a30e9a3d978c","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2023","description":"","img":{"alt":"","src":"-/media/assets/amerisourcebergen/jca-eu-flag-2/screenshot-20230622-at-103119-am.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/eu-jca-june-22-webinar","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On-demand webinar: The EU JCA process: Opportunities and challenges in bringing innovative medicines to patients in Europe"},"categories":["affordability","commercialization","consulting","legislation"],"segments":["manufacturers"],"timestamp":638230653600000000,"title":"on-demand webinar: the eu jca process: opportunities and challenges in bringing innovative medicines to patients in europe"},{"card":{"key":"9fde750f-e35f-4cb2-9ea8-319533775e94","authorName":"AmerisourceBergen","authorCompany":"","date":"May 2023","description":"","img":{"alt":"12-18-2019-screen4_edited","src":"-/media/assets/ion/images/12-18-2019-screen4_edited.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/how-payer-models-and-metrics-can-contribute-to-more-equitable-care---may-2023","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Roundtable discussion: How payer models and metrics can contribute to more equitable care"},"categories":[],"segments":[],"timestamp":638195077200000000,"title":"roundtable discussion: how payer models and metrics can contribute to more equitable care"},{"card":{"key":"87990cda-25d3-44bc-8537-848b5702712e","authorName":"Matt Sample","authorCompany":"AmerisourceBergen","date":"February 2023","description":"Good news for manufacturers, pharmacies, and all healthcare stakeholders: you don't need to feel overwhelmed by the DSCSA. This guide will help you better understand what to expect and how to prepare.","img":{"alt":"Dist_Drug_A-Frame_Bottles_016","src":"-/media/assets/amerisourcebergen/distribution/dist_drug_a-frame_bottles_016.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/dscsa-are-you-ready-for-november-2023","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"DSCSA: Are you ready for November 2024?"},"categories":["data","dscsa","distribution","policy","regulatory","secure supply chain"],"segments":["pharmacies","health systems","physician practices","manufacturers"],"timestamp":638121756090000000,"title":"dscsa: are you ready for november 2024?"},{"card":{"key":"6699d19a-2d57-43fb-b260-2ab567799c96","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2018","description":"Matt Wolf, Group Vice President, Consulting Practice at Pharmacy Healthcare Solutions, shares how pharmacy can help the health system generate revenue and contain costs.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/leveraging-the-health-system-pharmacy-as-a-strategic-asset","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Leveraging the Health System Pharmacy as a Strategic Asset"},"categories":[],"segments":["health systems"],"timestamp":636590743200000000,"title":"leveraging the health system pharmacy as a strategic asset"},{"card":{"key":"cf126efe-a880-4efe-86b2-7a2239eb1b16","authorName":"Kristin Chambers","authorCompany":"AmerisourceBergen","date":"April 2018","description":"How drug manufacturers, health systems and payers can collaborate more closely in the new world of patient-centered care.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/upping-the-game","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Upping the Game"},"categories":["patient care","transitional care","readmissions","product access"],"segments":["manufacturers"],"timestamp":636592288840000000,"title":"upping the game"},{"card":{"key":"3146d057-943c-4371-ae3b-3e962bdd412e","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2018","description":"Explore what is in store for the future of ambulatory pharmacy. Download the Ambulatory Pharmacy Outlook for Health Systems 2018 report to discover opportunities for health system leaders to fully leverage ambulatory pharmacy to improve revenue and enhance the patient experience. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/ambulatory-pharmacy-outlook","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Ambulatory Pharmacy Outlook for Health Systems 2018"},"categories":["ambulatory pharmacy"],"segments":["health systems"],"timestamp":636791815400000000,"title":"ambulatory pharmacy outlook for health systems 2018"},{"card":{"key":"354a7528-9d2d-4749-9ba8-33e000d876fe","authorName":"Brian McMillan","authorCompany":" American Health Packaging","date":"May 2018","description":"While suppliers are making fewer pre-packaged unit dose treatments available, health system pharmacies still have options for acquiring them. Learn which is best.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/commercially-available-unit-dose-products","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Commercially Available Unit Dose Products: Enhancing Access to Treatments and Promoting Pharmacy Efficiency"},"categories":["packaging","patient care","pharmaceutical storage and transport management","pharmacy operations","product access","distribution"],"segments":["health systems"],"timestamp":636626991940000000,"title":"commercially available unit dose products: enhancing access to treatments and promoting pharmacy efficiency"},{"card":{"key":"7767e356-3d32-4877-a1db-c9b30e007843","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2019","description":"Explore what is in store for the future of ambulatory pharmacy. Download the Ambulatory Pharmacy Outlook for Health Systems 2019 report to discover opportunities for health system leaders to fully leverage ambulatory pharmacy to improve revenue and enhance the patient experience. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/ambulatory-pharmacy-outlook-2019","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Ambulatory Pharmacy Outlook for Health Systems"},"categories":["ambulatory pharmacy"],"segments":["health systems"],"timestamp":637054848000000000,"title":"ambulatory pharmacy outlook for health systems"},{"card":{"key":"8039bfa8-68c9-4b9e-8bf4-266d2c2922d7","authorName":"Kristin Chambers","authorCompany":"AmerisourceBergen","date":"April 2018","description":"What challenges does the increased demand for care coordination create for health system specialty pharmacies and what opportunities does it present for demonstrating value?
","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/caring-for-the-whole-patient","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Caring for the Whole Patient"},"categories":["specialty pharmacy","patient care","oncology"],"segments":["health systems","manufacturers"],"timestamp":636591383130000000,"title":"caring for the whole patient"},{"card":{"key":"041a8277-66aa-4b3d-aeff-131dbaddfc28","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2019","description":"When it comes to unit dose packaging, is it time for health systems to re-evaluate how they acquire UD products? Is it more efficient to outsource or repackage in house? AHP goes beyond cost per dose to help health systems evaluate every option.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/rethink-unit-dose-product-acquisition","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Rethink: Unit Dose Product Acquisition"},"categories":["packaging","pharmacy operations"],"segments":["health systems"],"timestamp":636843877760000000,"title":"rethink: unit dose product acquisition"},{"card":{"key":"7894ff79-fd0e-4a11-822b-ba7ad057185f","authorName":"Darin Thornburgh","authorCompany":"AmerisourceBergen","date":"March 2020","description":"The end of 2019 brought new guidelines for the handling of hazardous drugs under the USP <800> ruling. What do health systems and hospitals need to know about changes to the ordering and distribution of hazardous drugs? What do health systems need to know about changes to the ordering and distribution of hazardous drugs?","img":{"alt":"Pharmacist looks at medication. ","src":"-/media/assets/phs/images/pharmacy/hs_ippharm_rec_area_totes_fms_013.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/health-systems/usp-800-compliance","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Health Systems","headline":"Partnering With Your Distributor for USP 800 Compliance"},"categories":["patient safety","regulatory"],"segments":["health systems"],"timestamp":637195508520000000,"title":"partnering with your distributor for usp 800 compliance"},{"card":{"key":"024eedbe-4bbc-42d1-9054-ee443f206097","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2024","description":"","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/streamlined-strategic-support-for-long-term-care-pharmacy-customers","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Insight","headline":"Streamlined strategic support for long-term care pharmacy customers"},"categories":[],"segments":[],"timestamp":638509010940000000,"title":"streamlined strategic support for long-term care pharmacy customers"},{"card":{"key":"0f6159d8-1d8b-4e2c-a947-4533ce666a12","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2024","description":"","img":{"alt":"Man and a woman meet in an office","src":"-/media/assets/amerisourcebergen/business-interactions/meetingopenareatable11160058.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/biosimilars-usage-is-lowering-costs-for-patients-and-the-medicare-program","linkText":"Download the report","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Report: Biosimilars usage is lowering costs for patients and the Medicare program"},"categories":["biosimilars","policy"],"segments":["manufacturers"],"timestamp":638584894200000000,"title":"report: biosimilars usage is lowering costs for patients and the medicare program"},{"card":{"key":"5af37440-1afa-4442-af91-5cfd6f9e04b8","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2021","description":"Blue Sky Specialty Pharmacy has found its footing in a hypercompetitive market thanks to a culture that puts people first, from patients and staff to the providers who bring them business.","img":{"alt":"blue_sky","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/blue_sky.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/pulling-a-passion-for-patients-into-specialty-pharmacy-marketing","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Pulling a passion for patients into specialty pharmacy marketing"},"categories":["innovation","patient care","our role in healthcare","specialty pharmacy"],"segments":["pharmacies"],"timestamp":637674105880000000,"title":"pulling a passion for patients into specialty pharmacy marketing"},{"card":{"key":"f2e6d945-ced9-4c99-bb70-c6f1d8f6c3aa","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2018","description":"“We found a model that worked, and it has allowed us to grow rapidly. The impetus was to do what the bigger guys do, but better.”","img":{"alt":"Product injectable","src":"-/media/assets/amerisourcebergen/product/product_injectable_syringes_2011-2012_002.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/specialty-pharmacy-customer-spotlight-encompass-rx","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Pharmacies","headline":"Specialty Pharmacy Customer Spotlight: Encompass RX"},"categories":["specialty pharmacy"],"segments":["pharmacies"],"timestamp":636513034720000000,"title":"specialty pharmacy customer spotlight: encompass rx"},{"card":{"key":"9996b3c1-130e-4ba5-8f51-3912889e1596","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2018","description":"By promoting health and wellness, pharmacists play a crucial role in their communities. Explore three examples of how pharmacists can positively impact the lives of the people they serve.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/promoting-health-and-wellness-in-the-community","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Promoting Health and Wellness in the Community"},"categories":["patient care","good neighbor pharmacy"],"segments":["pharmacies"],"timestamp":636657231540000000,"title":"promoting health and wellness in the community"},{"card":{"key":"fcc03d2b-e8f6-4d1a-9126-b10f64eac40a","authorName":"Danny Nelson","authorCompany":"AmerisourceBergen","date":"August 2017","description":"Tips for community pharmacies looking to keep inventory at the optimal level.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/taking-stock-inventory-management-best-practices-for-community-pharmacies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Taking Stock: Inventory Management Best Practices for Community Pharmacies"},"categories":["inventory management"],"segments":["pharmacies"],"timestamp":636396359400000000,"title":"taking stock: inventory management best practices for community pharmacies"},{"card":{"key":"7ffc3914-b3e0-4fde-a86b-8a67c6589247","authorName":"Tanya Mericle","authorCompany":"AmerisourceBergen","date":"June 2018","description":"When it comes to diabetes care, community pharmacies have an opportunity to be the leading resource for patients. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/caring-for-the-patient-with-diabetes","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Caring for the Patient with Diabetes"},"categories":["good neighbor pharmacy","patient care","medication adherence","medication therapy management","in-store experience"],"segments":["pharmacies"],"timestamp":636656249180000000,"title":"caring for the patient with diabetes"},{"card":{"key":"9b32de53-bbb4-46b4-8fb2-1d105ac662e3","authorName":"Marc Johnson","authorCompany":"AmerisourceBergen","date":"April 2020","description":"Technology can save time and encourage more efficient relationships and workflows. Consider these priorities when investing in a high-tech solution for your LTC pharmacy.","img":{"alt":"OralPillsBlisterPackLoading11160003","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/oralpillsblisterpackloading11160003.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/should-technology-be-a-priority-for-your-ltc-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Should Technology Be a Priority for Your LTC Pharmacy?"},"categories":["long term care","technology"],"segments":["pharmacies"],"timestamp":637224772200000000,"title":"should technology be a priority for your ltc pharmacy?"},{"card":{"key":"6d1a07ee-2bf8-46ff-9fea-71dba6dae027","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2024","description":"A look at how Xcenda's field reimbursement and access team leads help fuel patient access and better outcomes.","img":{"alt":"ThinkLive-web-hero-background-1200x800","src":"-/media/assets/amerisourcebergen/01-home-page-new-images/thinklive-web-hero-background-1200x800.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharma-in-the-field-barrett","linkText":"Meet Barrett","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pharma in the field: Barrett's story"},"categories":["affordability","commercialization","product access","reimbursement","field support"],"segments":["manufacturers"],"timestamp":638429358600000000,"title":"pharma in the field: barrett's story"},{"card":{"key":"f8d71c5a-a4df-467f-bd2d-0808fa4e2499","authorName":"Innomar Strategies","authorCompany":null,"date":"September 2017","description":"Understanding the unique considerations for reimbursement in the Canadian pharmaceutical market.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-route-to-market-access-in-canada","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Route to Market Access in Canada"},"categories":["market access","reimbursement"],"segments":["manufacturers"],"timestamp":636413640000000000,"title":"the route to market access in canada"},{"card":{"key":"2d411185-885b-4f26-9ce4-039571b2a192","authorName":"Lash Group","authorCompany":null,"date":"June 2020","description":"With the right data, manufacturers can pivot their patient support services in response to real-time trends. Learn the three data-driven decisions you can make when you work with the right partner.","img":{"alt":"data","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/data.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/next-level-analytics-part-2","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Next-level analytics part 2: Is your patient support program data actionable?"},"categories":["data","analytics","patient support services"],"segments":["manufacturers"],"timestamp":637274896030000000,"title":"next-level analytics part 2: is your patient support program data actionable?"},{"card":{"key":"ad1c50ab-7286-42c2-a6a1-626d4f277350","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2023","description":"","img":{"alt":"The EU JCA process","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/the-eu-jca-process-challenges-and-opportunities-in-bringing-innovative-medicines-to-patients-in-euro.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-eu-jca-process","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Q&A – Preparing for the EU Joint Clinical Assessment (JCA) process "},"categories":["commercialization","consulting","policy"],"segments":["manufacturers"],"timestamp":638284212260000000,"title":"q&a – preparing for the eu joint clinical assessment (jca) process "},{"card":{"key":"f1fbccd8-c6d3-4594-9e8f-c4a0a4bf0b7d","authorName":"Xcenda","authorCompany":null,"date":"November 2022","description":"Years of scrutiny of the pharmaceutical market in the US have resulted in significant drug pricing reforms. The reforms are part of the recently passed Inflation Reduction Act (IRA), enacted into law in August 2022.","img":{"alt":"Image of doctors and budgets and money","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-winter-2022/ira.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-winter-2022-ira-major-reforms-to-drug-pricing-in-usa","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"I-R-A or Eye-Ra - however you frame it, the new US drug pricing law is sure to have a significant impact on the global pharmaceutical market "},"categories":[],"segments":[],"timestamp":638034687600000000,"title":"i-r-a or eye-ra - however you frame it, the new us drug pricing law is sure to have a significant impact on the global pharmaceutical market "},{"card":{"key":"5362b8cb-2fe5-44cd-8834-8bf0db493b32","authorName":"AmerisourceBergen","authorCompany":"","date":"July 2023","description":"The annual reverification (AR) period is a time when the right combination of talent and technology can minimize disruptions in therapy for hundreds of thousands of patients. As a manufacturer, what do you need to know about annual reverification?","img":{"alt":"insurance card and tablet","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/insurance-card-and-tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/what-manufacturers-need-to-know-about-annual-reverification","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"What biopharma companies need to know about annual reverification"},"categories":["affordability","commercialization","patient support services","product access","technology","innovation"],"segments":["manufacturers"],"timestamp":638241691800000000,"title":"what biopharma companies need to know about annual reverification"},{"card":{"key":"8697bdd7-33b7-45f9-8356-82de7c6825db","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2019","description":"Watch Volker Kirchner, Director of Temperature Control Solutions discuss how Cocoon is the industry's most dependable solution for transporting pallet-sized shipments of temperature-sensitive materials","img":{"alt":"A forklift loads a shipping container into a World Courier truck at a loading dock.","src":"-/media/assets/worldcourier/english/images/pharma-storage-and-distribution/storage/world-courier_delivery-truck_ny_074-(2).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/understand-the-innovation-behind-cocoon","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Video: Understand the Innovation Behind Cocoon"},"categories":["commercial supply chain","temperature control solutions","packaging"],"segments":[],"timestamp":636893703060000000,"title":"video: understand the innovation behind cocoon"},{"card":{"key":"857292f2-cddf-4e55-98e4-65a07c9a0394","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2020","description":"What education and resources can manufacturers provide to build physician confidence in biosimilars? Learn what physicians want to know, what they need, and how you can help.","img":{"alt":"biosims video thumb1","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/biosims-video-thumb1.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/video-removing-barriers-for-biosimilars","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Video: Removing Barriers for Biosimilars"},"categories":["biosimilars","commercialization","reimbursement"],"segments":["manufacturers","physician practices"],"timestamp":637175633650000000,"title":"video: removing barriers for biosimilars"},{"card":{"key":"56c43df4-e90c-4016-85e6-92be2d585abd","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2018","description":"What are FTZs and why should pharma use them?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-role-of-foreign-trade-zones-in-pharmaceutical-manufacturing-success-part-one","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Role of Foreign Trade Zones in Pharmaceutical Manufacturing Success: Part One"},"categories":["commercialization","third party logistics"],"segments":["manufacturers"],"timestamp":636718635840000000,"title":"the role of foreign trade zones in pharmaceutical manufacturing success: part one"},{"card":{"key":"9ae4d205-b924-4ab4-b256-587cbb87ffef","authorName":"Lash Group","authorCompany":null,"date":"June 2021","description":"With the rapid growth of digital therapeutics, new products are entering a payer landscape that wasn't made for them. Here's how developers can adapt current payment models for emerging solutions.","img":{"alt":"woman on smartphone in urban setting","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/woman-on-smartphone-in-urban-setting.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/dtx-payer-landscape","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Navigating the payer landscape for digital therapeutics"},"categories":["affordability","data","commercialization","innovation","market access","medication adherence","patient support services","reimbursement","technology"],"segments":["manufacturers"],"timestamp":637595437260000000,"title":"navigating the payer landscape for digital therapeutics"},{"card":{"key":"ce64f028-8c96-4148-bc30-ad4edf845ab5","authorName":"Albert Cooksey","authorCompany":"","date":"July 2018","description":"How third-party logistics (3PL) solutions can help cell and gene therapy manufacturers manage the financial aspects of launching new therapies.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/financial-management-for-cell-and-gene-therapies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Financial Management for Cell and Gene Therapies"},"categories":["cell and gene therapy","commercialization","financial management"],"segments":["manufacturers"],"timestamp":636667627150000000,"title":"financial management for cell and gene therapies"},{"card":{"key":"e3126f5b-48b7-4433-b135-682566d5ab44","authorName":"Ruairi O'Donnell, PhD","authorCompany":"Cencora","date":"July 2024","description":"","img":{"alt":"Does EU HTAR put patients at the center","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/does-eu-htar-put-patients-at-the-center.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/from-pico-anxiety-to-pico-strategy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"From PICO anxiety to PICO strategy: planning for EU HTA success"},"categories":["consulting","regulatory"],"segments":[],"timestamp":638567462070000000,"title":"from pico anxiety to pico strategy: planning for eu hta success"},{"card":{"key":"8154ac9b-5d1f-483a-a1fb-aa6f1fd9ecd4","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2023","description":"","img":{"alt":"CGT Patient services","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/thumbnail-qa-dale.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/future-challenges-and-predictions-for-cgt-patient-focused-solutions","linkText":"Download Q&A","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Q&A – Future challenges and predictions for CGT patient focused solutions"},"categories":["cell and gene therapy"],"segments":[],"timestamp":638300355170000000,"title":"q&a – future challenges and predictions for cgt patient focused solutions"},{"card":{"key":"ede2fbcb-d443-42e9-8408-6a1a932336cb","authorName":"Lash Group","authorCompany":null,"date":"October 2018","description":"How leading patient support providers combine measurement with engagement to improve adherence.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-power-of-patient-activation-part-two","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Power of Patient Activation: Part Two"},"categories":["affordability","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":636758273660000000,"title":"the power of patient activation: part two"},{"card":{"key":"7c34a7d6-1ebe-450c-ac4d-15d5ae4403d0","authorName":"Xcenda","authorCompany":null,"date":"November 2022","description":"Establishment of the Danish Medicines Council (DMC) in 2017 was intended to ensure transparent assessment of hospital medicines and rapid, consistent access to effective medicines across Denmark, while balancing healthcare costs against demand. Five years later, we consider what impact the DMC has had on market access and implications for drug developers.","img":{"alt":"Danish Pig","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-winter-2022/danish-pig.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-winter-2022-hta-market-access-denmark","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Has mandatory HTA improved access to new medicine in Denmark? Learnings from the first 5 years with the Danish Medicines Council"},"categories":[],"segments":[],"timestamp":638034689400000000,"title":"has mandatory hta improved access to new medicine in denmark? learnings from the first 5 years with the danish medicines council"},{"card":{"key":"2cf339cc-8ee1-49ff-9268-c5e00b80376b","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2020","description":"What will it take to bring a treatment for COVID-19 to market? What have we learned from efforts to ensure supply chain stability at the height of the coronavirus pandemic? Leaders from AmerisourceBergen's Strategic Global Sourcing team share their perspective on how we'll make sure the right pieces are in place as manufacturers seek to commercialize new therapies.","img":{"alt":"COVID_masks_texture","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/covid_masks_texture.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-road-to-a-covid-19-treatment-launch","linkText":"Read the Q&A","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The road to a COVID-19 treatment launch"},"categories":["covid-19","distribution","commercialization","secure supply chain"],"segments":["manufacturers"],"timestamp":637390702800000000,"title":"the road to a covid-19 treatment launch"},{"card":{"key":"0a058181-b9c8-4e1d-b01a-ef6c778514ca","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2024","description":"As we enter 2024, the global healthcare landscape is experiencing fundamental changes ushered in by major policy shifts and challenging payer decisions. While groundbreaking legislative changes and increasing global pricing pressures may be the clear headliners, there are other changes—state-of-the-art technological and medical innovations, the growth of potentially curative therapies—swirling against a backdrop of uncertainty across different geographies. In the United States, the Inflation Reduction Act will not only accelerate pricing pressures on high-cost, highly utilized products, but it will also lead to downstream patient access impacts. Globally, payers continue to expect that manufacturers demonstrate the value of their products to the healthcare system and patients. In 2024, all stakeholders will need a clearer understanding of how these dynamic trends will affect patient access to innovative therapies across global markets. ","img":{"alt":"global market access trends in 2024","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/2024-global-market-access-trends/global-market-access-trends-in-2024.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/top-7-global-market-access-trends-for-2024","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Anticipating the top seven global market access trends for 2024: Cencora’s healthcare landscape outlook "},"categories":["market access","consulting","regulatory"],"segments":["manufacturers"],"timestamp":638400096000000000,"title":"anticipating the top seven global market access trends for 2024: cencora’s healthcare landscape outlook "},{"card":{"key":"0c324f6c-3ce3-4849-9593-43b1cf8144fb","authorName":"Lash Group","authorCompany":null,"date":"April 2021","description":"With multiple vendors vying to help you launch or optimize your patient support program, position yourself to make the biggest impact for patients by asking potential partners these questions.","img":{"alt":"AB_TextImage_01","src":"-/media/assets/amerisourcebergen/01-home-page-new-images/ab_textimage_01.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/five-questions-to-ask-a-potential-patient-support-partner","linkText":"Get the checklist","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Five questions to ask a potential patient support partner"},"categories":["affordability","commercialization","medication adherence","patient support services","product access","technology","innovation"],"segments":["manufacturers"],"timestamp":637534183330000000,"title":"five questions to ask a potential patient support partner"},{"card":{"key":"5755c5d2-cdd5-4c3f-bef9-3f2806a05c86","authorName":"Lash Group","authorCompany":null,"date":"October 2021","description":"The manufacturer of a leading biologics therapy improved therapy initiation among targeted patient groups using an AI-powered patient support program.","img":{"alt":"Lash Group Artificial Intelligence Patient Support Program","src":"-/media/assets/lashgroup/images/ai_technology_innovation.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/ai-case-study","linkText":"Get the case study","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case study: Improving therapy initiation with an AI-guided patient support program"},"categories":["commercialization","data","analytics","engagement","product access","patient support services","innovation","technology"],"segments":["manufacturers"],"timestamp":637699274250000000,"title":"case study: improving therapy initiation with an ai-guided patient support program"},{"card":{"key":"57f3acfe-b962-46a8-90c2-d3103cbe4476","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2023","description":"","img":{"alt":"HTA Quarterly","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/hta-quarterly.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-winter-2023-summary","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"HTA Quarterly Winter 2023"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638344438200000000,"title":"hta quarterly winter 2023"},{"card":{"key":"96dca497-f7d8-485e-9d31-bf4dd71d1dea","authorName":"Lash Group","authorCompany":null,"date":"January 2020","description":"The future of eBV is here. How manufacturers can use AI to help patients start life-changing therapies faster than ever.","img":{"alt":"White paper beyond the promise of artificial intelligence in electronic benefit verification","src":"-/media/assets/lashgroup/images/white-paper---beyond-the-promise-of-artificial-intelligence-in-electronic-benefit-verification.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/white-paper---beyond-the-promise-of-artificial-intelligence-in-electronic-benefit-verification","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Manufacturers","headline":"White paper: beyond the promise of artificial intelligence in electronic benefit verification"},"categories":["commercialization","patient support services","product access","technology"],"segments":["manufacturers"],"timestamp":637153076400000000,"title":"white paper: beyond the promise of artificial intelligence in electronic benefit verification"},{"card":{"key":"b4fd468c-e8e1-450c-b377-fb46af9692ed","authorName":"Christian Schneider, M.D.","authorCompany":"PharmaLex","date":"July 2024","description":"","img":{"alt":"webinar","src":"-/media/assets/amerisourcebergen/tl-cgt-webinar-image.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/leveraging-past-learnings-for-future-focused-solutions-to-clinical-manufacturing","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Leveraging past learnings for future-focused solutions to clinical manufacturing"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638569203560000000,"title":"leveraging past learnings for future-focused solutions to clinical manufacturing"},{"card":{"key":"fc0d2f4d-1310-49fb-8531-4c08da0a6ef9","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2023","description":"","img":{"alt":"Phacilitate Miami Advanced Therapies Week","src":"-/media/assets/amerisourcebergen/manufacturer/advanced-therapies-week-2022.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/answering-four-key-questions-about-hta-market-archetypes","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Answering four key questions about HTA market archetypes"},"categories":["commercialization","consulting","policy"],"segments":["manufacturers"],"timestamp":638132104970000000,"title":"answering four key questions about hta market archetypes"},{"card":{"key":"009bc3f8-8968-41cd-9b64-fc8067f06635","authorName":"Xcenda","authorCompany":null,"date":"January 2019","description":"What does Medicare claims data reveal about physician-administered drugs? An Xcenda survey reveals whether physicians choose treatment based on how much they're reimbursed.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/medicare-part-b-infographic","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Medicare Part B: Do Providers Choose Treatment Based on Payment?"},"categories":["policy","reimbursement"],"segments":["manufacturers"],"timestamp":636831781040000000,"title":"medicare part b: do providers choose treatment based on payment?"},{"card":{"key":"927e18ab-a4d9-4dad-9c85-79c67ca98866","authorName":"Corey Ford, MHA; Dale Hanna","authorCompany":"","date":"March 2021","description":"Experts from Xcenda and Lash Group discuss copay accumulators, the impact of the new CMS regulations, and operational solutions for manufacturers.","img":{"alt":"copay accumulator piggy bank","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pink-piggy-bank-and-stethoscope.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/strategies-for-addressing-copay-accumulators","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Strategies for addressing copay accumulators: What manufacturers need to know"},"categories":["affordability","commercialization","market access","patient support services","policy","regulatory"],"segments":["manufacturers"],"timestamp":637508352790000000,"title":"strategies for addressing copay accumulators: what manufacturers need to know"},{"card":{"key":"09570a88-b3df-433d-a1ba-67ff13266b30","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2019","description":"Learn how we are transporting the treatments that patients depend on every day worldwide ","img":{"alt":"Doctor with patient","src":"-/media/assets/worldcourier/english/images/article-images/doctor-with-patient.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/delivering-innovation-and-improving-lives","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"E-book: Delivering innovation, improving lives"},"categories":["clinical trial logistics","commercial supply chain","cell and gene therapy","commercialization","direct-to-patient","pharmaceutical storage and transport management"],"segments":[],"timestamp":637108978140000000,"title":"e-book: delivering innovation, improving lives"},{"card":{"key":"8bcb724b-5eb0-43c7-8f5b-409faa9db12b","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2024","description":"","img":{"alt":"Video 2","src":"-/media/assets/innomarstrategies/insights/video-2-graphic.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/drug-advertisement-in-canada-what-you-need-to-know","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Drug advertisement in Canada: What you need to know "},"categories":["our role in healthcare"],"segments":["manufacturers"],"timestamp":638616927600000000,"title":"drug advertisement in canada: what you need to know "},{"card":{"key":"395474f0-a582-4556-9657-dfa1468a77ab","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2023","description":"","img":{"alt":"PageDesign_Patient_Doc","src":"-/media/assets/lash/images/pagedesign_patient_doc.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/eu-jca-webinar-patients-at-center","linkText":"Register now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar on demand: Implications of the EU JCA on patient access and engagement"},"categories":["consulting","legislation","market access","regulatory"],"segments":["manufacturers"],"timestamp":638367264000000000,"title":"webinar on demand: implications of the eu jca on patient access and engagement"},{"card":{"key":"e5f57fec-d90a-45b6-a7d4-36dd278ab588","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2017","description":"An interview with Matt George, patient advocate and survivor of paroxysmal nocturnal haemoglobinuria (PNH), a debilitating, rare and life-threatening disorder.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/understanding-the-rare-disease-journey","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Understanding the Rare Disease Journey"},"categories":["orphan drugs","patient support services"],"segments":["manufacturers"],"timestamp":636228799800000000,"title":"understanding the rare disease journey"},{"card":{"key":"9602a29f-5a75-41a5-8e09-54e73fafd177","authorName":"Xcenda","authorCompany":null,"date":"July 2020","description":"How the field reimbursement specialist (FRS) differs from the sales rep — and where outsourced field teams can supplement sales teams to ensure patients and providers receive the support they need.","img":{"alt":"Medical staff wearing masks talking at laptop","src":"-/media/assets/amerisourcebergen/insights/medical-staff-wearing-masks-talking-at-laptop.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharma-in-the-field","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pharma in the field: Sales reps vs. reimbursement and access specialists"},"categories":["covid-19","commercialization","market access","patient support services","product access"],"segments":["manufacturers"],"timestamp":637309537050000000,"title":"pharma in the field: sales reps vs. reimbursement and access specialists"},{"card":{"key":"29e1d842-e156-41c7-9991-672cabbb6d35","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2021","description":"The commercialization of novel cell and gene therapies requires smart strategy and integrated solutions. Hear from AmerisourceBergen and TrakCel experts as they discuss key elements to consider when preparing, designing, and implementing a plan for moving from clinical to commercial. ","img":{"alt":"Commercial supply chain strategies for cell and gene therapies","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/cell-and-gene-therapies-clinical-supply-chain-considerations/commercial-supply-chain-strategies-for-cell-and-gene-therapies.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/commercial-supply-chain-strategies-for-cell-and-gene-therapies","linkText":"Watch on demand","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Commercial supply chain strategies for cell and gene therapies"},"categories":["cell and gene therapy","clinical trial logistics","commercial supply chain","commercialization","distribution","secure supply chain"],"segments":["manufacturers"],"timestamp":637642857000000000,"title":"webinar: commercial supply chain strategies for cell and gene therapies"},{"card":{"key":"c6571443-53b7-4036-a6c1-f2f29d240012","authorName":"Lung-I Cheng","authorCompany":"Biopharma Services","date":"February 2024","description":"","img":{"alt":"Cell and gene therapy consultants","src":"-/media/assets/amerisourcebergen/manufacturer/cell-and-gene-therapy-services.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/opportunities-and-pain-points-for-cgt","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Opportunities and pain points for CGT innovation and market access"},"categories":["cell and gene therapy","market access","patient care","patient support services","reimbursement"],"segments":["manufacturers"],"timestamp":638447437320000000,"title":"opportunities and pain points for cgt innovation and market access"},{"card":{"key":"ad3c120c-7bc2-453b-b19c-c4683ef579f8","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2024","description":"","img":{"alt":"Communicating With Your Payers_467x250","src":"-/media/assets/ion/images/communicating-with-your-payers_467x250.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/cencora-payerpulse","linkText":"Download the infographic","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Cencora PayerPulse: The unintended consequences of the Inflation Reduction Act (IRA)"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638618452800000000,"title":"cencora payerpulse: the unintended consequences of the inflation reduction act (ira)"},{"card":{"key":"bf89ba9a-7534-41c7-a9e5-d5ac405fbd04","authorName":"Lash Group","authorCompany":null,"date":"June 2021","description":"Patient support services are often tailored to pharmaceuticals. But they can also be beneficial in the emerging world of digital therapeutics. Here are a few ways to support patients in accessing new health technology.","img":{"alt":"asian woman on smartphone at home","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/asian-woman-on-smartphone-at-home.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/dtx-critical-elements-for-building-effective-patient-support-programs","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Digital therapeutics: Critical elements for building effective patient support programs"},"categories":["affordability","commercialization","data","innovation","medication adherence","patient support services","technology"],"segments":["manufacturers"],"timestamp":637594752920000000,"title":"digital therapeutics: critical elements for building effective patient support programs"},{"card":{"key":"e9b96d0c-79e8-4207-8eb4-ccb9bfa9f2ee","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"Launching a new pharmaceutical product is a complex endeavor, involving a web of interrelated activities from clinical trials through market maturity. How can manufacturers avoid common pitfalls on the journey toward product success? Strategic Partnerships for Unlocking Product Potential explores how manufacturers can benefit from integrated commercialization solutions. Learn how a partner with the right combination of solutions, perspectives, and scale can help manufacturers unlock product potential by optimizing everything from clinical trials and payer engagement to patient support and field solutions.","img":{"alt":"Strategic partnerships for unlocking product potential ebook","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/strategic-partnerships-for-unlocking-product-potential.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/strategic-partnerships-for-unlocking-product-potential","linkText":"Download ebook","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Ebook: Strategic partnerships for unlocking product potential"},"categories":["clinical trial logistics","commercialization","data","distribution","innovation","market access","patient support services","reimbursement"],"segments":["manufacturers"],"timestamp":637540018110000000,"title":"ebook: strategic partnerships for unlocking product potential"},{"card":{"key":"cb39e59e-62c0-44c8-a37f-ebc7efa57816","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2022","description":"Xcenda and FormularyDecisions joined AMCP for a live webinar on January 19, 2022 titled, “Bridging the HCEI Divide – Insights on an Effective Healthcare Economic Information (HCEI) Exchange.”","img":{"alt":"AB-Business-Meeting-2_RGB_card","src":"-/media/assets/sustainability/images/ab-business-meeting-2_rgb_card.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/bridging-the-hcei-divide-webinar","linkText":"Download slides","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Bridging the HCEI Divide – Insights on an Effective Healthcare Economic Information (HCEI) Exchange"},"categories":[],"segments":["manufacturers"],"timestamp":637781981400000000,"title":"webinar: bridging the hcei divide – insights on an effective healthcare economic information (hcei) exchange"},{"card":{"key":"e26d6499-7ca3-4dc4-9e0a-f383b9584bf2","authorName":"Xcenda","authorCompany":null,"date":"July 2021","description":"Over the past few years, there has been an increased focus on drug pricing, including some proposals for direct government involvement in negotiating or even setting drug prices. While none of the policies have been implemented, regulation of drug prices by the federal government would likely impact a variety of stakeholders, particularly those purchasing and managing drugs.

To evaluate the impact of government-mandated price reductions on coverage and patient affordability and access, Xcenda surveyed advisors from health plans, integrated delivery networks (IDNs), and pharmacy benefit managers (PBMs) and asked questions about the impact of government price regulation on access, including cost-sharing and benefit design. Federal price action could trigger some payers to modify formulary benefit design, shifting coverage and use of utilization management tools.","img":{"alt":"abstract lines ","src":"-/media/assets/xcenda/english/images/insights/ab-colors-abstract-lines.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/affordability-is-about-more-than-drug-prices","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Affordability is about more than drug prices"},"categories":["affordability","commercialization","legislation","managed care","patient care","patient support services","policy","regulatory","research"],"segments":[],"timestamp":637624007400000000,"title":"affordability is about more than drug prices"},{"card":{"key":"dd287477-7e69-492e-bd1e-c0abaa637b25","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2022","description":"","img":{"alt":"Biosimilars podcast ","src":"-/media/assets/amerisourcebergen/biosimilars-page/biosimilars-podcast-image.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/podcast-biosimilars-milestones-2022-looking-to-2023","linkText":"Listen now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Podcast: Milestones for biosimilars in 2022 and looking ahead to 2023"},"categories":["affordability","biosimilars","market access","product access","regulatory"],"segments":["manufacturers","pharmacies","health systems"],"timestamp":637944384600000000,"title":"podcast: milestones for biosimilars in 2022 and looking ahead to 2023"},{"card":{"key":"e8603321-c30e-4f60-b734-7b4b7647915f","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2023","description":"","img":{"alt":"eu flag","src":"-/media/assets/amerisourcebergen/jca-eu-flag.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/how-the-jca-may-help-to-address-medicine-inequality-across-europe","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How the JCA may help to address medicine inequality across Europe"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638210617390000000,"title":"how the jca may help to address medicine inequality across europe"},{"card":{"key":"bdbcd441-fc9e-4ec3-9f38-e070d4d78484","authorName":"Xcenda","authorCompany":null,"date":"June 2023","description":"The Part B Home Infusion Therapy benefit addresses some gaps but has provider qualifications and excludes drug and pump coverage. For a comprehensive understanding of access options, download this white paper for valuable insights.","img":{"alt":"Abstract","src":"-/media/assets/amerisourcebergen/about-us/abstract.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/reimbursement-considerations-for-home-infusions","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Reimbursement considerations for home infusions"},"categories":["commercialization","consulting","managed care","reimbursement"],"segments":[],"timestamp":638213086680000000,"title":"reimbursement considerations for home infusions"},{"card":{"key":"405c7c79-4526-4411-b4b9-08310d823168","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2023","description":"","img":{"alt":"cgt","src":"-/media/assets/amerisourcebergen/insights/52853133569_9fb286912e_c.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/creating-a-sustainable-business-model-for-cell-and-gene-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Report: Creating a sustainable business model for cell and gene therapies"},"categories":["cell and gene therapy"],"segments":["manufacturers"],"timestamp":638228008940000000,"title":"report: creating a sustainable business model for cell and gene therapies"},{"card":{"key":"a62aca4d-87f5-4fe5-bd3a-e0e0f4fe8273","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2021","description":"We’re discussing insulin biosimilars with Sean McGowan and Michelle Jesse from AmerisourceBergen’s biosimilars team, along with Brad Tallamy, Senior Director of Government Affairs at AmerisourceBergen. In part two of a two-part series on insulin biosimilars, we’ll talk about how pharmacies can prepare to dispense biosimilars once these products receive interchangeability status.","img":{"alt":"Insulin consultation","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/insulin-consultation.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/podcast-insulin-biosimilars-2","linkText":"Listen now","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Podcast: Insulin biosimilars part 2"},"categories":["biosimilars","affordability","policy","pharmacy operations"],"segments":[],"timestamp":637660341000000000,"title":"podcast: insulin biosimilars part 2"},{"card":{"key":"a095da7f-3784-41b7-82f4-b8c1dc05e07e","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2023","description":"Infused drugs have been around forever, with home infusion coming into prominence in the 1970s. So why is now a critical time for health systems to have a comprehensive infusion strategy to retain revenue and improve patient outcomes? AmerisourceBergen's Toni Giglio spoke with Dan Teich, vice president of Performance Based Contracting and Justin Whitsett, senior director of AmerisourceBergen's Infusion Portfolio Solution for their perspectives.","img":{"alt":"","src":"-/media/assets/gettyimages-1485546621.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/alternate-site-infusion-landscape-q-and-a-with-amerisourcebergen-infusion-experts","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Alternate site infusion landscape: Q&A with AmerisourceBergen infusion experts"},"categories":[],"segments":[],"timestamp":638374941670000000,"title":"alternate site infusion landscape: q&a with amerisourcebergen infusion experts"},{"card":{"key":"3a954268-80b9-4bb3-8cbc-8cb515f6ace5","authorName":"AmerisourceBergen","authorCompany":"","date":"June 2023","description":"Good news for manufacturers, pharmacies, and all healthcare stakeholders: you don't need to feel overwhelmed by the DSCSA. This guide will help you better understand what to expect and how to prepare.","img":{"alt":"People","src":"-/media/assets/amerisourcebergen/dscsa-vials.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/qtrly-gov-affairs-q-and-a","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Q&A with the AmerisourceBergen Office of Government Affairs and Public Policy (AB GA&P)"},"categories":[],"segments":[],"timestamp":638224164000000000,"title":"q&a with the amerisourcebergen office of government affairs and public policy (ab ga&p)"},{"card":{"key":"89fe2714-afbe-4527-82f8-71c3418627a2","authorName":"Lisa Harrison; Beth Mitchell","authorCompany":"","date":"September 2023","description":"","img":{"alt":"","src":"-/media/assets/amerisourcebergen/gettyimages-1348851748-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/navigating-cms-cy-2024---part-2","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Navigating the CMS' CY 2024 proposed rule: part 2"},"categories":[],"segments":[],"timestamp":638315748000000000,"title":"navigating the cms' cy 2024 proposed rule: part 2"},{"card":{"key":"db195600-bfdd-47a5-9465-d39fdee61508","authorName":"AmerisourceBergen","authorCompany":"","date":"June 2024","description":"","img":{"alt":"","src":"-/media/assets/amerisourcebergen/seasonal-vaccines/ab-dc-worker-male-pick-pack-2_rgb_large.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/understanding-seasonal-vaccines-efforts-far-beyond-the-vaccination-season","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Understanding seasonal vaccines efforts far beyond the vaccination season"},"categories":["covid-19","distribution","immunizations"],"segments":[],"timestamp":638551194180000000,"title":"understanding seasonal vaccines efforts far beyond the vaccination season"},{"card":{"key":"e0cc9e18-8866-40bb-a731-945039ef60c6","authorName":"FirstView","authorCompany":"","date":"April 2023","description":"","img":{"alt":"whitepaper","src":"-/media/assets/amerisourcebergen/fvf-advanced-strategies-whitepaper.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/advanced-strategies-to-reduce-barriers-to-patient-access","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"4 best practices for biopharma: Advanced strategies to reduce barriers to patient access"},"categories":["financial management"],"segments":[],"timestamp":638169264600000000,"title":"4 best practices for biopharma: advanced strategies to reduce barriers to patient access"},{"card":{"key":"d53d042e-dec4-4f65-a673-61a4e4e84ee8","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2024","description":"Beth Riggio, VP of Global Products and Solutions, recently shared her insights into the innovative use of RFID in a post published on RFID Insights.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/pharmacy-solutions/mt-phramacist-scan-0d0a0312-091222.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/rfids-role-and-potential-within-healthcare-settings","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"RFID's role and potential within healthcare settings"},"categories":["pharmacy operations","pharmaceutical storage and transport management","pharmacy transformation","pharmacy ownership"],"segments":["pharmacies","health systems"],"timestamp":638453592410000000,"title":"rfid's role and potential within healthcare settings"},{"card":{"key":"9e593ed4-63cc-4ff1-ab66-1d039606d8d7","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2023","description":"","img":{"alt":"case study","src":"-/media/assets/trade-insight-graphic-next/how-manufacturers-can/pharmacist-insight.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/how-biopharma-companies-can-help-address-pharmacy-under-reimbursement","linkText":"Download case study","hasImage":true,"isImageMode":true,"label":"Insight","headline":"How biopharma companies can help address pharmacy under-reimbursement"},"categories":["financial management"],"segments":[],"timestamp":638132955000000000,"title":"how biopharma companies can help address pharmacy under-reimbursement"},{"card":{"key":"1c26b7e8-8803-48c9-8b83-fbebb99a3785","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2023","description":"","img":{"alt":"GettyImages-1153883015_RGB_mobile","src":"-/media/assets/amerisourcebergen/careers/gettyimages-1153883015_rgb_mobile.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/latest-policy-trends-webinar","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Latest Policy Trends Webinar On Demand"},"categories":[],"segments":[],"timestamp":638258962720000000,"title":"latest policy trends webinar on demand"},{"card":{"key":"af8052cb-491f-4612-a43e-59af37db04be","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2021","description":"Revisiting the biosimilars market with Sean McGowan and Michelle Jesse from AmerisourceBergen’s biosimilars team, along with Brad Tallamy, Senior Director of Government Affairs at AmerisourceBergen. In part one of a two-part series on insulin biosimilars, we’ll talk about what these new drugs could mean for the category.","img":{"alt":"Insulin model texture","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/insulin-model-texture.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/podcast-insulin-biosimilars-1","linkText":"Listen now","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Podcast: Insulin biosimilars part 1"},"categories":["biosimilars","affordability","policy"],"segments":[],"timestamp":637624053510000000,"title":"podcast: insulin biosimilars part 1"},{"card":{"key":"f01fd3cd-8858-42ca-b9b0-50de643cfef3","authorName":"Lisa Harrison; Beth Mitchell","authorCompany":"","date":"October 2024","description":"","img":{"alt":"People","src":"-/media/assets/amerisourcebergen/dscsa-vials.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/q-and-a-2025-medicare-physician-fee-schedule-proposed-rule","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Q&A: 2025 Medicare Physician Fee Schedule Proposed Rule"},"categories":[],"segments":[],"timestamp":638633700000000000,"title":"q&a: 2025 medicare physician fee schedule proposed rule"},{"card":{"key":"3a19cc7f-d2ab-45fb-867c-664707f99492","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2024","description":"","img":{"alt":"support","src":"-/media/assets/besse/images/im/patient-with-specialty-provider.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/promise-and-challenges-of-workflow-integration","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The promise and challenges of workflow integration for patient support programs"},"categories":["financial technologies and processing","patient support services","patient care"],"segments":["manufacturers"],"timestamp":638488944790000000,"title":"the promise and challenges of workflow integration for patient support programs"},{"card":{"key":"3262242e-9494-43b9-afb0-e50f3d5da718","authorName":"Lisa Harrison; Beth Mitchell","authorCompany":"","date":"June 2024","description":"","img":{"alt":"People","src":"-/media/assets/amerisourcebergen/dscsa-vials.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/q-and-a-macra","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Q&A: The Medicare Access and CHIP Reauthorization Act (MACRA)"},"categories":[],"segments":[],"timestamp":638553348000000000,"title":"q&a: the medicare access and chip reauthorization act (macra)"},{"card":{"key":"4aab409a-a604-4e77-bbcd-4d4c8fa5fd16","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2020","description":"LTC pharmacies can position themselves to meet growing patient needs by focusing on a few key areas. The time to start is right now.","img":{"alt":"Product_Oral_Presc_Bottle_005","src":"-/media/assets/amerisourcebergen/pharmacy/product_oral_presc_bottle_005.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/the-growing-ltc-industry","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Infographic: The growing LTC industry"},"categories":["long term care","advocacy","technology"],"segments":["pharmacies"],"timestamp":637290558000000000,"title":"infographic: the growing ltc industry"},{"card":{"key":"574d7c60-5937-4e61-8489-b768cec6e6a8","authorName":"Mark Ciarlone, PharmD","authorCompany":"Good Neighbor Pharmacy","date":"August 2019","description":"Get guidance on how to make sure you’re focusing your attention on the right areas of your business.","img":{"alt":"Audio mixing board","src":"-/media/assets/gnp/images/gnp-insights-pharmacy-optimization.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/pharmacy-optimization","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Pharmacy Optimization: Knowing Where to Start Is Half the Battle"},"categories":["business performance"],"segments":["pharmacies"],"timestamp":637024159200000000,"title":"pharmacy optimization: knowing where to start is half the battle"},{"card":{"key":"f4565e63-9ef6-46b3-9680-895a1cdbb67c","authorName":"Tim Jones","authorCompany":"AmerisourceBergen","date":"September 2020","description":"Although participating in a preferred cost-share network may be promoted as a necessity, most independent pharmacies in standard cost-share networks are retaining patients and preserving prescription profitability.","img":{"alt":"A man writing notes on a notepad behind a scale","src":"-/media/assets/gnp/images/gnp-insights-preferred-vs-standard-networks.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/picking-the-cost-share-networks-that-fit-your-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Preferred vs. Standard: Picking the Cost-Share Networks That Fit Your Pharmacy"},"categories":["managed care"],"segments":["pharmacies"],"timestamp":637365439800000000,"title":"preferred vs. standard: picking the cost-share networks that fit your pharmacy"},{"card":{"key":"3ea7e60e-709b-4bcd-9274-eafc2c9b47e3","authorName":"Good Neighbor Pharmacy","authorCompany":null,"date":"February 2020","description":"Short-term and long-term pharmacy goals will help shape your strategy for buying the right pharmacy—one that should be able to evolve through optimization and the addition of new patient care services customized to community needs.","img":{"alt":"Distance markers laid out on a driving range with golf balls strewn across the grass","src":"-/media/assets/gnp/images/gnp-insights-how-to-identify-the-right-goals.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-identify-the-right-goals-when-acquiring-a-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to Identify the Right Goals When Acquiring a Pharmacy"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":637181629200000000,"title":"how to identify the right goals when acquiring a pharmacy"},{"card":{"key":"2f4da9b4-0527-4c3b-85bf-3261c6014449","authorName":" Phyllis Houston, MSOL ","authorCompany":"AmerisourceBergen","date":"June 2018","description":"Medication adherence matters for pharmacies and patients. Learn how can pharmacies connect with their non-adherent patients and keep them on their medication regimen.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/the-value-of-medication-adherence","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"The Value of Medication Adherence"},"categories":["medication adherence","medication therapy management","good neighbor pharmacy","patient care"],"segments":["pharmacies"],"timestamp":636658853570000000,"title":"the value of medication adherence"},{"card":{"key":"38bae145-c765-4a4d-90d4-6ee9a32df5a6","authorName":"George Rafferty","authorCompany":"AmerisourceBergen","date":"June 2021","description":"A good healthcare distributor is more than just a middleman. Pharmacies can only dream big if they have a distributor who will dream big with them, embracing and living out a larger purpose and applying that to how they partner with their pharmacy customers. These are a few of the ways in which a distributor should dream big on behalf of its large retail pharmacy customers.","img":{"alt":"Dist_Drug_A-Frame_Bottles_011","src":"-/media/assets/amerisourcebergen/distribution/dist_drug_a-frame_bottles_011.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/five-ways-distributors-should-dream-big-for-pharmacy-partners","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Five ways distributors should dream big for pharmacy partners"},"categories":["covid-19","distribution","health equity","innovation","large retail pharmacy","our role in healthcare","product access"],"segments":["pharmacies"],"timestamp":637587815710000000,"title":"five ways distributors should dream big for pharmacy partners"},{"card":{"key":"83bdba9f-0032-4b04-b50c-5b6a7183f6e7","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2022","description":"In an effort to accurately exclude 340B claims from commercial rebate collection, Pharmacy Benefit Managers (PBMs) are requiring mandatory identification of 340B dispenses. Let’s review a pharmacy’s billing requirements, (the different) claim identification approaches, potential PBM usage of data, and newly proposed state legislation to combat PBM efforts.","img":{"alt":"Doctor on computer","src":"-/media/assets/worldcourier/english/images/gettyimages-875949032_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/what-you-need-to-know-about-adjudicating-340b-claims","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"What you need to know about adjudicating 340B claims"},"categories":["340b","pharmacy operations"],"segments":["pharmacies"],"timestamp":637967808070000000,"title":"what you need to know about adjudicating 340b claims"},{"card":{"key":"a37f200a-24c8-4fcb-a862-a796d0974fa0","authorName":"Jeff Puetz","authorCompany":"Good Neighbor Pharmacy","date":"August 2021","description":"Building a profitable independent pharmacy practice in today's environment goes well beyond ramping up your prescription volume. Learn how to mitigate declining reimbursement by diversifying your pharmacy business.","img":{"alt":"female pharmacist with elderly female patient","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/female-pharmacist-with-elderly-female-patient.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/translating-business-diversification-into-dollar-signs","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Translating business diversification into dollar signs"},"categories":["business performance","covid-19","good neighbor pharmacy","in-store experience","marketing","medication adherence","patient care"],"segments":["pharmacies"],"timestamp":637636940850000000,"title":"translating business diversification into dollar signs"},{"card":{"key":"6aafe7ce-a21d-4ac7-ab06-fb6db40cc1ab","authorName":"Scott Welle","authorCompany":"AmerisourceBergen","date":"August 2019","description":"Preserving the legacy of an independent pharmacy after an ownership transition requires an adept buyer to lead the charge in maintaining strong relationships with patients and prescribers, motivating staff members, having financial discipline and continuing to improve upon the best management practices that the previous owner may have spent decades developing.","img":{"alt":"A quarterback handing off a football to a running back","src":"-/media/assets/gnp/images/gnp-insights-characteristics-of-a-pharmacist-who-can-carry-on-a-legacy.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/characteristics-of-a-pharmacist-who-can-carry-on-a-legacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Characteristics of a Pharmacist Who Can Carry on a Legacy"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":637006184400000000,"title":"characteristics of a pharmacist who can carry on a legacy"},{"card":{"key":"ffbc504a-7e6b-4ff3-9060-4b8a246879ea","authorName":"Scott Bradford","authorCompany":"AmerisourceBergen","date":"August 2020","description":"You can improve your cash flow and add dollars back to your bottom line simply by selecting the appropriate program to handle your unsold pharmaceutical products and then processing your unsaleable pharmaceutical returns on a consistent basis.","img":{"alt":"Someone using a broom to sweep dollar bills into a dust pan","src":"-/media/assets/gnp/images/gnp-insights-recouping-your-losses-on-unsaleable-pharmaceuticals.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/recouping-your-losses-on-unsaleable-pharmaceuticals","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Manage Your Margin: Recouping Your Losses on Unsaleable Pharmaceuticals"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":637330130400000000,"title":"manage your margin: recouping your losses on unsaleable pharmaceuticals"},{"card":{"key":"efe46bbc-0db8-4ff0-bb32-4773ba0d608a","authorName":"Tim Jones; Beth Lea","authorCompany":"AmerisourceBergen","date":"August 2021","description":"What are DIR fees and GER and BER recoupments? How do they impact pharmacy profitability?","img":{"alt":"pharmacy payment","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pharmacy-payment.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/what-pharmacies-should-know-about-dir-fees-and-ger-and-ber-recoupments","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"What pharmacies should know about DIRs, GERs, and BERs"},"categories":["business performance","cash flow management","dir fees","financial management","good neighbor pharmacy","managed care","reimbursement"],"segments":["pharmacies"],"timestamp":637649102710000000,"title":"what pharmacies should know about dirs, gers, and bers"},{"card":{"key":"d63ff856-20a7-43e0-bf39-43c56a293184","authorName":"Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"October 2018","description":"Now is the time to encourage patients to receive an annual flu shot. Start engaging patients in a conversation about the importance of this vaccine and keep your community healthy during this flu season.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/reminding-patients-of-the-importance-of-annual-flu-vaccines","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Keeping Communities Well: Reminding Patients of the Importance of an Annual Flu Vaccine"},"categories":["immunizations","patient care"],"segments":["pharmacies"],"timestamp":636742666720000000,"title":"keeping communities well: reminding patients of the importance of an annual flu vaccine"},{"card":{"key":"a2f32daf-13aa-4d86-a7bf-4d621efa6370","authorName":"Good Neighbor Pharmacy","authorCompany":null,"date":"July 2020","description":"Passing down a pharmacy legacy usually works out well for both parties when there’s already an existing relationship between the buyer and seller since the groundwork for a smooth transition has already been laid.","img":{"alt":"A father with his arm around his son as they walk and talk","src":"-/media/assets/gnp/images/gnp-insights-sell-to-someone-you-know.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-sell-your-pharmacy-to-someone-you-know","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Ensuring Success for Your Successor: How to Sell Your Pharmacy to Someone You Know"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":637314761400000000,"title":"ensuring success for your successor: how to sell your pharmacy to someone you know"},{"card":{"key":"3d3ee039-cc5c-40b4-b9d1-e93ebf6d3355","authorName":"Peter Kounelis; Beth Lea; Shaun Henry; Tracy Armstrong","authorCompany":"AmerisourceBergen","date":"August 2022","description":"","img":{"alt":"Cropped shot of a pharmacist using a digital tablet in a chemist","src":"-/media/assets/gnp/images/gettyimages-1135377819_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/elevate-provider-network-fights-to-prohibit-ger-ber-and-dir-recoupments","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Elevate Provider Network fights to prohibit GER, BER, and DIR Recoupments"},"categories":["business performance","cash flow management","dir fees","financial management","good neighbor pharmacy","managed care","reimbursement"],"segments":[],"timestamp":637969481290000000,"title":"elevate provider network fights to prohibit ger, ber, and dir recoupments"},{"card":{"key":"7083fea3-75f4-4bb1-9f2d-4b1c5f4a9e9c","authorName":"Braheim Knight, RPh","authorCompany":"Good Neighbor Pharmacy","date":"August 2020","description":"Flu season is going to make a difficult situation even more complex, but independent pharmacies are up to the task. Having already risen to the challenges of the COVID-19 pandemic, your ability to adapt your business operations and offer new services at the drop of a hat are the keys to keeping your patients healthy through flu season.","img":{"alt":"A pharmacist giving a patient a flu shot","src":"-/media/assets/gnp/images/gnp-insights-helping-patients-navigate-flu-season-part-2.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/helping-patients-navigate-flu-season-while-contending-with-covid-19-part-2","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Helping Patients Navigate Flu Season While Contending with COVID-19, Part 2"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":637344993000000000,"title":"helping patients navigate flu season while contending with covid-19, part 2"},{"card":{"key":"846915a6-e29f-4565-bead-1c29718435e4","authorName":"Scott Welle","authorCompany":"AmerisourceBergen","date":"September 2019","description":"A well-prepared plan does more than make your case to secure pharmacy financing. It also better positions you to capitalize on changing market conditions throughout your pharmacy’s business lifecycle.","img":{"alt":"Two men with laptops writing a business plan together","src":"-/media/assets/gnp/images/gnp-insights-business-plan.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/business-plan","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"The Ins and Outs of an Independent Pharmacy Business Plan"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":637032844800000000,"title":"the ins and outs of an independent pharmacy business plan"},{"card":{"key":"240580cc-fea1-4fbc-a99d-8a2b63fd7998","authorName":"Good Neighbor Pharmacy","authorCompany":null,"date":"May 2020","description":"A successful partnership between a hospice agency and an independent community pharmacy optimizes care for enrolled patients while opening new pharmacy revenue streams.","img":{"alt":"A female nurse handing medication to a woman laying in a hospital bed","src":"-/media/assets/gnp/images/gnp-insights-pharmacy-hospice-connection.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/the-pharmacy-hospice-connection","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"The Pharmacy Hospice Connection: Delivering Care to the Patients Who Need It Most"},"categories":["managed care"],"segments":["pharmacies"],"timestamp":637263715800000000,"title":"the pharmacy hospice connection: delivering care to the patients who need it most"},{"card":{"key":"daeaaab1-ca23-4b36-87c8-f9077be13650","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2021","description":"In an industry that seems designed to lock the little guy out, Blue Sky Specialty Pharmacy is thriving. One thing we love about this small specialty pharmacy is the leadership team’s ability to think big, whether they’re confronting the challenges of today’s healthcare environment or preparing for tomorrow. For their partnership with AmerisourceBergen, that means the Blue Sky team is nimble and ready to get creative when it comes to trying new solutions and exploring new ideas together.","img":{"alt":"blue_sky","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/blue_sky.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/customer-spotlight-blue-sky-part-1","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Customer spotlight: Blue Sky Specialty Pharmacy, Part 1 "},"categories":["innovation","our role in healthcare","patient care","product access","specialty pharmacy","technology"],"segments":["pharmacies","manufacturers"],"timestamp":637590294000000000,"title":"customer spotlight: blue sky specialty pharmacy, part 1 "},{"card":{"key":"7d97cb38-5ce3-4abe-b4d2-6afea2a86a1b","authorName":"Jordan Cupo","authorCompany":"Good Neighbor Pharmacy","date":"April 2023","description":"Learn how independent pharmacies can benefit from consumers' online activity by advertising with the Google Shopping Network.","img":{"alt":"woman using smartphone on yellow couch","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/woman-using-smartphone-on-yellow-couch.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/getting-started-with-google-shopping","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Digital marketing for independent pharmacies: Getting started with Google Shopping "},"categories":["good neighbor pharmacy","community pharmacy","marketing","technology"],"segments":["pharmacies"],"timestamp":638162213790000000,"title":"digital marketing for independent pharmacies: getting started with google shopping "},{"card":{"key":"c44cdc04-cf15-4e83-823f-b4638e8aa995","authorName":"Mark Pilkington, MS, RPh; Robert Mosby, PharmD, JD, MBA","authorCompany":"AmerisourceBergen","date":"September 2022","description":"Local hospices and local pharmacies should join forces to enhance patient care. Pharmacy service managers can facilitate this and optimize operational processes that will further improve patient care, but not all pharmacy benefit managers offer processes that actually improve patient care. ","img":{"alt":"AB brand abstract swirls","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ab-brand-abstract-swirls.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/spread-pricing-for-hospice-prescription-drug-benefits","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Spread pricing for hospice prescription drug benefits: What you need to know"},"categories":["managed care","patient care"],"segments":["pharmacies"],"timestamp":638001578520000000,"title":"spread pricing for hospice prescription drug benefits: what you need to know"},{"card":{"key":"ed073efe-86bc-4914-ab5b-03ad63c0998b","authorName":"John Pross ","authorCompany":"AmerisourceBergen","date":"November 2019","description":"Great deals happen for good buyers. Here’s how to work through the pharmacy search process to capture an ideal opportunity.","img":{"alt":"Rooftop binoculars looking out over a city","src":"-/media/assets/gnp/images/gnp-insights-searching-for-a-pharmacy.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/where-to-start-when-searching-for-a-pharmacy-to-buy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Where to Start When Searching for a Pharmacy to Buy"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":637098387000000000,"title":"where to start when searching for a pharmacy to buy"},{"card":{"key":"849d4ea9-766f-4ffc-803f-b6347a59f2fa","authorName":"Ronnie Baggett, PharmD","authorCompany":"Baggett Pharmacy","date":"January 2023","description":"When the COVID-19 pandemic hit, Baggett Pharmacy recognized that point-of-care testing (POCT) would help the community during a turbulent time. Learn how the pharmacy implemented point-of-care testing and what it takes for your pharmacy to offer POCT.","img":{"alt":"COVID test","src":"-/media/assets/amerisourcebergen/insights/covid19/covid-test.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/why-poct","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Community pharmacy POV: Point-of-care testing"},"categories":["point of care testing","good neighbor pharmacy","community pharmacy","covid-19","patient care"],"segments":["pharmacies"],"timestamp":638086215690000000,"title":"community pharmacy pov: point-of-care testing"},{"card":{"key":"402b4c81-d5dd-431c-8e20-6232985db6ea","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2021","description":"In an industry that seems designed to lock the little guy out, Blue Sky Specialty Pharmacy is thriving. One thing we love about this small specialty pharmacy is the leadership team’s ability to think big, whether they’re confronting the challenges of today’s healthcare environment or preparing for tomorrow. For their partnership with AmerisourceBergen, that means the Blue Sky team is nimble and ready to get creative when it comes to trying new solutions and exploring new ideas together.","img":{"alt":"Blue Sky Thumbs Up Trans","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/blue-sky-thumbs-up-trans.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/customer-spotlight-blue-sky-part-2","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Customer spotlight: Blue Sky Specialty Pharmacy, Part 2"},"categories":["innovation","our role in healthcare","patient care","product access","specialty pharmacy","technology"],"segments":["pharmacies","manufacturers"],"timestamp":637590294000000000,"title":"customer spotlight: blue sky specialty pharmacy, part 2"},{"card":{"key":"9f2b612a-15fc-4942-a48a-6de3421547d1","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2018","description":"Access to experienced coaches who offer innovative ideas for solving pharmacy challenges is the hallmark of Good Neighbor Pharmacy business coaching. Learn about some of the expert guidance a few of our business coaches have provided pharmacies. ","img":{"alt":"IP_FrontStore_Pharm_ABCrep_003","src":"-/media/assets/amerisourcebergen/pharmacy/ip_frontstore_pharm_abcrep_003.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/insights-from-our-business-coaches","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Pharmacies","headline":"Expert Guidance: A Spotlight on Business Coaches"},"categories":["good neighbor pharmacy","pharmacy operations","in-store experience","pharmacy ownership","inventory management"],"segments":["pharmacies"],"timestamp":636510289120000000,"title":"expert guidance: a spotlight on business coaches"},{"card":{"key":"05cd4364-2321-4248-99a0-431af1b8f13b","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2022","description":"Why a PSAO should be dedicated to helping independent pharmacies thrive today, while actively advocating for their future.","img":{"alt":"GettyImages-1070962948_JPG","src":"-/media/assets/amerisourcebergen/pharmacy/gettyimages-1070962948_jpg.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/investing-in-independent-pharmacy","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Executive Q&A: Investing in independent pharmacy"},"categories":["advocacy","business performance","dir fees","good neighbor pharmacy","managed care","reimbursement"],"segments":["pharmacies"],"timestamp":637776044330000000,"title":"executive q&a: investing in independent pharmacy"},{"card":{"key":"e3bb15c7-da60-487e-a5ea-7321a995e8bd","authorName":"Carla Frehn; Jason Montgomery","authorCompany":"AmerisourceBergen ","date":"March 2021","description":"How should pharmacies prepare to administer the COVID-19 vaccine in their communities? Our Good Neighbor Pharmacy team shares tips for a safe and stress-free experience.","img":{"alt":"covid_car","src":"-/media/assets/amerisourcebergen/insights/covid_car.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/six-tips-for-pharmacies-administering-the-covid-19-vaccine","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Six tips for pharmacies administering the COVID-19 vaccine"},"categories":["good neighbor pharmacy","immunizations","covid-19","in-store experience","marketing","patient care","patient safety","pharmacy operations"],"segments":["pharmacies"],"timestamp":637510805900000000,"title":"six tips for pharmacies administering the covid-19 vaccine"},{"card":{"key":"f426beff-f5d9-4c56-bd59-728c52a4e6a0","authorName":"Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"January 2015","description":"An executive Q&A on how Medication Therapy Management can impact Star Ratings.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/star-ratings-mtm-and-independent-pharmacy","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Star Ratings, MTM and Independent Pharmacy"},"categories":["star ratings","medication therapy management"],"segments":["pharmacies"],"timestamp":635574478200000000,"title":"star ratings, mtm and independent pharmacy"},{"card":{"key":"9a98a510-37e6-46be-a9ad-24dee2443564","authorName":"Mark Pilkington, MS, RPh","authorCompany":"AmerisourceBergen","date":"May 2022","description":"How pharmacies can make medication disposal easy for their communities","img":{"alt":"How to properly dispose of medication","src":"-/media/assets/amerisourcebergen/pharmacy/pharmacy_backofstore.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-properly-dispose-of-medication","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to properly dispose of medication"},"categories":["pharmacy ownership","pharmacy operations"],"segments":["pharmacies"],"timestamp":637874220120000000,"title":"how to properly dispose of medication"},{"card":{"key":"975b4591-f713-4697-9dfb-2467e433d362","authorName":"Scott Welle","authorCompany":"AmerisourceBergen","date":"March 2020","description":"Independent pharmacy owners who sell their store for a premium—at the ideal time and on their own terms—are the ones who measure and monitor the health of their business on an ongoing basis and take corrective action where warranted before making a final decision to divest.","img":{"alt":"The months of a calendar blowing in the wind","src":"-/media/assets/gnp/images/gnp-insights-when-is-the-right-time-to-sell-my-pharmacy.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/when-is-the-right-time-to-sell-my-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"When Is the Right Time to Sell My Pharmacy?"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":637203033600000000,"title":"when is the right time to sell my pharmacy?"},{"card":{"key":"8a6e4f7e-f4f7-43ec-97e0-a0a752973de0","authorName":" Phyllis Houston, MSOL ; Gold Eneyo, PharmD","authorCompany":"AmerisourceBergen","date":"March 2022","description":"Offering patient care services can increase your pharmacy's revenue stream and improve your community's health. Here's how to get started.","img":{"alt":"female pharmacist with elderly female patient","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/female-pharmacist-with-elderly-female-patient.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/using-unique-patient-care-services-to-drive-traffic-and-outcomes","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Using unique patient care services to drive traffic and outcomes"},"categories":["covid-19","good neighbor pharmacy","immunizations","in-store experience","packaging","patient care"],"segments":["pharmacies"],"timestamp":637829683450000000,"title":"using unique patient care services to drive traffic and outcomes"},{"card":{"key":"3bfa83be-96cb-4b5e-8743-cbde9ba04ce8","authorName":"Amanda Riedell","authorCompany":"","date":"June 2022","description":"The SUPPORT for Patients and Communities Act, passed in 2018 to help combat the nationwide opioid crisis, originally mandated that Medicare Part D prescribers use electronic prescribing for controlled substances (EPCS) technology by Jan. 1 ,2021. ","img":{"alt":"WorldCourier_2_3 Card-05-min","src":"-/media/assets/worldcourier/english/images/worldcourier_2_3-card-05-min.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/e-prescribing-ramps-up-through-federal-and-state-mandates","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"E-prescribing ramps up through federal and state mandates"},"categories":["pharmacy operations","pharmacy ownership","patient care"],"segments":["pharmacies"],"timestamp":637920100190000000,"title":"e-prescribing ramps up through federal and state mandates"},{"card":{"key":"15bb7713-2d53-4a3a-a332-a02bebe72f10","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2022","description":"Partnership spotlight: How OrderInsite and AmerisourceBergen are making inventory management easier for pharmacies","img":{"alt":"Pharmacist stocking bottles","src":"-/media/assets/amerisourcebergen/pharmacy/ip_backstore_pharm_stock_bottles_002.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/making-inventory-management-easier-for-pharmacies","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Partnership spotlight: How OrderInsite and AmerisourceBergen are making inventory management easier for pharmacies"},"categories":[],"segments":["pharmacies"],"timestamp":637876842000000000,"title":"partnership spotlight: how orderinsite and amerisourcebergen are making inventory management easier for pharmacies"},{"card":{"key":"8b7efb49-a57c-436d-bfcd-a6269a67ceae","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2020","description":"Long-term care (LTC) pharmacies have not only been on the front lines of the COVID-19 pandemic, but they're also finding ways to thrive. Liberty Drug in Murray, Utah, is just one example. Owner Jenna Merchant shares how the store opened in the midst of the pandemic and has managed to grow faster than they ever expected.","img":{"alt":"LD1","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/libertydrug/ld1.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/ltc-customer-spotlight-liberty-drug","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"LTC customer spotlight: Liberty Drug"},"categories":["long term care"],"segments":["pharmacies"],"timestamp":637340691700000000,"title":"ltc customer spotlight: liberty drug"},{"card":{"key":"d12bd907-f3ea-4cb6-aff9-113f3a634535","authorName":"Adelina Ardelean","authorCompany":"Good Neighbor Pharmacy","date":"August 2020","description":"Flu season always has a tendency to make patients feel confused and concerned, but the coronavirus is casting an even darker shadow on the months ahead. Although keeping patients healthy through flu season this year will be challenging, you have a unique chance to educate your community, deliver convenient flu shots and develop deeper relationships with your patients that will long outlast the COVID-19 pandemic.","img":{"alt":"A woman wearing a face mask reading a text message from her pharmacist on her phone","src":"-/media/assets/gnp/images/gnp-insights-helping-patients-navigate-flu-season-part-1.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/helping-patients-navigate-flu-season-while-contending-with-covid-19-part-1","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Helping Patients Navigate Flu Season While Contending with COVID-19, Part 1"},"categories":["marketing"],"segments":["pharmacies"],"timestamp":637344957000000000,"title":"helping patients navigate flu season while contending with covid-19, part 1"},{"card":{"key":"0456511c-eae6-49b5-bfaf-1117766564a8","authorName":"Charlie Le Bon","authorCompany":"AmerisourceBergen","date":"September 2017","description":"How strong is your community pharmacy’s financial picture?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-community-pharmacy-owners-can-avoid-serious-financial-mistakes","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Avoidable Financial Mistakes: A Must Read for Community Pharmacy Owners"},"categories":["financial management","pharmacy operations"],"segments":["pharmacies"],"timestamp":636409186800000000,"title":"avoidable financial mistakes: a must read for community pharmacy owners"},{"card":{"key":"e09b4727-98c3-4fab-bc6f-80effd07245c","authorName":"Curtis Ernst, RPh","authorCompany":"Good Neighbor Pharmacy","date":"April 2020","description":"Properly developing your pharmacy staff is the secret to enhancing patient experience and improving health outcomes, as it empowers them to be proactive while freeing up pharmacists to practice at the top of their license.","img":{"alt":"A customer laughing joyfully as a pharmacist helps her find the medication she needs","src":"-/media/assets/gnp/images/gnp-insights-patient-satisfaction.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/patient-satisfaction-starts-with-your-staff","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Patient Satisfaction Starts with Your Staff"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":637236814200000000,"title":"patient satisfaction starts with your staff"},{"card":{"key":"3a412867-1c92-427f-908d-fba13c57b727","authorName":"Phyllis Houston, MSOL","authorCompany":"AmerisourceBergen","date":"January 2020","description":"Independent community pharmacies remain essential to adherence because they see patients so frequently and have a unique ability to influence outcomes.","img":{"alt":"A pharmacist ringing up a prescription at a cash register","src":"-/media/assets/gnp/images/gnp-insights-star-ratings.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/what-star-ratings-really-mean-to-your-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"What Star Ratings Really Mean to Your Pharmacy"},"categories":["business performance"],"segments":["pharmacies"],"timestamp":637139211000000000,"title":"what star ratings really mean to your pharmacy"},{"card":{"key":"e01b4e88-e1c1-4ff9-8902-aa2dbe81918b","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2021","description":"As a pharmacy owner, are you struggling with which parts of your 340B pharmacy services agreement (PSA) to negotiate and/or exclude? You’re not alone. PSAs can vary by both 340B covered entity and third-party administrator (TPA) capabilities, but looking at five key areas can help you navigate your PSA with ease and negotiate the best terms for your pharmacy. ","img":{"alt":"GettyImages-1135377678_RGB_Large_JPG","src":"-/media/assets/amerisourcebergen/pharmacy/gettyimages-1135377678_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/understanding-your-340b-contract-pharmacy-agreement","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Understanding your 340B contract pharmacy agreement: Five areas worth negotiating"},"categories":["340b","pharmacy operations"],"segments":["pharmacies"],"timestamp":637659505960000000,"title":"understanding your 340b contract pharmacy agreement: five areas worth negotiating"},{"card":{"key":"0635f42f-7350-467c-a49a-de7bb98077bc","authorName":"Andy Clarey","authorCompany":"AmerisourceBergen","date":"February 2020","description":"Shoppers should never come to a screeching halt before they get to the checkout counter. By maintaining and nurturing your front end, you can keep customers moving along, enhance the overall patient experience and position your pharmacy as the go-to resource for health and wellness in your community.","img":{"alt":"A yellow and black striped speed bump on asphalt","src":"-/media/assets/gnp/images/gnp-insights-smoothing-out-the-speedbumps.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/smoothing-out-speed-bumps-in-your-pharmacy-front-end","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Smoothing Out Speed Bumps in Your Pharmacy Front End"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":637164895800000000,"title":"smoothing out speed bumps in your pharmacy front end"},{"card":{"key":"57f8a759-6b27-4e1a-9d1c-47f3291de717","authorName":"Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"","description":"Does your PSAO prioritize you (and not just prescription volume)? How can you tell? Learn the three priorities of the right partner.","img":{"alt":"Pharmacist examining a pill bottle behind the pharmacy counter","src":"-/media/assets/gnp/images/gnp-elevate-pha.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-the-right-psao-protects-patient-access-and-pharmacy-viability","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How the right PSAO protects patient access and pharmacy viability"},"categories":["advocacy","business performance","cash flow management","dir fees","good neighbor pharmacy","managed care","our role in healthcare","product access"],"segments":["pharmacies"],"timestamp":0,"title":"how the right psao protects patient access and pharmacy viability"},{"card":{"key":"769f327f-78e2-4d45-8d5d-52d0e898f8b6","authorName":"Bill LaRose, RPh","authorCompany":"AmerisourceBergen","date":"June 2019","description":"Although there's no standard formula you can use when it comes to determining the value of an independent pharmacy, there are several guidelines you can follow that will help you narrow down an accurate opinion of the pharmacy’s worth.","img":{"alt":"Marking up financial documents with calculations while conducting a pharmacy valuation","src":"-/media/assets/gnp/images/gnp-insights-realistic-valuation.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/what-goes-into-a-realistic-pharmacy-valuation","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"What Goes into a Realistic Pharmacy Valuation?"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":636970663200000000,"title":"what goes into a realistic pharmacy valuation?"},{"card":{"key":"faa01a65-f954-4716-9ec8-2bbeb45ba2a7","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2018","description":"The decision to purchase a pharmacy is a big one. Once that decision is made, there are a few key steps to finding the right pharmacy and closing a deal. ","img":{"alt":"Pharmacy Counter Consult","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pharmacycounterconsultrep1116053.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/ready-to-buy","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Pharmacies","headline":"Ready to Buy? How to Find Your First Pharmacy "},"categories":["pharmacy ownership","pharmacy ownership","financial management","pharmacy operations"],"segments":["pharmacies"],"timestamp":636603670240000000,"title":"ready to buy? how to find your first pharmacy "},{"card":{"key":"eabd1e2d-a504-44c4-b981-db78dffdbbae","authorName":"Don Via","authorCompany":"Good Neighbor Pharmacy","date":"June 2020","description":"While there's no magic formula for finding the appropriate pharmacy staffing levels, there are subtle shifts you can make that will have a big impact on your bottom line.","img":{"alt":"Two pharmacists filling prescriptions in a pharmacy","src":"-/media/assets/gnp/images/gnp-insights-changes-you-can-make-to-your-staffing.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/three-small-staffing-changes-that-can-boost-your-pharmacys-profits","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Three Small Staffing Changes That Can Boost Your Pharmacy's Profits"},"categories":["business performance"],"segments":["pharmacies"],"timestamp":637291344000000000,"title":"three small staffing changes that can boost your pharmacy's profits"},{"card":{"key":"c92e0926-996d-4681-bb80-10975d5f57f2","authorName":"Kelley De La Fuente","authorCompany":"Good Neighbor Pharmacy","date":"June 2019","description":"Differentiation, supported by in-store branding and staff expertise, helps independent pharmacies pave a path toward long-term profitability.","img":{"alt":"A pharmacist educating a patient on vitamin supplements","src":"-/media/assets/gnp/images/gnp-insights-how-to-construct-a-one-of-a-kind-front-end-shopping-experience.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/one-of-a-kind-front-end-shopping-experience","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to Construct a One-of-a-Kind Front-End Shopping Experience"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":636960187200000000,"title":"how to construct a one-of-a-kind front-end shopping experience"},{"card":{"key":"2d3ab1f3-7d4f-4b46-9c2b-ebf5e4cb20f4","authorName":" Phyllis Houston, MSOL ","authorCompany":"AmerisourceBergen","date":"April 2019","description":"Pharmacists can build stronger patient relationships, increase medication adherence and build lasting brand loyalty by initiating routine phone calls to share information. Done well, an automated outbound communication system can send messages on behalf of the pharmacist in a personal and authentic way. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/three-easily-avoidable-mistakes-pharmacists-make-when-communicating-with-patients","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Three Easily Avoidable Mistakes Pharmacists Make When Communicating with Patients"},"categories":["marketing","good neighbor pharmacy","pharmacy operations","medication adherence"],"segments":["pharmacies"],"timestamp":636897434570000000,"title":"three easily avoidable mistakes pharmacists make when communicating with patients"},{"card":{"key":"2426422e-42da-408f-bf24-6de8c75d6e5b","authorName":"Good Neighbor Pharmacy","authorCompany":null,"date":"October 2022","description":"Among the 300,000 actively practicing U.S. pharmacists, more than 65% are female.","img":{"alt":"female pharmacist with elderly female patient","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/female-pharmacist-with-elderly-female-patient.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/women-gain-ground-at-pharmacys-forefront","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Women gain ground at pharmacy's forefront"},"categories":["good neighbor pharmacy","our role in healthcare","business performance","patient care","pharmacy ownership"],"segments":["pharmacies"],"timestamp":638017107050000000,"title":"women gain ground at pharmacy's forefront"},{"card":{"key":"916937fb-89c8-4389-a13f-a84dea320a9d","authorName":"Carla Frehn","authorCompany":"AmerisourceBergen ","date":"September 2019","description":"Is it time to evolve your advertising strategy? Find out how traditional advertising stacks up against targeted digital marketing as we explore the effectiveness and cost of broadcast against digital.","img":{"alt":"Infographic comparing targeted digital advertising to traditional broadcast advertising","src":"-/media/assets/gnp/images/gnp-insights-advertising-effectiveness.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/advertising-effectiveness","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Advertising Effectiveness: Targeted Digital vs. Traditional Broadcast"},"categories":["marketing"],"segments":["pharmacies"],"timestamp":637054496400000000,"title":"advertising effectiveness: targeted digital vs. traditional broadcast"},{"card":{"key":"e05e2db8-a8dd-4a28-8dbd-1452121535e1","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2023","description":"The 340B program is becoming easier to navigate for contract pharmacies. Learn how the process works.","img":{"alt":"Pharmacist stocking bottles","src":"-/media/assets/amerisourcebergen/pharmacy/ip_backstore_pharm_stock_bottles_007.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-are-retail-prescriptions-captured-into-the-340b-program","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How are retail prescriptions captured into the 340B program?"},"categories":["340b","distribution","inventory management","pharmacy operations"],"segments":["pharmacies"],"timestamp":638086258080000000,"title":"how are retail prescriptions captured into the 340b program?"},{"card":{"key":"41fa84a4-6a21-4413-bbc4-36f4fad641bc","authorName":"Cathy Humphrey","authorCompany":"Good Neighbor Pharmacy","date":"March 2020","description":"By consistently engaging with local families, you’ll multiply the number of patients under your care and ways to profitably meet their needs.","img":{"alt":"Two pharmacists help a mother and her daughter","src":"-/media/assets/gnp/images/gnp-insights-attracting-families.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/attracting-families-to-your-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Attracting Families to Your Pharmacy: How to Wow Parents While Wooing Their Little Ones"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":637191122400000000,"title":"attracting families to your pharmacy: how to wow parents while wooing their little ones"},{"card":{"key":"602e5f39-da4b-4dff-aef0-ff7aa58c6bd4","authorName":"Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"January 2018","description":"Learn how immunizations present an opportunity for additional pharmacy revenue and enhanced patient care.","img":{"alt":"shutterstock_572712955","src":"-/media/assets/amerisourcebergen/pharmacy/shutterstock_572712955.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/diversification-through-immunization","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Pharmacies","headline":"Diversification through Immunization"},"categories":["immunizations"],"segments":["pharmacies"],"timestamp":636519050310000000,"title":"diversification through immunization"},{"card":{"key":"a967e47b-3914-4260-9b6a-b2ef1e5f5e8a","authorName":"Mark Ciarlone, PharmD; Kelley De La Fuente; Don Via","authorCompany":"Good Neighbor Pharmacy","date":"June 2021","description":"Good Neighbor Pharmacy business coaches share real-world ways of making care more accessible and overcoming health disparities at the pharmacy.","img":{"alt":"latino women smiling and laughing in mural alley","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/latino-women-smiling-and-laughing-in-mural-alley.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/health-equity-making-personalized-care-accessible-to-minority-groups","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Health equity: Making personalized care accessible to minority groups"},"categories":["covid-19","good neighbor pharmacy","health equity","immunizations","in-store experience","patient care"],"segments":["pharmacies"],"timestamp":637598907290000000,"title":"health equity: making personalized care accessible to minority groups"},{"card":{"key":"4ab4094c-f977-4991-8c3d-ae9c3cdf08ca","authorName":"Mark Pilkington, MS, RPh","authorCompany":"AmerisourceBergen","date":"April 2021","description":"Independent pharmacies may find themselves at a disadvantage when competing against PBMs for hospice business. Learn how a partner like Hospice Pharmacy Connect can put independents on a level playing field.","img":{"alt":"pharmacist female pulling product","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pharmacist-female-pulling-product.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/why-your-direct-hospice-business-might-not-withstand-pbm-poaching","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Why your pharmacy's direct hospice business might not withstand PBM poaching"},"categories":["marketing","patient care","pharmacy operations"],"segments":["pharmacies"],"timestamp":637548061430000000,"title":"why your pharmacy's direct hospice business might not withstand pbm poaching"},{"card":{"key":"7f7408f1-4301-4417-bd15-ea5608ecff11","authorName":"Tanya Mericle; John Duffy","authorCompany":"AmerisourceBergen","date":"March 2022","description":"Learn how pharmacies can adapt their front end to meet the needs of patients.","img":{"alt":"pharmacy_curbside","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pharmacy_curbside.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-create-a-more-community-driven-pharmacy-front-end","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to create a more community-driven pharmacy front end"},"categories":["business performance","covid-19","data","good neighbor pharmacy","in-store experience","marketing"],"segments":["pharmacies"],"timestamp":637823606450000000,"title":"how to create a more community-driven pharmacy front end"},{"card":{"key":"9a44fa8c-5c70-486c-a05c-d3b600bdfdfb","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2018","description":"The Good Neighbor Pharmacy of the Year Award recognizes a pharmacy that exemplifies what it means to be a pillar in their community. Beyond filling prescriptions, they display excellence in patient care, community outreach and innovative pharmacy practice.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/best-practices-from-our-2018-good-neighbor-pharmacy-of-the-year-award-nominees","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Best Practices From our 2018 Good Neighbor Pharmacy of the Year Award Nominees"},"categories":["good neighbor pharmacy"],"segments":["pharmacies"],"timestamp":636664863980000000,"title":"best practices from our 2018 good neighbor pharmacy of the year award nominees"},{"card":{"key":"6aab6ed2-8e1e-4889-9401-ee4179eb75fa","authorName":"MWI Animal Health","authorCompany":"","date":"June 2022","description":"Aligning on single-source vendors like MWI Office Supply with the associated price savings benefits practices. ","img":{"alt":"business planning couple","src":"-/media/assets/mwianimalhealth/images/insights-images/business-planning-couple.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/animal-health/how-destination-pet-redefined-practice-autonomy","linkText":"Read the case study","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How Destination Pet redefined practice autonomy for its financial benefit"},"categories":["veterinary practices","distribution","inventory management"],"segments":["animal health"],"timestamp":637913691520000000,"title":"how destination pet redefined practice autonomy for its financial benefit"},{"card":{"key":"25b6add5-0910-4614-b24f-eb1cdab2079e","authorName":"Mike Sweeney; Kim McLeod, MPH","authorCompany":"World Courier","date":"September 2020","description":"Executive Q&A: COVID-19 has made more and more trial and provider sites inaccessible. How can manufacturers and trial sponsors adapt?","img":{"alt":"insights CTA DtP image","src":"-/media/assets/worldcourier/english/images/direct-to-patient/patients/insights-cta-dtp-image.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/is-a-contact-free-clinical-trial-possible","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Is a contact-free clinical trial possible?"},"categories":["clinical trial logistics","direct-to-patient","market access"],"segments":["manufacturers"],"timestamp":637365668170000000,"title":"is a contact-free clinical trial possible?"},{"card":{"key":"4cc160ac-b318-4f5f-9eb4-8f9f83a0fcc6","authorName":"Innomar Strategies","authorCompany":null,"date":"April 2021","description":"Now more than ever, Canadian payers and regulators find value in outcomes-based evidence beyond randomized controlled trials in regulatory and reimbursement decision-making. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-value-of-rwe-in-canadian-drug-commercialization-part-2","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"The Value of Real-World Evidence in Canadian Drug Commercialization: Part 2"},"categories":["market access","regulatory","commercialization","data"],"segments":["manufacturers"],"timestamp":637533936000000000,"title":"the value of real-world evidence in canadian drug commercialization: part 2"},{"card":{"key":"9793c2b6-391c-4f28-bd66-dbd7ab0211aa","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2018","description":"","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-road-to-commercialization-in-canada","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Insight","headline":"Infographic: The Road to Commercialization in Canada"},"categories":["commercialization","market access","third party logistics","legislation"],"segments":[],"timestamp":636608804290000000,"title":"infographic: the road to commercialization in canada"},{"card":{"key":"40ee2b9c-96a9-4063-a931-71fc25067e63","authorName":"AmerisourceBergen","authorCompany":"","date":"September 2022","description":"Amid an evolving policy landscape, legacy copay programs need a reimagined approach. By incorporating financial wellness platforms into patient support services, biopharma companies can ready their programs for the uncertainty to come.","img":{"alt":"fv-ab-webheader10","src":"-/media/assets/firstview/images/proxe360-platform/fv-ab-webheader10.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/maintain-an-agile-copay-program-in-a-changing-policy-environment","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Maintain an agile copay program in a changing policy environment"},"categories":["affordability","legislation","reimbursement"],"segments":["manufacturers"],"timestamp":637993637990000000,"title":"maintain an agile copay program in a changing policy environment"},{"card":{"key":"cd5bb042-84f2-4580-b4e9-aaa4e9b9c0f1","authorName":"Rita Norton","authorCompany":"","date":"March 2022","description":"Developments in potential reform for DIR fees, the pending Medicaid copay assistance benefit rule, and the effects of white bagging legislation. ","img":{"alt":"doctor at computer","src":"-/media/assets/besse/images/general/doctor-financial.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/government-affairs-q-and-a-with-rita-norton","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Q&A: Legislative updates and healthcare advocacy report"},"categories":["practice management","regulatory","advocacy"],"segments":["physician practices"],"timestamp":637824408200000000,"title":"q&a: legislative updates and healthcare advocacy report"},{"card":{"key":"a8105a53-2162-4565-a842-39daecf821da","authorName":"Innomar Strategies","authorCompany":null,"date":"August 2021","description":"","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/digital-innovation-in-patient-support","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Digital innovation in patient support"},"categories":["commercialization","patient support services","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637636953850000000,"title":"digital innovation in patient support"},{"card":{"key":"ac0f0fd0-fcda-4191-9891-ab40f4625679","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2023","description":"","img":{"alt":"Pharma Europe QA","src":"-/media/assets/amerisourcebergen/manufacturer/pharma-europe-qa.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharma-europe-qa","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pharma Europe Q&A"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638247705800000000,"title":"pharma europe q&a"},{"card":{"key":"029e27da-cd83-41d3-b846-d72ebd8c45f8","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2022","description":"","img":{"alt":"GPOconnect","src":"-/media/assets/amerisourcebergen/manufacturer/gpoconnect.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/how-to-reach-customers-and-cut-through-the-noise-pdf","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How to reach customers in the new world of work"},"categories":["commercialization","marketing","data"],"segments":["manufacturers"],"timestamp":637910083200000000,"title":"how to reach customers in the new world of work"},{"card":{"key":"f42cdb83-d305-43bc-85b2-564ba490ade0","authorName":"Lash Group","authorCompany":null,"date":"November 2020","description":"Why is incorporating pharmacy benefits into eBV essential? As technology continues to advance with automation, new opportunities emerge to deliver more detail for real-time pharmacy benefits.","img":{"alt":"provider at computer from back","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/provider-at-computer-from-back.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/speeding-access-to-therapy-with-pharmacy-ebv","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Speeding access to therapy with pharmacy eBV"},"categories":["affordability","patient support services","product access"],"segments":["manufacturers"],"timestamp":637399312010000000,"title":"speeding access to therapy with pharmacy ebv"},{"card":{"key":"422c04b9-bd39-4344-9665-4bb0a305a0c6","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2023","description":"","img":{"alt":"Partnership on CGTs","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/partnership-on-cgts.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/increasing-advanced-therapies-connectivity-and-speed-to-market-through-partnership","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Interview: Increasing advanced therapies’ connectivity and speed to market through partnership"},"categories":["cell and gene therapy","commercialization"],"segments":["manufacturers"],"timestamp":638113779520000000,"title":"interview: increasing advanced therapies’ connectivity and speed to market through partnership"},{"card":{"key":"0ed7a339-a439-41aa-983a-a4b78df9b53f","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"May 2023","description":"","img":{"alt":"","src":"-/media/assets/worldcourier/english/images/article-images/shutterstock_2181846889-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/ensuring-a-patients-cell-and-gene-therapy-goes-the-distance-with-perfect-last-mile-logistics","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Nagaraj's hope restored: Perfecting multistep logistics of delicate cell therapy for a rare cancer"},"categories":[],"segments":[],"timestamp":638205732000000000,"title":"nagaraj's hope restored: perfecting multistep logistics of delicate cell therapy for a rare cancer"},{"card":{"key":"ed322e44-2856-404d-a2b9-fb5cd9879c00","authorName":"Laurie Fazio","authorCompany":"Xcenda","date":"May 2021","description":"Laurie Fazio, Head of FormularyDecisions Market Access Solutions & Growth Strategies at Xcenda, covers why the information exchange platform is worth a pharmaceutical manufacture's investment of time and resources.","img":{"alt":"abstract-blues-tech","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/abstract-blues-tech.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/work-worth-doing-formularydecisions","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Work worth doing: FormularyDecisions"},"categories":["commercialization","covid-19","data","innovation","market access","reimbursement","technology"],"segments":["manufacturers"],"timestamp":637577372200000000,"title":"work worth doing: formularydecisions"},{"card":{"key":"25ca12f5-f70b-47e3-8a7d-a4f68b9b9109","authorName":"Lash Group","authorCompany":null,"date":"September 2020","description":"The launch of a novel therapy can be simultaneously exciting and challenging. By following a phased approach, manufacturers can ensure their patient support program positions their therapy to improve outcomes for patients.","img":{"alt":"Man working on a laptop computer","src":"-/media/assets/xcenda/english/images/formularydecisions/formularydecisions-hero-3840x2194.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/essential-guide-launching-patient-support-for-a-novel-therapy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Patient support launch guide: novel therapies "},"categories":["market access","marketing","medication adherence","patient support services","product access"],"segments":[],"timestamp":637362869400000000,"title":"patient support launch guide: novel therapies "},{"card":{"key":"883ead32-384c-4ae4-9984-699a269da7ea","authorName":"Lash Group","authorCompany":null,"date":"December 2020","description":"Entering a crowded marketplace with a new therapy comes with challenges, but manufacturers can find success with the right patient support program launch plan. Learn how to outperform competitive products and deliver value from day one with this essential guide from Lash Group.","img":{"alt":"FormularyDecisions-body1-504x504x2","src":"-/media/assets/xcenda/english/images/formularydecisions/formularydecisions-body1-504x504x2.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/patient-support-launch-guide-competitive-markets","linkText":"Get the guide","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Patient support launch guide: competitive markets"},"categories":["medication adherence","patient support services","product access"],"segments":["manufacturers"],"timestamp":637439180400000000,"title":"patient support launch guide: competitive markets"},{"card":{"key":"7f93e0e0-a159-4e5f-9282-f9992a9c40a4","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2023","description":"","img":{"alt":"biopharmadive playbook","src":"-/media/assets/amerisourcebergen/insights/gettyimages-1323704378-rt-rgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/improving-access-and-support-for-cell-and-gene-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Improving Access and Support for Cell and Gene Therapies"},"categories":["cell and gene therapy","patient support services"],"segments":["manufacturers"],"timestamp":638212478550000000,"title":"improving access and support for cell and gene therapies"},{"card":{"key":"a6d44136-c1eb-4c5a-8fad-ff9c5ed8da94","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2024","description":"","img":{"alt":"Market access","src":"-/media/assets/innomarstrategies/services/regulatory-services/marketaccess.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/a-game-changer-for-pharma-to-accelerate-patient-access","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Value-Based Healthcare (VBHC): A game changer for pharma to accelerate patient access"},"categories":["consulting"],"segments":["manufacturers"],"timestamp":638560617900000000,"title":"value-based healthcare (vbhc): a game changer for pharma to accelerate patient access"},{"card":{"key":"868541b1-9856-48c8-bb43-db5563ecca7a","authorName":"Victoria Loo, MPH; Scott Shields, MBA","authorCompany":"Cencora","date":"November 2023","description":"In 2005, the Centers for Medicare and Medicaid Services introduced the Coverage with Evidence Development (CED) paradigm that requires Medicare patients to enroll in a CMS-approved CED clinical study as a condition of coverage for that product or service. Although CED has never been explicitly authorized by Congress, over the years, CED has been employed 27 times across 8 therapeutic areas, with 20 remaining CED policies in place for over 15 years, and with little indication from CMS on the conclusion of its CED data-collection progression.","img":{"alt":"Cost and Resource Burden","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/cost-and-resource-burden.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/cost-and-resource-burden-of-coverage-with-evidence-development","linkText":"Download paper","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Cost and resource burden of coverage with evidence development"},"categories":["affordability","policy","consulting"],"segments":["manufacturers"],"timestamp":638357643380000000,"title":"cost and resource burden of coverage with evidence development"},{"card":{"key":"48d6d622-43e9-4249-b149-22efc899d4db","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2022","description":"Experts from AmerisourceBergen and TrakCel recently participated in a webinar on commercial supply chain strategies for cell and gene therapies. In this webinar recap, you'll get highlights from the conversation and fast facts on optimizing the commercial supply chain. Think of it like Cliff's Notes for important ideas in the CGT space.","img":{"alt":"Cell and gene therapy cryo storage","src":"-/media/assets/amerisourcebergen/manufacturer/ics_brooks_3pl_ultra_low_freezer_063_rgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-optimize-the-commercial-supply-chain-for-cell-and-gene-therapies","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How to optimize the commercial supply chain for cell and gene therapies"},"categories":["cell and gene therapy","commercial supply chain","commercialization"],"segments":["manufacturers"],"timestamp":637783705190000000,"title":"how to optimize the commercial supply chain for cell and gene therapies"},{"card":{"key":"e7a55c02-0e86-4193-ab72-62519f75d264","authorName":"Xcenda","authorCompany":null,"date":"October 2022","description":"Your brand story is one that sets your patient assistance program apart and benefits patients

","img":{"alt":"a young woman looks at a computer while at home","src":"-/media/assets/xcenda/english/images/insights/women-at-home-computer.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-difference-between-good-and-great-patient-assistance-programs","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Branding: The difference between good and great patient assistance programs"},"categories":["patient support services","product access","advocacy"],"segments":["manufacturers"],"timestamp":638028282000000000,"title":"branding: the difference between good and great patient assistance programs"},{"card":{"key":"312f7ef6-7dd0-44ab-b079-c8eb0b8ed3f0","authorName":"Andrea Zobel","authorCompany":"World Courier","date":"October 2024","description":"To support the growth of the advanced therapy industry and enable more patients than ever before to be treated with these life-changing therapies, World Courier has created a worldwide network of over 100 LN2 charging stations.","img":{"alt":"CGT cells","src":"-/media/assets/worldcourier/english/images/cell-and-gene/cgt-cells.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/our-global-advanced-therapy-charging-stations","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Our global advanced therapy medical product charging stations"},"categories":["cell and gene therapy","clinical trial logistics","temperature control solutions"],"segments":[],"timestamp":638659296000000000,"title":"our global advanced therapy medical product charging stations"},{"card":{"key":"05534471-4cd1-4618-82ee-f1bac9520b80","authorName":"World Courier","authorCompany":"","date":"October 2024","description":"Explore the dynamic landscape of cell and gene therapies (CGTs), critical for therapeutic success in drug development and distribution.","img":{"alt":"","src":"-/media/assets/worldcourier/english/images/cell-and-gene/shutterstock_1873353655.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/exploring-the-landscape-modalities-and-logistics-of-cell-and-gene-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Exploring cell and gene therapy logistics and modalities"},"categories":["cell and gene therapy"],"segments":[],"timestamp":638659314000000000,"title":"exploring cell and gene therapy logistics and modalities"},{"card":{"key":"eeeb438b-caa9-45d0-9812-00a8aa931a1e","authorName":"Xcenda","authorCompany":null,"date":"May 2023","description":"Is artificial intelligence (AI) set to take over the world? In this article, we reflect on an interview we conducted with one of the current AI tools, in which we explored its “knowledge” of and potential role in health technology assessment (HTA).","img":{"alt":"HTAQ AI File 1","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-ai-file-1.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-summer-2023-ai-and-hta","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Reflections on an interview with a ghost "},"categories":[],"segments":[],"timestamp":638185384200000000,"title":"reflections on an interview with a ghost "},{"card":{"key":"fc60944d-23de-4d5e-837d-981f62e7adbb","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2024","description":"Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options. To date, there have been 41 approvals and 30 launches in the U.S. biosimilar market.biosimilar market. As this market matures, its pipeline continues to grow. This reference guide is a useful tool for visualizing the current product landscape and potential future of this emerging market.","img":{"alt":"Biosimilar_2020_Pipeline","src":"-/media/assets/worldcourier/english/images/worldcourier_2_3-card-05-min.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilar-pipeline-report","linkText":"Download report","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Biosimilars pipeline report: A guide for understanding the growing market"},"categories":["biosimilars","our role in healthcare"],"segments":["manufacturers"],"timestamp":638660647800000000,"title":"biosimilars pipeline report: a guide for understanding the growing market"}]